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NUMEROUS ORIGINALS
IN COLOUR
A b s t r a c t
The mycobacterial cell envelope is a complex structure the components of which have been 
implicated in the survival, virulence, permeability and resistance to antibiotics of 
Mycobacterium. The elucidation of the synthesis o f the cell envelope would improve the 
understanding of the structure and its influential properties and could lead to the identification 
of drug target sites. The isolation of genes encoding proteins involved in the biosynthesis of 
the cell envelope structures and their mutants would enable the biosynthetic pathways and 
functions of individual structures to be determined.
The objective of this project was to isolate genes encoding cell envelope structures in 
Mycobacterium leprae, using Mycobacterium smegmatis as model organism. The aim was 
to isolate an M. smegmatis strain with a mutant cell envelope and to complement the mutation 
using a genomic library of M. leprae.
M. smegmatis mc2155 was successfully mutagenised using /V-methyl-N-Nitro-fV- 
nitrosoguanidine (NTG), generating 0.1-0.2% auxotrophic mutants. A bank of 2,000 NTG- 
treated M. smegmatis strains were screened for alterations in phenotypes that may have 
reflected a change in the cell envelope i.e. mycobacteriophage resistance, temperature 
sensitivity and increased resistance and sensitivity to antibiotics. M. smegmatis strains with 
increased resistance to ofloxacin and ciprofloxacin (15) were isolated along with strains more 
sensitive to penicillin G(5) and pyrazinamide (1).
The pyrazinamide sensitive mutant, Pyramidll was further characterised and found to be 20% 
more sensitive to pyrazinamide than the M. smegmatis mc2155 wild type strain. Pyramidll was 
found to be less hydrophobic than the wild type strain, variably more sensitive to penicillin G 
and to exhibit a smooth colony morphology. The cell wall components of Pyramid II were 
analysed but no gross differences were observed in comparison to the wild type M. smegmatis 
strain. Pyramidll is believed to contain a mutation effecting its permeability to pyrazinamide.
Pyramidll was transformed with an M. leprae genomic pYUB18 shuttle vector library and 
complementing clones isolated (6%). A complementing cosmid, 57, found to map to cosmid 
B1308 in the ordered M. leprae library, was used to create a sub-library in pMV206 from 
which a 3.5kb fragment of complementing M. leprae DNA was isolated and found to contain 
three complete putative coding regions, possibly involved in osmoregulation.
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Chapter 1
Introduction
1.1 The mycobacteria
The mycobacteria are actinomycètes and are closely related to Nocardia, Corynebacterium 
and Rhodococcus. They are Gram-positive, aerobic, rod-shaped organisms, identified by their 
acid-fastness, whose genomes are 2-5x10*03 in size with a G+C content o f 58-69% (Clark- 
Curtiss, 1990). The majority of mycobacteria are saprophytic soil dwelling bacteria i.e. 
Mycobacterium smegmatis and Mycobacterium avium, but four members o f the genera 
Mycobacterium tuberculosis, Mycobacterium africanum and Mycobacterium bovis and 
Mycobacterium leprae are obligate pathogens. The mycobacteria can be grouped into two 
classes, the fast-growers and the slow-growers. The fast-growers which grow in less than 
seven days and are generally environmental bacteria e.g. Mycobacterium chelonae. The slow- 
growers require 2-4 weeks for growth and include the pathogens. These grouping were 
reinforced by the conserved 16SRNA sequence data obtained for slow and fast-growing 
mycobacteria (Clark-Curtiss, 1990).
The slow-growers are further divided into nonphotochromogenic species i.e. the M. 
tuberculosis complex and M. avium complex and the photochromogenic species. The 
members of the M. tuberculosis complex are the causative agents o f tuberculosis, M. 
tuberculosis, Mycobacterium bovis and Mycobacterium africanum, members o f this complex 
are slow-growing, acid-fast bacilli that display 95% DNA/DNA homology with each other. 
M. tuberculosis can be distinguished as it is niacin and nitrate reductase positive. The M. 
avium complex cause pulmonary and nonpulmonary infections, primarily in the 
immunocompromised and is composed of M. avium and Mycobacterium intracellulare 
although their DNA/DNA homology clearly indicated they are different species. The members 
of this complex are niacin and urease-negative and hybridise to MAC specific insertion 
element DNA probes (McFadden, 1990).
The slow-growing photochromogenic species are further subdivided into Runyon group I, 
which produce pigment on exposure to light e.g. Mycobacterium kansasii and Mycobacterium
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marinum  and Runyon group II species which produce pigment in the dark e g. 
Mycobacterium gordonae.
Fast-growing mycobacteria include the Mycobacterium fortuitum complex and M. smegmatis. 
The members of the M. fortuitum complex cause the most human disease out of the fast 
growers. The complex consists of M. chelonae, Mycobacterium peregrinum, and 
Mycobacterium abscessus.
Mycobacterium leprae is a straight rod bacillus of l-8^m long by 0.3/^m in diameter, the 
causative agent of leprosy and is unculturable in vitro, it has therefore been classed in a group 
alone. M. leprae is detected using specific antibodies, DNA probes and the identification of 
acid-fast bacilli (reviewed by Shinnick, 1994).
1.2 T h e  m y c o b a c t e r ia l  c e l l  e n v e l o p e
A simplified model of the mycobacterial cell envelope is shown in Fig 1., this model was 
initially based on the chemical properties of individual cell wall components and has 
subsequently been borne out by other experimentation i.e. x-ray crystallography and electron 
microscopy (EM) (Minnikin, 1982; Nikaido et al., 1993; Brennan and Nikaido, 1995). The 
mycobacterial plasma membrane is surrounded by a cell wall, thought to be an asymmetrical 
bilayer, the major components of which are lipid and polysaccharide.
The major lipid components of the cell wall are the characteristic mycolic acids, 70-90 carbons 
long, these are only found in other actinomycètes e g. Corynebacterium and Nocardia where 
they are 40-60 carbons long. The major mycobacterial polysaccharides are peptidoglycan, 
which is of chemotype IV, and the unique arabinogalactan.
-2-
In t r o d u c t io n
PHENOLIC IQLYCOUPIDim  m  n i nI  I  I  I  I  I  MYCOCEROSIC ACIDS
UPOARAE DM ANNAN
MANNOPHOSPHOINOSmDES, 
^  V c3
iiiiium pi iiiuiuuiuiV? (ins
CELL MEMBRANE
Fig. 1. A cartoon depiction of the cell envelope of Mycobacterium leprae 
(This picture was taken from Brennan, 1989).
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The cell wall consists of peptidoglycan covalently linked to arabinoglactan to which mycolic 
acids are covalently bound to form a surrounding monolayer and creating the 
mycolylarabinogalactan-peptidoglycan complex, mAGP. The mAGP complex, or covalent 
skeleton of the cell wall, is believed to make up the inner layer of the cell wall bilayer. The 
mycolates are arranged with their main and branched chains parallel to each other and 
perpendicular to the plane o f  the cell surface and the peptidoglycan (Brennan and Nikaido, 
1995). The mycolates therefore produce a close packed inner structural permeability barrier 
(Nikaido et at., 1993; Besra et al., 1995). The inner leaflet of mycolic acids is in turn believed 
to be covered by an outer leaflet of variable intercalating extractable lipids. The whole 
structure thus producing an asymmetrical lipid bilayer (Fig. 1). The extractable lipids are 
species-specific glycolipids and peptidolipids, the main variables in an otherwise fairly generic 
cell wall. The other dominant cell wall component is lipoarabinomannan, LAM, which is 
believed to be anchored in the plasma membrane and to span the cell wall; it is analogous to 
the lipopolysaccharide (LPS) of Gram-negative bacteria. The cell wall also contains 
intercalating proteins and porins which span the cell wall. The cell wall is in fact more 
analogous to the outer membranes found beyond the peptidoglycan in the cell walls of Gram- 
negative bacteria (Brennan and Nikaido, 1995).
1.2.1 Cell envelope components
The mycobacterial cell envelope is composed of numerous individual components o f varying 
complexity, many of which are lipid based. As a result the cell envelope is 30 to 60% lipid, 
depending on the growth environment (Ratledge, 1982). The lipids range from non polar 
waxes to sugar and amine-containing polar lipids. Mycobacteria contain a number of novel 
lipid components unobserved in most bacteria other than actinomycetes (Minnikin and 
Goodfellow, 1980; Minnikin, 1982) e g. phosphatidylinositol mannosides (PIMs), 
tuberculostearic acid and mycolic acids. Other conventional lipids e.g. isoprenoids, quinones, 
carotenoids and membrane polar lipids are also found in mycobacteria. Polysaccharides and
-4-
In t r o d u c t io n
proteins are the other main components of the cell wall.
The major and unique lipid, polysaccharide and protein components of the mycobacterial cell 
wall and their location within the cell envelope are discussed below.
1.2.1.1 The Plasma membrane
The plasma membrane of the mycobacterial cell envelope is a typical phospholipid bilayer, 
which appears asymmetrical when observed by EM (Paul and Beveridge, 1992). Other 
components such as proteins are integrated primarily into the outer layer of the membrane, 
hence its increased diameter. Some components of the plasma membrane are discussed below.
1.2.1.1.1 Phospholipids
These are the most common polar lipid types in mycobacteria and are generally 
phosphodiacylglycerol derivatives of phosphatidic acid. Phosphatidylglycerol (PG), 
diphosphatidylglycerol (DPG), phosphatidylethanolamine (PE) and PIMs are the most 
common. They are all amphipathic, being composed of polar phosphatidic heads with long 
chain fatty acids of less than 20 carbons esterified to C-l and C-2 (Fig.2a). The glycerol, 
ethanolamine, inositol or phosphatidylglycerol groups are attached to the oxygen o f  the 
phosphate group. The fatty acids are a mixture o f straight chain monounsaturated palmitic 
(C,6:l)  oleic (C „:l) and 10-methyl branched tuberculostearic acids (Minnikin, 1982).
PE is almost universally found, DPG and PI are widespread and PG is less common (Minnikin, 
1982). PIMs (Fig. 2b) are the most unusual and highly characteristic phospholipids found in 
mycobacteria and other actinomycètes (Minnikin and Goodfellow, 1980; Minnikin, 1982). 
Phosphatidylinositol dimannoside (PIMJ from M. tuberculosis and Mycobacterium phlei was 
found to  consist o f a glycerol phosphate moiety attached to the L-l position of the myo- 
inositol ring with mannose residues glycosidically-linked to the 2 and 6 positions o f  the
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a )  R", R-
Man = D-mannopyranosyl
R, R't R", R" =  long-chain acyl groups
For n = 5 oligomannoside is Man 1 ------> 2 Man 1 > 2 Man
1 * > 6 Man 1 —— > 6 Man 1 6 Inositol
OH
Fig.2. The general structure of phospholipids and phosphatidylinositolmannosides, 
PIMj and PIM6
a) generalised phospholipid structure (taken from Minnikin, 1982)
b) phosphatidylinositol dimannoside PIM2 (taken from Besra and Chatterjee, 1994)
c) phosphatidylinositol hexamannoside PIM« (taken from Besra and Chatteijee, 1994)
-6-
In t r o d u c t io n
inositol ring (Lee & Ballou, 1964) (Fig.2b). PIM2 (n=l) is the most commonly isolated PIM 
in mycobacteria (Minnikin 1982). Phosphatidylinositol mannoside homologs PIMj (n=2), 
PIM4 (n=3), PIM5(n=4) and PIM6(n=5), (Fig.2c), have also been isolated (Lee and Ballou, 
1965; Chalteijee et al., 1992a). They also have a single a-D-mannopyranosyl group at the 2 
position of the mannose oligosaccarides e.g. [a  -D-MaryK 1 ~2)-]2-[a -D-Maqp-( 1 -6 )-]2-a  -D- 
Mapp in PIMg are found at the 6 position on the inositol ring.
PIM2 has been shown to have an additional acyl group attached at the 2 or 6 position of the 
dimannoside (Brennan and Ballou, 1967; Khoo et al., 1995a), this structure is known as a tri 
or monophosphatidylinositol dimannoside. PIMs are also believed to contain a  second acyl 
group which is thought to be on the C-3 position of the inositol ring (Ballou, 1972). The 
diacylated PIMs are not found in M. leprae, where they seem only to exist in a mono-acylated 
form (Minnikin et al, 1985).
1.2.1.1.2 Isoprenoid and related compounds
These are lipids synthesised by condensation o f isoprene units to form polyterpene-based 
products e.g. menaquinones and carotenoids.
1.2.1.1.2.1 Menaquinones
Menaquinones (2-methyl-3-polyprenyl-1,4,-naphthoquinones) are the predominant isoprenoid 
lipoquinones found in mycobacteria and are involved in electron transport. They generally 
have nine isoprene units, one o f which is hydrogenated; the precise structure of a 
menaquinone fromM phlei is shown in Fig.3a. This has all trans double-bond configurations. 
Non-isoprenoid lipoquinones have been isolated inM  avium (Minnikin, 1982).
1.2.1.1.2.2 Carotenoids
These are linear polyterpenes containing around 40 carbons (Fig. 3b) and are responsible for
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Fig. 3. The general structure of mycobacterial menaquinones, carotenoids and 
polyprenols
a) The most abundant menaquinone structure found in M. phlei (taken from Minnikin, 1982)
b) Carotenoid structures 1 ) lycopene 2) P -carotene (taken from Minnikin, 1982)
c) Phosphodecaprenol with a P-D-linked-arabinofuranosyl unit attached, P-D- 
Arabinofiiranosyl-l-phosphodecaprenol (Wolucka et al., 1994) (taken from Besra and 
Chatterjee, 1994).
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the characteristic yellow-orange colour of scotochromogenic and photochromogenic 
mycobacteria such as M. gordonae and M  kansasii.
1.2.1.1.3 Glycosylphosphopolyprenols
Glycosylphosphopolyprenols o f mycobacteria contain the polyprenols decaprenol and 
octahydroheptaprenol, rather than the undecaprenol found in common bacteria, and are 
believed to be carrier molecules associated with the plasma membrane (Brennan and Nikaido, 
1995). P-D-mannopyranosyl phosphodecaprenol and P-D-mannopyranosyl- 
phosphooctaheptaprenol were discovered inM  smegmatis and M. tuberculosis (Takayama 
et al., 1973; Takayama and Goldman, 1970) Fig.3c. Recently, P-D-arabinofuranosyl 
phosphodecaprenol, P-D-ribosyl-l-monophosphodecaprenoI and 6-O-mycolyl- P-D- 
mannopyranosyl phosphooctahydroheptaprenol have been found in M. smegmatis (Wolucka 
et al., 1994; Wolucka et al., 1995; Besra et al., 1994a). The polyprenols are thought to be 
involved in cell wall biosynthesis as carrier molecules for arabinose, ribose and mycolates.
1.2.1.2 The cell wall skeleton
The covalently-linked skeleton o f the cell wall consists of the peptidoglycan linked to the 
arabinogalactan, the side chains o f which are esterified at their distal ends with mycolic acids 
to form mAGP.
1.2.1.2.1 The peptidoglycan
Peptidoglycan makes up 18-25% of the cell wall and lends it rigidity and shape. It consists of 
long polysaccharide chains cross-linked by short polypeptide chains to form a net-like 
macromolecule. The polysaccharide chains of the mycobacteria and the Nocardia are 
composed of repeating N-acetyl- P -D-glucosaminyl-( P 1-4)-Af-glycosylmuramic acid units; 
in other bacterial species the muramic acid residues are A^-acetylated. The cross-linking 
peptide chains consist o f L-alanyl-D-isoglutaminyl-meso-diaminopimelyl-D-alanine, the
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diaminopimeiic acids (mDAP) being amidated. M. leprae is an exception in that it contains 
glycine in the place of L-alanine (Draper et al., 1986). The peptide chains are linked to each 
other by interpeptide linkages between alanine and mDAP residues and between mDAP 
residues. The peptide chains are in turn linked to the carboxyl groups of the N-glycolyl 
muramic acid residues of the polysaccharide chains (Fig.4a)
1.2.1.2.2 Mycolyl-AG
Arabinogalactan constitutes about 35% of the cell wall mass o f mycobacteria. Arabinogalactan 
is linked to the peptidoglycan via an unusual diglycosylphosphoryl bridge, 5-Gal/(l-4)-L- 
Rhap-(l-3)-D-GlcNAc(l-P) to the C-6 of the muramic acid residues (McNeil et al., 1990).
Arabinogalactan consists of arabinosyl (Ara) and galactosyl (Gal) residues, all in the furanose 
form which is rarely found in nature. The galactan segment is thought to exist as a 
homopolysaccharide linear strand of alternating 5- and 6-linked P -D-Gal/residues, [5)-P-D- 
Gal/^ 1 -6)- P-D-Gal/"-( 1 -  ]n, up to 30 units long (DafFe et al., 1990; Besra et al., 1995). The 
arabinan branched chains are thought to be attached to the C-5 of C-6-linked Galf  residues 
24-27 at the reducing end of the galactan backbone, near the peptidoglycan (Besra et al., 
1995) (Fig.4b). Arabinan exists as branched chains (Fig.4c), the majority of the homoarabinan 
chains are composed of linear 5-linked a-D-Ara/- residues with branching introduced by 3,5- 
a-D-Ara/-residues, substituted at both branch positions with 5-a-D-Ara/(Fig.4c). Arabinan 
chains were found to be terminated by a unique branched hexaarabinofuranosyl structure [p- 
D-Ara^-(1 -  2)-a-D-Ara/]2-3,5,-a-D-Ara/‘-(l-'5)-a-D-Ara/'(DafFe et al., 1990; McNeil et 
al., 1994). Recent work has shown the arabinan branches are now believed to consist of two 
hexaarabinofuranosyl residues linked to two l-5a-D-Ara/"residues joining at a 3-5 a-D-Ara/" 
making a 23-residue arabinan unit (Besra et al., 1995).
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Fig.4. The structure o f mycobacterial peptidoglycan a n d  arabinogalactan
a) the general structure o f  chemotype IV peptidoglycan, where f=furanosyl;n+m =8-10 units 
and x+y=8-10 units, (taken from Brennan, 1989)
b) the proposed structure o f arabinogalactan (taken from Besra et al., 199S)
c) the proposed structure of arabinogalactan branching (taken from Brennan and Nikaido, 
1995)
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’ I
R—C H —C H —COOH 
I
( C H j ) j j — C H j
b) Table 1. The structures of some mycobacterial mycolic acids
76-82 carbons, do not contain oxygen functions, 
apart from the inherent hydroxy group. Can be 
unsaturated, methyl-branched or contain 
cyclopropane rings, as in the example shown.
a - Mycolates from M. tuberculosis. Found in all mycobacteria.
C O O H
46-68 carbons, shorter versions of the mycolates, 
which are diunsaturated or monounsaturated and 
slightly more polar than mycolates.
a ’-Mycolates Found in M. smegmatis and M. chelonae.
Contain ketogroups in their main carbon 
backbone. M. tuberculosis cis and trans 
ketomycolates are shown, the trans form is the
Ketomycolates
most abundant. Found in many mycobacteria 
including M. kansassi, M. leprae, M. bovis and 
M. avium (Minnikin and Goodfellow, 1980)
C H a 9 * »  O H
Methoxy my col ates
Contain a methoxy group in their main carbon 
backbone again the methoxymycolates of M. 
tuberculosis shown are cis and trans forms, the 
cis being the most common. Also found in M. 
bovis, M. kansassi, M. marinum and M. gordonae 
(Reviewed by G. Dobson et al., 1985)
CHa OH
W h m m « n « 3 2
Epoxy mycol ates
Contain an epoxy group in their main carbon 
backbone and have only been found in M. 
smegmatis and M. fortuitum ( reviewed by 
Dobson et al., 1985)
C H , O  OH
C H , ( C H , | , , ^ o A  <c„HM K * f <CH’ ’" C ^
C O O H
W h«i*  n  ■ 31 -39
Wax ester mycolic acids have been observed in M. 
avium, M. intracellulare, M.scrofulaceum, M. 
vaccae, M. aurum and M. paratuberculosis 
among (reviewed by Dobson et al., 1985). Wax 
ester mycolates are difficult to isolate intact as 
they are degraded to Svcarboxymycolates and 2-
Wax ester mycolic acids eicosanol or alkali hydrolysis
Fig.5. The general structure of mycolates and a table o f the various types
a) general mycolate structure (taken from Minnikin, 1982)
b) Table. 1. The structure of the mycolates and the species in which they are found
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Two thirds o f the hexaarabinofuranosyl units are then mycolated. Long chain a -alkyl- P- 
hydroxy mycolic acids are selectively and equally distributed on the 5-hydroxyl functions of 
terminal p-D-Ara/and internal 2 a-D-Ara/-residues (Fig.4b). Mycolyl units are clustered in 
groups of four in each hexaarabinofiiranosyl non-reducing terminus; they are packed parallel 
to each other and extend upwards from the arabinogalactan, perpendicular to the cell surface 
(McNeil et al., 1991; Besra etal., 1995).
1.2.1.1.3 Mycolic acids
Mycolic acids are high molecular weight long chain P(C-3)-hydroxy fatty acids o f 70 to 90 
carbons in length. The acid group in the C-l position is at the terminus o f the main backbone 
o f50-60 carbons with a(C-2) side chains o f  20-24 carbons and a hydroxy group at the C-3 
position (Fig.5a). The main carbon backbone, or meromycolate, may also contain up to two 
unsaturations, double bonds (cis or trans), cyclopropane rings, oxygen functions (additional 
to the P-hydroxy group e g. keto groups) or methyl branches. These additional features of 
the carbon backbone distinguish mycobacterial mycolic acids from those o f Corynebacterium, 
Nocardia and Rhodococcus.
The structure of different types of mycolates has been reviewed by Minnikin (1982) and Besra 
and Chalteijee (1994). Six types of mycolates have been defined: a , a ', keto, methoxy, epoxy 
and wax ester mycolates. The structures o f  the various mycolates and the mycobacterial 
species in which they are found are described in Table 1 (Fig. 5b).
1.2.1.3 Extractable cell wall lipids
A wide variety o f cell wall lipids are not covalently bound and can be extracted by treatment 
with appropriate solvents. Extractable lipids are believed to make up the outer lipid leaflet 
which intercalates with the bound mycolates and those present in each species of mycobacteria 
vary. The most commonly found extractable lipids are described below in order o f increasing
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polarity, which generally coincides with a larger sugar component.
1.2.1.3.1 Waxes
True waxes consist o f long chain fatty acids esterified to long chain alcohols. An array of 
waxes are found in mycobacteria, particularly slow growers i.e. M. leprae. They are generally 
long chain diols, phthiocerols A and B, phthiodiolone A and phthiotriol A, in which 
mycocerosic acids are esterified to both hydroxyl groups (Fig.6: Table.2). The 
phenolphthiocerols are a related family, which form the basic lipid core of phenolic glycolipids 
(Fig.6: Table 2 ) (Minnikin, 1982; Besra and Chatteijee, 1994).
1.2.1.3.1.1 Mvcocerosates
The mycocerosic acids isolated from waxes are a complex mixture of multi-methyl branched 
acids, the major component of which is C32 2,4,6,8,-tetramethyloctacosanoate (Fig.6: Table 
2) (Minnikin, 1982; Besra and Chatteijee, 1994).
1.2.1.3.2 Phenolic glycolipids
Phenolic glycolipids (phenol phthiocerol glycosides, PGLs) have been found in five 
mycobacterial species to  date: M. kansasii (Mycoside B), M. bovis (Mycoside B), M. 
marinum (Mycoside G), M. leprae (PGL-1) and some strains o fM  tuberculosis (attenuator 
lipid) (reviewed in Brennan, 1989). PGLs consist of a phenolic phthiocerol group with 
two Cj, mycocerosate fatty acids attached (Fig.7a. where R=mycoserosate). There is also an 
oligosaccharide attached to  the phenol group which consists of 1-4 sugar residues depending 
on the species. The oligosaccharide o f M. bovis is a monoglycosyl unit, M. leprae and M. 
tuberculosis (Canetti) have triglycosyl units and M  kansasii has a tetraglycosyl unit (Fig. 7b, 
Table. 3). The sugar residues are not very hydrophilic, consisting of deoxy sugars that are 
multiply 0-methylated. PGLs are the major extractable lipid produced by M  leprae in vivo.
-14-
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Table.2
Phthiocerol B CH3(CH2 )20j>2''flN^ «
OH OH
Phthiodiolone A CH3(CH2)20^ 2y/«s x fl
OH OH
Phthiotriol A CH3(CHz)2 0 X ' r ^ r
Phenolphthiocerol A HO— ^  /)—  (CH2)14.18^ W  
x * Mycoœrosic Acid
CH3 CH3 CH3 CH3
Mycocerosic Acid CH3 (CH2 ) COOH
Fig. 6 .Waxes and mycocerosates found in the mycobacteria
Table 2. The structure of waxes and mycocerosates found in M. tuberculosis (taken from 
Besra and Chatteijee, 1994)
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CH j
R = Long Chain Fatty Acyl
b) Table. 3. Summary o f structures o f  major phenolic glycolipids from M ycobacterium  species.__________________________________________
Mycobacterial species Structure of carbohydrate chain_______________________________
Mycobacterium bovis 2-0-Me-o-t-Rhap-( 1 -phenol-dimycocerosyl phthiocerol)
Mycobacterium leprae 3,frdi-0-Me-P-D^3Ml-4)-2,3-di-0-Me-o-L-Rhap-(l-S>-3-0-Me-a-L-Rhap-(l-pheiiol-dimycocerosyl phthiocerol)
Mycobacterium kansasii 2,6-dideosy-4-0-Me-c-«ratom>-hexp-(l-*3M-0-Ac-2-0-Me-<i-Futp-2-0-Me-a-Rhap-(l-*3>-2,<-di-0-Me-«-Rhsp<l-* phenol-
dimycocerosyl phthiocerol)
Mycobacterium tuberculosis 2,3,4-tri-O-Me-o-l-FucpK 1 -3)-a-L-Rh«p-< 1 -3)-2-Q-Me-a-i-Rh»rK I -phenol-dimycocerosyl phthiocerol)______________
Fig.7.The structure of mycobacterial phenolic glycolipids and their specific oligosaccharide haptens.
a) General structure of phenolic glycolipids (taken from Besra and Chatteijee, 1994)
b) Table.2. The specific oligosaccharide haptens of PGLs from the PGL containing mycobacterial species (taken from Brennan, 1989)
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J. 2.1.3.3 Glycopeptidolipids
Glycopeptidolipids (GPLs) are peptide-containing surface glycolipids and can be divided into 
two main types, simple apolar and complex polar hydrophilic molecules. Generally, GPLs 
consist of a core head group, the tripeptide, D-Phe-D-cr//oThr-D-Me-L-alaninol, where the 
alaninol is substituted with a 3,4 di-O-methyl-X-rhamnose and the aminogroup of the D- 
phenylalanine residue is substituted with a fatty acid residue. The D-a//o-threonine residue is 
substituted with oligosaccharides of varying length, the proximal portion of which are 
generally a-L-rhamnopyranosyl (l-*2)-6-deoxy-L-talopyranose in complex GPLs (Fig.8a). 
The simple polar GPLs differ from the complex GPLs in that they are singly glycosylated at 
the threonine substituent and are found in species which contain complex GPLs and others 
e.g. M. smegmatis which do not.
Complex GPLs are the major cell surface antigens of M. avium, M. intracellulare and M. 
scrofulaceum (MAIS complex) and M  peregrinum, M. chelonae and M. absessus, of the M. 
fortuitum  complex. The variable oligosaccharide region o f the MAIS complex GPLs is 
serospecific allowing the MAIS complex to be subdivided into 31 distinct serotypes, 12 of 
which have been completely defined (Fig.8b: Table.4) (reviewed by Brennan, 1989; Belisle 
and Brennan, 1994). The GPLs o f the M. fortuitum  complex vary slightly in that these 
oligosaccharides are attached to the alaninol (Lopez Marin et al., 1991, 1992 and 1994). 
Other variations include sulphated GPLs in M . peregrinum, Mycobacterium senegalense and 
Mycobacterium porcinum  (Lôpez-Marin et al., 1992 and 1993) and a novel GPL with a 
serine-containing lipoprotein core structure in M. xenopi (Rivière and Puzo, 1992; Rivière et 
al., 1993).
1.2.1.3.4 Acylated trehaloses
There are three families o f trehalose based lipids, trehalose 6,6'-dimycolate (cord factor) 
(Fig.9a), the simple acylated trehaloses, which contain a combination o f saturated straight
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a) Ç*Hj
CHj
R-NH-CH-CO-NH-ÇH-CO-NH-CH-CO-NH-CH-CH; 
HÇ-CHj
Oligosaccharide----0
OCHj
b) Table. 4. Structure of oligosaccharide haptens from the glycopeptidolipids of some serovariants of Mycobacterium avium.
Serovariant no. Structure
2
4
«
»
12
14
17
19
20 
21
25
26
2,J-Di^J-Me-L-FucrKol-*J)-l-Wiap(«l-2)W-l-Tal 
4^Me-i-RhtuHaI-4)2-0-Me-L-FucpXal-0)L-Rluu*«l—2)6d-iT«l 
4,Ml’ortttxyethytidene)3-0-Me-D<ilc/>®l"3H-RhV(®l'*2)M-i.-Til
2.3- Di-0-Me-i-Fucp(al-*4>-i>^31cA/>(|>l-*4)2,J-Di-0-Me-i.-Fucp(<il-'J>-i.-Rh»p(al"*2)6d-L-Tal 
4-A/-lactyl-3^3.Me-4,6-dideoxygliico(l-, 3)-40.Me-i-RhaF(«l'*3)-fahaF(ol-, 3H-Rhv(ol-*2)-6-d-i-Tal 
4-Formamido-3f4,6-trideoxy-2-O-Me-3-C-Me-Man(l-*3)2-0-Me-i>-Rhas(<tl"*3)2-O-Me-i.-Fuc/j(«l"*3)i.-Rhap(al-*2)6434.-Tal 
4K2'-methyl-3'-hydroxy-butyr)aniido-4,6-dideoxy-Hex(l-»3)40-Me-L-Rhtu>(nl"*3)i.-Rhap(<tl"*3)i.-Rhap(al'*2)6-d-l.-Til
3.4- Di-0-Me-D^3k A/XPI ~J)2.4-Di.O-Me-3-C-Me-6-dHex(ol-3)l-Rh«/><o I -3)L-Rhv(a I — 2)6-d-L-T«l 
2-O-Me-D-Rh v («  I -*3)2-O-Me-i.-Fuçp<0 I-3X-RIUUH« I -2 )W-l T«1 
4,6<l'<irobyxyethyUdene)-D-Clcp(Pl-*3)-L-Rh»p<ol-»2>6-d-i-T»l
4-ictumido4,W ideoxy 2^)-Me-Hex(ol-4)D<ilcAp(il-4)2^)-Me-L-Fucp(«l-3)i-RhatX«l-2)64l-L-Tal
2.4- Di-O-Me-Fuc/Xa 1 -4)OlcAp(P 1 ~4)2-0-Mc-l-FucpKa I-3)l.-Rh«rKal-»2)6-d-L-T»l___________________
Fig.8. The general structure of the glycopeptidolipids found in mycobacteria and the serovar specific oligosaccharide haptens of the M. 
avium complex
a) General GPL structure (taken from Besra and Chatteijee, 1994)
b) Table. 4. The serovar specific oligosaccharide haptens from 12 M  avium  serovars (taken from Brennan, 1989)
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chain mycocerosate (CI6-C„, C21-C25), mycolipanolic (C24-C2g) and mycolipenic fatty acids 
(C25-C 27) and the sulpholipids (Fig.9b). The sulpholipids consist of trehalose 2'-sulphate 
acylated with hydroxyphthioceranic, phthioceranic and saturated straight-chain fatty acids 
(Besraand Chatteijee, 1994).
1.2.1.3.5 Lipooligosaccharides
Lipooligosaccharides (LOSs) consist o f  variable oligosaccharides with an acylated a , a ' 
trehalose unit at one end (Fig.9c). LOSs vary from multi-glycosylated forms found in M. 
kansasii (Hunter et ai., 1985) to the simpler singly glycosylated compounds found in M  
smegmatis and M. fortuitum  (Kamisango et al., 1985; Besra et al., 1992).
The multi-glycosylated acyltrehaloses o f  M. kansasii were isolated from eight smooth colony 
variants (Hunter et al., 1985). Their oligosaccharides are composed o f variable residues of 
xylose, 3-0-methylrhamnose, fucose and N-acylosamine, a novel N-acylamino sugar linked 
to a common tetraglucose core, which contains an a  a'-trehalose moiety. The terminal 
glucose residue of the trehalose is usually acylated at positions 3, 4 and 6 by 2,4- 
dimethyltetradecanoic acid residues. Multiglycosylated LOSs with similar structures to  those 
found inM  kansasii have been found in M. gordonae and M. tuberculosis Canetti (Besra et 
al., 1993; Dafle e t al., 1991).
The simpler LOS of M. smegmatis consists of a pentaoligosaccharide unit of D-glucose 
residues. Two of the glucose residues are pyruvylated and one is 3-0-methylated. Acyl groups, 
2,4-dimethyl-2-eicosenoic acid and hexadecanoic acid are found on the 4 and 6 positions 
respectively, on both glucose molecules of the trehalose unit (Kamisango et al., 1985). The 
two pyruvate methyl groups and the 3-O-methyl ether group lie together on one side of the 
sugar and with the fatty acid chains are thought to result in a molecule with a non-polar 
surface.
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Fig.9.The structure of trehalose containing mycobacterial lipids
a) Trehalose 6,6,’dimycolate (taken from Besra and Chatteijee, 1994)
b) Sulpholipids of M. tuberculosis (taken from Besra and Chatteijee, 1994)
c) General structure of LOSs (taken from Besra and Chatteijee, 1994)
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1.2.1.3.5 Glycerophospholipids
Recent work by Rosenburg and Nikaido has revealed that the cell wall of M . chelonae 
contains at least two short chain (C,6-C„) fatty acid residues per bound molecule o f mycolic 
acid residue (Nikaido et al., 1993), some of the short chain acids found in PIMs (Brennan and 
Nikaido, 1995), implying PIMs are present in the cell wall. The cell wall extracts o fM  
chelonae contained less than 1% plasma membrane so it is unlikely that the 
glycerophospholipids found were contaminants from the plasma membrane.
1.2.1.4  Lipoarabinomannan
Lipoarabinomannan (LAM) is a major constituent of mycobacterial cell envelopes and is 
believed to be present in all mycobacterial species. Detailed structural analysis o f  LAM from 
M. leprae and M. tuberculosis Erdman has revealed that LAM is a multiglycosylated 
extension o f PIM2, consisting o f a mannose backbone with branched arabinogalactan 
extending perpendicularly (Fig. 10) (Hunter et al., 1986; Chatteijee et al., 1992a). The C6 of 
the inositol is the point of attachment o f a mannan backbone (Chatteijee et al., 1992a) which 
consists of a ( l - 6)-linked D-mannose {M ap) residues, with a variable degree o f a ( l-2 ) -  
Mary? linked side branches (Misaki et al., 1977; Chatteijee et al., 1992a; Venisse e t al., 1995). 
The main arabinan backbone consists of a(l-5)-linked a-D-arabinofuranosyl (Ara/) residues, 
w ith branches introduced by a -3,5-a-D-Ara/" linkages. There are two types o f arabinan 
branches shown in Fig.10. One type [ P -D-Ara/’-i 1 -  2)-a -D-Ar%/] 2-3,5 - a  -D-Ara/'-( 1 -  5)- a  -D- 
Ara/'is similar to arabinogalactan and the other, P-D-Ara/'-(l->2)-a-D-Ara/(l-5)-a-D-Ara/', 
is linear (Chatteijee et al., 1991).
Recently, the arabinose terminus o f LAM from M. tuberculosis Erdman, H37RV and H37Ra 
(Chatteijee et al., 1992b; Khoo et al., 1995b), M. bovis BCG (Prinzis et al., 1993) and M. 
leprae (Khoo et al., 1995b) have been shown to be mannose-capped (ManLAM). The 
branched or linear termini are extensively capped with mono, di or trimannosides (1-5)
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Fig. 10. The structure of lipoarabinomannan, LAM
(taken from Besra and Chatteijee, 1994)
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linked to an a-Ara/-residue (Fig. 10) and the terminal Mary? residues are a-D -M app-(l-2)-a- 
D-Manp-linked (Fig. 10), an arrangement that is uncommon in mycobacteria but is common 
on the glycoproteins of mammalian cell surfaces. The extent of the mannose-capping varies 
between species from 70% in M . tuberculosis Erdman to 30% in M. leprae (Khoo et al., 
1995b).
The non-reducing terminus o f LAM in fast-growing mycobacteria e.g. M. smegmatis, is 
devoid o f mannose-capping and has been shown to exhibit a degree of inositol phosphate 
capping (Khoo et al., 1995b). The inositol capping is believed to be restricted to the linear 
arabinan termini and attached at position 5 o f the terminal P-Ara f  residue.
The general structure of LAM does vary slightly from species to species e g. M . bovis BCG 
ManLAM has a shorter mannose backbone o f only 5 units of 2,6 linked mannose, a highly 
branched arabinofiiranosyl side chain and up to three 2-linked mannopyranosyl segments at 
the non-reducing ends of the molecule (Prinzis et al., 1993).
LAM was believed to be anchored in the plasma membrane by a PIM anchor and to span the 
cell wall, however the recent discovery of PIMs in the cell wall imply that LAM could be 
extractable and embedded in the cell wall (Brennan and Nikaido, 1995) .
1.2.1.5 Cell wall associated proteins
The lipoproteins found in M  tuberculosis are believed to be analogous to the periplasmic 
protons of Gram-negative bacteria and to be cell wall associated (Young and Garbe, 1991). 
The 38kDa protein of M. tuberculosis has 30% homology to the periplasmic PstS (PhoS) 
from E. coli which captures phosphate transported through the porin and releases it via a 
phosphate specific phosphate channel which spans the cytoplasmic membrane. The synthesis 
of the 38kDa protein is upregulated during phosphate starvation, implying the protein could
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be involved in phosphate biosynthesis (Andersen et a l., 1990).
The 19kDaM tuberculosis lipoprotein is anchored in the cell wall (Young and Garbe, 1991) 
and is also believed to be involved in phosphate uptake (Andersen and Brennan, 1994) but its 
exact functions are unknown.
Excreted proteins e.g. superoxide dismutase (Zhang et al., 1991; Abou-Zeid et al., 1988; 
Thole etal., 1992) must transverse the cell wall to reach the exterior. The 30/3 lkDa antigen 
85 complex contains signal sequences required to transverse the cell wall and has been found 
to be at least temporarily associated with the cell wall surface before release into the exterior 
(Rambukkana et al., 1991).
The high affinity iron binding compounds, exochelins and mycobactins are also cell wall 
associated. Exochelins are excreted into the extracellular environment, while mycobactins are 
thought to facilitate the transport of iron across the cell wall to the interior o f the bacterium 
(Ratledge, 1982). The mycobactins are highly lipophilic and the exochelins have recently been 
shown to share a common core structure with the mycobactins (Sharman et al., 1995).
Cell wall associated proteins with unknown functions have been found in a number of 
mycobacterial species e.g. the major 35kDaM leprae protein (Hunter et al., 1990) and the 
30kDa protein o fM  chelonae (Nikaido et al., 1993). Porins have also been found in the cell 
walls o fM  chelonae and M. smegmatis (Trias et al., 1992; Trias and Benz, 1994).
1.2.1.6 Physical organisation o f the cell envelope
The proposed model for the physical organisation o f the cell envelope of a plasma membrane 
surrounded by a bilipid cell wall was described in section 1.2. The model, based on the 
chemical properties of the cell envelope components (Minnikin, 1982) has largely been borne
-24-
In t r o d u c t io n
out by subsequent experimental evidence (Nikaido et al., 1993; Brennan and Nikaido, 1995).
1.2.1.6.1 Ultrastructure evidence
The ultrastructure of mycobacteria has been extensively studied using a variety of techniques 
including freeze-fracture, freeze-etching, negative staining, metal shadowing, thin sectioning 
and ffeeze-substitution (Reviewed by Draper, 1991; Brennan and Draper, 1994). These 
experiments have attempted to relate the visible structure to the physical organisation of the 
chemical components in the cell envelope.
The mycobacterial plasma membrane appears as two electron dense layers separated by a 
transparent layer, with integral membrane proteins and a freeze-fracture plane across the 
transparent layer (Nguyen et al., 1979; Silva and Macedo, 1983). The plasma membrane is 
asymmetrical, the outer electron dense layer appears thicker than the inner layer, due perhaps 
to  the presence of carbohydrate in molecules such as PIMs or LAM (Silva and Macedo, 1983; 
Paul and Beveridge, 1992). A pseudo-periplasmic space between the plasma membrane and 
the cell wall has not been categorically established through electron microscopy.
Observation o f the cell wall of mycobacteria by electron microscopy has given variable and 
contradictory data depending on the methods used. The wall appears to consist o f three 
layers; an inner layer (IL) of moderate electron density, a wider layer electron-transparent 
layer (ETL) and an outer electron-opaque layer (OL) of variable thickness and appearance.
The (IL) is 5.6-6.2nm wide (Paul and Beveridge, 1992) and is believed to contain the 
peptidoglycan because o f  the consistency of its moderate electron density across the species 
and the ability of the carboxyl groups o f diaminopimelic acid in this layer to bind metal ions 
during staining (Beveridge and Murray, 1980).
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The ETL represents the arabinogalactan-mycolate region of the cell wall. It is the most 
hydrophobic region and the most lacking in reactive chemical groups to bind the electron 
microscopy stains. The mycolic acids are thought to prevent access of the stain to the 
arabinogalactan making it part of the electron-transparent layer (Rastogi et al., 1984). The 
ETL disappeared following extraction o f  lipids with acetone in M . kansasii, and the lipid 
extracted was also shown by TLC analysis to contain large quantities of phenolic glycolipid. 
(Paul and Beveridge, 1994). This experiment implies that the ETL contains shorter-chain 
lipids predicted to intercalate with the mycolates in the models of the cell wall (Minnikin 1982; 
Nikaido etal., 1993; Brennan and Nikaido, 1995). The ETL was found to be 5-10nm in width 
by freeze-substitution (Paul and Beveridge, 1992).
The OL, approximately 5nm wide (Paul and Beveridge, 1992), is the most variable from 
species to species and has been identified in 18 mycobacterial species (Brennan and Draper, 
1994). The OL appears fibrillar, granular, or homogenous and varies in thickness and electron 
density; this is thought to be due to the various staining methods and growth conditions 
employed, as well as genuine differences between species. The OL is believed to consist of 
delicate surface structures and has been shown to contain polysaccharides, glycoproteins, 
proteins, phospholipids and complex glycolipids inM. avium (David eta l., 1988).
Ruthenium red staining was the first to allow clear and consistent observation o f the OL layer 
in different species. The dye binds to charged groups and does not penetrate the membrane; 
it is not clear which specific components of the mycobacterial cell wall bind to the dye 
(Rastogi et al., 1984). Recent freeze-substitution experiments ofM . kansasii showed a very 
feint OL towards the edge of the ETL but contained within it, suggesting that the components 
o f  the OL may be found in structures that also make up part of the ETL (Paul and Beveridge, 
1994). This indicates that the OL contains the sugar and protein components of the 
intercalating lipid o f the cell wall leaflet.
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A freeze-fracture plane has also been observed in the mycobacterial cell wall and supports the 
concept that the cell wall exists as a lipid bilayer (Draper and Brennan, 1994; Brennan and 
Nikaido, 1995).
1 2 1 6 1.1 Intracellular ultrastructure
The ultrastructure o f some mycobacteria inside macrophages has been studied. The 
mycobacteria were generally found within a vacuole but separated from its contents by a 
distinct "electron transparent zone" (ETZ). This ETZ is different from the ETL in 
mycobacteria grown in vitro and the boundary between the two is generally visible inside 
vacuoles. The ETZ corresponds with the position o f the outer layer o f cells grown in vitro.
In A/, leprae an ETZ was observed surrounding the bacilli in vivo (Nishiura et al., 1977). The 
use of a specific PGL-1 monoclonal antibody and indirect immunofluorescence resulted in a 
fluorescent zone surrounding the bacilli (Gaylord and Brennan, 1987) demonstrating the 
surface location o f the glycolipid antigen and implying the presence o f PGL-1 in the ETZ of 
M. leprae. InM  avium the ETZ consisted of a multilamella coat of parallel straight fibrils and 
is thought to contain GPLs (Rulong et al., 1991).
1.2.1.6.2 Biochemical evidence
The proposed arrangement of the arabinan branching in the arabinogalactan, at the base of the 
galactan chain (Besra et al., 1995) would allow the mycolates to extend upwards 
perpendicular to the cell surface, as proposed in the model.
The amounts of mycolic acid present in whole cell hydrolysates are comparable with the 
nonhydroxylated fatty acids of the plasma membrane suggesting there are sufficient mycolates 
to form the proposed lipid domain (Minnikin, 1982).
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The lack of acylation of the P-hydroxyl group of the mycolates implies that intramolecular 
and intermolecular hydrogen bonds could form between the hydroxy group and the carbonyl 
group of each mycolate (Besra et al., 1995). It is thought that the hydrogen bond would result 
in the a  branch and the meromycolate backbone of each mycolate being parallel to each other 
forming the predicted parallel packing of the mycolates. Recent x-ray diffraction studies of 
the cell wall of M  chelonae showed that a large part o f  the hydrocarbons are tightly packed 
in a parallel array, perpendicular to the surface (Nikaido et al., 1993).
If this arrangement is correct the mycolic acid structure would be predicted to produce 
domains of different fluidity, an inner region of low fluidity and a distal region of increased 
fluidity (Brennan and Nikaido, 1995). The a  branch is without double bonds or cyclopropane 
rings and the proximal portion o f the meromycolate chain generally contains a tram  double 
bond that does not introduce kinks, which would result in low fluidity in the region close to 
the arabinogalactan. In contrast, the distal end of the mycolates contains the second double 
bond or cyclopropane group with a cis configuration; oxygen-containing substituents may also 
be present at this position. These groups would strongly disrupt the lateral packing at the 
distal end o f the mycolates leading to increased fluidity towards the outer edge of the 
mycolate region (Brennan and Nikaido, 1995). The x-ray data showed that a large fraction 
of the cell wall lipid was in an almost crystalline arrangement o f low fluidity in M. chelonae 
(Nikaido et al., 1993). These two regions of fluidity would assist in the formation of the 
predicted outer bilayer (Brennan and Nikaido, 1995).
The model also requires sufficient amounts of extractable lipids as components of the outer 
leaflet. As the meromycolates and a  branches differ by about 26 carbons, lipids and fatty 
acids with between 14-18 and 30-40 residues are required to intercalate with the mycolates 
to form the outer leaflet o f  the lipid bilayer. M . chelonae was found to contain 
glycerophospholipids, GPLs and unknown lipids with intermediate chain length in ample
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quantities to form an outer leaflet (Nikaido et al., 1993; Brennan and Nikaido, 1995). Other 
species also have extensive quantities of extractable lipids which are thought to be located in 
the outer leaflet of the bilayer, e g. PGLs of M. leprae (Gaylord and Brennan, 1987) and 
GPLs o f M. avium (Rulong et al, 1991).
Some lipids may form independent aggregates outside the bilayer, particularly when over 
produced. The form in which these lipids exist outside the cell will vary e g. PGL-I of M. 
leprae is apolar and exists as oil droplets (Gaylord and Brennan, 1987) whereas GPLs ofM. 
avium  are amphiphilic and form micelles or fibrils (Barrow et al., 1980). Other extractable 
lipids, i.e. trehalose dimycolate, LOSs and sulpholipids, are more ideally shaped to form the 
lipid bilayer and are unlikely to exist outside the cell wall bilayer (Brennan and Nikaido, 1995).
1.2.2 B i o s y n t h e s i s  o f  s o m e  c e l l  w a l l  c o m p o n e n t s
The elucidation of biosynthetic pathways is important in the search for drug target sites for 
mycobacteria. Mutational analysis of operons encoding the cell wall components would help 
elucidate the pathways as shown by Mills et al., (1994) with the GPLs ofM  avium serovar2. 
Generally a larger number of individual enzymes are required to form oligosaccharides, while 
lipid synthesis appears to involve multifunctional enzyme complexes. This section describes 
what is known about the some o f the more unique mycobacterial cell wall components.
1.2.2.1 PIM  and L A M  biosynthesis
A proposed biosynthetic pathway for PIMs is shown in Fig. 11a. The recent discovery that an 
additional acyl group is attached either to the C-6  or C-2 position of the dimannoside moiety 
(Khoo etal., 1995a) has implications for LAM biosynthesis, as the addition o f an acyl group 
to the C-6  position would prevent the formation o f the mannose backbone.
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Fig. 11. The proposed pathways of PIM and phthicerol biosynthesis
a) The proposed pathway of PIM biosynthesis (taken from Minnikin, 1982)
b) The later stages of phthiocerol A biosyntheis (taken from Besra and Chatteijee, 1994)
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1.2.2.2 Arabinogalactan
Little is known o f  the biosynthesis of this compound. However, recently, a family of 
monoglycosyl polyprenylphosphates have been isolated from M. smegmatis which contain 
arabinose and ribose, P-D-arabinofuranosyl phosphodecaprenol and P-D-ribosyl-1- 
monophosphodecaprenol (Wolucka et al., 1994 and 1995). The polyprenols are thought to 
be involved in cell wall biosynthesis as carrier molecules for arabinose and ribose. The destiny 
o f the ribose is as yet unknown; it could be a component o f an unknown polysaccharide or a 
precursor for arabinose (Wolucka el al., 1995). Pulse-chase metabolic labelling o f  cells with 
[14C]-glucose indicated that decaprenyl-P-arabinose is an active intermediate in the 
biosynthesis of arabinogalactan and arabinomannan (Wolucka et al., 1994).
1.2.2.3 Mycotic acids
The complete biosynthetic pathways of mycolate formation have not yet been determined, 
although a number o f  individual steps have been established.
Initial studies on Corynebacterium diphtheriae (Gastambide-Odier and Lederer, 1960) 
showed that C32 mycolates were formed by Claisen condensation and reduction o f two CJ6 
acids. Similar condensations were subsequently revealed in the formation of mycolates of M. 
smegmatis (Etemadi, 1967a, b and c) as reviewed by Minnikin (1982).
A general pathway for the synthesis of the a  dicyclopropyl mycolates of M. tuberculosis 
H37Ra was initially proposed by Takayama and coworkers following detailed investigations 
(reviewed by Minnikin (1982)). An updated version of this pathway has been proposed by G. 
Besra (Brennan and Nikaido, 1995) (Fig. 12)
A Cj« fatty acid, formed in the cytosol by fatty acid synthesis FASI/FASII, is believed to enter 
one o f two branches o f the pathway. In one branch of the pathway the C24 acid is thought to
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Fig. 12. T he  proposed pathway of a  mycolate biosynthesis in M. tuberculosis H37Ra 
The proposed anabolic pathway o f mycolic acid biosynthesis in M. tuberculosis H37Ra was 
taken from Brennan and Nikaido,1995. The key products are (I) hexacosanoate-Rl (II) A -5- 
tetracosanoate-R2, (HI) C5i54 meromycolate-R^ and (TV)oxomycolate-R„ and (V) mycolate- 
R2. Carrier group, R is believed to be the P-D-mannopranosyl-monophosphoryl- 
polyisoprenol, and R2 may be either CoA or ACP. The reactions are 1) elongation and 
introduction of carrier group R, 2) carboxylation 3) introduction of carrier group R2 4) A -5- 
desaturation S) elongation and A -3-desaturase 6) introduction of cyclopropane rings and 
elongation 7) Claisen type condensation 8) decarboxylation 9) reduction 10) mycolate transfer 
to AG 11) mycolate transfer to trehalose and 12) trehalose mycoyltransferase.
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be elongated to  a CM molecule by the addition o f £  attached to  a carrier molecule R 
(Fig. 12). The carrier molecule R, is possibly the recently discovered mycolyl phospholipid 
(Myc-PL), 6-0 mycolyl-P-D-mannopyranosyl-phosphaoctahydroheptaprenol, which contains 
an appropriate acyl carrier group (Besra et al., 1994a). The molecule is then thought to 
be caiboxylated to form an acid, tetracosanyl malonate, (CH3(CH2)23CH(COOH)2) (Fig. 12).
The C24 acid entering the other branch of the pathway is thought to  be attached to an acyl 
carrier molecule Rj, which could be CoA, an acyl carrier protein (ACP) or a membrane-bound 
protein (Brennan and Nikaido, 1995). The C24-R2 molecule is thought to be desaturated by 
A-5-desaturase to form C ^ l ,  A -5-tetracosanoate-R2. The A-5-tetracosanoate (Fig. 12 II) is 
then thought to  be elongated to a C32 molecule by the sequential addition of Q molecules 
before undergoing a second desaturation. The cyclopropane rings are then thought to be 
formed at the positions o f the double bonds before further elongation o f the C32 molecule to 
a meromycolate (C52-C54) (Fig. 12 III). The meromycolates and the £  acid, tetracosanyl 
malonate-R„ are then thought to undergo a Claisen condensation producing a ketomycolyl-R, 
intermediate. The intermediate is thought to be decarboxylated yielding an oxomycolate-R, 
which is reduced to give mycolate-R,. The mycolate-R, (R, = Myc-PL) may then be directly 
transferred to the non-reducing terminus of the D-arabinose residue o f  arabinogalactan matrix. 
Myc-PL could transfer the mycolate residues to trehalose to form trehalose monomycolates 
which are also thought to be the carriers of mycolic acid to the D-arabinose residues 
(Takayama and Armstrong, 1976).
Evidence has been gathered for some steps in the proposed pathway from a wide range o f 
studies, including investigations into the effect of antituberculous drugs.
That A 5-unsaturated C24 fatty acids are precursors of mycolates has been implicated by a 
number of groups. Asselineau et al. (1970) showed that a series o f  A 5-unsaturated C22, C24
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and C26 non-hydroxylated fatty acids (FA), from M. phlei, were structurally similar to the 
hydrocarbon terminal portion of its di-unsaturated mycolates. Oxidative cleavage of the 
double bonds in both the mycolates and FA gave identical degradation products. It was 
therefore suggested that A 5-acids may be formed by aerobic desaturation of C24 tetracosanoic 
acids. Investigation o f the monounsaturated FA of H37Ra (Takayama et al., 1978) revealed 
the position of the double bonds in the FA corresponded exactly with positions of the 
cyclopropane rings in the alkyl terminal portion of the a  mycolates (Qureshi et al., 1978). It 
was concluded that these unsaturated FA esters may be precursors of mycolic acids.
A system was developed to follow mycolic acid synthesis in intact M. tuberculosis H37Ra by 
measuring incorporation of a radioactive [MC]-acetate precursor into mycolates (Takayama 
et a l., 1972). A cell-free system able to synthesize whole mycolic acids was subsequently 
developed forM  aurum, again using [l4C]-acetate as a precursor (Lacave et al., 1990). The 
synthetic activity was found in an insoluble fraction extracted from disrupted M .aurum  cells. 
The addition of isoniazid (INH) to both systems inhibited mycolic acid synthesis and led to 
the accumulation o f non-hydroxylated fatty acids, implying that non-hydroxylated fatty acids 
are the precursors o f  mycolic acid.
Analysis o f the [,4C]-acetate distribution in the newly synthesized mycolic acids o f the cell-free 
system revealed that the [14C]-acetate was not uniformly incorporated into the unsaturated, 
oxy, dicarboxy and meromycolates formed by the system (Lacave et al., 1990b). Extraction 
and oxidation of the resulting mycolates fragmented the meromycolate chains at their double 
bonds and demonstrated that the methyl terminus and the next 18 carbon atoms were virtually 
unlabelled, indicating an endogenous C24:1 cisS precursor.
The fatty acids are probably synthesized by fatty acid synthases (FASs) FASI and
FASH. In M  tuberculosis this is a multifunctional enzyme system, a de novo synthase forms
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C ,6 acids which are elongated to the C24 or CM acids required as mycolate precursors.
Recently, cis  tetracos-5-enoic (A 5 tetracosenoic acid) acid was positively identified as a 
putative precursor in mycolic acid biosynthesis (Wheeler et al., 1993a). Following extraction 
with hexane to remove endogenous fatty acids, the incorporation of [,4C]- acetate into the a , 
a '  and epoxymycolates of M. smegmatis was observed, following addition o f the cis 
tetracosenoic as a precursor; other lengths of fatty acids had no effect. The use o f  a structural 
analogue in this system, methyl-4-(2-octadecylcyclopropene-l-yl) butanoate, inhibited mycolic 
acid biosynthesis (Wheeler et al., 1993b).
The subsequent elongation of the C24 fatty acid or C24:1 c/s-5-precursor in mycolate synthesis 
could be initiated by FAS enzymes or specific elongases. Analysis o f the cell free system of 
mycolate formation (Lacave et al., 1990a) revealed that [l4C]-acetate incorporation into 
mycolates was up regulated by CoA, biotin, KHC03 and MgCl2. As mycolate biosynthesis 
requires elongation, condensation, dehydrations and desaturation, Lacave et al., (1990a) 
concluded that a multi-enzyme complex is likely to exist. The recently discovered inhA gene, 
when mutated or over-expressed, confers resistance to  INH by preventing the inhibition of 
mycolic acid biosynthesis (Baneijee et al., 1994). Initial characterisation of the gene and its 
product revealed homology to envM of E. coli. NAD/NADH binding and a P-ketoacyl-ACP- 
reductase gene downstream of the inhA  gene suggested it was an enoyl-ACP-reductase and 
therefore, involved in elongation events. The 32kDa InhA protein has been expressed 
revealing its crystalline structure which contains an NADH binding site (Dessen et al., 1995). 
The protein has recently been shown to catalyse the NADH-specific reduction o f 2-trans- 
enoyl-ACP (Quemard et al., 1995) and possibly exists as a multienzyme-complex involved in 
mycolic acid biosynthesis.
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The incorporation of (S)-methyl-[uC]-adenosyl-methionine provides the methyl groups for 
cyclopropane rings. This is thought to occur late in the pathway as incorporation of (S)- 
methyl-[I4C] adenosyl methane and unlabelled malonyl CoA gave Q rC *  acids in a cell-free 
extract o fM  tuberculosis H37Ra (Qureshi et al., 1984). The correct double bond position 
was also essential for effective elongation. Recently, an M. tuberculosis gene cm a\ has been 
isolated which confers the ability to form cyclopropane rings at the double bond positions of 
a  mycolates inM  smegmatis, which is normally unable to produce cyclopropane rings (Yuan 
et al., 1995). Regions of the M  tuberculosis DNA adjacent to the cm al gene display 
homology to other fatty acid synthases and may represent part of an operon involved in 
mycolic acid biosynthesis (Yuan et al., 1995).
The mycolic acids of a number of mycobacteria have been found in the trehalose 
monomycolate (TM) form. These esters were thought to be carriers of the mycolic acids to 
the cell wall. The recently discovered Myc-PL may be a precursor of TM or may transfer the 
mycolate residue to trehalose (Besra et al., 1994; Brennan and Nikaido, 1995) .
The proposed biosynthetic pathway described was for a  mycolates of M. tuberculosis. Other 
studies indicated that a parallel pathway exists for the formation of oxygen containing 
mycolates (Quemard et al., 1992). The absolute configuration of the methyl group in 
epoxymycolates when compared to the (S) methyl group adjacent to keto, methoxy and wax- 
ester function has ruled out epoxides as common intermediates (Minnikin, 1982). Metabolic 
studies with different chain lengths indicate that cl mycolates are not precursors o f oxygenated 
mycolates. Pathways for a  mycolates and oxygenated mycolates appear to diverge from a 
common intermediate.
A strain o f M. smegmatis with defective mycolate synthesis has been isolated (Kundu et al.,
1991) which is believed to be unable to undergo the Claisen type condensation as it only
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produces short chain fatty acids. The isolation of other such mutants or those resistant to 
drugs which inhibit mycolate biosynthesis should help elucidate this pathway.
1.2.2.4 Phenolic glycolipids
The carbon atoms in the methyl branched structures of the mycocerosates and in phthiocerol 
had previously been shown to be derived from  propionate (Gastambide-Odier el al., 1963) 
(Fig. 1 lb). The mycocerosates themselves have recently been shown to be synthesised by a 
mycocerosic acid synthase (MAS), a novel fatty acid elongating multifunctional enzyme from 
the M. tuberculosis complex. The operon encoding the MAS enzyme contains a ketoacyl 
synthase, acyl transferase, dehydratase, enoyl reductase, P-ketoreductase, and acyl carrier 
protein in that order (Mathur and Kolattukudy, 1992).
The phenol-phthiocerols come from p-hydroxybenzoate, which is then elongated to  yield long- 
chain diols (Gastambide-Odier, 1970). The aromatic ring o f the phenol can be derived from 
tyrosine but not from phenylalanine (Minnikin, 1982).
Recent experiments in which M. microti was grown in the presence o f 2-[uC]-propionate led 
to the isolation of two lipids which were identified as phthiocerol dimycoserosate and 
phenolphthiodiolone dimycocerosate, the aglycosyl derivatives of mycoside B (the PGL o f M. 
microti and M  bovis). Cell-free extracts o f th e  organism were able to glycosylate the two 
lipids to  form the PGL in vitro. The lipids are  therefore believed to be intermediates in the 
biosynthesis of PGLs in mycobacteria (Thurman eta l., 1993).
-3 7 -
I n t r o d u c t i o n
1.2.2.5 Glycopeptidolipids
Recent experiments have begun to elucidate the biosynthetic pathway of GPLs using a genetic 
approach (Belisle eta l., 1991; Mills et al., 1994). Initially, the gene cluster ser2 encoding the 
oligosaccharide hapten responsible for the serovar specificity of M  avium  serovar 2 was 
cloned and expressed in M. smegmatis. Expression of the ser2 genes in M. smegmatis 
produced a recombinant serovar 2-specific GPL, with a non-specific GPL (nsGPL) M. 
smegmatis base and the serovar 2-specific disaccharide 2,3,di-0-methyl-a-L-fiicopyranosyl- 
(l-3)-a-L-rhamnopyranose attached to the 6-deoxytalose of the nsGPL base (Belisle et al.,
1991). Subsequent transposon mutagenesis o f the ser2 gene cluster and screening o f the 
recombinants for ser2 expression revealed four essential loci spanning 14kb of M. avium 
DNA. These loci are believed to encode at least a rhamnosyltransferase, a fucosyltransferase 
and the methyltranferases required to methylate the fucose. It is possible the enzymes 
responsible for the de novo production of fucose are also encoded within this region (Mills 
eta l., 1994). Isolation of truncated versions o f the recombinant GPL following transposon 
mutagenesis of ser2 implied a chain of events in the biosynthetic pathway o f the GPLs of 
serovar 2. Synthesis is thought to be initiated by the transfer of a rhamnose unit to the 6- 
deoxytalose of the peptide core followed by the addition of the fucose and subsequent 
methylation of the fiicosyl unit.
1 .2 .3  FUNCTIONS ASSOCIATED W ITH  THE COM PONENTS O F THE C E LL  W A LL
1.2.3.1 Antigenicity
The glycolipids present in the cell wall outer leaflet of a number mycobacterial species are 
antigenic as a result o f their specific oligosaccharide components e.g. PGLs, LOSs, LAM and 
GPLs. The glycolipids can be sufficiently antigenic to evoke specific antibodies and thereby
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allow serodiagnosis or serotyping of the mycobacterial species in question. The glycolipids, 
although antigenic, are not always immunogens; for example, M. fortuitum  LOS reacts with 
antiserum raised against the whole bacteria strongly but only weakly against antibodies raised 
specifically against the glycolipid (Besra et al., 1992).
Multiglycosylated species-specific glycopeptidolipids (ssGPLs) are the major surface 
glycolipids o f M. avium, M .intracellulare and M  scrofulaceum  species and their 
oligosaccharide components are the determinants o f the 31 serovars within the MAIS 
complex. Glycopeptidolipids have also been isolated from M. chelonae, M. peregrinum  and 
M . absessus (of theM  fortuitum  complex) andM. porcinum. Non-specific singly glycosylated 
glycolipids are also found in these species.
M . gordonae is a serocomplex like the M . avium complex, but based on the trehalose 
containing LOSs rather than glycopeptidolipids as demonstrated by the dominant LOS of M. 
gordonae 990 reacting strongly with antiserum raised against it, but only very weakly with 
antiserum raised against M. gordonae 989 and vice versa (Besra et al., 1993). The 
multiglycosylated LOSs ofM. kansasii, M. szulgai, M. gordonae and M. tuberculosis Canetti 
are also highly antigenic (Brennan and Nikaido, 1995; Daffe et al., 1991). The serological 
dominance is resident in the terminal non-reducing arrangements o f the most polar LOSs from 
M . kansasii, M. szulgai andM  gordonae (Besra eta l., 1993).
PGLs are particularly antigenic evoking specific antibodies, e.g. in M. leprae recognition of 
P G H  with a monoclonal antibody (mAb) can be used to diagnose the disease. LAM found 
in all mycobacteria is also highly antigenic (Hunter et al., 1986; Gaylord and Brennan, 1987).
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J. 2.3.1.1 PGLs, LOSs and GPLs
PGL-1 has also been implicated in the pathogenicity of M  leprae. It is believed to contribute 
to the intracellular survival o f M. leprae within macrophages through its ability to scavenge 
oxygen radicals (Gaylord and Brennan, 1987). PGL-1 has also been implicated as an acceptor 
molecule on the bacilli for the C3 ligand which combines with the complement receptor to 
form a complex which initiates phagocytosis of the bacteria by the macrophage (Schlesinger 
and Horwitz, 1991). Ligation of complement receptors by C3 does not trigger an appreciable 
oxidative burst and ingestion of M. leprae is not accompanied by a significant oxygen burst. 
The C3 fixation to M  leprae has been shown to be mediated by natural antibody in the serum 
of nonimmune hosts (Schlesinger and Horwitz, 1994).
The LOSs are not thought to interact directly with the host but are thought to mask 
underlying virulence determinants such as LAM, preventing their pathogenic effects (Daffe 
et al., 1991).
There is mounting evidence from in vitro studies that GPLs may play a role in host-parasite 
interactions. GPLs have been shown to be immunosuppresive, decreasing the 
lymphoprolifération of murine splenic lymphocytes (Brownback and Barrow, 1988). 
Subsequent experiments with P -lipid, essentially the peptide core o f the GPLs, show it also 
had the ability to suppress lymphoprolifération of splenic lymphocytes (Tassell et al., 1991). 
Purified GPL and p-lipid also induced secretion of tumour necrosis factor a  (TNFa) 
(Pourshafie et al., 1993). The peritoneal macrophage membranes were disturbed by both GPL 
and P-lipid which may have caused their altered function. Barrow et al., (1993) gained similar
_________________________________________________________________________In t r o d u c t i o n
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results with human peripheral blood mononuclear cells (HPBMs) and serovar 4 (3-lipid.
The oligosaccharide moiety of serovar 4 or 2 was not immunosuppressive nor did it induce 
TN Fa or prostaglandin 2 (PGE2). However, M. avium serovar 8 GPL has been shown to 
induce secretion o f PGEj, which GPLs o f serovars 4 and 2 were unable to do, implying 
induction was due to  the variable oligosaccarides of the GPLs (Barrow et al., 1995).
1.2.3.1.2 Trehalose 6,6'-dimycolate
Trehalose 6,6 -dimycolate (cord factor) has been shown to induce cytokine-mediated events 
such as systemic toxicity (Kato, 1973), anti-tumour activity (Lepoivre et al, 1982), 
granulomagenic activity and macrophage release of chemotactic factors (Matsunaga et al 
1990). Cord factor also inhibits Ca2+ induced fusion between phospholipid vesicles (Spargo 
e t al., 1991) and migration of leukocytes (Goren and Brennan, 1979). Recently, lung 
inflammation produced by cord factor was shown to induce a coagulative response in murine 
lungs rather than the fibrinolytic response associated with lungs resistant to cord factor (Perez 
e ta l., 1994).
1.2.3.1.3 Sulpholipids
Sulpholipids are thought to inhibit phagosome activation thus promoting intracellular survival 
o f  the pathogen and have been shown to have multiple affects on the signal transduction 
pathways leading to phagosome activation and priming (Zhang et al., 1991b). They have been 
shown to prevent the release of superoxide (Oj‘) by the macrophage-activating factors LPS 
gamma interferon (IFN-y) interleukin-1P (IL-1P), TNFa and muramyl dipeptide. The 
inhibition o f macrophage priming was accompanied by an increase in the secretion of IL-1P
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and TNFa (Brozna et al., 1991).
J.2.3.1.4 LAM
In earlier investigations, LAM ofM. leprae andM tuberculosis (now known to be ManLAM) 
was shown to inhibit T-cell proliferation (Kaplan et al., 1987; Molloy et al., 1990). The IFN- 
Y mediated activation of macrophages via T-cell lymphokines was also inhibited by the 
presence o f M. leprae LAM in murine macrophages (Sibley et a i, 1988). Both inhibitory 
effects were prevented by the deacylation of LAM (Molloy et a i, 1990; Sibley et a l., 1988). 
LAM o f M . leprae and M  tuberculosis was also shown to scavenge potentially cytotoxic 
oxygen free radicals and inhibit protein kinase C activity (Chan et a i, 1991). The scavenging 
was upregulated by deacylation of LAM (Chan et a i, 1991).
LAM has also been shown to induce an array o f cytokines. AraLAM of the attenuated 
Mycobacterium strain initially thought to beM  tuberculosis H37Ra (Chatterjee et a l., 1992c) 
was shown to induce TNFa at levels 100-fold greater than those induced by ManLAM 
(Chatterjee et a i, 1992c). AraLAM was subsequently shown to increase production o f  TNFa, 
granulocyte macrophage-colony-stimulating factor (GM-CSF), IL-1 a , IL-1 P, IL-6, IL-8 and 
IL-10, generally produced by macrophages and resulting in increased antigen-induced T-cell 
proliferation (Adams et a i, 1993). ManLAM, lipomannan (LM) and PIMs were also found 
to induce the same cytokines to a lesser extent in both experiments. Deacylation of both types 
of LAM prevented the molecule inducing cytokines. (Chatteijee et a i, 1992c; Barnes et a i,
1992).
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AraLAM has also been shown to induce macrophage early gene expression (c-fos, KC and 
JE) and T N F a in murine macrophages which ManLAM was unable to do (Roach et al.,
1994). AraLAM has recently been shown to be a potential stimulator of intracellular nitric 
oxide synthase (iNOS) expression whereas ManLAM was not; the inability of ManLAM to 
induce iNOS was not due to the induction of inactivating IL-10, as AraLAM also induced IL- 
10 production. IFN-y was however found to completely inhibit the IL-10 production induced 
by AraLAM, implying an immunoregulatory role in determining the macrophage response 
(Roach et a l., 1995). The TNFa induction by AraLAM has been shown to be modulated 
through th e  binding activities o f transcriptional factors, NF-kb and NBF1, as with LPS. 
ManLAM was found to be considerably less potent at stimulating NF-kb (Brown et al., 1995). 
These experiments indicate that LAM is a potential regulator of macrophage functions.
Recently ManLAM has been shown to selectively enhance adherence of polystyrene 
microspheres to human monocyte derived macrophages whereas AraLAM did not. Adherence 
was decreased by down-modulating the mannose receptor on the macrophages or by 
removing the terminal mannose units of ManLAM, implying that ManLAM enhances 
adherence by interacting with the macrophage mannose receptors, providing a novel receptor- 
ligand pathway in phagocytosis o f  M . tuberculosis (Schlesinger et al., 1994).
ManLAM from M. leprae has been shown to be presented to T-cells by human CD lb; this 
presentation required internalisation and endosomal acidification as well as the presence of 
maimosides with (1-2) linkages and a phosphatidylinositol unit. LAM, a lipoglycan, can act 
as an antigen and be recognised by human T-cells (Sieling et al., 1995)
-43-
I n t r o d u c t i o n
1.3 Permeability of the mycobacterial cell envelope
1.3.1 P e r m e a b i l i t y  o f  t h e  m y c o b a c t e r i a l  c e l l  w a l l
The mycobacterial cell wall acts as an effective permeability barrier to both hydrophilic and 
hydrophobic solutes. Hydrophilic molecules are expected to transverse the cell wall through 
porins whereas lipophilic solutes are more likely to diffuse through the lipid bilayer.
1.3.1.1 Permeability to hydrophilic solutes
The permeability to hydrophilic solutes has been tested in two non-pathogenic mycobacterial 
species, M. chelonae andM  smegmatis mc2155 (Jarlier and Nikaido, 1990; Trias and Benz, 
1994). Precise measurement of the permeability of mycobacteria has not been straightforward 
as attempts to measure uptake of radioactively-labelled drugs were hampered by drugs binding 
to their targets, an inability to distinguish between partition into the lipid interior of the walls 
from true entry across the barriers, unequal distribution caused by the proton motive force 
across the membrane and the modification o f some drugs e.g. penicillins.
The Zimmermann-Rosselet method was used to measure the permeability o f intact 
mycobacteria to hydrophilic cephalosporins by measuring their rate of hydrolysis. The cell wall 
permeability was calculated by assuming that the drug molecules diffused through the cell wall 
following Flick's first law of diffusion and that they were then hydrolysed by periplasmic P- 
lactamase, following Michaelis-Menten kinetics. The rates of hydrolysis were then used to 
determine the permeability coefficients. The cell wall permeability coefficient of M. chelonae 
ranged between 0.9xl0",-10xl0'*, three orders of magnitude lower than E. coli and one order 
of magnitude lower than the notoriously impermeable Pseudomonas aeruginosa. Penetration 
of the cephalosporins was not dependent on temperature or the hydrophobicity o f the
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cephalosporin and the rate of diffusion was directly proportional to the hydrated size of the 
cephalosporin. These results indicated that permeation occurred mainly through aqueous 
channels. The permeability to hydrophilic nutrient molecules such as glucose and glycerol was 
also low. It was also noted that cephalosporins with no net charge diffused more rapidly than 
monoanionic cephalosporins. The cell wall permeability o fM  smegmatis mc2155 and M. 
tuberculosis to hydrophilic solutes, e g. hydroxalamine, has recently been investigated and 
found to be an order o f magnitude higher than in M. chelonae, although this is still low in 
comparison to other bacteria (Trias and Benz, 1994; Brennan and Nikaido, 1995).
Porins (aqueous diffusion channels) have been identified in M  chelonae and M. smegmatis 
(Trias et a l., 1992; Trias and Benz, 1994). M. chelonae cell wall proteins were extracted, 
added to reconstituted liposomes and the permeability of the liposome investigated by 
studying the diffusion o f hydrophilic compounds, e g glycine, glucose and maltose (Trias et 
al., 1992). The porin was formed by a 59kDa protein, which was found in small amounts in 
the cell wall. The porin formed was a water-filled channel with a large pore size, 2.2nm, and 
a  low ion specificity (Trias et al., 1992). The channels were voltage-gated; at 40mV of 
applied voltage the porin switched to a closed configuration; they were observed in an open, 
closed or flickering state in the reconstituted membranes (Trias et al., 1992; Trias et al.,
1993).
The porins are cation-selective due to the presence of 2.5 negative point charges at the mouth 
o f  the pore (Trias et al., 1993). The 59kDa protein appeared to be the only porin-like protein 
present in the cell wall o f  M. chelonae; the major 30kDa cell wall protein o f M. chelonae 
showed no porin-like activity (Trias et al., 1992).
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Similar porins were also found inM  smegmatis me2155; they are non specific water filled 
cation selective channels with a 3nm diameter and four negative point charges (Trias and 
Benz, 1994).
1.3.1.2 Permeability to hydrophobic solutes
The lipid bilayer is generally permeable to hydrophobic solutes but the permeability is 
inversely proportional to the fluidity of the lipid membrane. The rigid organisation of the 
mycolates within the mycobacterial cell wall implies an inner region o f very low fluidity. 
However, due to the relatively low permeability of the hydrophilic pathway, the hydrophobic 
pathway is o f greater importance in mycobacteria. This is borne out by the large number of 
relatively lipophilic antimycobacterial agents e g. tetracyclines, rifamycins, macrolides and 
fluoroquinolones. It has also emerged that the lipophilic derivatives o f a number o f these 
classes of antimycobacterials are more active against mycobacteria, presumably as a result of 
their improved penetration rate. The efficacy of the fluoroquinolones increases with increased 
lipophilicity, e g. more hydrophobic derivatives such as WIN57273 and sparfloxacin, are more 
effective than ciprofloxacin against M. leprae (Franzblau and White 1990; Gelber et al.,
1992) . The more hydrophobic tetracyclines such as minocycline and doxycycline are also more 
effective against mycobacteria than hydrophilic tetracyclines. There is no correlation between 
lipophilicity and efficacy in other bacteria such as Staphylococcus aureus because of the 
already rapid diffusion o f the compounds across the lipid membrane (Nikaido and Thanassi,
1993) .
The addition of alkyl groups to known antimycobacterials has also been known to increase 
their efficacy, for example the addition of palmitoyl to the hydrophilic agent INH, believed to
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utilise the porin route, enhanced the efficacy of INH against M. avium, which appeared to 
have a low hydrophilic permeability (Rastogi and Goh, 1990).
The penetration rate o f certain antimycobacterial agents is improved with an increase in 
temperature indicating the importance of the lipid pathway for diffusion in mycobacteria. For 
example the penetration rates o f norfloxacin into M  tuberculosis increased six-fold with a 
10°C increase in temperature (Brennan and Nikaido, 1995).
The permeability of different species of mycobacteria is variable in saprophytic fast-growing 
and soil-dwelling mycobacteria, e g. M. chelonae, M. fortuitum  and M. smegmatis, have less 
permeable outer membranes and are intrinsically more resistant to  lipophilic antibiotics. This 
is presumably as they must defend themselves against antibiotics and other toxic molecules 
in their natural habitat. Members of the M . avium complex, although slow growing, are 
thought to exist in the soil and are also resistant to many lipophilic and hydrophilic agents and 
presumably have poor porin permeability as well. The mycobacteria pathogenic for 
mammalian hosts, e.g. M. tuberculosis and M. leprae, are more susceptible to lipophilic 
agents, dyes and detergents. This is illustrated by the resistance of all the soil-species 
mentioned to rifampicin which is active against M  tuberculosis and M  leprae.
It is thought that the resistance o f the soil organisms stems from the type of mycolates found 
in these species. 41-75% of the a  mycolates o f M. chelonae, M. fortuitum , M. smegmatis and 
M. phlei contain irons double bonds at the proximal (inner) ends o f the mycolates. The trans 
bonds decrease the fluidity and therefore the permeability of the innermost part of the bilayer 
(Brennan and Nikaido, 1995). The more susceptible species however have cis double bonds
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or cyclopropane rings at this position, which would increase the fluidity and therefore the 
permeability of the innermost part of the cell wall (Brennan and Nikaido, 1995).
Some organisms exhibit intermediate levels of permeability with, for example, a low 
permeability to hydrophilic agents such as INH but susceptible to more hydrophobic 
compounds such as rifamycins e g. M. marinum. In this case it is assumed that the porin 
pathway has an exceptionally low permeability.
Despite the low permeability of the mycobacterial cell wall the half-equilibration times (the 
time needed for intracellular concentration to reach one-half of the external concentration) 
across the cell wall are only a few minutes, much less than the generation time of the 
organisms.
1.3.1.3 E fflu x  systems
For an organism to display resistance the low permeability must act in synergy with another 
mechanism such as hydrolysis or efflux of the compound. Efflux systems play an important 
role in the resistance of other bacteria to antibacterials. There are currently four major efflux 
systems; the major facilitator family, the resistance-nodulation division family, staphylococcal 
multidrug resistance and the ABC adenosine triphosphate binding cassette. As yet no efflux 
systems have been identified in mycobacteria, although six ABC-type transporters genes have 
been identified in theM  leprae genome. The intrinsic resistance o f P. aeruginosa was shown 
to be due as much to an efflux system as to the low permeability o f the outer membrane. An 
efflux operon, mexa mexB -oprK, believed to function in the export of siderophores was 
recently discovered in P. aeruginosa; when inactivated by insertional mutagenesis the strain
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became nearly as susceptible as E. coli to tetracycline and chloramphenicol (Poole et al.,
1993). The efflux system is thought to be the main reason the species displays the general 
drug-resistance phenotype and a similar system could exist in mycobacteria (Nikaido, 1994).
1 .3 .2  PER M E A B ILIT Y  OF T H E  CELL MEMBRANE
Information available about the permeability of the cell membrane in mycobacteria is limited 
and has been gleaned through studies o f nutrient uptake. Evidence for both active and 
facilitated diffusion of nutrients has been obtained. Glycerol is universally transported by 
facilitated diffusion and kinetic evidence for uptake of glycerol in mycobacteria suggests they 
are no exceptions (Connell and Nikaido, 1994). Studies inM. smegmatis showed that D- 
glutamic acid and D-aspartic acid are also taken up by passive diffusion, whereas D-alanine 
is taken up by active transport which would require a permease (Connell and Nikaido, 1994). 
Proline uptake inM  phlei has been the most extensively studied in membrane vesicles. It was 
found to  be an active transport which was dependent on the oxidation of the substrate and had 
a requirement for Na+ or Li+ (Lee and Brodie, 1979). The Na+ ions increased the activity of 
the active transport but not the specificity (Lee and Brodie, 1978). The transport was driven 
by an electrochemical gradient as it was found to be sensitive to uncouplers, which change the 
pH gradient, but not to ionophores which change the permeability of the membrane to ions 
(Lee et al., 1979). These results suggested a symport system where the substrate and H+ move 
across the membrane simultaneously driven by a proton-motive force created by a chemical 
gradient. The transport was also insensitive to respiratory inhibitors and is thought to bypass 
the respiratory chain using molecular oxygen as a terminal acceptor. A 20kDa monomeric 
protein was isolated from the membrane vesicles which when reconstituted into liposomes 
restored specific proline uptake (Lee et al., 1979) and is likely to be a permease. The
-49-
In t r o d u c t io n
membrane vesicles ofM. phlei are also capable of active transport o f  glutamine and glutamic 
add.
The M . leprae 46kDa protein is thought to be membrane associated; its exact function is 
unknown (Oskame/ al., 1995). TheM  leprae genome sequencing project has also revealed 
67 genes showing homology to known membrane transport proteins in other species.
1.4 Colony morphology
The colony morphologies of strains of mycobacteria within a given species differ. This has 
previously been attributed to alterations in the components of the cell wall; recently cytosolic 
proteins have also been implicated (Prinzis et al., 1994). There appears to be a complex link 
between morphology and virulence.
A number of cell wall components have been shown to help determine colony morphology. 
Strains ofM. kansasii containing LOSs were found to be smooth variants, while those without 
LOSs had a rough colony morphology (Hunter et al., 1985). Smooth M. kansasii were 
avirulent whereas rough colony variants o f  M . kansasii contained no LOS and were found to 
be virulent. The LOS-containing avirulent strain Canetti of M. tuberculosis has a smooth 
colony morphology, whereas virulent M . tuberculosis strains, e.g. H37Rv, have a rough 
colony morphology and are devoid of LOSs (Daffe et al., 1991). However, subsequent work 
showed that a spontaneous rough mutant o f  the M. tuberculosis Canetti strain still contained 
LOS and that other smooth variants ofM. bovis and M. tuberculosis H37Rv did contain LOS 
(Lemassu et al., 1992).
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LOS-containing strains of M. fortuitum  biovar fortuitum  also exhibit rough colony 
morphology. The LOSs o f these strains are however elemental acyl trehaloses and the lack 
o f  a large oligosaccharide could account for their rough colony morphology (Besra et at., 
1992).
Three distinct colony forms are described for the M. avium  complex; smooth transparent 
(SmT), smooth domed (SmD) and rough (Rg) (Vestal & Kubica, 1966; Belisle and Brennan,
1994).
The genetic basis o f colony morphology has been investigated in M. avium  serovar 2 (Belisle 
et a t., 1993b). The studies revealed that two types of Rg variant occur which arise from 
separate genomic deletions. Those Rg variants still able to produce the lipopeptide core had 
a deletion in the ser2 cluster in the region responsible for the synthesis of the haptenic 
oligosaccharide. Those Rg variants that have lost total GPL had a large deletion to the right 
of the ser2 gene cluster; this implied the region was encoding the lipopeptide or controlled the 
regulation of its production (Belisle et at., 1993b).
The difference in morphology between the SmT and the SmD has recently been investigated. 
The smooth transparent variants have been shown to produce significantly larger quantities 
o f nsGPL and generally more total GPL than the SmD variants (Belisle et at., 1989). 
Subcellular fractions of the different morphological forms o f M. avium  serovar 2 and serovar 
4 were extracted and analysed. Cell wall proteins were remarkably conserved but a novel 
cytosolic protein o f 66 kDa was observed in large amounts in all batches o f SmT cells and was 
barely visible in other variants (Prinzis et at., 1994). Three proteins o f 33.41 and 66 kDa have
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been observed previously in smooth but not rough variants ofM  avium serovar 20 (Ramasesh 
et al., 1992).
1.5 Antimycobacterial drug targets 
1.5.1 Cell wall biosynthesis
Cell wall biosynthesis is believed to be a target o f a number o f antimycobacterial drugs 
including ethambutol, ethionamide, INH and cycloserine.
1.5.1.2 Cycloserine
Cycloserine inhibits incorporation of D-alanine into the peptidoglycan precursor, by 
competitive inhibition of the alanine racemase and D-alanine:D-alanine synthase by binding 
to  the D-alanine binding sites in the enzymes. Alanine racemase converts L-alanine to D- 
alanine (Winder, 1982).
1.5.1.3 Ethambutol
Ethambutol, a polyamine, inhibits the biosynthesis o f the arabinan and galactan components 
o f arabinogalactan (Takayama et al., 1989; Deng et al., 1995) and LAM to a lesser extent 
(Deng et al., 1995). Treatment with ethambutol also results in the cleavage of arabinosyl 
residues; over 50% were removed from the cell wall following a lhr exposure to the drug 
resulting in severe disruption to the cell wall (Deng et al., 1995). Ethambutol also results in 
accumulation of the decaprenyl-P-arabinose implying that the drug interferes with the transfer 
of arabinose to the acceptor molecule from the donor, decaprenol carrier (Wolucka et al.,
1994). If ethambutol interferes with an arabinose transfer enzyme then an explanation is still 
required for the arabinosyl cleavage activity; this may be an inherent function noticed only
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when arabinose synthesis is interrupted or the ethambutol may upregulate the function in some 
way (Deng etal., 1995). Ethambutol may also inhibit early glucose biosynthesis, as its effects 
can be overcome by the addition o f specific monosaccharides (Silve et al., 1993). The exact 
mode of action remains unclear although the ability to transfer resistance between strains using 
cloned DNA fragments may elucidate the situation (Young, 1994).
1.5.1.3 IN H  and Ethionam ide
INH and ethionamide are both believed to inhibit the biosynthesis of mycolic acids. Mycolic 
acid synthesis in whole cells of M. tuberculosis were shown to be inhibited by INH by 
following the incorporation of radioactively labelled [,4C]-acetate (Takayama et al., 1972). 
INH and ethionamide have both been shown to inhibit mycolic acid synthesis in cell-free 
systems of wall extracts from M. aurum, again inhibiting the incorporation of radioactively 
[I4C]-acetate into mycolates (Lacave et al., 1990b; Quemard et al., 1991 and 1992). The 
inhibition o f  mycolic acid biosynthesis by INH appears to be non-reversible in cell-free 
systems implying that INH is covalently bound to a component o f mycolate biosynthesis 
(Quemard et al., 1992).
In recent experiments an INH and ethionamide resistant strain ofM  smegmatis (mc2651), was 
isolated (Baneijee et al., 1994). A genomic library was made from this strain and used to  
transform wild type M. smegmatis, recombinant clones were screened for their ability to  
confer drug resistance. A single gene, irihA, thought to encode a 32kDa enoyl-ACP-reductase 
protein (section 1.2.2.2), was found to confer INH resistance when present on a multicopy 
plasmid in M  smegmatis and M. bovis BCG(Baneijee et al., 1994). A single point mutation 
was revealed in the inhA genes o f resistant strains o f M . smegmatis and M. bovis which
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converted a serine to an alanine (Baneijee et al., 1994) in the NADH binding site of the 
protein, suggesting that INH binds to this region of the protein preventing the NADH-specific 
reduction of 2-trans-enoyl-ACP (Dessen et al., 1995; Quemard et al., 1995). The InhA 
protein may represent a common target for both drugs and appears to explain the ability o f 
INH to inhibit the mycolic acid synthesis.
The development o f even higher levels o f INH resistance (up to 0.5mg/ml) has been 
associated with the loss of catalase and peroxidase activities, which has been confirmed by 
genetic evidence. The gene encoding catalase-peroxidase (katG) was found to be absent in a 
number of resistant M  tuberculosis and M  smegmatis strains and transformation of these 
strains with the functional katG  gene restored their INH sensitivity (Zhang et al., 1992 and 
1993). The sequencing of the entire katG gene (Heym et al., 1993) has allowed the use o f 
PCR-SSCP on resistant clinical isolates ofM. tuberculosis and M. bovis (Heym et al., 1993). 
Sequencing o f the PCR products has revealed missense mutations in the N-terminal 
peroxidase domain o f the protein which reduces the enzyme activity and in the C-terminal 
domain of the protein (Heym et al., 1995; Wilson et al., 1995). INH is thought to  act as a 
prodrug, being converted to an active form inside the bacteria, possibly by the catalase enzyme 
and it is this active form which appears to inhibit mycolic acid biosynthesis.
1.5.2 Protein synthesis and nucleic acids
Proton synthesis is the target o f the aminoglycosides streptomycin, kanamycin and amikacin. 
The drugs are believed to bind to the 16S rRNA resulting in misreading o f the genetic code 
and the inhibition o f translational initiation. The ribosomal S12 protein is believed to  stabilise 
a pseudoknot in the 530 loop o f the 16S rRNA involved in the selection o f cognate tRNAs
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at the ribosomal A site. Streptomycin resistant M. tuberculosis strains have been found to 
have point mutations in the 530 loop o f 16S rRNA and in their S12 protein (rpsL) genes 
(Finken et al., 1993; Meier et al., 1994; Honoré and Cole., 1994).
Fluoroquinolones disrupt the bacterial chromosome by inhibiting the supercoiling activity of 
DNA gyrase, DNA topisomerase II. The DNA gyrase genes, gyrA and gyrB, of M  
tuberculosis have been sequenced and resistant M. tuberculosis strains were found to have 
point mutations in the gyrA gene, causing mutations in the N-terminal sequence o f  the gyrase 
protein and presumably preventing binding of the fluroquinones (Takiff et al., 1994).
Rifampicin inhibits transcription by interacting with the P-subunit of the RNA polymerase. 
TheM  leprae and M. tuberculosis rpoB genes encoding the P-subunit have been cloned and 
analysed (Honoré and Cole, 1993; Telenti et al., 1993) Point mutations within the rpoB genes 
of M. leprae, M. tuberculosis and M. avium have been shown to confer resistance to 
rifampicin and have been found in two main regions of the gene, at a 23 aa cluster and at the 
serine-531, areas which correspond to the mutated regions in E. coli mutants.
1.5.3 Pyrazinamide
Pyrazinamide is a bacteriostatic, prodrug only active against M. tuberculosis (Konno et al., 
1967; Stottmeier et al., 1967). Pyrazinoic acid is the active form and has been shown to be 
active against resistant strains o f M. tuberculosis (Konno et al., 1967; Speirs et al., 1995). 
M. tuberculosis sensitive and resistant strains are also susceptible to an ester o f  pyrazinoic 
add, n-propyl-pyrazinoate (Speirs eta l., 1995). Pyrazinamide is converted to pyrazinoic acid 
by a pyrazinamidase enzyme, thought to be a pyrazinamidase/nicotinamidase enzyme, as cross
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resistance to both nicotinamide and pyrazinamide has been observed in M. tuberculosis 
(Konno et al., 1967). The activity of pyrazinamide is reliant on low pH (pH5.2) in vitro, 
not believed to reflect the intracellular conditions within phagocytic vesicles (Crowle et al., 1991). 
The low  pH is not a requirement for the action of the pyrazinamidase which has an optimal 
pH of 7.0 (Konno et al., 1967) but it may be a requirement for the action o f pyrazinoic acid 
on its target site. The specific site of action of pyrazinamide is unknown.
The natural resistance of M. bovis to pyrazinamide is believed to be due to a lack o f active 
pyrazinamidase enzyme, as pyrazinoic acid is active against M. bovis (Konno et al., 1967). 
The mechanisms of resistance o f  other mycobacterial species which possess pyrazinamidase, 
e.g. M . smegmatis, are unknown. Pyrazinoic acid has been shown to be inactive against M. 
smegmatis indicating poor uptake or an internal mechanism to prevent the action of the drug 
(Konno e ta l, 1967). The resistance may result from a lower level o f permeability to the drug, 
increased efflux o f pyrazinamide or pyrazinoic acid, a lack of target site or a combination of 
a number o f these factors.
1.6 M y c o b a c t e r io p h a g e s
Over 250 types o f  mycobacteriophage have been identified which have been reviewed by 
Grange and Redmond (1978). Mycobacteriophages have been widely employed for the phage 
typing o f  strains due to their variable host range and more recently for genetic studies.
1.6.1 Structure of the mycobacteriophages
Mycobacteriophages generally have hexagonal or oval heads and long non-contractile tails 
(Grange and Redmond, 1978), although occasional variants have been found, e.g. the
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contractile tail of 13. The head has been shown to consist of distinct circular capsonars, 
containing double stranded DNA (Grange and Redmond, 1978). Mycobacteriophages also 
show differences in the terminal structure of their tail and in the length and number of tail 
fibres. Mycobacteriophages also contain lipids which allow their inactivation by organic 
solvents i.e. chloroform and acetone (Castelnuovo et al., 1970).
Mycobacteriophages infect by initial adsorption to a receptor site on the cell wall through a 
terminal structure on their tails. Tail termini vary between mycobacteriophages indicating that 
their receptor sites on the cell wall are also variable (Imadeda and San Bias, 1969). The simple 
apolar nsGPLs have been shown to be receptor sites for mycobacteriophage D4 in M  
smegmatis (Goren et al, 1972) and other mycobacterial species. Other strains of M. 
scrofulaceum, M. avium and Mycobacterium butyricum were however unsusceptible to 
infection by D4. This has been shown to be due to the haptenic oligosaccarides of the ssGPLs 
which are thought to mask the terminal methylated rhamnose phage receptor site, thereby 
preventing phage adsorption and subsequent infection (Dhariwal et a l., 1986).
The pyruvulated simple LOSs of M. smegmatis have recently been shown to be the receptor 
sites for mycobacteriophage D29 (Besra et al., 1994b). The LOSs in M. smegmatis strains 
pseudolysogenic for D29 were found to exhibit extensive 0-methylation and 0-acylation, 
increasing the hydrophobicity of the molecule and rendering the bacteria resistant to infection 
by further D29 mycobacteriophages (Besra et al., 1994b). D29 is a lytic phage of 
M.smegmatis, that has also been shown to absorb to the surface o f  M .leprae (David et al., 
1978). Other phage receptor substances, although not fully characterized, appear to contain 
lipids and sugars and are probably lipopolysaccharides (Imaeda and San Bias, 1969; Grange
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and Redmond, 1978).
1.6.2 Mycobacteriophage infection
Infecting mycobacteriophages establish a lytic, lysogenic or pseudolysogenic relationship with 
the mycobacterial host.
1.6.2.1 Lytic and lysogenic infection
The mechanisms by which a lytic or a lysogenic infection are established have been greatly 
elucidated by the work of Hatfull, on the temperate mycobacteriophage L5. The whole linear 
genome (52kb) o f  L5 has been sequenced and found to contain 85 putative coding regions 
(Fig. 13) including a central att? site with an adjacent integrase, ini gene (Hatfull and Sarkis, 
1993; Lee and Hatfull, 1991). The genes on the right arm are transcribed in the leftwards 
direction and control the lysogenic state while the genes on the left arm encode the assembly 
proteins and are transcribed in the rightwards direction (Hatfull and Sarkis, 1993; Donnelly- 
Wu et al., 1993; Nesbit et al., 1995). The lysogenic state is thought to be induced by the 
production of the gp71 protein shown to confer superinfection immunity (Donelley-Wu et al., 
1993). The protein is initially expressed from the PkB promoter and thought to  be established 
by a phage encoded protein in the 72-82 region. This establishment protein prevents 
degradation o f gp71 by the host enzymes; the Pkft promoter is then repressed by gp71 and 
gp71 can initiate its own production from three promoters just upstream o f it ( PI, 2 and 3). 
The high expression is enough to maintain lysogeny despite still being degraded to some 
extent by the host proteins as the establishment protein is now switched off.
An imbalance in the gp71 and degradative host proteins is thought to lead to  the induction of
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the lytic cycle. Transcription from Pkft is initiated due to reduced gp71 which will initiate 
production o f the early lytic genes, resulting in the inhibition o f host RNA polymerase and 
total shutdown of host protein production. Late lytic expression of left arm genes may 
overcome the host shutdown by modification o f the host RNA polymerase (Nesbit et al., 
1995).
1.6.2.2 Pseudolysogeny
Pseudolysogeny is a state where the interaction of the phage with their host superficially 
stimulates the conditions of lysogeny, not replicating or integrating, but preventing further 
infection by other mycobacteriophage (Hayes, 1968). There are two mechanisms by which this 
is achieved; the first in which the host is infected with phage and strains are produced which 
appear to be resistant to phage infection, however the subsequent generations o f the resistant 
strains are susceptible to infection. This is caused by lysed bacteria releasing an enzyme which 
removes all the phage receptors from the surrounding cells preventing their infection. The 
second is carrier state pseudolysogeny in which the phage exist as a non-integrating prophage 
within the cell which prevents infection. The carrier cells will only allow the transfer of the 
prophage to one daughter cell following replication and so a proportion o f second generation 
cells become infectable. However, a proportion o f unstable prophages will also enter the lytic 
cycle, reinfecting surrounding daughter cells no longer harbouring phage and so maintaining 
the pseudolysogenic state in subsequent generations.
Pseudolysogeny has been reported in a number of mycobacteria including M. kansasii, M. 
chelonae, M . marinum and M. smegmatis (Grange and Redmond, 1978).
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1.7 Molecular genetics of mycobacteria
1.7.1 Expression systems for recombinant DNA in mycobacteria
1.7.1.2 Expression systems in E  coli
Eariy work in the isolation of mycobacterial genes was carried out using E. coli-based vectors 
and was mainly directed towards the cloning and expression of protein antigens for possible 
use in recombinant vaccines.
E  coli cosmid vectors such as pHC79 and Lorist 6 have been used to construct genomic 
libraries o f mycobacteria such asM  leprae (Clark-Curtiss et al., 1985; Eiglmeier et al., 1993). 
However, it was found that mycobacterial genes were not always expressed in these E. coli 
vectors e.g. a citrate synthase mutant of E .coli could not be complemented by an M  leprae 
homolog present in pHC79; only when the M. leprae homolog was expressed from a 
Streptococcus promoter in the E. coli pYA626 was complementation observed (Clark-Curtiss 
eta l., 1985). Defective expression of mycobacterial genes in E. coli was widespread, but not 
complete e.g. BCG libraries in pBR322 (Moss eta l., 1987) and pEMBL3 (Thole et al., 1985), 
without additional promoters were found to express the 65kDa antigen.
Recombinant DNA expression libraries of M . leprae and M. tuberculosis were constructed 
in the£L coli expression vector Agtl 1 to improve mycobacterial gene expression (Young et 
al., 1985a and b). The DNA (l-7kb) was inserted into the P-galactosidase gene (lacZ) and 
genes were expressed as fusion proteins from E. coli transcription signals. Plaques formed 
were immunoblotted with monoclonal antibodies and polyclonal antisera (Young et al., 1985a 
and b; Young et al., 1987; Vega-Lopez et a l., 1988) and a number o f M. leprae and M  
tuberculosis antigen genes isolated, e.g. members of the heat shock protein family, such as the
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65kDa (GroEL) of M. tuberculosis and M. leprae (Young et al., 1985a and b)
The first mycobacterial genes, encoding protein antigens of M. leprae (Young et al., 1985a; 
Clark-Curtiss et al., 1985) M. tuberculosis (Young el al., 1985b) and M. bovis BCG (Thole 
e t al., 1985) were therefore cloned and expressed in E. coli based vectors. Again, many 
mycobacterial genes could be not be expressed in these systems which was attributed to the 
inability o f the E. coli transcriptional apparatus to recognise mycobacterial transcriptional 
signals and emphasised the need for systems to express recombinant genes encoding 
mycobacterial antigens and enzymes in surrogate mycobacterial hosts e g. M. smegmatis, M. 
bovis,M. vaccae and Mycobacterium w (Snapper eta l., 1988; Jacobs eta l., 1991; Winterer 
al., 1991; Garbe eta l., 1994).
1.7.1.2 Expression systems in Mycobacteria
The nature o f the mycobacterial cell wall has made it difficult to extract the large amounts of 
recombinant DNA required for manipulation in expression systems, from mycobacteria. As 
a result the majority o f vectors developed for use within mycobacteria are shuttle vectors, also 
able to replicate in E. coli.
1 .7.1.2.1 Shuttle phasmids
Shuttle phasmids were among the first mycobacterial vectors to be developed and consisted 
o f  the E  coli cosmid pHC7 containing the regions of mycobacteriophage TM4 or LI 
(phAE19) genome required for replication in mycobacteria (Jacobs et al., 1987; Snapper et 
al., 1988). The shuttle phasmids replicate as phages in mycobacteria, which can go into lytic 
or lysogenic cycle, and as cosmids in E. coli. In a lysogenic state these vectors provide the
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means to introduce and express foreign genes in mycobacteria. The TM4 vectors did not form 
stable lysogens, unlike the LI shuttle phasmid (phAE19) which proved capable of expressing 
the kanamycin resistance aph gene (Tn90i), in M. smegmatis and M. bovis BCG and also 
prevented LI superinfection (Snapper et al., 1988). The size of DNA (2-4kb) which can be 
cloned into these vectors is limited by the requirements of mycobacteriophage packaging.
1.7.1.2.2 Shuttle plasmid-based expression systems
Plasmid shuttle vectors with an increased cloning capacity, a higher copy number (5 copies/ 
genome (Stover et al., 1991)) and an improved ease of manipulation, compared to the shuttle 
phasmids, were developed for mycobacteria. When the first plasmid vector was produced no 
native plasmids had been identified in slow-growing mycobacteria, so a derivative o f the M. 
fortuitum  plasmid, pAL5000 (Labidi et al., 1985) was created. The plasmid developed, 
pYUB12, was constructed from the E . coli pIJ666 plasmid (6.2kb), which contains the Tn5 
neomycin gene, the p i5A origin o f  replication and the chloramphenicol acetyl transferase 
(CAT) gene and pAL5000. pU666 was randomly inserted into pAL5000 (5kb) and kanamycin 
selected transformants able to grow in M. smegmatis were isolated; the plasmid DNA from 
one of these transformants was used as the vector, pYUB12. (Snapper et al., 1988 and 1990).
The pU666 plasmid was consistently inserted into one side o f the plasmid implying that the 
other side o f pAL5000 contained the mycobacterial origin o f  replication. pYUB72 contains 
a 2.6kb EcoRV-Hpal fragment from the side of pAL5000 apparently essential for replication 
and was found to stably transform M . smegmatis and M. bovis BCG when ligated to the 
Tn903 aph gene (Snapper et al., 1990). The number o f open reading frames (ORFs) believed 
to be present in pAL5000 varies from two (Labidi et al., 1992) to five (Rauzier et al., 1988).
-63-
In t r o d u c t io n
The EcoKL-Hpal region of the genome contains ORF1 (Labidi et al., 1992) or ORF1, 2 and 
5 (Rauzier et al., 1988). Construction of second generation shuttle plasmids further localised 
the mycobacterial replicon to 1.8kb (Ranes et al., 1990; Stover et al., 1991).
Various derivatives of the pAL5000 plasmid replicon have been combined with E. colt 
plasmid replicons, e g. ColEl and pl5A, to form shuttle vectors. The vector pMV261, an 
example of a second generation plasmid, also contains a multiple cloning site, the M. leprae 
hsp60 promoter and a transcriptional terminator (Stover et al., 1991). Selection markers other 
than kanamycin cassettes have also been used, section 1.7.1.2.4.
17 1.2.2 1 Integrative vectors
Integrating plasmid vectors have been developed to express single copies of genes in 
mycobacteria that can be maintained for many generations without selection which may be 
useful for vaccine formation. These vectors can be formed by insertion of the integration 
region o f a temperate phage or integrating plasmid.
The non-replicative integration-proficient vectors pMH94 and pMV361 were constructed by 
inserting the attP-int region of the mycobacteriophage L5 (Lee e ta l., 1991) into pUC119 and 
pMV261 On place o f oriM) respectively (Lee et al., 1991; Stover et al., 1991). pMH94 was 
found to form stable recombinants in M. smegmatis, M. tuberculosis and M. bovis BCG (Lee 
etal., 1991) while pMV361 has been found to  stably express foreign genes i.e. HIV-1 gpl20 
as fusion proteins in M  bovis BCG (Stover et al., 1991).
The integrating region of plasmid pSAM2 from Streptomyces ambofaciens was inserted into
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a vector containing the E.coli pBR322 replicon and Tn903 to create pTSN39, which stably 
integrated into M. smegmatis (Martin et al., 1991). There is also an attB  attachment site in 
theM  leprae chromosome (Eiglmeier et al., 1991) so it may therefore be possible to follow 
the growth, viability and drug susceptibility using pTSN39 with a reporter gene e g. luciferase 
(Jacobs eta l., 1993).
Suicide and conditional plasmids based on transposons have recently been created for 
insertional mutagenesis (section 1.7.3.2) (McAdam eta l., 1995; Guilhot et al., 1994)
1.7.1.2.3 Shuttle cosmid-based expression systems
A number of E. coli-Mycobacterium  shuttle cosmid vectors have been constructed 
appropriate for the formation o f mycobacterial genomic libraries. The large insert size (30- 
40kb) allows the mycobacterial genome (3-5Mb) to be represented in approximately 100 
clones and to provide the possibility for opérons o f genes encoding complex polysaccharides 
or lipids be cloned together, thereby increasing the likelihood of their expression; e g. the 
glycolipids o fM  avium cloned were expressed in M  smegmatis (Belisle et al., 1991).
Shuttle cosmids have been constructed by the insertion of bacteriophage X cos sequence into 
plasmid shuttle vectors e.g. Xcos was inserted into pYUB12 to form pYUB18 (Jacobs et 
al., 1991). Other shuttle cosmids include pMSCl (Hinshelwood and Stoker, 1992a) and 
Tropist4 based on the X origin double cos-site vector E. coli vector Lawrist4, the £coRv- 
Hpa\ fragment of pAL5000 and a number of unique cloning sites (De Smet et al., 1993).
1 .7 .1231 Integrating cosmid vectors
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An integrative cosmid vector pYU178 (5kb) has been developed which consists of the oriE, 
from pUC19, the L5 attP-int region, the aph kanamycin gene (Tn903) and the X cos sequence 
(Pascopella el al., 1994). This vector has been used to form integrating genomic libraries o f  
M. tuberculosis H37Rv and M. bovis BCG in surrogate mycobacterial host genomes Kf. 
tuberculosis H37Ra (Pascopella et al., 1994) and M. smegmatis, (Falcone et al., 1995), 
respectively.
1.7.1.2.4 Selectable markers
The choice o f antibiotic markers available for use in mycobacteria is limited by their natural 
resistance to a number o f antibiotics. The E. coli kanamycin resistance genes from Tn5 and 
Tn903, encoding aminoglycoside phosphotranferase are the most commonly used selection 
markers in mycobacteria (Snapper et al., 1988; Ranes et al., 1990; Stover et al., 1991). 
Hygromycin was first used as a selectable marker in M. smegmatis and M. bovis BCG 
(Radford and Hodgson, 1991); since then problems encountered in recovering transformants 
from M . tuberculosis (Zhang et al., 1992) Mycobacterium vaccae and Mycobacterium w  
(Garbe et al., 1994), when using kanamycin resistance, have been overcome by the use o f  
hygromycin as a selectable marker (Zhang et al., 1993; Garbe et al., 1994). Hygromycin is 
possibly more efficiently expressed than kanamycin in some Mycobacterium species as the 
gene is from Streptomyces hygroscopicus. It also provides a second selectable marker for 
genetic experiments in mycobacteria. Other selectable markers include the chloramphenicol 
acetyl transferase gene (cat) functional in M. smegmatis (Snapper et al., 1988) and the 
mercury resistant gene (pier) from Pseudomonas aeruginosa, functional in M. smegmatis, M . 
bovis BCG and M. tuberculosis. The mycobacteriophage L5 repressor gene 71 (Donnelly-Wu 
eta l., 1993), conferring superinfection immunity to phage L5, could be used as a selectable
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marker in recombinant vaccines thereby avoiding the use of antibiotic selection which may be 
transferred to a pathogenic bacteria in the host. A green fluorescence protein, (GFP) has 
recently been used as a selectable marker in M. smegmatis and M. bovis BCG on agar and in 
liquid culture. GFP has the advantage o f not requiring a substrate as it is detectable by 
exposure to ultraviolet (UV) light (Kremer et al., 1995a).
1.7.1.2.5 Reporter genes
A number of reporter genes have been successfully used in mycobacteria. The E. coli lacZ 
gene was first used to form fusion proteins with mycobacterial genes in E. coli expression 
systems (Young et al., 1985 a and b) and since has been successfully expressed in M. 
smegmatis and M . bovis BCG as a fusion protein (Timm et al., 1994). Transcriptional fusions 
have also been created with the lacZ gene to isolate and analyse mycobacterial promoters 
fromM  smegmatis andM  bovis BCG (Barletta et al., 1992; Dellagostin et al., 1995). The 
lacZ  gene also proved a successful reporter gene for mycobacterial gene expression in M. 
bovis BCG within macrophages (Dellagostin et al., 1995). E. coli phoA  has proved a reliable 
reporter gene for the isolation o f  M. tuberculosis and M. fortuitum  genes encoding exported 
protons in anM  smegmatis host (Lim et al., 1995; Kremer et al., 1995b; Timm et al., 1994). 
The E. coli cat gene (Das Gupta et al., 1993) and the xylE  (Curcic et al., 1994) have also 
been used to analyse and isolate M  tuberculosis promoters. The green fluoresence protein gfp 
gene (Kremer et a l., 1995a) and the firefly luciferase lux gene (Jacobs et al., 1993) are also 
important mycobacterial reporter genes.
1.7.1.2.6 Introduction o f DNA into mycobacteria
The cell wall of mycobacteria make them difficult to transform with DNA. Protoplasts were
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initially used to transform mycobacteria with plasmid and phage DNA at efficiencies of 103- 
104 pfu or cfii/yug of DNA (Jacobs et al., 1987). This was superseded by electroporation with 
efficiencies o f 10M06 cfu///g in M. smegmatis me2155 (Snapper et al., 1990) and M. bovis 
BCG (Snapper et al., 1988; Jacobs et al., 1991 ).M . smegmatis me2155 is an electroporation- 
efficient strain believed to have a mutation that affects plasmid replication or maintenance, as 
the efficiency of phage transfection and transformation of integrating plasmids is similar in 
mc2155 and the parentM smegmatis mc26 (Snapper et al., 1990). The introduction of DNA 
into M. smegmatis, M. tuberculosis and M  bovis BCG by means of recombinant 
mycobacteriophages e g. phAE40 is even more efficient (Jacobs et al., 1993). Conjugative 
transfer of plasmid DNA between E. coli and M. smegmatis has also been reported (Gormley 
and Davies., 1991).
1.7.1.2.7 M ycobacterial cloning host
M. bovis BCG has proved a useful host for the expression of foreign and mycobacterial genes 
(section 1.7.2.4) (Stover et a l , 1991 and 1993, Haeseleer et al., 1993).
M. smegmatis is a useful model host for the expression of mycobacterial genes as it is a non- 
pathogenic fast-growing species. M. smegmatis has proved a successful surrogate host for the 
faithful expression of mycobacterial genes o f M. tuberculosis (Zhang et al., 1992; Garbe et 
al., 1993; Yuan et al., 1995), M. avium  (Belisle et al., 1991; Mills et al., 1994) and M. bovis 
BCG (Falcone etal., 1995). M. smegmatis is however not always the most appropriate host; 
for example hybrid superoxide dismutase enzyme is produced when the M. tuberculosis sodA 
gene is expressed in M. smegmatis (Zhang et al., 1991; Garbe et al., 1994). However, the 
recombinant M. tuberculosis sodA gene is expressed in the native form in M. vaccae (Garbe
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etal., 1994) which may prove to be a more appropriate cloning host for some mycobacterial 
genes.
1.7.2 A pplications of recombinant dna systems in mycobacteria 
Gene transfer systems for mycobacteria have provided an important new tool for the study 
of mechanisms of drug resistance (section 1.5), the generation of novel recombinant vaccines, 
the isolation and regulation o f virulence factors and for genome mapping and sequencing.
1.7.2.1 Genome organisation and sequence
The formation of ordered genomic cosmid libraries of the two major mycobacterial pathogens 
M. leprae (Eiglmeier etal., 1993) andM tuberculosis (Cole and Smith, 1994) has unified the 
known genetic information and facilitated the project to sequence the genomes. The revealed 
sequence of both the M. leprae and the M  tuberculosis genome will provide an invaluable 
source o f  information (D. Smith, Collaborative Research Inc.) in the biochemical and 
immunological characterization of mycobacteria by identifying genes encoding relevant 
antigens and enzymes.
1.7.2.1.1 TheM. leprae genome
The ordered cosmid library o f  M. leprae was made in Lorist 6 (Eiglmeier et al., 1993) by 
blunt end ligation o f 35-50kb fragments o f M. leprae DNA into the vector, yielding 1000 
clones. The clones were subjected to fingerprint analysis and chromosome walking 
experiments from which the inserts were grouped into four contigs. Attempts made to close 
the gaps in the chromosomal map failed as adjacent clones are often highly unstable and 
readily delete on subculturing, implying that the regions could be toxic sequences (Eiglmeier
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e t al., 1993). With average insert sizes of 40kb the genome size was estimated at 2.8Mb 
which was in keeping with the predicted 3.3 ± 0.5Mb (Clark-Curtiss et al., 1985; Eiglmeier 
e ta l., 1993).
Thirty known M. leprae genes were mapped to positions on the contig map (Fig. 14) along 
with 13 housekeeping genes from M. tuberculosis, E. coli, Bacillus subtilis and various 
Streptomyces species, which, among others, enabled the rpoB, rpoC, tu f, rpoD, aroA, asd and 
recA genes of M. leprae to be identified. Most antigen coding sequences were found to be 
randomly distributed, whilst multiple copies o f known M  leprae repetitive elements RLEPs, 
were found in some regions and not in others. A total o f 29 RLEPs were identified which 
were grouped into four classes. Clustered RLEPs may represent a site recognised by proteins 
maintaining the structural integrity o f the chromosome.
The ordered set of M . leprae clones provided the starting material for the systematic 
automated sequencing of the M . leprae genome by Collaborative Research Inc. The 
sequencing is carried out using the multiplex sequencing method (Church and Kiefer-Higgins, 
1988) which is based on sample mixing and molecular decoding by oligonucleotide 
hybridisation (Fig. 15). Complete sequences are submitted to GenBank and MycDB (Bergh 
and Cole, 1994), which also contains all the physical mapping data from the M. leprae and M. 
tuberculosis ordered libraries. 2,238,856nt o fM. leprae and M. tuberculosis DNA has been 
sequenced to date and 3,234 sequence objects identified (GenBank update 1995; World Wide 
Web ate). O f the M  leprae ORFs identified just over half have been assigned functions based 
on their homologies with other known bacterial genes. The identified genes include those 
involved in DNA replication, recombination and repair, respiration, catabolism o f amino
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Fig. 14. The contig map of the M. leprae genome formed using an ordered cosmid library
The contig  map show s the position o f  selected sets o f  cosmids, their overlapping regions are shown below  the the contigs. The 
estimated size o f  each cosmid is also given. The positions o f  all known M  leprae genes (at the time o f  writing ,1993) and the RLEP 
sequences and their respective classes (1 ,2 ,3 ,5 ) (taken from Eiglmeier et al., 1993).Contig 35 contains cosmid BI308 at its left hand 
end (see section 3 .3.1).
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Fig .15 The sequencing strategy for the Genome Sequencing Projects of M. leprae and 
M. tuberculosis
High purity DNA preparations are made for each cosmid to be sequenced and a shotgun 
subclone library is then constructed in one of a set of 20 uniquely tagged “plex” vectors . 
Individual clones from 15-20 different subclone libraries are pooled and the DNA is purified 
from enough of the pools to guarantee a final eightfold random coverage for each cosmid. 
These samples are chemically sequenced, separated on polyacrylamide gels and transferred 
onto nylon membranes by using the direct transfer electrophoresis technique. The membranes 
are probed with labeled oligonucleotides to visualise sequence ladders from each subclone 
library individually. The membranes are stripped and reprobed upto 40 times providing a large 
number of films from each gel. The films are scanned using a CCD-based film or a lazer- 
scanning device, entered into the computer and assembled using the REPLICA and GTAC 
programmes (taken from Cole and Smith, 1994). Finished sequences are submitted 
electronically to GenBank and a mycobacterial mapping and sequence database MycDB.
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acids, organic acids, and aromatic compounds, regulatory functions, nucleotide biosynthesis, 
fatty acid and lipid biosynthesis, protein and carbohydrate synthesis, transport across the cell 
wall and cell wall synthesis. Operons of genes have also been observed e g. the polyketide 
synthesis gene complex, in cosmid BS18.
Two sequenced M. leprae cosmids have been analysed in detail, cosmid B1790 (Honoré et 
a l., 1993) and B961 (Fsihi and Cole, 1995). B1790 was found to contain 12 ORFs in 
36,716bp, 40% of the coding capacity, which encoded 5 ribosomal proteins, two elongation 
factors, the P and P' subunits of ribosomal RNA and two unknown proteins. One of the 
unknown proteins, end gene is homologous to the nfo gene of E. coli and the apurinic 
endonuclease of yeast both of which are involved in the repairing the base-free lesions in DNA 
caused by free radicals which may be important for the survival o f M. leprae in the 
macrophage, a prolific source of free-radicals (Honoré et al., 1993). B961 revealed 10 ORFs, 
7 isocitrate catabolite genes, 2 ATP-dependent transport systems and a novel polA  locus 
flanked by RLEPs, which may contain a promoter site (Fsihi and Cole, 1995).
Seventy-five percent of the codons end in G or C, initiation codons GTG and ATG were 
found and TAG was the most common termination codon in both cosmids (Honoré et al., 
1993; Fsihi and Cole, 1995).
1.7.2.1.2 M. tuberculosis genome and sequencing
Two cosmid libraries ofM. tuberculosis, in shuttle vector pYUB18 (Jacobs et al., 1991) and 
E. coli vector pYUB328 (Cole and Smith, 1994) are being ordered to form a map of the 
chromosome which currently contains 15 contigs. The contigs account for most of the
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chromosome (4Mb) predicted by the D ral physical map formed using pulse field gel 
electrophoresis (PFGE), with which the contigs can be correlated (Philip et al., 1993).
Twenty five known M. tuberculosis genes have been mapped to cosmids, these include katG, 
inhA, regX  and the fibronectin binding protein genes (Cole and Smith 1994). The one M. 
tuberculosis cosmid (TBC2, 32kb) sequenced so far was found to contain 23 ORFs which 
include the polyketide synthase operon and a homolog of the M. bovis BCG mycocerosic acid 
synthase gene (mas) (Cole and Smith, 1994); other cosmids are currently being sequenced.
1.7.2.2 Cloning o f genes involved in cell w all biosynthesis
The products of genes involved in cell wall biosynthesis may be potential drug target sites and 
possible virulence determinants; a few of these genes have been cloned.
The mas gene ofM  bovis BCG was cloned by N-termina! sequencing o f  the purified protein 
and screening of a Agtl 1 genomic library expression library (Mathur and Koiattukudy, 1992). 
The ORF was 6.3kb long, encoding a 22.5kDa elongating multifunctional enzyme with S 
domains: P-ketoacyl synthase, acyl transferase, dehydratase-enoyl reductase, P-ketoreductase 
and an acyl carrier protein (Mathur and Koiattukudy, 1992). The M. leprae and M. 
tuberculosis accBC genes, for the biotin carboxylase-biotin carrier protein have been cloned; 
the protein is believed to be a subunit of acyl-CoA carboxylase which carries out the first 
committed step fatty acid biosynthesis (Norman et al., 1994). This was achieved by the 
selection of a false-positive, biotin containing protein when screening an M . leprae Agtl 1 due 
to the streptavidin detection system (Norman et al., 1994). The M. bovis BCG NADP- 
dependent alcohol dehydrogenase gene, adh has been cloned, the protein is required for the
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esterification of long chain alcohols to form cell wall waxes (Stelandre et al., 1992).
The genes, set'!, involved in the biosynthesis o f the oligosaccharide segment of the M. avium 
serovar 2-specific glycopeptidolipid were cloned and expressed in M. smegmatis from a 
pYUB18:M avium genomic library (Belisle et al., 1991). The region of the M. avium genome 
responsible for the expression has been narrowed down to 5.7kb, with 4 essential loci, serA- 
D, serB and D  encode methyltransferases, serA rhamnosyltransferases and serC or serD the 
fucosyltransferases (Mills et al., 1994) (section 1.2.2.5). M. smegmatis was also used as a 
surrogate host to clone and express the M. tuberculosis cm al gene responsible for the 
formation o f cyclopropane rings at the double bond positions of M  smegmatis a mycolates 
(Yuan etal., 1995). The inhA gene encodes an enoyl-ACP-reductase thought to be involved 
in mycolic acid biosynthesis (sections 1.2.2.2 and 1.5.1.3) (Baneijee et al., 1994; Dessen et 
al., 1995; Quemard et al., 1995). The trehalose-6-phosphate synthases o fM  leprae andM. 
smegmatis have been cloned and expressed (De Smet et al., unpublished, 1995). The M. bovis 
BCG weso-diaminopimelate genes (m-dap) involved in peptidoglycan biosynthesis were 
cloned by complementation o f E. coli mutants (Cirillo et al., 1994). TheM. tuberculosis 
UDP-N-acetyl-glucosamine-enolpyruval transferase (murA) gene which catalyses the first step 
in peptidoglycan biosynthesis has also been cloned (Kempsell eta l., 1995, unpublished).
1.7.2.3 Virulence determinants
The construction of integrative cosmid vectors has allowed the non-virulent H37Ra strain of 
M. tuberculosis to be transformed with the entire genome o f the virulent strain H37Rv in an 
attempt to restore virulence. A 25kb genomic fragment, ivg, was isolated from the 
pYUB178::H37Rv library that conferred a more rapid growth rate o fM  tuberculosis H37Ra
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on passage through mice (Pascopella et al., 1994). The same in vivo complementation 
technique has been used to restore virulence to attenuated strains of M. bovis as assessed by 
a guinea pig model and lead to the isolation of a 2.7kb fragment of DNA which restored 
virulence (Collins et al., 1995). The complementing DNA encoded a principal sigma factor, 
rpoV, which was shown to contain a point mutation, that caused an arginine to  histidine 
change in a region of the protein known to interact with promoters. The RpoV is homologous 
to the sigma factors ofM. smegmatis (Predich et al., 1995) and is likely to be involved in the 
regulation of virulence genes (Collins et al., 1995). The formation of promoter probe and gene 
fusion libraries with reporter genes such as lacZ (Dellagostin et al., 1995), gfp  (Kremer et al., 
1995) and phoP  (Timm et al., 1994) are being used to investigate the regulation o f genes 
expressed inside macrophages (Dellagostin et al., 1995; Dhandayuthapani et al., 1995;). The 
phoA reporter gene is also being used to isolate genes encoding secreted proteins (Lim et al.,
1995) which may also be virulence factors. The differential production o f M. bovis BCG 
(Monahan et al., 1994) and M. tuberculosis (Lee and Horwitz, 1995) proteins inside 
macrophages is also being studied and a number of potential virulence proteins have been 
observed. The differential intracellular gene expression of M. avium in human macrophages 
is also being analysed by subtractive RNA analysis (Plum and Clark-Curtiss, 1994).
1.7.2.4 Recombinant vaccines
The one of the goals for mycobacterial molecular genetics is the development of a 
recombinant BCG (rBCG) vaccine system delivering heterologous antigens. Foreign genes 
e.g. HTV-lpl7 gag have been successfully expressed in M. bovis BCG (Stover et al., 1991) 
using pMV261 and pMV361 and were shown to elicit an immune response. Foreign proteins 
expressed in rBCG have also been shown to be protective in animal models of disease e.g.
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BCG expressing the OpsA protein of Borellia burgdorferi has been shown to elicit sterilising 
immunity in mice (Stover et al., 1993).
The simultaneous expression and delivery of multiple foreign antigens is also a priority in the 
development of rBCG vaccine vectors. The simultaneous expression of two antigens from P. 
falciparium  in rBCG (Haeseleer et al., 1993) is an encouraging result for the potential 
production of multivalent rBCG vaccines, which would elicit a protective immune response 
to each foreign antigen.
Early experiments in E. coli expression vectors led to the isolation of a number of 
mycobacterial protein antigens in the search for protective antigens. It remains unclear which 
additional M  tuberculosis protein antigens would provide effective protection against 
infection when expressed from rBCG. M  smegmatis is also a potential vaccine delivery 
vehicle and has been shown to express immunogenic recombinant M. bovis BCG genes 
(Falcone et al., 1995).
1 .7 .3  M u t a g e n e s i s  i n  m y c o b a c t e r i a
The isolation and characterisation o f mutations in the genomes of mycobacterial species is 
crucial for the analysis of gene function and regulation. A variety of strategies for the creation 
of mutant strains of the fast and slow-growing mycobacterial species have been developed.
2 .7.3.1 Chemical mutagenesis
A number o f fast growing mycobacterial species i.e. M. smegmatis (Holland and Ratledge, 
1971; Subramanyametal., 1989; Hinshelwood and Stoker, 1992b)M. fortuitum ,M . vaccae
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(Subramanyam et a l., 1989) and M. phlei (Konickova-Radochova et al., 1970) have been 
successfully mutagenised using the chemical mutagen N-methyl-N'-nitro-N-nitrosguanidine 
(NTG). The percentage of stable auxotrophic mutants produced by the treatment varied from 
0.02% in M. vaccae to  0.46% in M. smegmatis (Subramanyam et al., 1989); the highest 
values were found in M . smegmatis and M. phlei. INH-enrichment of mutagenised cultures 
increased the efficacy o f mutagenesis up to 0.9% in KÍ. smegmatis (Holland and Ratledge, 
1971). As INH is only effective against actively growing bacteria it enriches for slow growing 
auxotrophs. Other mutagens tested on M. phlei included UV irradiation, hydroxylamine and 
ethyl methanesulfonate, only the latter produced levels of stable mutants comparable with 
NTG (Konickova-Radochova., 1970).
1.7.3.2 Transposon mutagenesis
Transposon mutagenesis is an efficient means of generating libraries o f insertion mutants. The 
mutant mycobacterial strains can be easily selected by antibiotic resistance marker, e g. 
kanamycin, and the problems of clumping are avoided. Two transposon mutagenesis libraries 
have been formed in mycobacteria, one in the slow-growing M .bovis BCG (MeAdam et al.,
1995) and the other in the fast-growing M. smegmatis (Guilhot et al., 1994).
TheM  bovis BCG mutagenesis procedure has employed the use o f a suicide vector which is 
unable to replicate in M . bovis BCG, transformants can therefore be isolated by selection on 
the selectable marker encoded for by the transposon. The transposon was constructed by 
inserting the aph kanamycin resistance gene into the M. smegmatis IS1096 insertion element. 
The transposon was cloned into a derivative of pMV261 in which the oriM  had been disabled 
and which contained a tetracycline resistance gene (tetr). The vector was transformed into M
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bovis BCG by electroporation and kanamycin resistant transformants (102-103 cfu/ug) 
selected. O f923 transformants screened 3 auxotrophs (two leucine and one methionine) were 
isolated, an efficiency o f 0.325%. The auxotrophs were all stable with reversion frequencies 
of 1x10"7-2x10'7 (McAdam et al., 1995).
The M. smegmatis transposon library was formed using a conditionally- replicating plasmid 
(Guilhot et al , 1992). The plasmid, pCG79, is a thermosensitive shuttle vector (pCG63) that 
replicates at 30°C but not at 39°C, (due to the thermosensitive mutations for replication in 
the pAL5000 replicón) and that contains the Tn<5/7 transposon (Guilhot et al., 1994). Stable 
auxotrophic mutants were isolated at frequencies o f  0.1-0.4% with reversion rates o f  2x10' 
‘/cell.
Random shuttle insertional mutagenesis has also been successfully performed on an M  
smegmatis plasmid DNA library in an E. coli host using an E. coli transposon Tn5 seql. The 
transposon containing recombinant plasmids were reintroduced into the M. smegmatis 
chromosome by homologous recombination and three auxotrophic mutants were isolated 
(Kalpana et al., 1991). This approach has been used subsequently for mutational analysis of 
the M. avium ser2 loci (Mills et al., 1994).
1.7.3.3 Homologous recombination
Homologous recombination has been successfully employed in other bacterial systems to 
create specific chromosomal mutations to investigate gene functions. Although homologous 
recombination has been achieved inM  smegmatis (Husson et al., 1990; Kalpana et al., 1991) 
attempts to use this approach in the clinically important slow-growing M. tuberculosis and
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M. bovis BCG have been unsuccessful (Kalpana et al., 1991). M. tuberculosis and M. bovis 
BCG exhibit high levels o f illegitimate recombination (Kalpana et al., 1991; Colston and 
Davies, 1994) and single rather than double cross-over events obtained (Aldovini et al., 
1993). Recently, gene replacement has been achieved in M  bovis BCG, with the accBC gene 
(Norman et al., 1995) and theM  tuberculosis urease gene, ureBC, (Reyrat et al., 1995), in 
M. intracellulare (Marklund et al., 1995) and in M. tuberculosis with 40-50kb lengths of 
DNA (Balasubramanian et al., 1996).
Homologous recombination may be limited by the unusual nature of the M. tuberculosis Rec A 
protein which contains an additional internal sequence (intein), that has to be removed by a 
protein splicing mechanism (Davis et al., 1991; Davis et al., 1992; Davis et al., 1994). A 
similar structure has been observed for M. leprae Rec A but not other mycobacteria eg . M  
smegmatis (Davis et al., 1994; Colston and Davis, 1994).
1.8 P r o j e c t  a im s  a n d  o b je c t iv e s
The main objective of this project was to isolate M. leprae genes encoding cell envelope 
biosynthetic enzymes using an M  smegmatis model system.
The cell envelope of mycobacteria is a complex structure which is believed to contain many 
of the elements responsible for the pathogenicity, toxicity and virulence associated with M. 
leprae, M. tuberculosis and M. avium. The cell envelope also confers a permeability barrier 
that underlies the resistance of mycobacteria to many existing antibacterial agents. The 
isolation and subsequent mutational analysis o f cell envelope genes should elucidate the 
function and biosynthetic pathways o f  encoded cell envelope components. Ultimately, this
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may lead to the design of target specific antimycobacterial drugs.
The inability to culture M. leprae has made it extremely difficult to determine the functions 
o f A/, leprae components. The proven ability to express M. leprae genes in a surrogate 
mycobacterial host e g. M. smegmatis would provide a useful system for the further study o f 
M. leprae and so the decision was made to try and isolate M. leprae genes functional in an 
M. smegmatis host.
The aim of the project was to isolate a cell envelope mutant of M. smegmatis and to 
complement the mutation with a functional, possibly homologous M  leprae gene from an M. 
leprae genomic shuttle cosmid library.
The isolation of a cell envelope mutant o f mycobacteria is difficult as there are no clear cut 
phenotypes to select such mutants. Phenotypic changes which may define cell envelope 
mutations include alterations in antibiotic resistance and sensitivity, phage resistance, the 
binding o f mAb specific to cell wall components, e g. PGL-1, and binding of lectins to 
carbohydrate components of the cell wall. A single cell wall mutant o f M . smegmatis, 
defective in its mycolate formation (Kundu et al., 1991), had been isolated at the initiation o f 
this project. This mutant was isolated by the screening of M. smegmatis mutants for increased 
sensitivity to penicillin G.
1 .8 .1  T h e  isolation of an M  s m e g m a  r i s  mutant
The initial aim was to screen M . smegmatis mc2155 for spontaneous resistance to 
mycobacteriophage which may be caused by the alteration of the phage receptor in the
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mycobacterial cell wall.
The screening for spontaneous phage resistance proved unsuccessful and it was decided to 
form  an M. smegmatis mutant bank which could be screened for a number phenotypic 
changes. It was decided to create mutant M. smegmatis mutants using the chemical mutagen 
N TG  shown to generate 0.1-0.9% auxotrophic mutants (Holland and Ratledge, 1971) as the 
methodology was available in the laboratory (Hinshelwood and Stoker, 1992b). Transposon 
mutagenesis was not available and as NTG produces point mutations rather than truncated 
proteins it would possibly result in fewer lethal mutations of cell wall components.
1.8.1.1 Screening methods fo r  potential cell envelope mutants o f  M. smegmatis 
A bank of these treated mutants were screened for resistance to lytic mycobacteriophage, eg. 
D29, D4, D33, and changes in antibiotic sensitivity and resistance.
Lytic mycobacteriophage were used, some which have known receptor sites on the cell wall 
e.g. D29, the LOSs (Besra et al., 1994b) and D4 the GPLs (Goren et al., 1972).
Resistance to antibiotics could be caused either by a change in the permeability of the cell 
envelope or by an alteration in the drug target sites. NTG-treated M  smegmatis strains were 
therefore mainly screened for resistance to drugs whose target site is thought to be associated 
w ith cell wall biosynthesis i.e. ethambutol, ethionamide and cycloserine; as well as for 
resistance to other antibiotics in which resistance could be caused by a decreased permeability.
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Increased antibiotic sensitivity could be due to increased cell envelope permeability, the NTG- 
treated strains were therefore screened for increased sensitivity to penicillin G and 
pyrazinamide, to which M. smegmalis is naturally resistant; this was a similar method to that 
employed by Kundu et a/.(1991) to isolate the mycolate mutant o fM  smegmatis.
Any mutants isolated would be fully characterised in an attempt to determine the target of the 
mutation, the analysis would include biochemical analysis of the lipid components of the cell 
wall to look for any alterations in the components of the cell wall (Dobson et al., 1985).
1 .8 .1  C o m p l e m e n t a t i o n  w i t h  M. leprae g e n o m i c  l i b r a r y
Having isolated an M  smegmatis mutant the aim was to complement the mutation using an 
M. leprae cosmid library. The mutant strain would be transformed with the M. 
leprae:.pYUB18 cosmid library. It was elected to use a cosmid library because if the 
complementing M. leprae gene was part of an operon it was more likely to be expressed. 
Operons of mycobacterial genes have been shown to be expressed in surrogate hosts i.e. the 
ser2  genes of M. avium have been expressed in M. smegmatis (Belisle et al., 1991). The 
complementing region of the cosmid DNA would then be isolated by the formation o f a 
sublibrary of the cosmid DNA in the plasmid pMV206. The complementing DNA could also 
be sent for mapping to the ordered M. leprae cosmid library (Eiglmeier et al., 1993), to 
determine whether it had been sequenced in the M  leprae genome sequencing project.
This thesis describes the formation of a bank ofM. smegmatis mc2l 55 NTG treated cells with 
0.1-0.2% levels o f auxotrophy and the isolation of a number o f M. smegmatis mutants 
including a pyrazinamide sensitive M  smegmatis mutant, with decreased hydrophobicity
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which has been complemented using th eM  leprae pYUB18 genomic cosmid library. The 
complementing region ofM. leprae DNA, which restores pyrazinamide resistance to theM  
smegmatis mutant, is 3.5kb region of th eM  leprae B1308 cosmid and has been shown to 
contain three complete putativeM leprae open reading frames (MycDB and GenBank, 1995;
D. Smith, Collaborative Research, Inc).
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Materials and M ethods
2.1 Determination of concentration and purity of DNA solutions
100-fold dilutions of sample DNA were prepared with sterile distilled water (SDW) in 1.5ml 
microfiige tubes. A quartz cuvette containing SDW was used to blank a UV 
spectrophotometer set at a wavelength of 260nm. 1ml of the dilute DNA solution was placed 
in the quartz cuvette and placed in the spectrophotometer and an absorbance (A260) reading 
taken. This was repeated with the spectrophotometer set at a 280nm wavelength. The 
concentration and purity of the DNA was determined whereby 1.0A26„=50pg/ml of double 
stranded DNA and the sample is pure when A260/2g0=l .8or greater, as stated in Sambrook et 
al., (1989).
2.2 Gel electrophoresis
Electrophoresis in agarose gels was used according to the methods described in Sambrook 
et al., (1989). Agarose gel electrophoresis was carried out using 0.8% agarose 
(Electrophoresis grade agarose, Gibco, BRL) containing 0.2^g/ml ethidium bromide (Sigma), 
in TAE buffer (Appendix B), unless otherwise stated. Medium gels 16.5x 12cm (Flowgen) or 
15x14cm (NBL) were run at 80V for 3-4hr or at 15V for 16-20hr. Minigels 7x7.5 cm (NBL) 
were run at 100mA for 20-40min. 2//1 of bromophenol blue loading dye (0.25% w/v 
bromophenol blue [Sigma], 0.25% w/v xylene cyanol FF [Sigma], 30%v/v glycerol [BDH]) 
were added for every 10/zl of DNA sample prior to loading on the gel for samples >1.5kb. 
Orange G dye (0.25%w/v Orange G [Sigma], 30%v/v glycerol [BDH]) was used with DNA 
samples <1.5kb in size, often PCR products, as the dye runs ahead of small products ensuring 
the DNA remains visible under UV light. 3/zl of Orange G were used for every 10/zl of DNA 
sample to be loaded. DNA size markers A///«dill (AH3 [Promega]) and A.Z/mdlH/EcoRI 
(XH3E1 [Promega]) were diluted with bromophenol blue loading buffer and SDW to give a
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concentration of 0.05/^g//ri and 10/^ 1 run on gels to determine the size of the sample DNA 
loaded. For DNA samples <1.5kb such as PCR products a 123bp ladder (NBL) was diluted 
with SDW and Orange G loading buffer to a concentration of 0.05/zg//ri and 10^1 were 
loaded. The DNA was visualised on a UV transilluminator and recorded photographically with 
a Gel Documentation System (UVP)
2.3 Phenol extraction of DNA
Phenol extractions were performed as stated in Sambrook et al., (1989). The aqueous DNA 
solution was made up to at least 200//1 with SDW when extracting impurities. An equal 
volume of TE-equilibrated phenol pH 7.5 (Sigma) was added to the DNA , in a 1.5ml 
microfuge tube (unless otherwise stated). The solution was mixed by inversion, and the two 
phases separated by centrifugation at 10,000xg (13,000rpm) in a microfuge tube, (unless 
otherwise stated) for lmin. The upper aqueous phase was transferred to a new 1.5ml 
microfuge tube taking care not to carry over any debris from the interface. An equal volume 
of phenol: chloroform: isoamylalcohol (25:24:1) (Sigma) was added, the phases mixed and 
then separated by centrifugation. Again the aqueous phase was removed and re-extracted with 
an equal volume of chloroform:isoamylalcohol (24:1) (Sigma), as above. The DNA was then 
recovered from the final aqueous solution by ethanol precipitation (section 2.4).
2.4 Ethanol precipitation of DNA.
Ethanol precipitations were performed as stated in Sambrook et al., (1989). DNA was 
precipitated from aqueous solution by the addition of 0.1 volume 3M Na acetate pH4.8, and 
2 volumes 100% ethanol and followed by incubation at -20°C for 30min. The solution was 
then centrifuged at at 10,000xg (13,000rpm) for 15min to pellet the DNA. The excess ethanol 
was removed with a 200//1 Gilson pipette, taking care not to dislodge the DNA pellet. The 
DNA pellet was washed, to remove excess salt by resuspension in a 0.1 volume o f 70% 
ethanol followed by centrifugation as above. The 70% ethanol was removed and the DNA
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pellet was air-dried and resuspended in TE buffer (Appendix B).
2.5 DNA MODIFICATION PROCEDURES
The majority of these procedures were carried out as stated in Sambrook et al„ (1989), unless 
otherwise stated.
2 .5 .1  Restriction enzyme digests
Restriction enzyme digestions were carried out according to the manufacturers instructions 
i.e. with one unit of enzyme///g of DNA present in the reaction volume. Reaction buffers were 
added in 0.1 or 0.2 volumes depending on the concentration of the buffer provided by the 
manufacturer. The reactions were usually carried out in 20pl for small digests (l^g) and 
100/^ 1 for large scale digests (10-20Mg). Care was taken to ensure that the volume of enzyme 
added did not exceed 1/10th of the entire reaction volume, above which the glycerol in the 
enzyme storage buffer could become inhibitory. The reactions were left to proceed at 37°C, 
unless otherwise stated, for lhr or overnight. Restriction enzymes were supplied by Promega, 
Gibco BRL and Boehringer Mannheim.
2 .5 .2  Alkaline phosphatase treatment
Alkaline phosphatase treatment was used to prevent the re-ligation of compatible ends of 
linear DNA, when required. The linear DNA was treated with 0.1 unit/yug of calf intestinal 
alkaline phosphatase (CIAP, Boehringer Mannheim) in a reaction volume containing 0.1 
volume of lOx CIAP buffer, at 37°C for 15min. The solution was then heated at 72°C for 
lOmin to halt the reaction and the DNA cleaned using the Wizard DNA Clean Up Kit 
(Promega; section 2.6.1).
2 .5 .3  DNA end-repair
End repair of sonicated insert was performed to create blunt ended DNA. 2.5mM dNTPs and
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2M MgCl2 were added in l/10th volumes to a given volume of DNA solution resulting in a 
final concentration of 0.5mM dNTPs and 50mM MgCl2. 1.5/ri (5-10u/|il) of T4 DNA 
polymerase (Promega) were added to the solution which was left at room temperature for 15 
min. This was followed by the addition of 1//1 (5-10 units/pl) Klenow DNA polymerase 
(Promega) and a further 15min incubation at room temperature. The reaction was inhibited 
by heating at 68 °C for 15min.
2 .5 .4  D N A  LIG A TIO N
Ligation reactions were usually performed in a 10/^ 1 reaction volume containing 750ng of 
insert DNA, 250ng of vector DNA, 1//1 of lOx ligase buffer and 3 units of T4 DNA ligase 
enzyme (3,000u/ml, Boehringer Mannheim). The reactions were left to proceed overnight at 
4°C.
2.6 DNA PURIFICATION
Following restriction enzyme digestion, alkaline phosphatase treatment or DNA size selection 
from agarose gels, DNA samples required purification. The removal of enzymes, buffer and 
agarose allowed the DNA to be successfully manipulated in further reactions.
2 .6 .1 . W i z a r d  C l e a n  U p  S y s t e m  ( P r o m e g a )
DNA purification was achieved with the Wizard DNA Clean Up Kit produced by Promega. 
The kit was used according to the manufacturers instructions. 1ml of DNA purification resin 
was added to the designated DNA solution in a 1.5ml microfuge tube and mixed by gentle 
inversion. On purification of DNA from agarose, the DNA band was excised using a sterile 
scalpel blade in approximately 300mg of agarose and transferred to a 1.5ml microfuge tube. 
The agarose was then incubated at 70°C, with 3x w/v 6M Nal until it had completely 
dissolved, before adding the resin. A 2ml disposable syringe was taken, the plunger removed 
and the syringe attached to the barrel of a Wizard minicolumn. The resin/DNA mix was
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pipetted into the syringe and the slurry gently pushed through the minicolumn with the syringe 
plunger. The syringe was removed from the minicolumn, its plunger was removed and the 
syringe reattached to the minicolumn. 2ml of 80% isopropanol were then pipetted into the 
syringe and gently pushed through the minicolumn with the plunger. The minicolumn was then 
transferred to a 1.5ml microfuge tube and centrifuged for lmin at 10,000xg (13,000 rpm) to 
dry the resin. The minicolumn was transferred to a new 1.5ml microfuge tube and 30-50/ri of 
TE buffer pre-heated to 70°C was added to the minicolumn and left for lmin. The minicolumn 
was then centrifuged at 10,000xg (13,000rpm) for lmin to elute the DNA. The 30-50/ri of 
DNA sample were stored at -20°C.
2.7 C u l t u r e  o f  E. c o l i
Cultures were grown in Luria Broth (LB; Appendix A) and incubated at 37°C with shaking 
(200rpm), for 16-20hr, or on LB plates and incubated at 37°C for 16-20hr. Antibiotic 
selection for plasmid or cosmid maintenance was achieved by the addition of kanamycin 
(Sigma) or ampicillin (Sigma) to give a final concentration of 50^g/ml.
2.8 P r o d u c t io n  o f  c o m p e t e n t  E. c o l i  c e l l s .
The following method was described by D. Hanahan and developed by V. Simanis (Imperial 
College London). 100ml of SOB (Appendix A) in a 11 flask was inoculated with several, 2-3 
mm, E. coli colonies grown overnight on minimal media, at 37°C. The culture was incubated 
for 4 hours at 37°C until the cell density was 4-7 xlO7 viable cells/ml (A ^  0.6-0.8). The 
culture was transferred to two chilled 50ml polypropylene tubes and incubated on ice for 
15min. The cells were pelleted by centrifugation at 3500xg (4,000rpm) for 15min at 4°C. The 
supernatant was discarded and the pellet gently resuspended in 1/3 volume of RF1 ( lOOmM 
RbClj, 50mM MnCl2.4H20 , 30mM K acetate, lOmM CaCl2.2H20 , glycerol 15%w/v, pH5.8) 
and the cell suspension incubated on ice for 15min. The cells were pelleted, as before, 
resuspended in 1/25 volume RF2 (lOmM MOPS, [BDH] lOmM RbCl2,75mM CaCl2, 15%
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glycerol, pH6.8 ) and incubated on ice for a further 15min. 1ml aliquots of the cell suspension 
were then distributed into chilled screwcapped tubes, snap frozen in an ethanol/dry ice bath 
and stored at -70°C.
2.9 Transformation of E . c o u
Transformation of competent E. coli was carried out using the method described in Sambrook 
et al., (1989). A 200//1 aliquot of competent E. coli cells (section 2.8), thawed on ice, was 
added to a pie-chilled 1.5ml microfuge tube containing 1/^g of the appropriate DNA solution. 
The cells were incubated on ice for 30min, heat shocked at 42°C for 90s and returned to ice 
for 2min. The cells were then inoculated into 1ml of LB and incubated at 37 °C with shaking 
for 1 hr. When small (ng) or unknown amounts of DNA were used the cells were pelleted by 
centrifugation at 3500xg (4,000rpm), resuspended in 200/^1 of LB and spread on LB agar 
plates (6cm), containing the appropriate antibiotic. When larger amounts of DNA (¿¿g) were 
used 200/^1 (1/5 volume) of cell culture was spread onto the plate, without pelleting the cells 
first. All plates were then incubated at 37°C for 16-20hr to allow colony formation.
2.10 Transformation of E . c o u  with M . l e p r a e  cosmid library phage
LYSATE
This method was carried out as stated by Eiglmeier et al., (1993). 100ml of LB supplemented 
with 0.02% maltose and 10mM MgS04 were inoculated with 2-3 colonies of E. coli NM554 
and the culture was incubated at 37°C for 3-4hr with shaking (200rpm). When the culture 
reached late log-phase growth (0.6-0.SA ^), the cells were pelleted by centrifugation at 
3500xg (4,000rpm) in 50ml polypropylene tubes. The cells were washed twice in 10ml of 
10mM MgS04 and finally resuspended in 8ml LB. 100^1 of cell suspension was placed in a 
1.5ml microfuge tube and 5//1 of phage lysate added. The cells were left at room temperature 
for 30min whereupon 800//1 of LB were added and the solution was incubated at 37 °C
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(without shaking) for lhr. The cells were then pelleted by centrifugation at 10,000xg 
(13,000ipm) for 2min and resuspended in 200/ri LB. The cells were then spread on selective 
LB agar plates containing kanamycin at a concentration of 50^g/ml.
2.11 Small scale plasmid preparation from E . c o l i
All plasmid DNA isolation from E. coli was based on the alkaline lysis method of Bimboim 
and Doly (1979).
Cells from a 5ml overnight culture, incubated at 37°C in Luria broth (LB) containing 50//g/ml 
of the selective antibiotic, were pelleted by centrifugation at 3500xg (4,000rpm) for 7min. 
The pellet was resuspended in 200//1 of GET (50mM glucose, 70mM EDTA, 50mM Tris-Cl 
pH8) containing 2mg/ml lysozyme (Sigma), transfered to a 1,5ml microfuge tube and placed 
on ice for 5min. 400/ri of alkaline SDS solution (0.2M NaOH, 1%SDS) were added, the 
solution mixed thoroughly and left on ice for 5min. This was followed by the addition of 
300//1 of 3M sodium acetate pH4.8 and a 5min incubation on ice. The precipitate was pelleted 
by centrifugation at 10,000xg for lOmin and the supernatant was decanted into a clean 1.5ml 
microfuge tube. An equal volume of phenol:chloroform:isoamyl alcohol (25:24:1) (Sigma) 
was added to the supernatant, the solutions mixed by inversion and centrifuged at 10,000xg 
for lmin. The upper aqueous layer was retained, transferred to another 1.5ml microfuge and 
the extraction procedure repeated. A 0.5 volume of isopropanol (BDH) was added to the 
retained aqueous upper layer, the solution was left at room temperature for 15min before 
being centrifuged at lO.OOOxg for 15 min to pellet the DNA. The supernatant was discarded 
and the DNA pellet air dried before being washed in 200/ri of 70% ethanol. The solution was 
recentrifuged at 10,000xg for lOmin to repellet the DNA and the 70% ethanol discarded. The 
DNA pellet was air dried and resuspended in 50/u\ of TE buffer. 1 //I (19 units) of RNAase T 1 
(1930 units/^1; Boehringer Mannheim) was added to the DNA solution which was incubated 
at 37°C for lhr.
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2.12 Midi plasmid preparation from E .  c o u .
The strain of E. coli carrying the plasmid DNA was streaked out onto LB agar containing 
50/^g/ml of the selective antibiotic required by the plasmid and grown for 16-20hr at 37°C. 
50ml of LB, containing 50/zg/ml of the appropriate antibiotic, was inoculated with a single 
colony from the overnight plate. The culture was then incubated at 37°C, with shaking, for 
16-20hr. The cells were then pelleted by centrifugation at 3,500xg (4,000rpm) in 50ml 
polypropylene tubes for 15min. All traces of excess medium were removed from the E. coli 
cells, which were the resuspended in 5ml GET solution (section 2.11) containing lysozyme 
(Sigma) at 2mg/ml and incubated on ice for 30min. The cells were then lysed by the addition 
of 10ml alkaline SDS (section 2.11) followed by incubation on ice for lOmin. 7.5ml o f  3M Na 
acetate was then added to the solution and incubated for a further 60min before pelleting the 
cell debris by centrifugation of the solution at 3,500xg for 20min. The supernatant was 
retained and placed in a clean 50ml polypropylene tube with an equal volume of 
phenol:chloroform:isoamylalcohol (25:24:1 [Sigma]) and mixed by inversion. The two phases 
were separated by centrifugation and the upper aqueous layer was removed without disturbing 
the debris at the interface of the two phases. An equal volume of chloroform was added to the 
aqueous layer and the solution mixed and centrifuged, as stated above. Again the aqueous 
upper layer was retained and 0.5 volumes of isopropanol were added. The solution was mixed 
by inversion and left to stand at room temperature for 15min. The DNA was then pelleted by 
centrifugation of the solution at 3,500xg for 20min. The supernatant was discarded and any 
excess removed using a Gilson pipette 200/ri tip. The DNA pellet was washed in 1ml 70% 
ethanol, to remove any excess salt and recovered by centrifugation of the solution at 3500xg 
for lOmin. Excess ethanol was removed and the DNA pellet left to air dry before being 
resuspended in 500^1 TE buffer. 200U of RNAase T1 (Gibco BRL) were added to the DNA 
solution and incubated at 37°C for 16-20hr to digest any RNA present. The RNAase and 
excess nucleotides were removed by further phenol xhloroform and chloroform extractions 
(section 2.3), the DNA was then recovered by ethanol precipitation (section 2.4). The DNA
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was resuspended in 300//1 of TE and stored at -20°C until use.
2.13 Large scale plasmid preparation from E. c o l i using the Qiagen
METHOD
The Qiagen maxi prep method has a maximum yield of 500mg DNA from 150-500ml. The 
cells of a 400ml culture, grown at 37°C overnight, were pelleted by centrifugation at 3,500xg 
(4,000rpm) for 15min. The cells were gently resuspended in 10ml of solution PI (RNAase A 
[lOOmg/ml] in 50mM Tris-Cl, lOmM EDTA pH8.0) and transferred to a 50ml Beckman 
centrifuge tube. 10ml of solution P2 (0.2M NaOH, 1% SDS) was then added and the solution 
incubated a t room terr^jerature for 5min. 10ml of solution P3 (2.55M K acetate pH4.8) were 
added immediately, the solution was mixed gently forming a precipitate and then centrifuged 
at 20,000xg (17,000rpm) for 30 min, at 4°C. The supernatant was retained and recentrifuged 
under the same conditions for 10 minutes, to give a particle-free clear lysate. A Qiagen ion 
exchange 500 column was equilibrated by the addition of 10ml of QBT buffer (750mM NaCl, 
50mM M OPS, 15% ethanol pH7.0). The lysate was then poured into the Qiagen column, 
invading the resin by gravity flow. The Qiagen column was washed three times with 10ml of 
QC buffer (lOOmM NaCl, 50mM MOPS, 15% ethanol pH 7.0) and the DNA eluted with 15ml 
of QF buffer (120mM NaCl, 50mM MOPS, 15% ethanol) into a 50ml polypropylene tube. 
0.7 volumes of isopropanol were added to the eluate and the solution was left at room 
temperature for 30min before being centrifuged for 15min at 3,500xg (4,000rpm). The DNA 
pellet was then recovered by centrifugation, washed with 1ml 70% ethanol, repelleted under 
the same centrifugation conditions, air dried and dissolved in 1ml TE.
2.14 C o s m id  EXTRACTION fr o m  E. c o l i
2ml of LB containing 50//g/ml of selective antibiotic was inoculated with a single colony of 
a cosmid-containing E. coli strain, maintained on LB agar (plus antibiotic) at 37 °C. The 
culture w as then incubated at 37°C to grow, for 16-20hr. The cells were pelleted by
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centrifugation at 3,500xg (4,000rpm) for 5min, the supernatant discarded and the cells 
resuspended in 200//1 of GET buffer (section 2.11) containing 2mg/ml lysozyme and 
transferred to 1.5ml microfuge tube. The cells were left on ice for 30min before the addition 
of400/d of alkaline/SDS (section 2.11) and a further lOmin incubation on ice. 300/d of 3MNa 
acetate were then added to the solution which was left on ice for a further 60min. The cell 
debris was pelleted by centrifugation at 10,000xg (13,000rpm) in a microfuge for 15min. The 
supernatant was retained and an equal volume of phenol:chloroform:isoamylalcohol (25:24:1) 
was added and the solution mixed by inversion. The two phases were separated by 
centrifugation at lO.OOOxg (13,000rpm) for lmin and the upper aqueous layer removed, 
talcing care not to disturb any debris at the interface. This step was repeated, again retaining 
the upper aqueous layer, to which 0.5 volumes of isopropanol were added. The solution was 
mixed, by inversion and left to stand at room temperature for 15min. The solution was 
centrifuged at 10,000xg (13,000 rpm) for 15min to pellet the DNA, which was then washed 
in 70% ethanol, repelleted and left to air dry. The DNA pellet was dissolved in 25 /^1 TE, 
19units (1//1) of RNAase T1 (Gibco BRL) was added and the solution incubated at 37°C for 
Ihr before storing the DNA sample at -20°C until used.
2.15 Plasmid preparation from M . s m e g m a t is  mc2155
This method is based on the alkaline lysis method of Bimboim and Doly, (1979) but has been 
adapted for mycobacteria by the addition of lipase IV to the GET buffer. 5ml-10ml 
Middlebrook 7H9 media, containing kanamycin at 25/^g/ml, were inoculated with a single 
colony taken from an M. smegmatis plasmid-containing strain maintained on Middlebrook 
agar, containing kanamycin (25//g/ml), at 37°C. The culture was incubated at 37°C, with 
shaking, for48-72hr (until the culture reached late log-phase) and the cells were pelleted by 
centrifugation at 3,500xg for lOmin. The supernatant was discarded and any recalcitrant liquid 
removed by pipetting. The cells were resuspended in 200//1 GET buffer containing 30mg/ml 
lipase IV (Sigma) and lOmg/ml lysozyme (Sigma). The suspension was incubated at 37 °C
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with shaking for 16-20hr before being transferred to an 1.5ml microfuge tube and placed on 
ice for 30min. 400//1 of alkaline/SDS solution was added to the suspension which was kept 
on ice for 60min before the addition of 300//1 3M Na acetate solution and a further 60min 
incubation on ice. The cell debris was pelleted by centrifugation at 10,000xg for 20min; the 
supernatant was retained and phenol ¡chloroform extracted (section 2.3). The DNA was then 
recovered by ethanol precipitation (section 2.4), air dried and resuspended in 25//1 of TE. The 
plasmid recovery from M. smegmatis is generally less efficient (0.05//g/ml) than from E. coli; 
in order to prevent further loss of the plasmid DNA it was not RNAase treated and the whole 
sample was transformed directly into E. coli DH5a.
2.16 COSMID PREPARATION FROM M . SMEGMATIS MC2155
Cosmid preparation from M. smegmatis me2155 was identical to that stated for plasmid 
preparation (section 2.15) except that smaller 5ml cultures were always used due to the 
instability of the cosmid DNA. Cosmid DNA recovery was poorer than plasmid recovery 
(<0.05pg), so to prevent further loss of the cosmid DNA it was not RNAase T1 treated and 
the whole sample was then transformed into E. coli DH5a.
2.17 Sequencing
2.17.1 Preparation of double stranded recombinant DNA for sequencing 
50//1 (3pg) of dsDNA were added to 50pl of denaturation solution (0.4M NaOH, 0.2mM 
EDTA) and incubated at 37°C for 30min, denaturing the DNA. The single stranded ssDNA 
was precipitated by the addition of 10//1 of 3M Na acetate pH5.2 and 200//1 of 100% ethanol, 
followed by a 30min incubation at -20°C. The solution was centrifuged in a microfuge at 
10,000xg (13,000rpm) for 15min to pellet the DNA. The DNA pellet was washed in 200//1 
of 70% ethanol, dried and dissolved in 7pl of TE. This ss DNA was sequenced as stated in 
section 2.17.2.
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2.17.2 Single stranded sequencing of recombinant DNA
Single stranded recombinant plasmid DNA was prepared as described above (section 2.17.1) 
and sequenced using the United States Biochemical (USB) Sequenase Kit Version 2.0, 
according to the instructions provided by the manufacturers. 3pg (7pi) of ss recombinant 
plasmid DNA was mixed with 3ng (1/zl) of primer (-40) and 2pl of 5x Sequenase Buffer 
(200mM Tris-Cl pH7.5, lOOmM MgCl2,250mM NaCl) in a 1.5ml microfuge tube and placed 
in a water bath maintained at 65 °C for 2min. The water bath was then left at room 
temperature until it reached 30°C. A labelling master mix had been prepared which contained 
4.4//1 0.1M Dithiothreitol (DTT), 8.8//1 5X Labelling Mix (7.5pM dGTP, 7.5//M dCTP, 
7.5//M dTTP), 2.2/d [ a '35S]dATP (lOMCi/ml, Amersham) and 8.0/ul of diluted Sequenase 
v2.0 enzyme ( 1/zl enzyme and 7/d Enzyme Dilution Buffer (lOmM Tris-Cl pH7.5, 5mM 
DTT, 0.5mg/ml BSA), enough for four reactions. 5.5^1 o f the labelling "cocktail" was 
immediately added to the primer/template DNA and left at room temperature for 3min. Four 
0.5ml microfuge tubes were taken and 2.5^1 of the dideoxynucleotide termination mixes were 
placed in each and preheated to 37 °C. 3.5^1 of the labelled template/primer was added to each 
termination mix and incubated at 37 °C for 5min. The reaction was stopped by the addition 
of 4/d of Stop solution buffer. Samples were then denatured by heating to 80°C, in a heating 
block, for 7min prior to loading on the sequencing gel.
2.17.3 Preparation and electrophoresis of sequencing gel
Two sequencing plates, 33x39.5cm and 33x42cm, were cleaned thoroughly with detergent 
(Decon) and wiped down with absolute ethanol. The smaller plate was wiped down with 
Sigmacote (Sigma) then placed on top of the larger plate with 0.3mm spacers in between the 
plates at their outer edges. The plates were sealed around three sides with electrical tape. 75ml 
of a 6% polyacrylamide gel mix was prepared from a 40% acrylamide:/?«' acrylamide (19:1) 
stock solution (CAMLAB) in lx TBE and 8M urea (Sigma). 240pl 20%(w/v) ammonium 
persulphate (APS, Sigma) and lOOpl N,N,N',N'-tetramethyl-ethylenediamine (TEMED,
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Sigma) were added to 70ml of gel solution and mixed gently. The gel solution was taken up 
in a 50ml syringe and injected between the plates from one comer, allowing the plates to fill 
from one side, reducing the risk of air bubbles. Any air bubbles formed were removed with 
a Bubble Remover (Promega). A shark's tooth comb with 23 teeth was immediately inserted 
inverted into the top of the gel, to later form twenty arch shaped wells. Generally 
polymerization occurred within 5min, but gels were left 16-20hr before electrophoresis. The 
lower strip of tape was removed from the plates, which were placed in the sequencing 
apparatus (Life Technologies) and secured. The gels were prewarmed by running in 1 xTBE 
buffer for 30min at 60V until they reached 55°C. Urea which had accumulated in the wells 
was flushed out using a 20ml syringe containing lxTBE buffer from the upper chamber of the 
gel tank. 2/ri of the four termination reactions, for every sequenced clone, was loaded into 
four adjacent wells (TCGA). The reactions were loaded using a flat-ended sequencing tip 
(Gilson). The gels were run at 60W for l-3hr, depending on the length of sequence to be 
obtained; gels were run for lhr to read approximately 200bp of sequence (blue dye migrated 
3/4 length of the gel) and 3hr (blue dye run off the gel) to read 200-400bp of a given clone. 
Following electrophoresis the shorter plate was removed, the gel adhering to the larger plate. 
The larger plate and gel were placed in a tray and submerged in 11 of fixer (5% acetic acid 
[BDH], 15% methanol [BDH]) for 15min. The plate was removed from the tank, draining 
excess fixer and the gel carefully transferred to Whatman 3MM paper. The gel was covered 
in Saran wrap and dried for 90min at 80°C, on a heated vacuum gel dryer. The dried gel was 
placed in an autoradiography cassette and a photographic X-film (Kodak) placed on the gel. 
The film was exposed to the gel for 16-72hr, depending on the strength of the signal and then 
developed in an automatic film processor. Sequence data were read manually, entered into 
the computer and assembled using the Staden software. The software was accessed through 
the MRC Human Genome Mapping Project.
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2.18 Culture of M y c o b a c t e r iu m  s m e g m a t is
M. smegmatis mc2155 (Snapper et al., 1990) was obtained from W.R.Jacobs and mutant 
strains were created by NTG mutagenesis (section 2.27). Both wild type and mutant strains 
of M. smegmatis mc2155 were stored as frozen cultures in 25% glycerol at -70°C. The strains 
were maintained at room temperature on Lowenstein-Jensen (LJ) slopes (Difco) following 
initial growth at 37 °C for 16-20hr.
M. smegmatis strains were streaked to single colonies on Lemco (Appendix A) or 
Middlebrook 7H10 agar (Difco) and incubated at 37°C, for 2-6 days or at 28°C for 4-10 
days. Small scale liquid cultures (5-10ml) were generally grown in Lemco broth containing 
0.1% Tween, but in certain circumstances in Middlebrook 7H9 media containing 0.1% Tween 
80 was used. Large scale liquid cultures (100ml-11) of M. smegmatis were grown in 
Middlebrook 7H9 medium containing 0.1% Tween 80 for 1-3 days at 37 °C or 2-6 days at 
28 °C with shaking at 150rpm (incubation times were dependent on the size of the inoculum 
and the volume of the culture). 0.1% Tween 80 was used in all liquid cultures unless 
otherwise stated, to reduce clumping.
Kanamycin selection for the mycobacterial plasmid and cosmid DNA used in M. smegmatis 
strains was achieved by using the antibiotic at 15//g/ml and 20^zg/ml in Lemco and 
Middlebrook media, respectively. M. smegmatis cosmid-containing strains were grown in 5ml 
Middlebrook 7H9 media at 37°C for DNA extraction and in 20ml volumes at 28°C for lipid 
extraction (section 2.29).
2.19 A c id -F a s t  s t a in in g  o f  M . s m e g m a t is
Cultures of M. smegmatis were acid-fast stained to ensure their identity and their purity, using 
the TB Staining Kit (Difco). 1ml of a culture was transferred to an microfuge tube and the 
cells pelleted by centrifugation in a microfuge for 2min at 10,000xg (13,000rpm). The excess
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medium was discarded and the cells resuspended in 200/d of medium. The cell suspension was 
spread on a glass slide, air dried and flamed to heat fix the cells. The slide was left to cool 
before being covered in carbolfuschin for 5min. The carbolfuschin was gently poured off and 
the slide covered in acid-alcohol (15% ethanol 5% H2S 04) for 30s to decolourise the cells. 
The slide was gently washed with water and then counterstained with malachite green for 
5min. Again the slide was rinsed in water and then left to air dry. The cells were viewed under 
a microscope at lOOOx magnification using immersion oil to ensure they were stained the 
characteristic magenta of acid fast bacilli and that there were no green staining contaminants 
presenL
2.20 Large scale mycobacteriophage preparation
Four plaques were picked with a sterile wire loop and placed in 10ml of Lemco broth (without 
Tween) and incubated at 37°C, with shaking (200rpm) for 16-20hr. The culture was taken 
up in a 10ml syringe and pushed through a 0.2^m sterilising filter (Acrodisc). The retained 
phage suspension was stored at 4°C. To determine the phage concentration 1-lxlO'9 dilutions 
of the solution were made and 10/d of each used to infect 200//1 of M. smegmatis as stated 
(section 2.21). The number of plaques on each plate was counted and the number of plaque 
forming units/ml (pfu/ml) calculated for a given phage type.
2.21 Infection ofM. s m e g m a t is  with mycobacteriophages
Mycobacteriophage were provided by Dr.J.Grange, The Middlesex Hospital, London. The 
mycobacteriophages were either stored in Lemco broth at 4°C (short term) or freeze-dried 
in glass ampoules (long term). The mycobacteriophages were released from long term storage 
by adding the freeze-dried material to 1ml Lemco broth, in a 1.5ml microfuge tube, mixing 
them by inversion and incubating at 37 °C for 4hr. 10ml of Luria broth (without Tween) was 
inoculated with a single colony of M. smegmatis, maintained on Middlebrook agar at 37 °C 
and incubated at 37°C for 16-20hr. 10/d of a given mycobacteriophage solution (1x10s
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pfu/ml) was added to 200//1 of the overnight M. smegmatis late log-phase (A ^  0.8) culture 
and left for 30min for the phage to adhere to the bacteria. The mixture was then added to 3ml 
of Lemco soft top agar and poured on to a Lemco agar plate, allowed to set and incubated 
at 37°C for 24 -36hr until a lawn of bacteria formed and any plaques were visible.
2.22 Drop method for testing phage sensitivity
200//1 of an overnight late log-phase M. smegmatis me2155 culture were added to 3ml of 
Lemco soft top agar, mixed by inversion, poured onto a Lemco agar plate and left to set. 10^1 
of mycobacteriophage solution were then pipetted ("dropped") onto the surface of the Lemco 
soft top agar containing the M. smegmatis cells. The plates were then incubated at 37°C for 
12-24hr until a bacterial lawn was formed and any clearing caused by phage infection could 
be observed. On testing of a given M. smegmatis strain for infectability with a number of 
mycobacteriophage, the phage solutions were placed in the wells of a microtitre plate (in a 
known order). A multichannel pipette was used to take up 5//1 of each phage solution. The 
solutions were then released from the pipette onto the soft agar containing the M. smegmatis 
cells, and the test plate was then incubated at 37 °C as above. The maximum number of phages 
which could be used to test a given M. smegmatis strain for infectability on a single plate was 
six.
2.23 Overinfection method for the isolation of phage resistant
COLONIES
lxlO9 pfu (100/ri of lxlO10 pfu/ml phage stock) were added to 200//1 o f late log-phase M. 
smegmatis mc2155 in a 1.5ml microfuge tube and left for 20min at room temperature. The 
infected culture was then plated out in 3ml Lemco soft top agar onto Lemco agar before being 
incubated at 37°C. The infection plates were observed after 24hr to ensure complete lysis had 
occurred and no bacterial lawn had been formed. The plates were then incubated at 37°C for 
a further 4 days to allow for the formation of colonies by any phage resistant M. smegmatis
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cells.
2.24 Testing for pseudolysogeny in M . s m e g m a t is
Mycobacteria often exhibit pseudolysogeny i.e. they are able to harbour individual phage 
which inhibit infection by other phage, but are not integrated into the mycobacterial genome. 
The following method was developed to determine if a given strain of M. smegmatis was 
pseudolysogenic. The test strain and the wild type M. smegmatis strains were streaked out 
from frozen culture to single colonies on Lemco agar, and grown at 37°C for 20-40hr. Single 
colonies of each strain were inoculated into 10ml of Lemco broth (no Tween) and incubated 
at 37°C, shaking, for 16-20hr. 200//1 of M. smegmatis culture were added to 3ml of Lemco 
soft top agar and plated out onto a Lemco agar plate. 10//1 of the test strain were pipetted on 
to  the centre of one half of the soft top agar and 10/zl of the wt on to the other half. This 
procedure was carried out in duplicate. The plate was incubated at 37°C for 24-36hr until a 
bacterial lawn had formed. Any clearing in the lawn around the test strain indicated the 
presence of phage in the strain infecting the susceptible wild type M. smegmatis.
2.25 Production o f  competent M . s m e g m a t is  mc2155
Competent M. smegmatis were produced using a method developed by Snapper et al., (1988 
and 1990). A 5ml volume of Middlebrook 7H9 media was inoculated with a single colony of 
M. smegmatis and grown for 16-20hr at 37°C, with shaking. A 500ml volume of Middlebrook 
7H9 was inoculated with 1ml of the overnight M. smegmatis culture, incubated at 37°C with 
shaking (200rpm) and grown for 24-36hr, to late-log phase (A ^ ^ .S ) . The flask was placed 
on ice and the culture incubated for 60min. The culture was transferred to a 11 Beckman 
container and centrifuged at 3500xg (4,000rpm) to pellet the cells. The cells were resuspended 
in 100ml (1/5 volume) of ice cold 10% (v/v) glycerol (BDH) and repelleted by centrifugation 
at 3500xg (4,000rpm) for 15min. The cells were then resuspended in 20ml (1/25 original 
volume) o f ice cold 10% (v/v) glycerol and pelleted by centrifugation as before. The cells
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were finally resuspended in 5ml (1ml for library efficiency) of ice cold 10% (v/v) glycerol, 
transferred to 1.5ml microfuge tubes and stored frozen at -70°C. This gives a final 
concentration of between 2-5x109 cfu/ml and a transformation efficiency of ltf-lCf cfu//ig 
D N A .
2.26 Transformation of M . s m e g m a t is  mc2155 by  electroporation
M . smegmatis cells were transformed using the method developed by Snapper et al., (1988 
and 1990). A frozen stock of competent M. smegmatis cells (section 2.25) were thawed on 
ice, aliquotted and placed into a  pre-chilled 1.5ml microfuge tube containing the DNA 
solution to be transformed. Care was taken to ensure the DNA and cells were evenly 
suspended and the DNA/cell suspension was left on ice for 30min. The cell suspension was 
mixed gently by pipetting, avoiding the introduction of air bubbles and was transferred to a 
pre-chilled 200p\ electroporation cuvette. A Bio-Rad Gene Pulse and Pulse Controller were 
set at 2.5kV, 25//F and 1000Q. The cuvette was placed in the chamber of the pulser and the 
cells electroporated. The cuvette was placed on ice for lOmin before the cell suspension was 
transferred using 2ml of Lemco broth into a universal and incubated, with shaking (200rpm), 
at 37°C for 2hr. The cells were then centrifuged at 3,500xg (4,000rpm) for lOmin and 1ml 
o f the Lemco broth removed. The cells were resuspended in the remaining 1ml of Lemco 
broth and spread on Lemco o r Middlebrook 7H9 agar (12cm plates), containing the 
appropriate selective antibiotic. T he cells were then incubated at 37°C for 4 days or at 28°C 
for 8 days.
2.27 Mutagenesis of M . s m e g m a t is  with N-methyl-N-Nitro-N- 
nitrosoguanidine (NTG)
The mutagenesis procedure was carried out according to a method established by Holland and 
Ratledge (1971). 100ml supplemented minimal medium (MM+AA; Appendix A) containing 
0.1% Tween 80 were inoculated with 1ml of an overnight M. smegmatis mc2155 culture and
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incubated at 37°C, with shaking (150rpm) until the culture reached late log-phase (A^O.S), 
approximately 40hr. 1ml of the culture was removed at this point and plated onto Lemco 
plates in serial dilutions (1-lxl0"9) to determine the percentage killing of cells following the 
NTG treatment. The remaining cells were harvested by centrifugation in J6B rotor (Beckman) 
at 3,500xg (4,000rpm) for 7min and resuspended in 10ml of unsupplemented minimal media, 
pH6.3. 10ml of minimal medium (pH6.3) had previously been injected into a sealed bottle 
containing lOmg of NTG (Sigma) and the 10ml of M. smegmatis me2155 cell suspension was 
injected into the sealed bottle giving a final concentration of 0.5mg/ml NTG. The M. 
smegmatis/NTG suspension was incubated at 37°C, with shaking (150rpm) for45min, in the 
sealed container. The suspension was removed from the bottle with a syringe and the NTG- 
treated cells were pelleted, washed four times with 0.2M phosphate buffer (KH2P 04/K0H 
pH6.3) containing 0.5% Tween 80 and finally resuspended in 2ml MM. The wash solutions 
containing NTG were pooled and treated with 0.1M HC1 to destablise the remaining NTG 
before disposal. This procedure was carried out on two individual M. smegmatis me2155 
cultures and known as the first and second mutagenesis procedures. The NTG-treated cells 
of these two procedures were treated differently following exposure to NTG.
2.27.1 F i r s t  m u t a g e n e s i s  - i n h  t r e a t m e n t
The use of INH in this method was previously described by Holland and Ratledge ( 1971). 
The 2ml of NTG-treated M. smegmatis cells were divided into two. 1ml of NTG-treated cells 
were resuspended evenly in 100ml MM+AA (0.5% Tween 80). 1ml of this cell suspension 
was removed, serially diluted 1-lxlO'9 and plated in 200/d volumes onto Lemco agar (12cm 
plates) and incubated at 37°C for 24hr. The cells were then incubated at 28°C for 48hr to 
allow the cells to recover. These NTG-treated cells left to recover at 28°C were known 
collectively as SetA.
The remaining NTG-treated cells from the first mutagenesis were evenly resuspended in
-103-
M a t e r i a l s  a n d  M e t h o d s
100ml MM+AA (0.5% Tween 80) containing 50//g/ml INH and then incubated at 37°C for 
24hr, with shaking (150rpm). The INH-treated cell culture was transferred to 50ml Falcon 
tubes, the cells precipitated by centrifugation at 3500xg (4,000rpm) and the cells were then 
resuspended in 30ml MM. The cells were washed 3x in MM and finally resuspended in 100ml 
MM+AA (0.5% Tween 80) and incubated at 28°C, with shaking (150rpm) for 48hr. The 
NTG and INH-treated M. smegmatis cells were known collectively as SetB(INH).
2.27.1.1. Dilution procedure o f NTG-treated M. smegmatis from  the first mutagenesis 
Following recovery at 28°C the NTG-treated M. smegmatis cells of SetA and SetB(INH) 
were transfered to 50ml Falcon tubes (50ml stored at 4°C and 50ml stored at -20°C, from 
each of SetA and SetB(INH)). 10ml of culture from SetA and SetB(INH) were taken and 
dilutions of 1-10-9 in final volumes of 5ml were made up in 10ml uni versáis with SDW. 1ml 
volumes of each dilution from SetA and SetB(INH) were plated onto MM+AA and MM agar 
plates (14cm), in duplicate. The 1ml volumes of each dilution were passed through 25 gauge 
needles, to reduce clumping. One set of MM+AA and MM serial dilution plates from both 
SetA and SetB(INH) w ere incubated at 37°C for 48 hr; the duplicate sets of MM+AA and 
MM agar serial dilution plates, from SetA and SetB(INH), were incubated at 28 °C for four 
days. The number of colonies formed on MM+AA and MM, at comparable dilutions were 
compared within SetA and SetB(INH); as well as the colonies formed at 28°C and 37°C on 
MM+AA and MM, within SetA and SetB(INH).
1000 colonies from MM+AA dilution plates of SetA and SetB, incubated at 28°C, were 
randomly selected and transferred to Middlebrook 7H10 agar. The 2000 colonies were 
arrayed in the dimensions of a 96 well microtitre plate, on the Middlebrook 7H10 agar plates 
(14cm), and incubated a t 28°C for 6 days. The set of 2000 colonies was known collectively 
as Bank 1.
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2.27.2 Second mutagenesis
Following treatment with NTG the M. smegmatis cells of the second mutagenesis procedure 
were left to recover at 28°C in 100ml MM+AA (0.5% Tween 80) for 48hr. The culture was 
then transferred to two 50ml polypropylene tubes and all but 10ml was stored at -20°C. The 
10ml of NTG-treated cells were used to make serial dilutions 1-lxl 0"9 which were then plated 
in 1ml volumes onto Middlebrook 7H10 agar and incubated at 28°C for 6 days to allow 
colony formation. 1,000 of the colonies formed were randomly selected and transferred to 
Middlebrook 7H10 plates in arrays of 96 as above, the arrays were incubated at 28°C to 
recover. The 1,000 colonies of NTG-treated M. smegmatis from the second mutagenesis were 
known collectively as Bank 2.
2.28 Screening of NTG-treated M . s m e g m a t is  colonies for
RESISTANCE OR SENSITIVITY TO ANTIBIOTICS 
2.28.1. Replica plate screening of NTG-trf.ated M. smegmatis 
Initially arrayed NTG-treated M. smegmatis colonies from Bank 1 or 2 were replica plated 
onto Lemco agar containing the test antibiotic at the MIC, when looking for resistance and 
just below the MIC, when looking for sensitivity to the test antibiotic. The colonies were 
replica plated using a replicating device with 96 pins arranged in the dimensions of a microtitre 
plate. The 96 pin device was sterilised, placed in the arrayed colonies, removed and plunged 
into the Lemco agar containing the test antibiotic. This was repeated for all the colonies in the 
Bank and the inoculated Lemco agar plates containing the test antibiotic were incubated at 
28°C for 8 days.
2.28.2 Large scale screening for mycobacteriophage and antibiotic 
resistance
100ml of Middlebrook 7H9 media was seeded with 1ml of NTG-treated cells from a frozen 
stock. The cell suspension was incubated at 28 °C with shaking for 48hr until the culture
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reached a 0.8A ^ . 10/d, 100/^ 1 and 1ml volumes of the NTG-treated M. smegmatis me2155 
cells were plated onto Lemco agar plates (14cm) containing the test antibiotic (MIC) or 
spread with 1ml phage solution (xlO^fu/ml). The test plates were then incubated at 28°C for 
8 days before being read for growth. Any resistant strains were analysed further.
2.28.3 C o n f i r m a t i o n  o f  a n t i b i o t i c  r e s i s t a n c e
Any M. smegmatis strains which appeared resistant to a given antibiotic were subcultured 
from the master plates and subsquently retested against the same concentration of the given 
antibiotic. Initially a single colony of the subcultured strain was streaked out onto a Lemco 
plate containing the test antibiotic at the same concentration. If the M. smegmatis strain 
remained sensitive or resistant to the test antibiotic the strain was subcultured and a single 
colony was retested on solid agar (plus antibiotic) or used to seed 5ml Lemco broth (0.5% 
Tween) which was incubated at 28°C until the culture reached late log-phase (A ^  0.8); the 
liquid culture was then streaked on Lemco agar containing the same concentration of the test 
antibiotic. Any strains remaining resistant or sensitive to the test antibiotic at this stage were 
subcultured again, a Lemco liquid culture created as before and again cells streaked onto two 
Lemco agar plates containing the test antibiotic, one of which was incubated at 37°C (48- 
72hr) and the other at 28°C (6-8 days). In some cases equal numbers of the test strain cells 
(2.5xl07) and M. smegmatis mc2155, cells were added to 5ml liquid Lemco containing the test 
antibiotic in the test concentrations. Control cultures of wild type and test strains without 
antibiotic were also set up. The liquid cultures were incubated at 37°C, with shaking 
(150rpm), for 48hr. The A ^  of the test and wild type cultures with and without the test 
antibiotic were read and compared.
2.28.4 A n t i b i o t i c  s e n s i t i v i t y  t e s t i n g  i n  l i q u i d  c u l t u r e
An overnight culture, seeded with a single colony of an antibiotic sensitive strain of M. 
smegmatis, was grown to late log-phase culture (0.8 A ^ ). 100//1 of the cell culture (2.5x107
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cfu, unless otherwise stated) was then added to a series of 9x5ml volumes of Lemco, eight of 
which contained increasing concentrations of the test antibiotic (200-900/ig/ml); the ninth, 
control culture, contained no antibiotic. An identical series was set up seeded with 2.5x107 
M. smegmatis me2155, wild type cells. The two test series were incubated at 37°C or 28°C 
until the control cultures reached 0.8 A***, or 1.5 A ^  and then the A ^  of all the cultures in 
the two series were read. The growth of the test strain at each increasing concentration of 
the antibiotic was then compared with that of the wild type at the same concentration of 
antibiotic.
2.29 E x t r a c t io n  o f  f r e e  m y c o b a c t e r ia l  l ip id s
These methods were carried out as described by G.Dobson et al., (1985).
2.29.1 N o n  p o l a r  l i p i d s
A 50mg dry biomass sample was placed in an 8.5ml PTFE-capped Coming tube. 2ml of 
aqueous methanol (10ml 0.3% NaCl: 100ml methanol [BDH, HPLC grade]) and 1ml of 
petroleum ether (BDH, HPLC grade) boiling point (b.p.) 60-80°C were added to the sample 
and mixed vigorously on a shaking platform for 15min. The solution was then centrifuged at 
3,500xg (4,000rpm) for 7min to separate the two phases. The upper phase was transferred 
with a glass pasteur pipette to 5ml glass vial and another 1ml of petroleum ether (b.p. 60- 
80°C) added to the remaining lower layer. The mixture was mixed vigorously for a further 
15min, centrifuged again for 7min and the upper layer retained with the previous one. The 
upper layers were dried with N2 at <37°C, redissolved in 70/d of chloroform:methanol (2:1) 
and stored at -20°C until use. The lower layer was retained for the extraction of polar lipids.
2.29.2 P o l a r  l i p i d s
The retained lower layer residue was heated at 100°C in a heating block for 5min and allowed 
to cool to 37°C before the addition of 2.3ml of solution 1 (chloroform: methanol:0.3% NaCl,
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90:100:30). The mixture was shaken vigorously for 60min and centrifuged for 5min, at 
3,500xg (4,000rpm) to pellet the cell debris. The upper solution was retained and the cell 
debris resuspended in 0.75ml of solution 2 (chloroform: methanol: 0.3% NaCl, 50:100:40). 
The suspension was mixed vigorously for 30min and centrifuged at 3,500xg (4,000 rpm) for 
7min to pellet cell debris. The upper aqueous layer was retained and added to the 8.5ml tube 
containing the previous extraction. This step was then repeated. The supernatants were 
combined by the addition of 1.3ml chloroform and 1.3ml 0.3% NaCl, followed by vigorous 
mixing for 30min. The two phases were separated by centrifugation at 3,500xg (4,000rpm) 
for 7min and the upper layer was discarded, carefully removing any debris at the interface. The 
lower layer was retained and evaporated with N2 The residue was then dissolved in 70/d of 
chIoroform:methanol, 2:1 and stored at -20°C.
2 .3 0  TW O DIMENSIONAL THIN LAYER CHROMATOGRAPHIC (T L C ) SYSTEMS 
FOR THE ANALYSIS OF POLAR AND NON POLAR LIPIDS OF MYCOBACTERIA.
A 7/d sample of a nonpolar or polar lipid fraction was applied to a 6.6x6.6cm aluminium 
backed TLC plate (Merck 5554) using a glass capillary tube in one comer of the plate, 1cm 
away from each side and left to air dry. One of the following solvent systems was then 
applied.
2.30.1 System A
This system is used to detect menaquinones, triacylglycerols and mycocerosates of the 
phthiocerol family as it separates the least polar of the non polar lipids. A TLC plate loaded 
with non polar lipid extract, was developed with petroleum ether (bp 60-80°C): ethyl acetate 
(98:2 v/v) the first direction solvent, until the solvent reached the top of the plate. The TLC 
plate was removed and left to air dry; this procedure was repeated twice. The TLC plate, was 
turned 90° and developed with petroleum ether:acetone (98:2), the second direction solvent, 
once. The TLC plate was left to air dry, before observation under ultraviolet light for the
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presence of menaquinones. The separated lipid components could then be revealed by 
spraying the plate with 5% (w/v) ethanolic molybdophosphoric acid (MPA) solution and 
subsequent heating at 180°C for lOmin.
2.30.2 System D
This system separated the most polar of the non polar lipids and the least polar of the polar 
lipids. A TLC plate loaded with non polar or polar lipid extract was developed with 
chloroform;methanol water (100:14:0.8), the first direction solution, until the solvent reached 
the top of the plate when it was removed and left to air dry. The plate was then turned 90° 
and developed with the second direction solvent, chloroform:acetone:methanol (50:60:2.5), 
until the solvent reached the top of the plate. The plate was left to air dry before being sprayed 
with MPA and placed at 180°C for lOmin, to detect lipids. In order to detect any sugars 
present on the lipids, the system was repeated and the plate ultimately sprayed with a- 
naphthol-sulphuric acid (NAS) and incubated at 120°C for 2min. This system detected 
trehalose dimycolates and sulpholipids from non polar extracts and glycopeptidolipids from 
polar lipid fractions.
2.30.3 System E
This system detected the most polar lipids in the polar lipid extract. A TLC plate loaded with 
polar lipid extract was placed in a TLC tank containing chloroform:methanol:water (10:5:1) 
until the solvent reached the top of the plate. The plate was air dried before being placed, at 
a 90° turn, in the second direction solvent, chloroform:acetic acid:methanol:water ( 40: 
25:3:6), until the solvent reached the top of the plate. The plate was sprayed with MPA and 
heated at 180°C to detect the lipids. The process was repeated and the plate sprayed with 
NAS and heated at 120°C to detect sugars. This system detects phospholipids and glycolipids 
including forms of phosphatidylinositol.
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2 .3 0 .4  S y s t e m  F
This system also detected the most polar lipids in the polar lipid extract and was an adaptation 
of system E. A TLC plate loaded with polar lipid extract was developed with a first direction 
solvent chloroform: methanol: water (65:25:4) until the solvent reached the top of the plate. 
The plate was left to air dry before being placed, at a 90“turn in the second direction solvent 
chloroform: acetic acid: methanol: water (80:15:12:4) until the solvent reached the top of the 
plate. The plate was sprayed with MPA and heated at 180°C for lOmin to detect the lipids. 
The process was repeated and the plate sprayed with NAS and heated at 120°C, to detect 
sugars. This system detects phospholipids and glycolipids including forms of 
phosphatidylinositol.
2.31 Extraction and detection of mycolic acids
50mg samples of dried biomass were placed in an 8.5ml Coming tube, 2ml of 5%v/v aqueous 
tetrabutylammoniumhydroxide was added and the mixture placed at 100°C for 16-12hr. The 
mixture was cooled, centrifuged and the supernatant transferred to a Coming tube containing 
2ml dichloromethane (Sigma) and 25//1 iodomethane (Sigma). The preparation was shaken 
for 30min, the upper layer discarded, and the lower layer washed with 1ml of 10% aqueous 
HC1 followed by 1ml distilled water and evaporation to dryness under N2.
2 .31 .1  T L C  O F  M Y COLIC M ETHYL ESTERS
The alkaline methanolysates were dissolved in 0.1ml petroleum ether (b.p. 60-80°C) and 2/^ 1 
applied to 6.6 x 6.6cm aluminium backed TLC plates. The plates were developed three times 
with petroleum ether (b.p. 60-80°C):acetone (95:5 v/v) in the first direction and once with 
toluene:acetone (97:3) in the second direction. The positions of the separated components 
were revealed by spraying with 5%, w/v ethanolic molybdophosphoric acid followed by 
heating at 180°C for 15min.
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2.32 Analysis o f  bacterial h y d r o p h o b ic it y
The hydrophobicity of M. smegmatis cultures was measured using an adaptation of the 
method of Rosenberg et al., (1980). Two 200ml cultures of the test strain and of the wild type 
strain of M. smegmatis were grown to late-log phase (0.8 A ^ ) and early stationary phase 
growth (1.6 A^ oq). The cells from each culture were pelleted following centrifugation at 
3500xg (4,000rpm) and washed twice and resuspended in 20ml of PUM buffer (22.2g 
K2HP04.3H20, 7.26g KH2P04, 1.8g urea, 0.2g MgSO4.7H20 in ll,pH7.1). 1.5ml of each of the 
cell suspensions were added to individual round bottomed Coming tubes followed by addition 
of 15/ri of the hydrocarbon n-hexadecane (Sigma) and incubation at 30°C. Each suspension 
was vortexed for 120s before being left to stand at room temperature for 15min. The lower 
aqueous phase was removed carefully with a glass Pasteur pipette and transferred to a 1ml 
cuvette. The optical density of the aqueous phase was measured at 400nm, using a 
spectrophotometer. The optical densities of the test strain and the wild type strain from the 
same stage of growth were compared, as were the A400 from different stages of growth of the 
same strain.
2.33 Api-Zym TEST
The Api-Zym test was carried out according to the manufactures instructions. An overnight 
M. smegmatis culture was diluted with SDW to 0.5-0.6 A ^  (105- 107 cfu/ml). An incubation 
tray was taken, 5ml of water placed in the bottom, and an Api-Zym strip was then placed in 
the incubation tray. Using a Pasteur pipette, two drops of culture were added into each cupule 
of the strip. Following inoculation, the plastic lid was placed on the tray and the tray incubated 
at 37°C for 4hr. After incubation one drop of ZYM A (25% w/v Tri-hydroxmethyl-amino- 
methane,3.7% HC1, 10% w/v Laryl sulphate) and one drop of ZYM B (0.35% w/v Fast blue 
BB [2-methoxyethanol diluent]) were added to each cupule. The strips were left in daylight 
for five minutes for the colour to develop. A value ranging from 0-5 was assigned to the 
colours produced when compared with the colour chart where 0 is a negative result, 1 - 4 are
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intermediate reactions (1=5 nmoles, 2=10 nmoles, 3=20 nmoles, 4=30 nmoles) and 5 is a 
reaction of maximum intensity (5=40nmoles and above).
-112-
Chapter 3
R e s u l t s
3.1  T h e  a t t e m p t  t o  is o l a t e  a  c e l l  e n v e l o p e  m u t a n t  M. sm e g m a  n s  
m c 25 5  m u t a n t
The initial approach to isolating a cell wall mutant of M  smegmatis mc2155 was to find or 
create a mycobacteriophage-resistant strain ofM  smegmatis mc2155. This strategy was based 
on the theory that as mycobacteriophages adhere to receptor sites on the cell wall (Grange and 
Redmond, 1978; Goren et al., 1972; David et al., 1978) of the bacteria then resistance to 
phage infection may be as a result of an altered cell wall, which lacked the appropriate phage 
receptor site.
3.1.1  ISOLATING SPONTANEOUS PH A G E RESISTANT MUTANTS OF M . SM EG M A  T IS  MC2155 
The original aim was to isolate a spontaneous phage resistant mutant of M. smegmatis 
me2155.
3.1.1.1 Overinfection method
The strategy adopted was to overinfect an M. smegmatis mc2l 55 population with sufficient 
numbers of a lytic mycobacteriophage so as to cause confluent lysis of the infectable portion 
o f the population. Any spontaneously resistant M. smegmatis cells within the population 
would be able to replicate in the surrounding "sea" of phages and form visible colonies. The 
overinfection method was used in an attempt to isolate strains of M. smegmatis mc2155 
resistant to three mycobacteriophage D29, D4, and D33. D4 and D29 were chosen as their 
receptors had been shown to be a nsGPL in M. avium (Goren et al., 1972: Dhariwal et al., 
1986) and a simple LOSs in M  smegmatis (Besra et al., 1994b), respectively. D29 has also 
been shown to adsorb to the cell wall o fM. leprae (David et al., 1978)
Initially straightforward infections were performed with 1x10s pfu/ml of each phage (section
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2.21) , to ensure infection o f M. smegmatis mc2155 was possible. The three phages D29, D4 
and D33 all successfully infected M. smegmatis mc2155. D29 produced 2mm clear circular 
plaques, D4 produced large, 3-4mm, clear circular plaques and D33 produced small 0.5- 1mm 
clear circular plaques.
Having established that the three phages infected wild type M . smegmatis mc2155, the 
overinfection method (section 2.23) was performed with each phage type. The overinfection 
plates were observed after 24hr, to ensure that total lysis o f the M. smegmatis lawn had 
occurred and then incubated at 37°C for a further 4 days to allow for the formation of 
colonies by any phage resistant M. smegmatis cells. This method was carried out three times 
for each phage with three independent M. smegmatis me2155 cultures, seeded with single 
colonies, to  increase the chances of isolating independent mutants.
The number of colonies formed on the overinfection plates varied slightly between the three 
phages but remained consistent for each o f the three infections for individual phages. On 
average lx l0 2 colonies were formed on D29 infection plates; they were mucoid and l-3mm 
in diameter. 2xl02 colonies o f 0.5-lmm in diameter were formed on D4 infection plates; the 
colony morphology was of two types, mucoid and rough, in equal proportions, lx l 02 colonies 
formed on average on the D33 infection plates and were small (1mm) in diameter and mucoid.
Twelve colonies which were "resistant" to each phage were selected, four from each of the 
three overinfection plates for each mycobacteriophage, and subcultured. The 36 "resistant" 
strains were then retested for infectability by the phage to which they were "resistant" (section
2.21) . Control infections, to which no phages were added, were set up for each "resistant" 
strain.
Initially four D4, eight D29 and twelve D33 "resistant" strains remained resistant to infection.
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These strains were subcultured again and retested. On retesting, more strains became sensitive 
to  phage infection and only two D4, six D29 and five D33 strains remained resistant to 
infection. However, the control plates of these thirteen strains produced mottled bacterial 
lawns, which appeared to contain a background of plaques, or in some cases clear plaques. 
Following four subsequent subcultures and retesting, all of the strains became infectable.
These results implied that the strains were losing their "resistance" on serial transfer, which 
would be expected from unstable mutant strains; however the presence o f clear and 
background plaques in the control infections of the strains indicated that the strains were in 
fact harbouring phages.
This suggested that the "resistant" strains were in fact pseudolysogenic, containing a non 
integrated phage which prevented induction o f  the lytic cycle on attempted reinfection, while 
forming clear plaques on subculture without infection due to the instability o f  the lysogenic 
state.
3.1.1.2 Pseudolysogeny
A rapid method was developed to test large numbers of resistant strains for pseudolysogeny. 
The test was simply to "drop” liquid culture (10 /^1 of late log-phase culture; 0.8 A ^ ) of the 
test strain onto a lawn of wild type M. smegmatis cells and to incubate the plate overnight at 
37°C (section 2.24). The rationale was that some cells in the liquid culture of a 
pseudolysogenic strain would revert to the lytic cycle releasing phage which would infect the 
wild type M. smegmatis cells, forming a visible "halo" of clearing. Non-pseudolysogenic 
strains should not create a clearing "halo" and would form a confluent bacterial lawn.
The original 36 "resistant" strains obtained from the D4, D33 and D29 overinfection plates 
were tested for pseudolysogeny using this method. Three visible outcomes were obtained
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from the pseudolysogeny test o f the 36 phage "resistant" strains tested. The predicted "halo" 
o f clearing was observed around a few pseudolysogenic strains, caused by lysis of the 
surroundingM smegmatis mc2155 lawn cells (Fig. 16a). The region in which the culture was 
"dropped" of the majority o f these strains was mucoid and translucent, apparently caused by 
lysis o f the underlying lawn cells. A larger number of test strains did not produce distinct 
clearing and formed a uniform lawn were the culture had been "dropped", (Fig. 16b).
Of the 36 strains retested for pseudolysogeny 34 were found to be pseudolysogenic. One D4 
and one D29 strain did not appear to be pseudolysogenic. Both the D4 and D29 non- 
pseudolysogenic and "resistant" strains were retested for infectability, using fresh cultures 
seeded with single colonies. The non-pseudolysogenic D4 strain was infectable, as it had been 
when previously tested, in the overinfection experiment. The non-pseudolysogenic D29 strain 
was not infectable, but had previously only been infectable following two subcultures of the 
frozen stock whereas the colonies used for this D29 infection and the pseudolysogeny test 
were formed directly from frozen stocks. The non-pseudolysogenic D29 resistant strain was 
therefore subcultured and six cultures, seeded from single colonies, were tested for 
pseudolysogeny and infectability. One culture was pseudolysogenic but uninfectable while the 
remaining five were infectable but not pseudolysogenic.
The results suggested that this D29 "resistant" strain contained a mixed population o f  
pseudolysogenic and non-pseudolysogenic cells and therefore colonies which gave varying 
results in culture i.e. both pseudolysogenic uninfectable, and non-pseudolysogenic infectable 
cultures. The "nonpseudolysogenic" D4 strain could well have been a mixed population o f  
pseudolysogenic and non-pseudolysogenic strains but the two cultures tested were non- 
pseudolysogenic and infectable concurring with a negative test.
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smegmatis rnd lSS  strains.
a) shows the test plate for a strain pseudolysogenic for mycobacteriophage D4.
b) shows the test plate for a strain non pseudolysogenic for mycobacteriophage D29.
a+b show M. smegmatis me2155 bacterial lawns formed in Lemco soft top agar following 
incubation at 37° C for 24-48hr divided into sections 1, 2 and 3. 5/ri of mycobacteriophage 
solution lx l05pfu/ml), was "dropped" onto section 1 of each plate, D4 on la  and D29 on lb. 
The test cultures (10/ri of late log phase culture) were "dropped" onto sections 2 and 3. 2a 
and 3 a clearly show the "halo" of clearing created by the lysis of lawn cells with D4 phage 
released from the pseudolysogenic strain. In sections 2b and 3b a complete bacterial lawn was 
formed following the addition of a non pseudolysogenic from an apparently D29 resistant 
strain.
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3.1.1.3 UV induction o f  the lytic cycle in pseudolysogenic strains
In order to improve the clarity of the pseudolysogeny test, by creating unequivocal "halos" 
o f clearing, the overinfection plates were exposed to UV following complete lysis in an 
attempt to induce the lytic cycle in any pseudolysogenic strains.
Two overinfection plates were set up for D29, D33 and D4, respectively using the same M. 
smegmatis culture for lawn cells. One overinfection plate for each phage type was exposed 
to 40x10-3 J of UV, following total lysis of the lawn cells, before reincubation of the  plates 
(4 days at 37°C) to allow for colony formation. Similar numbers of colonies were produced 
on the overinfection plates following exposure to UV as were formed on the unexposed plates 
and had previously formed on the overinfection plates. A total o f 50 strains "resistant" to  each 
o f the three phage types were selected, 25 from the UV exposed plates and 25 from the 
unexposed overinfection plates. All the strains were subcultured and tested for 
pseudolysogeny. 144 strains appeared to be pseudolysogenic. The pseudolysogenic strains of 
D4 and D33 exposed to UV light exhibited more distinguishable clearing zones than those that 
had not been exposed to UV light; 80% in D4 strains and 20% in D33 strains. The UV 
exposed D29 strains did not exhibit any increase in those producing a distinct clearing zone.
The six apparently non-pseudolysogenic strains were all isolated from UV exposed 
overinfection plates, two D33, three D4 and one D29 strains. All six of these non- 
pseudolysogenic possibly resistant strains were found to be infectable with their respective 
phage. No truly phage resistant strains were obtained from this screen of 150 "resistant" 
colonies produced on overinfection plates.
The results of the pseudolyogeny testing suggested that within a given strain, varying 
proportions of cells were pseudolysogenic and that this proportion decreased with serial 
subculture, which would be expected from an unstable lysogen. The pseudolysogeny test
________________________________________________________________________ R esu lts
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whilst screening out the vast majority o f positively pseudolysogenic strains could also give 
false negatives in strains with higher proportions of non-pseudolysogenic cells. These false 
negative pseudolysogenic strains could give a negative infectability test if the culture used was 
generated from a pseudolysogenic single colony of the strain; this could give the impression 
that the strain was phage resistant. The false negative pseudolysogeny results could have been 
reduced by carrying out the initial pseudolysogeny tests on the same culture o f each strain and 
by performing both tests on more than one culture from each strain at a time, however this 
would have defeated the object of providing a quick screen for pseudolysogeny. The exposure 
to UV increased the clarity of the test, although this may have been improved upon by 
increasing the amount o f UV to which the overinfection plates were exposed. Overall the 
pseudolysogeny test proved a quick method of screening large numbers o f "resistant" strains 
produced by the overinfection method for pseudolysogeny.
No mycobacteriophage resistant mutants were isolated by the overinfection method which was 
possibly because an insufficient number o f "resistant" strains had been screened. Due to the 
difficulties associated with this method, caused by pseudolysogeny, the search for a 
spontaneous M. smegmatis mutant was abandoned.
An alternative approach was to increase the probability o f finding a resistant strain by 
mutating a population o fM  smegmatis mc2lSS cells and screening for phage resistant strains. 
The strategy had the advantage that the M. smegmatis strains would not have been previously 
exposed to  phage and would not therefore be pseudolysogenic.
3.1.2 Mutagenesis of M .  s m e g m a t i s  mcj155 with N-Methyl-N’-Nitro-N- 
Nitrosoguanidine (NTG)
The proposal was to create and isolate a mutant strain o f M. smegmatis mc2155 with a 
defective cell wall, which would manifest itself as a screenable altered phenotype i.e. phage
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resistance or antibiotic resistance. N TG  was used to generate mutated strains o f M. 
smegmatis, acting by intercalation into the DNA double helix during replication and causing 
point mutations by preventing correct incorporation o f nucleotides. The formation o f point 
mutations can be an advantage as mutations in essential genes could possibly be isolated. A 
bank o f  NTG-treated strains would then be screened for phenotypic alterations which may 
indicate an altered cell wall structure.
M. smegmatis mc2155 cultures were treated with NTG as described in section 2.27. A late 
log-phaseM smegmatis mc2155 culture was treated with 0.5/yg/ml NTG at 37°C for 45min, 
before being washed with buffer, resuspended in minimal medium supplemented with 
Casamino acids (MM+AA) and incubated at 28°C; this temperature was used because the 
mycolic acid mutant (Kundu et ai„ 1991) was isolated at 28 °C and found to be 
thermosensitive, presumably due to the altered properties of the lipids in the cell envelope (Dr. 
P. Chakrabati, personal communication). This mutagenesis procedure was performed twice, 
on individual late log-phase cultures o f M . smegmatis mc2155, and described below.
Following recovery o f the cells at 28°C  the NTG-treated cells o f the first mutagenesis 
procedure were serially diluted ( 1-lxl 0"9) and plated onto duplicate sets o f  minimal media 
(MM) agar and MM+AA agar plates and incubated at 28°C and 37°C (section 2.27.1.1; 
Fig. 17). This was done in order to be able to determine the levels o f  auxotrophy and 
temperature sensitivity within the NTG-treated population, directly after the mutagenesis 
event, before subculture.
On the basis o f the results obtained from phenotypic screening o f the first mutagenesis a 
second mutagenesis procedure was carried out. NTG-treated cells were diluted (1-lxlO'9), 
plated onto Middlebrook 7H10 agar and incubated at 28°C (section 2.27.2)
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The colonies initially formed by the NTG-treated cells, from both mutagenesis procedures, 
were mucoid after incubation at 28°C and 37°C. Some white and orange colonies, with 
altered chromogenesis, were observed on plates of colonies from each mutagenesis, at both 
temperatures.
3.1.2.1 Percentage survival following the NTG treatment o f M. smegmatis mc2155 cultures 
It was important to ensure a balance was kept between the loss of viability and effective 
mutagenesis caused by the NTG treatment of M. smegmatis cultures. The percentage survival 
was therefore measured following each NTG treatment as a measure o f  this balance and 
therefore as an indication of the success of the mutagenesis procedure. The results for both 
the mutagenesis procedures are shown in Table 5.
Table 5. Effect on survival of M. smegmatis mc2155 following exposure to NTG
Mutagenesis
procedure
Untreated cells 
cfii/ml
Treated cells 
(NTG) cfu/ml
% Killing % Survival
2xl09 1.6x10* 92 8
l____ l _________ 1.36x10* 2.4x10* 82.3 17.6
The percentage survival was 8% and 17.6% following NTG treatment in the first and second 
mutagenesis procedures respectively. These results were within the levels described by 
Holland and Ratledge (1971) and Hinshelwood and Stoker (1992b) as resulting in successful 
mutagenesis without a damaging loss o f viability.
3.1.2.2 IN H  enrichm ent
INH kills only actively growing cells and has been found to enrich for mutant strains with poor 
growth at 37°C in mycobacteria (Holland and Ratledge, 1971). In an attempt to enrich for 
mutated strains, half o f the NTG-treated M. smegmatis cells from the first mutagenesis
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experiment were exposed to INH (50^g/ml) at 37°C (24hr) before being left to recover at 
28°C (2.27.1.) The first mutagenesis therefore resulted in two groups of NTG-treated cells 
Set A, not exposed to INH and SetB(INH) which were INH treated (Fig. 17). Following 
recovery at 28 °C the NTG-treated cells of the first procedure, SetA and SetB (INH), were 
serially diluted, each dilution was plated onto MM and MM+AA in duplicate and incubated 
at 37°C and at 28°C (section 2.27.1.1; Fig.17). The numbers o f colonies formed were 
compared at corresponding dilutions (Table.6).
SetB(INH) from the first mutagenesis produced a greatly reduced number of colonies on both 
MM and MM+AA than at comparable dilutions for SetA at both incubation temperatures. 
The percentage survival of SetB(INH) following INH treatment varied from 5% at 37°C to 
13.6% at 28 °C on MM+AA. On unsupplemented MM the percentage survival following INH 
treatment was slightly lower at both temperatures, 11.6% at 28 °C and 4% at 21°C. Strains 
which were incubated at 28 °C following INH treatment showed higher survival levels than 
those incubated at 37°C, (Table.6).
Table 6. Effects of INH treatm en t and subsequent incubation tem perature on survival 
of NTG-treated strains
Incubation
temperature
Percentage survival on MM+AA 
SetB/SetA Percentage
Percentage survival on MM 
SetB/SetA Percentage
28°C 676/5325 12.7 515.5/5087 10
37°C 68/1314 5.1 55/1318 4
These initial results suggested that the INH treatment had significantly reduced the percentage 
survival under all conditions and appeared to be enriching for NTG-treated strains better able 
to survive at 28°C.
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M. sm egm atis me2155 
Log phase culture ( A ^  = 0.8) MM
^  37 °C
NTG (500 mg/ml) 
Incubate 37 °C (45 min)
Set (A) +
second mutagenesis Set (B)
Recovery at 28 °C
MM + aa (48 hr)
Recovery at 37 °C + INH
MM + aa (24 hr)
I
Recovery at 28 °C 
MM + aa (48 hr)
Plate out
MM MM + aa
96 well array
Fig.17. A schematic diagram of the first mutagenesis procedure.
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3.1.2.3 Auxotrophy
3.1.2.3.1 First mutagenesis
The NTG-treated M  smegmatis me2155 strains from both procedures were screened for 
auxotrophs, as a marker of the efficiency of the mutagenesis.
An initial estimate of the level of auxotrophy in SetA and SetB(INH) was made by comparing 
the number of colonies formed on the original MM and MM+AA dilution series (Fig. 17 and 
2.27.1.1), at 37°C and 28°, (Table.7).
Table 7. The initial levels of auxotrophy observed following the first NTG mutagenesis
procedure
NTG-treated 
M . smegmatis 
( 1 st procedure)
Level o f auxotrophy at 28°C 
No. of colonies 
MM/MM+AA Percentage
Level o f  auxotrophy at 37°C 
No. o f  colonies 
MM/MM+AA Percentage
Set A 5175/5450 5.3 1318/1314 -0.3
Set B (INH) 600/744 24.0 575/696 21.0
The estimated percentage of auxotrophs within the NTG-treated M. smegmatis strains of 
SetA was 5.3% at 28°C and -0.3% at 37°C. The estimated percentage of auxotrophs within 
SetB(INH) was 24% at 28°C and 21% at 37°C, higher than in the cells of SetA, which were 
not INH treated. The estimated levels of auxotrophy were higher at 28°C than at 37°C for 
both sets of NTG-treated cells.
The actual percentage o f  stable auxotrophs within the NTG-treated cell populations o f SetA 
and SetB(INH) was then established. 2,000 colonies were randomly selected, 1,000 from 
SetA and 1,000 from SetB(INH) from the MM+AA plates incubated at 28°C. The colonies 
were maintained on Middlebrook 7H10 plates arranged in arrays o f 96 and were known
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collectively as Bank 1.
The 2,000 colonies of Bank 1 were replica plated onto MM and MM+AA plates, at 28°C. 36 
o f the NTG-treated strains of Bank 1 showed no growth on MM while exhibiting growth on 
MM+AA. 14 (0.67%) of the 36 strains were from Set A (1.4%/of Set A) and 22 (1.11%) from 
SetB(INH) (2.2% of SetB). These strains were picked from the MM+AA plates, grown to 
late log-phase in liquid culture at 28 °C, before being individually retested on MM and 
MM+AA agar at both 28°C and 37°C. Five strains (0.25%), one from SetA and four from 
SetB remained auxotrophic only growing on MM+AA, at both temperatures; AM2 and 
AM I,3,4,5 although three of these appeared leaky showing a little growth on MM agar, at 
both temperatures.
3.1.2.3.2 Nutritional requirements o f the auxotrophs
Determination of the nutritional requirements of the auxotrophs was then carried out. To 
determine the amino acid required for survival, each of the five auxotrophic strains (AM 1-5) 
were tested on "dropout" plates containing 19 of the 20 Casamino acids. Strains AM2 and 
AM4 exhibited weak growth on drop out plates without tryptophan, proline, asparagine, 
glycine or methionine. AMI did not grow on agar without proline. AM3 and AM5 grew on 
all 20 dropout plates.
The five strains were then tested on MM agar containing single amino acids. AMI only grew 
on proline-containing MM agar. AM2 grew on MM agar containing only arginine, aspartic 
acid, phenylalanine, serine or valine. AM3, 4 and 5 grew on all 20 single amino acid plates.
Thus two stable auxotrophs were isolated: AMI a proline mutant from SetB(INH) and AM2 
(SetA), a mutant requiring aspartate, phenylalanine, arginine, serine and valine. The overall 
percentage of stable auxotrophs was found to be 0.1% within this population of NTG-treated
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M . smegmatis me2155. The percentage o f  stable auxotrophs was the same within both the 
INH treated, SetB(INH), and untreated sets o f cells (Set A), although three additional leaky 
auxotrophs (AM3, AM4, AM5) were isolated from SetB(INH). The reduction in the 
estimated levels of auxotrophy to the actual level of stable auxotrophs from initial estimates 
o f  5.3% in SetA and 24% SetB(INH) to 0.1% in both was also observed by other groups 
(Konickova-Radochova et al., 1970; Subramanyam et a l, 1989).
3.1.2.3.3. Second mutagenesis
One thousand NTG-treated M. smegmatis strains from the second mutagenesis were randomly 
selected and maintained on Middlebrook 7H10 agar arranged in arrays of 96 following 
incubation at 28 °C. The 1,000 strains, known collectively as Bank 2, were then replica plated 
on to MM and MM+AA agar and incubated at 28°C. Fifty eight strains grew poorly or not 
at all on M M  agar and these strains were subcultured from the master plates before being 
retested individually. Two stable strains 570 and 657 were consistently unable to grow on 
MM following subculture. Although the nutritional requirements o f these auxotrophs has not 
yet been determined, they were taken to be auxotrophs. The cell population o f the second 
mutagenesis therefore had a 0.2% level o f  auxotrophy.
The actual percentage of stable auxotrophs derived from both mutagenesis procedures 0.1% 
and 0.2% were comparable to those found by other groups (Holland and Ratledge, 1971; 
Hinshelwood and Stoker, 1992b).
3.1.2.4 A ltered  chromogenesis
A number o f  NTG-treated strains with altered chromogenesis were observed in SetA but not 
in SetB(INH) following the first mutagenesis procedure. Three strains (17, 143 and 186) 
appeared to have no colouring, remaining white even after prolonged growth and exposure 
to  light. Two strains 96 and 356 were observed to be a bright orange colour from an early
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stage of growth. One white strain, 17, one orange strain, 96, and the parent M. smegmatis 
mc2155 were cultured at 28°C and 37°C to late stationary phase (0.8 A ^ ). The cells were 
freeze dried, their pigments extracted and their absorption spectra analysed. The pigment 
analysis was carried out by Dr.G.Britton, Department of Biochemistry, University of 
Liverpool.
The analysis revealed small amounts o f a P-carotene like-pigment in wild type mc2155 M  
smegmatis strain but the main pigment was theophytin, a chlorophyll degradation product 
which absorbed at 409nm. No pigment was found in the white NTG-treated M. smegmatis 
strain, 17, while the orange strain 96, produced higher levels o f both pigments. The amounts 
of pigment produced by the strain 96 at 37°C were slightly higher than the amounts produced 
at 28°C.
3.1.2.5 M elanin and Mitomycin C mutants
One thousand of the NTG-treated strains of Bank 1 were also screened for a number of other 
altered phenotypes, including increased sensitivity to Mitomycin C and lack o f melanin 
production. This work was carried out by R.Rees, LSHTM. The 1,000 NTG-treated strains 
were screened for Mitomycin C sensitivity, in the search for a recA  strain. Initially the strains 
were screened by replica plating onto Lemco plates containing 0.5/zg/ml Mitomycin C and 72 
strains with poor or no growth were isolated. The 72 strain were subcultured, retested and 
ultimately 12 stable Mitomycin C sensitive strains were isolated, strains 42, 43, 147, 149, 218, 
316, 386, 426, 427, 460, 681, and 734 all from SetB(INH).
The screen for melanin mutants initially produced 10 possible mutants, with pale colour when 
replica plated onto tyrosine Lemco agar containing CuS04. These strains were subcultured and 
retested, revealing 2 strains which were consistently white when grown on tyrosine medium, 
387(INH) and 418(INH). The Mitomycin C sensitive strains and the melanin mutants are
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currently being investigated.
The isolation of auxotrophic mutants at 0.1 and 0.2% indicated that both mutagenesis 
experiments had been successful. The additional chromogenesis, Mitomycin C and melanin 
mutants retrieved from Bank 1 were further evidence that the first mutagenesis was successful 
and had produced diverse mutations. Having established the success o f the mutagenesis 
procedures the NTG-treated strains could then be screened for any alteration in phenotypes 
that may indicate a change in the cell envelope of the strain.
3.1.3 Screening and selection for M .  s m e g m a  t i s  mutants with altered cell
EN V ELO P ES
In order to isolate cell envelope mutant strains of M. smegmatis from the NTG-treated 
population the strains were screened for altered phenotypes which may indicate a defective 
cell envelope. The NTG-treated M  smegmatis strains were initially screened for temperature 
sensitivity and mycobacteriophage resistance and then for increased resistance and sensitivity 
to  a variety of antibacterials.
3.1.3.1 Mycobacteriophage resistance
Following unsuccessful attempts to  isolate a spontaneous phage resistant mutant o f M. 
smegmatis me2155 NTG-treated M . smegmatis strains were screened for resistance to a 
number of mycobacteriophages.
3.1.3.1.1 First screening o f Bank 1 strains
1170 colonies from Bank 1 of NTG-treated M. smegmatis strains, 584 from SetA and 586 
from SetB(INH), were screened for resistance to four mycobacteriophages: D29, D4, D33 
and DNAIII8. The strains were initially screened using the "drop" method (section 2.22). The 
basis of this method was to pipette mycobacteriophage solution (105 pfu/rnl) onto a lawn of
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the NTG-treated test culture and to incubate at 37°C. Resistant strains would form a 
complete lawn where as infectable strains should form a clearing zone, caused by 
mycobacteriophage lysis of the surrounding cells. The NTG-treated M. smegmatis mc2l 55 
strains were replica plated into 96 well micronic tubes containing 800/d of Middlebrook 7H9 
media and incubated at 37 °C with shaking for 48hr before 200//1 of each culture was plated 
out in Lemco soft top agar. 5^1 o f D29, D4 D33 and DNAIII8 solutions were then dropped 
onto the soft top and the plates incubated at 37°C for 48hr.
A total o f 28 NTG-treated M. smegmatis strains, 14 each from SetA and SetB(INH), 
appeared resistant to one or more of the mycobacteriophage tested (Table. 8). Seven strains 
initially appeared resistant to all four mycobacteriophages and another seven were apparently 
resistant to D29, D33 and DNAIII8. Two strains appeared resistant to both D33 and DNAIII8 
and three to D29 and DNAHI8. Six strains were resistant to D29, the most frequent resistance 
to a single mycobacteriophage, with single strains showing resistance to D33, DNAII8 and 
D4.
Table 8. The results of the initial screening of Bank 1 strains for mycobacteriophage
resistance
Type o f phage resistance No. of NTG-treated 
resistant strains
D29, D4, D33 and DNAIII8 7
D29, D33 and DNAIII8 7
D33 and DNAIII8 2
D29 and DNAIII8 3
D29 6
D33 1
D4 1
D29 i
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The 28 "resistant" strains were subcultured onto Middlebrook 7H10 plates before being 
retested for phage resistance by the infection method (section 2.21). On retesting all 28 strains 
were found to be sensitive to infection by all four mycobacteriophage types.
3.1.3.1.2 Second screening o f an additional 1,000 SetA mutants
Having been unable to isolate any stable mycobacteriophage resistant strains from Bank 1 of 
NTG-treated strains, a  further batch of 1,000 NTG strains from SetA were screened. The 
1,000 NTG-treated M . smegmatis strains were grown to late log-phase in 5ml Lemco at 
37°C, with shaking. Each culture was then tested for infectability with D29, D4, DNAIII8, 
D33 and Lg (1x10s pfii/ml) using the "drop" method (section 2.22). Those strains which 
appeared to be resistant following this initial screen were retested following subculture using 
the infection method (section 2.21).
Table 9. The results of serial screening of 1,000 NTG-treated M. smegmatis for 
mycobacteriophage resistance
Phage Screen 1 
"Drop" Method
Screen 2 
Infection
Screen 3 
Infection
Screen 4 
Infection
D4 4 0 « _
D29 94 24 4 0
D33 0 _ _ 0
DNAIII8 2 0 _ _
______________
0 - - -
Following the initial screen using the drop method 100 strains appeared resistant; 94 o f  these 
(94%) to D29, 4 to D 4 and 2 to DNAIII8 (Table.9). The high numbers o f D29 "resistant" 
strains indicated that the titre of the phage solution had fallen and a new preparation (section 
2.20) was used in subsequent experiments. On retesting of the 100 strains using the infection 
method (section 2.21) only 24 strains resistant to D29 remained, a five fold reduction. After
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subculture the 24 strains were retested twice following subculture, using the infection method 
and all the strains were found to be infectable with D29 implying the strains were unstable 
mutants which would have been unsuitable for complementation.
3.1.3.1.3 Large scale selection fo r  mycobacteriophage resistance
To increase the chances of isolating a mycobacteriophage resistant strain o fM  smegmatis 
larger numbers of NTG-treated M  smegmatis mc2155 strains, derived from frozen stocks and 
grown to late log-phase at 28°C, were screened for mycobacteriophage resistance (section 
2.28.2). The selection involved plating large numbers of NTG-treated M. smegmatis strains 
onto plates soaked in mycobacteriophage and analysing any M. smegmatis strains able to 
survive this "sea" o f phage. The mycobacteriophage solutions used were of lower 
concentrations (lxlOM xlO5 pfu/ml) than those which had previously resulted in 
pseudolysogenic strains (lxl0*-lxl09pfu/mlXsection 3.1.1). 1ml (3xl0‘ cfu) 100/d (3xl07cfu) 
and 10//1 (3x10® cfu) of a late log-phase culture o f NTG-treated M. smegmatis cells from 
SetB(INH) was spread onto Lemco plates soaked with 1ml of individual mycobacteriophage 
solution (Ix l0 4-lx l0 5pfu/ml). Colonies were only formed on plates seeded with 3x1 (f cfu, 
no colonies were observed when lower numbers of NTG-treated M. smegmatis strains were 
used. No colonies were formed on any plates spread with equal numbers of wild type M. 
smegmatis mc2155 cells. A similar number of resistant colonies were formed for each phage 
type used, 35 with D29, 30 with DNAIII8, 25 with D33 and 24 with D4.
The "resistant" strains were all subcultured, tested for pseudolysogeny (section 2.24) and then 
infectabilty with D29, D33, DNAIII8 and D4, using the drop method (section 2.22). All 24 
D4 strains were found to be non-pseudolysogenic but infectable with D4 and the three other 
phage on retesting. All 30 DNAIII8 and D29 strains were found to be pseudolysogenic and 
were not therefore tested for infectabiiity. Of the 25 D33 resistant strains only 13 were 
successfully subcultured and tested for pseudolysogeny and infectabiiity. Seven D33 strains
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were non-pseudolysogenic and infectable with all four phages.
Six D33 "resistant” strains remained uninfectable with both D33 and also DNAIII8 but four 
of these were pseudolysogenic on the initial screen. Two uninfectable strains 2 and 21 were 
retested for pseudolysogeny and infectability, using the infection method. On rescreening two 
strains were found to be pseudolysogenic and remained resistant to infection by both D33 and 
DNAIII8.
This large scale screen for phage resistant mutants was unsuccessful in isolating any stable 
mycobacteriophage resistant strains o fM  smegmatis, although initially colonies were formed 
on phage-soaked plates spread with NTG-treated M. smegmatis which were not found on the 
wild type plates, suggesting these were resistant strains. The resistant strains were all 
pseudolysogenic apart from the D4 derived colonies. The experiment implied that strains 
pseudolysogenic for D33 were resistant to infection with DNAIII8 as well as D33. 
Unfortunately as the DNAIII8 strains were all pseudolysogenic they were not tested for 
infectability with any phage including D33. The levels of pseudolysogeny observed for 
DNAIII8, D29 and D33 indicated that the Ix l04-lx l0 5 pfu/ml required to cause confluent 
lysis, was still capable of producing pseudolysogenic strains.
The individual (2170) colonies and large scale screening of NTG-treated M. smegmatis strains 
for resistance to a range of mycobacteriophage failed to isolate a stable phage resistant mutant 
strain ofM. smegmatis. The decision was made to discontinue this approach to the isolation 
of M  smegmatis cell wall mutant strains and to commence the search for temperature 
sensitive strains o r strains with altered antibiotic resistance or sensitivity as a phenotypic 
indication o f an altered cell wall.
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3.1.3.2 Temperature sensitivity
All NTG-treated M. smegmatis cells were left at 28 °C to recover in an attempt to retain any 
temperature sensitive mutants, as there is some evidence that cell wall mutants may survive 
better at lower temperatures. This approach was also adopted by P. Chakrabarti (personal 
communication) when isolating the M. smegmatis mycolic acid mutant strain (Kundu et al., 
1991).
An initial estimate of the percentage o f temperature sensitive mutants, from the first 
mutagenesis was determined by comparing the number of colonies formed on the initial 
MM+AA dilution plates (2.27.1.1 and Fig.17) at 28°C and at 37°C, for SetA and 
SetB(INH)(Table. 10).
Table 10. Initial levels of temperature sensitivity observed following the first 
mutagenesis procedure
NTG-treated Levels of temperature sensitivity Levels of temperature sensitivity
M. No. of colonies on MM+AA No.of colonies on MM
smegmatis 28°C/37°C Percentage 28°C/37°C Percentage
Set A 1325/1314 0.83 1087/1318 -21.0
Set B(INH) 744/696 6.9 600/575 4.3
A greater number of colonies were formed on MM+AA plates incubated at 28 °C than those 
incubated at 37°C, for both SetA and SetB(INH). The estimated percentage of temperature 
sensitive strains was 0.83% for SetA and 6.9% for SetB(INH). These results implied that both 
recovery at 28°C and particularly INH treatment o f the NTG-treated cells had initially 
enriched for strains only able to survive at 28 °C on MM+AA.
The initial number of colonies formed from SetA and SetB(INH) on MM at 28°C and 37°C 
was also compared (Table. 10). Within SetA the number of colonies able to  survive at 37°C
-133-
Results
on MM was 21% higher than those able to survive at 28°C. The colony counts for SetB(INH) 
were 4.3% higher for those able to survive at 28°C than at 37°C on MM. These results 
suggested that the INH treatment was enriching for temperature sensitive mutants, although 
th e  numbers able to survive on MM were lower than those able to survive on MM+AA. 
Recovery at 28°C was insufficient to select for mutants which were stable at 28°C on MM.
These initial results on MM indicated that while INH treatment was probably enriching for 
strains truly stable at 28°C and sensitive to growth at 37°C. Recovery at 28°C was possibly 
allowing metabolic mutants to survive at the slower growth rate incurred at 28°C on 
MM+AA; while on MM with the added disadvantage o f poor nutrition these strains were 
unable to survive.
In an attempt to  isolate stable temperature sensitive strains, Bank 1 was replica plated onto 
duplicate sets Middlebrook 7H10 agar plates. One set o f duplicates was incubated at 28°C 
and the other at 37°C. The colonies were then screened for those with poor growth at 37°C 
and strong growth at 28°C. Twenty one strains were found which fulfilled this criteria, five 
o f  these strains were from SetB(INH) and 16 from Set A. The 21 strains were subcultured 
onto duplicate 7H10 agar plates and their growth at 28°C and 37°C retested. Three strains 
continued to show poor growth at 37°C while retaining proliferative growth at 28°C; one 
strain, 228, from Set A and strains 166 and 621 from SetB(INH). A subsequent subculture of 
these three strains and a repeat testing o f their growth at 37°C and 28°C showed an apparent 
reversion to growth at 37°C. No stable temperature sensitive mutants were isolated from 
Bank 1.
3.1.3.3 Screening fo r  altered antibiotic resistance and sensitivity
There are a variety o f antibiotics whose mode o f action is thought to involve the 
mycobacterial cell wall, as well as those whose uptake would be affected by a change in the
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permeability of the cell envelope (section 1.5). An increased antibiotic resistance or sensitivity 
could therefore be due to an altered cell envelope. The NTG-treated M. smegmatis strains 
were screened for altered antibiotic resistance and sensitivity in an attempt to isolate a strain 
with a defective cell wall, while remaining aware that other non-cell wall target site mutations 
could be involved.
3.1.3.3.1 Minimum Inhibitory Concentrations, MICs
Initially MICs of the selected antibiotics were determined on solid Lemco agar at 28°C . A 
late log-phase (0.8-1 A*«,) liquid culture of wild type M. smegmatis m e2155 was streaked onto 
Lemco agar containing increasing concentrations of the given antibiotic, from 0 - 1  mg/ml, in 
doubling increments i.e. 2, 4, 8, 16, 32, etc. The plates were incubated at 28°C for 6 days 
before being read. The results are shown in Table 11.
The MICs of each antibiotic for M. smegmatis mc2155 on Lemco agar at 28°C were on the 
whole similar to those found by other groups (Table. 11); variations were put down to the 
differing conditions of media, temperature and growth stage and size o f  inoculum under which 
these values were established. M. smegmatis mc2155 was, as expected, sensitive to 
antimycobacterials 1-7 (Table. 11) and resistant to penicillin G and pyrazinamide. The most 
suitable concentrations for the initial screening of the banks of NTG-treated M. smegmatis 
strains for increased resistance to antimycobacterials 1-7, or sensitivity to penicillin G and 
pyrazinamide, were determined (Table. 11).
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Table 11. The Minimum Inhibitory Concentrations (MICs) of nine antibiotics against
M. sm egm atis mc2155 at 28°C
Antibiotic M. smegmatis me2155 
MIC (Mg/ml) at 28 °C 
(on Lemco media)
Published M. smegmatis 
MIC's (¿¿g/ml), at 37°C 
(in various media)
Screening
concentration
(//g/ml)
1) Minocycline 32 2-5 (Yamada et al., 
1991)
50
2) Ethambutol 2-4 3-5 (Silv e e ta l., 1993) 5
3) Ethionamide 32 10 (Baneijee et al., 
1994)
50
1 4) Amikacin 32-64 Unknown (5-20 for M. 
tuberculosis Dulwich, 
PHL)
75
5) Cycloserine 128 Unknown (< 50 for M. 
tuberculosis, Dulwich 
PHL)
200
6) Ofloxacin 2-4 < 2 in M. tuberculosis 5
7) Ciprofloxacin 2-4 5
8) Penicillin G 1024 200 + 500
9) Pyrazinamide 600 at least 500 (Konno et 
al., 1967)
500
3.1.3.3.2 Antibiotic resistance
NTG-treated M . smegmatis were screened for resistance to ethambutol, ethionamide and 
cycloserine as their target site is believed to be in the cell wall (section 1.5.1.); the tetracycline, 
minocycline, was used as its efficacy against mycobacteria is attributed to its ability to traverse 
the lipid permeability barrier, an alteration in the cell wall could result in increased resistance 
to this antibiotic. Amikacin is a polycationic aminoglycoside whose uptake is self promoted 
and believed to be due to the negative surface charges on the mycobacterial cell wall; the drug 
was used as an alteration in the cell wall could again lead to reduced uptake of the drug. The 
fluoroquinones, despite the fact that their main target site is DNA gyrase, were used as a
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permeability alteration could also result in increased resistance.
Bank 1 of 2,000 NTG-treated M. smegmatis strains were screened for resistance to seven 
antibiotics. The 2,000 strains were replica plated onto Lemco agar containing an inhibitory 
concentration of the given antibiotic and subsequently incubated at 28 °C for 5 days. Any 
strains able to grow were subcultured onto Middlebrook 7H10 agar before being retested by 
streaking single colonies onto Lemco agar containing an inhibitory concentration o f antibiotic. 
The strains were subsequently incubated at 28 °C for 5 days. Any resistant strains isolated 
were retested in liquid Lemco media containing increasing concentrations of the antibiotics.
If  no resistant strains were isolated from Bank 1 then a large scale screen of NTG-treated 
M. smegmatis strains was undertaken. 1ml (3x10* cfu) o f  a  late log-phase culture o f  NTG- 
treated M. smegmatis strains, seeded from frozen stocks o f  SetB(INH), was spread onto 
Lemco agar containing the inhibitory concentration of the  antibiotic. Again any resistant 
strains were subcultured and retested individually.
3.1.3.3.2.1 Minocycline
Bank 1 was replica plated onto Lemco agar containing SOjug/ml of minocycline and 12 
apparently resistant strains were observed. These 12 strains were found to be sensitive to the 
same concentration when subcultured and retested. No stable minocyline resistant strains were 
isolated from Bank 1.
A large scale screen (section 2.28.2) for minocycline resistant strains at 50>ug/ml concentration 
was then carried out which was also fruitless .
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Bank 1 was replica plated onto Lemco agar containing 2/^g/ml ethambutol and incubated at 
28°C. The majority of the Bank 1 strains appeared sensitive to the 2/^g/ml MIC, which had 
been difficult to determine exactly. Twenty-nine strains, 18 from SetA and 11 SetB(INH), 
grew on the ethambutol containing agar. These strains were subcultured and restreaked onto 
agar containing ethambutol at 2//g/ml and 5//g/ml. One strain showed growth on 2//g/ml 
ethambutol, five strains showed some growth on 2 and 5Aig/ml of ethambutol. The other 23 
strains showed no growth on either concentration of ethambutol. Concentrations o f 2/^g/ml 
and 5/^g/ml ethambutol were used to determine the degree o f resistance exhibited by resistant 
strains. The six apparently resistant strains were retested on 2/^g/ml and 5^g/ml of ethambutol 
on solid and liquid Lemco agar and were found to be sensitive to both concentrations on solid 
and in liquid media.
Large scale screening (section 2.28.2) yielded two apparently resistant strains which were 
found to be sensitive on subculture and retesting, again no strain was found.
3.1.3.3.2.3 Ethionamide
Bank 1 was replica plated onto Lemco agar containing 50/^g/ml of ethionamide. Thirty nine 
strains showed growth on ethionamide, 24 from SetA and 15 from SetB(INH). On subculture 
and retesting, nine strains, all from SetA were found to be weakly resistant, whereas the other 
30 were all sensitive. On subsequent subculture and retesting of these 9 strains on solid and 
in liquid media the resistance was not maintained.
Large scale screening (section 2.28.2) for ethionamide resistance involved the plating out of 
NTG-treated M . smegmatis strains from SetA and SetB(INH). The screen yielded 45 resistant 
colonies, 21 from SetA and 24 from SetB(INH). The 45 strains were subcultured and 
restreaked onto plates containing ethionamide; 19 SetA strains and 20 SetB(INH) strains
________ R esu lts
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remained resistant. The test was repeated by streaking from liquid cultures of each strain on 
to ethionamide plates. This repeat test resulted in 4 strains from Set A and 3 from SetB(INH) 
retaining very weak resistance, only 3-4 resistant colonies per plate. The seven weakly 
resistant strains were deemed unsuitable for complementation experiments and therefore 
further investigation.
3.1.3.3.2.4 Amikacin
Bank 1 was replica plated onto Lemco agar containing 75^g/ml amikacin. Four strains were 
found to grow strongly on the Lemco agar containing amikacin. These strains were 
subcultured and retested on Lemco agar with 75>ug/ml amikacin. The four strains no longer 
showed resistance to this concentration of amikacin.
A large scale amikacin screen (section 2.28.2) did not produce any resistant strains. No stably 
amikacin resistant strains were isolated.
3.1.3.3.2.5 Cycloserine
Bank 1 was replica plated onto Lemco agar containing 200/ig/ml cycloserine. 150 strains were 
found to grow on cycloserine following this initial screen, 65 from SetA and 85 from 
SetB(INH). These strains were subcultured and retested on Lemco agar containing 200/^g/ml 
cycloserine. Forty nine strains retained resistance, 22 from SetA and 27 from SetB(INH). 
These strains were again subcultured and retested and all forty nine strains regained their 
sensitivity.
3.1.3.3.2.6 Ofloxacin
Bank 1 was replica plated onto Lemco agar containing 5/ug/ml ofloxacin. Forty five strains 
showed growth on 5/zg/ml ofloxacin, 25 from SetA and 20 from SetB(INH). O f these only 
12, eight from SetA and four from SetB(INH), were found to remain resistant following
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subculture and subsequent retesting. The strains from Set A were 4, 134, 290, 291, 486, 934, 
944 and 1008, those from SetB(INH) were 259, 601, 712 and 720. The strains retested on 
Lemco agar containing 5/^g/ml and 10/^g/ml ofloxacin and found to remain strongly resistant 
to  5/zg/ml and weakly resistant to 10^g/ml.
The resistance of the 12 strains was also tested in 5ml Lemco media with a 5/^g/ml 
concentration. Seven of the strains were found to remain resistant to 5/zg/ml in liquid culture, 
while five (134, 486, 1008, 259(INH) and 712(INH)) were inhibited at this concentration in 
liquid culture.
The 12 strains were also tested for cross reactivity to ciprofloxacin by streaking them onto 
5 and 10^g/ml of ciprofloxacin.
Two strains 486 and 712(INH) were found to be sensitive to 5//g/ml ciprofloxacin, the other 
ten strains were resistant. It was more likely that those strains resistant to both ofloxacin and 
ciprofloxacin had all sustained mutations in their gyrA or gyrB  genes, the primary site of 
action of both drugs. It was also conceivable that those strains resistant to ofloxacin only had 
acquired mutations in other genes which resulted in resistance through decreased permeability 
possibly due to an alteration in the cell envelope.
3.1.3.3.2.7 Ciprofloxacin
Bank 1 of NTG-treated M. smegmatis cells were replica plated onto Lemco agar containing 
5/^g/ml ciprofloxacin. Eighteen strains were found to grow on this concentration of 
ciprofloxacin, 12 strains from SetA and 6 from SetB(INH). The strains were subcultured and 
retested and three of the strains from SetA remained resistant (273, 487 and 719). The other 
15 strains were sensitive to 5/zg/ml ciprofloxacin. None o f the cross resistant ofloxacin 
resistant strains were picked up from this screen for ciprofloxacin resistance.
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In summary, NTG-treated strains were screened for resistance to seven antimycobacterial 
agents at concentrations to which they were normally susceptible. Although initial screens 
appeared to pick up some strains resistant to each antibiotic the majority o f these strains 
became sensitive following serial subculture and retesting. Finally, the only stable NTG- 
treated M  smegmatis mutant strains isolated were resistant to ofloaxcin and ciprofloxacin 
(Table. 12)
3.1.3.3.3 Antibiotic Sensitivity Testing
NTG-treated M. smegmatis me2155 strains were screened for increased sensitivity to 
compounds to whichM smegmatis mc2l 55 possessed a naturally high level o f resistance i.e. 
pyrazinamide and penicillin G (Table. 11). An increased level o f sensitivity may be have been 
due to a change in permeability, caused by an alteration in the cell envelope structure, as with 
the penicillin G sensitive mycolic acid mutant ofM  smegmatis (Kundu et al., 1991).
3-1.3.3.3.1 Penicillin G
Bank 1 was screened for sensitivity to penicillin G by replica plating onto two sets of Lemco 
plates containing 500/rg/ml and 200//g/ml penicillin G respectively, followed by incubation 
at 28°C. As the MIC for penicillin G was >lmg/ml at 28°C, any strains unable to survive 
these concentrations of penicillin G would be exhibiting increased sensitivity to the antibiotic. 
From the initial screening nine strains were isolated from SetA and five of these showed weak 
growth at 200jug/ml penicillin G as well as no growth at 500/zg/ml penicillin G. Eight strains 
showing no growth on 50<Vg/ml penicillin G  were isolated from SetB(INH). These seventeen 
strains were retested for sensitivity to 200//g/ml and 500/ug/ml. Seven SetA strains and one 
SetB(INH) strain continued to show increased sensitivity to penicillin G at 500/^g/ml. These 
strains 251, 255, 357, 396, 730, 758 and 826 from SetA and 722 from SetB(INH), were 
subcultured and further analysed. Two single colonies from each strain were streaked out onto 
Lemco plates containing penicillin at 200^g/ml and 500//g/ml. All showed increased
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sensitivity in that they were sensitive to 500^g/ml penicillin G, although resistant to 200/^g/ml 
on solid medium.
The penicillin G sensitivities of liquid cultures of these strains were then investigated at 28°C 
and 37°C. Eight single colonies from each of the penicillin sensitive strains were picked and 
used to inoculate 5ml o f Lemco broth. Four cultures from each strain were incubated at 28°C 
and four from each strain were incubated at 37°C. The cultures were then streaked onto 
duplicate 200//g/ml penicillin G and 500/^g/ml penicillin Lemco plates, one set of duplicates 
were incubated at 37°C and the other set at 28°C. The eight cultures derived from single 
colonies o f  the eight initially sensitive strains were all resistant to 200^g/ml, at 28 °C and 
37°C. All cultures o f the three strains 251, 357 and 826 also showed complete resistance to 
500//g/ml penicillin G at both temperatures. In contrast five strains 255, 396, 758, 730 and 
722 (INH) showed variable results when their eight liquid cultures were plated onto solid 
Lemco containing 500/^g/ml penicillin G; although the results were consistent at both 
temperatures.
These five cultures showing variable results were analysed further. The cultures of each strain 
unable to survive 500/^g/ml penicillin were subcultured onto Lemco plates at 28 °C, five single 
colonies from each of these strains were cultured and retested on 500 ¿¿g/ml penicillin G at 
28°C and 37°C. Three strains (255, 396 and 758) were found to be resistant to 500/^g/ml 
penicillin G  at both temperatures. The cultures of strains 730 and 722 showed variable 
sensitivities to penicillin G. Four cultures o f 722 were sensitive to 500yug/ml penicillin G and 
one was resistant, at both temperatures. Two cultures o f 730 were sensitive to 500/^g/ml at 
37°C and 28°C. One 730 culture was sensitive to 500/^g/ml penicillin G at 28°C one at 37°C 
and one was contaminated. The inconsistency of the results obtained for both strains 730 and 
722 indicated that the strains were mixed or unstable and had reverted to the wild type in 
some o f the cultures.
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In conclusion, two strains, 730 and 722, showing some penicillin sensitivity were isolated; 
since they did not appear stable it was concluded that neither were suitable for further use.
3.1.3.3.3.2. Screening of NTG-treated strains from the second mutagenesis for penicillin 
sensitivity
The screen for penicillin sensitivity had unearthed some sensitive strains, albeit unstable and 
the decision was taken to continue the search. The majority o f the sensitive strains isolated 
from the previous screen were from SetA, strains which had not been INH treated; the repeat 
screen was therefore carried out on the INH untreated strains of Bank 2 from the second 
mutagenesis procedure (section 2.27). The NTG-treated strains were again screened by 
replica plating for sensitivity to penicillin G at 28°C.
57 strains initially appeared sensitive to  penicillin G, these were subcultured and retested on 
Lemco agar containing 500/ug/ml penicillin G from single colonies on Lemco plates. 
Seventeen strains appeared sensitive, showing no growth on 500/ug/ml o f penicillin G. The 
strains were retested by streaking liquid culture, derived from single colonies, onto Lemco 
agar containing 500/^g/ml penicillin. 15 strains were found to remain sensitive to  a 500/ug/ml 
concentration of penicillin G  at both 28 °C and 37°C.
The antibiotic sensitivity of these fifteen strains was then compared to the wild type in liquid 
culture. Equal numbers (2xl07 cfu) of test strain cells were added to a series o f 5 ml volumes 
of Lemco media containing increasing concentrations of penicillin G (1 OO^g/ml-1 mg/ml). A 
series was set up for each test strain and wild type M. smegmatis mc2155, all the series were 
incubated at 37°C for 48hr (section 2.28.4). The A*,*, o f the individual cultures o f  each series 
was taken as a measure of growth at each concentration of penicillin. The antibiotic sensitivity 
o f the fifteen test strains were then compared to the wild type. The results represented 
graphically in Fig. 18.
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Fig. 18. Graphs depicting the penicillin G sensitivity of NTG treated M. sm egm atis 
strains in liquid culture
An approximately equal number o f cells (2xl07) of each strain were added to 5ml Lemco 
containing increasing concentrations (100/ig/ml) of penicillin G and incubated at 37°C. The 
A^o of each of the individual cultures, at increasing penicillin G concentrations, o f each strain 
were then taken. Strains 221, 442, 605, 611 and 650 (a-e) exhibited increased sensitivity to  
penicillin G. Strain 557 (f) showed such poor growth that a proper comparision with wild type 
could not be made. Strain 21 (g) is an example of a strain exhibiting no increased sensitivity 
to penicillin G.
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Five of the strains clearly showed increased sensitivity to penicillin G: 221, 442, 605, 611 and 
650 (Fig. 18). Eight of the strains (140, 190, 350, 463, 570, 557, 879, 889) showed poor 
growth in comparison to the wild type in Lemco alone (only 557 is shown in Fig. 18) and as 
well as at the lower concentrations of penicillin G. One o f these strains, 570, was also pulled 
out on the screen for auxotrophs from the second mutagenesis procedure. Four strains, 21, 
922, 939 and 806 showed no increased sensitivity to penicillin G (only 21 is shown Fig. 18). 
This experiment also revealed a reduced MIC of 500/^g/ml for penicillin G against the M. 
smegmatis mc2155 strain in liquid culture at 37°C following a 48hr incubation when compared 
with the 1 mg/ml MIC on solid media. Similar results were obtained on repetition of this 
experiment.
Penicillin G sensitive strains 221, 442, 605 and 611 showed increased sensitivity to penicillin 
G with an MIC o f 400/^g/ml, 100^g/ml less than the wild type (500^g/ml) in liquid culture. 
Strain 650 showed the greatest increase in sensitivity, with an MIC of 200^g/ml, 300^g/ml 
lower than the wild type in liquid culture (Fig. 18). The five penicillin G sensitive strains were 
therefore candidates for further analysis and possible complementation.
3.1.3.3.3.3 Pyrazinamide
The bank of 2,000 NTG-treated colonies was screened for increased sensitivity to 
pyrazinamide by replica plating onto Lemco agar pH5.2 containing 500^g/ml pyrazinamide, 
at a concentration o f  100^g/ml lower than the 600/^g/ml MIC. Fourteen strains from Set A 
and from SetB(INH) were isolated which appeared to show increased sensitivity to 
pyrazinamide. These were subcultured and retested on solid medium at pH5.2, at a 
concentration of500^g/ml pyrazinamide at 28°C and 37°C. Two strains, 826 and 415, were 
found to remain sensitive to 500//g/ml pyrazinamide at 28 °C, showing no growth on solid 
medium. The 415(INH) strain showed weak growth at 37°C and with strain 826 only the 
inoculum was visible. The two strains were subcultured, the test repeated and the same results
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obtained.
Both strains 415(INH) and 826 had been selected from other screens. Strain 415(INH)(AM2) 
had previously been isolated from the auxotroph screen and was found to require aspartate, 
phenylalanine, arginine, serine or valine for growth. Strain 826 had been selected on the initial 
screen for penicillin G sensitive strains although it appeared not to be consistently sensitive 
to penicillin G on retesting.
The sensitivity o f 415(INH) and 826 to pyrazinamide was then compared to the wild type 
strain in liquid culture (section 2.28.3). Equal numbers of cells (5x10® cfu) from strains 415, 
826 and the parent M. smegmatis mc2l 55 were added to a series often 5ml volumes of Lemco 
broth pH5.2 containing concentrations of pyrazinamide, from 0-1054/^g/ml in doubling 
quantities. The series were set up in duplicate, one series for each strain was incubated at 
37°C and the duplicate at 28°C for 48hr and 72hr, respectively.
The MIC of pyrazinamide for the wild type strain was reduced in liquid culture (by 1 OO^g/ml 
to 500/^g/ml) as had been observed for penicillin G. Strain 415(INH) did not show significant 
sensitivity to pyrazinamide in liquid culture at either temperature when compared with the 
wild type, (Fig. 19a+b). Strain 826 was considerably more sensitive than the wild type to 
pyrazinamide in liquid culture, particularly at 28°C (Fig.l9a+b). As was observed for 
penicillin G, the MIC of pyrazinamide for the wild type strain was reduced in liquid culture, 
by 100^g/ml to 500//g/ml.
The fact that 415 was not sensitive to pyrazinamide in liquid culture implied that 415(INH) 
was not specifically sensitive to pyrazinamide but showed poor growth on solid media 
containing pyrazinamide due to another mutation which resulted in a poor growth rate; 
alternatively the strain could have been specifically pyrazinamide sensitive but unstable in
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b)
pyrazinamide concentration (ng/ml)
Fig 19. A graph depicting the pyrazinamide sensitivity of two NTG treated strains of 
M. sm egm atis.
An approximately equal number of cells (5xl06) were added to 5ml Lemco (pH 5.2) with 
increasing concentrations of pyrazinamide (2//gml-1054^g/ml in doubling quantities) which 
were incubated at a) 37°C and b) 28°C Strain 826 (Pyramid II) exhibited increased sensitivity 
to pyrazinamide in liquid culture, (particularly at 28 °C) while strain 415 did not, when 
compared with theM  smegmatis mc2155 wild type resistance (500pg/ml).
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liquid culture.
Strain 826 appeared to be a stable specific pyrazinamide sensitive mutant and as such was 
considered a candidate for further investigation and possible complementation experiments.
In conclusion the screen o f NTG-treated M. smegmatis strains for sensitivity to penicillin G 
and pyrazinamide yielded five stable penicillin G-sensitive strains and one stable pyrazinamide- 
sensitive strain. The two sensitivity screens also selected seven other slow growing, possibly 
mutant strains, two known auxotrophic strains 415(INH)(AM2) and 570 and the 
pyrazinamide mutant 826 on the penicillin G screen.
This suggested that the initial sensitivity screening was less specific than the resistance 
screening, picking up other mutant strains which were not specifically sensitive to the test 
drug. These nonspecific mutant strains were probably picked up because of their poor growth 
rates. The sensitivity screening ultimately proved successful in isolating a number o f mutant 
strains.
3.1.3.3.4 Summary o f antibiotic screening
The screen for antibiotic resistant and sensitive strains of NTG-treated M. smegmatis 
successfully isolated 12 ofloxacin and 3 ciprofloxacin resistant strains as well as 5 penicillin 
G and 1 pyrazinamide sensitive mutant (Table. 12). The isolation o f  strains resistant to 
antibiotics whose mode of action was thought to be involved directly with the cell wall i.e. 
ethambutol, ethionamide proved elusive.
The initial screening procedure by replica plating pulled out apparently resistant strains or 
sensitive strains for every antibiotic tested. However, on subsequent subculture and retesting 
the majority o f these strains appeared to lose their resistance or sensitivity (Table. 12).
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Num ber o f  serial transfers
(a) A ntibiotic  
resistance
1 2 3 A ctual
m utan ts
M in o c y c l in e 12 0 0
E th a m b u to l 3 0 6 0 0
E th io n a m id e 3 9 9 0 0
A m ik a c in 4 0 0
C y c lo s e r in e 1 5 0 4 9 0 0
O f lo x a c in 4 5 12 12 12
C ip ro f lo x a c in 18 3 3 3
(b) A ntibiotic  
sensitivity
P e n ic i l l in  G  - 
B a n k  1
17 8 5 2  v a r ia b le
P e n ic i l l in  G  -  
B a n k  2
17 15 5 5
P y r a z in a m id e 14 2 1 1
Table. 12. Antibiotic resistant and sensitive mutant strains of isolated from Bankl and 
Bank2 of NTG-treated M. smegmatis strains
a) shows the results of screening for antibiotic resistance
b) shows the results of screening for antibiotic sensitivity
The numbers of potential mutants following each serial transfer are shown as well as the final 
number o f  mutants isolated.
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This phenomenon has been observed by other groups screening NTG-treated mycobacteria 
and was put down to the instability o f the mutations.
At this point a decision had to be made about which strains to investigate further and it was 
considered appropriate to pursue the penicillin G and pyrazinamide sensitive mutants. The 
basis for the selection o f the penicillin G mutants was the previous isolation of a penicillin G 
sensitive mutant with defective mycolic acid biosynthesis (Kundu et al., 1991); while 
remaining aware that the penicillin G sensitive strains may have defective P -lactamases 
resulting in increased sensitivity to penicillin. Of the penicillin G sensitive strains, 650 (PenG 
650) was selected for further investigation as it exhibited the greatest degree o f sensitivity. 
The pyrazinamide sensitive mutant 826 (Pyramidll) was chosen as it could be a permeability 
mutant with some form o f cell envelope alteration; as little w as known o f the mode o f action 
o f pyrazinamide and the levels of resistance to the drug in M . smegmatis it was considered 
preferable to follow this mutant further.
3.1.4 Biochemical analysis of candidate strains for  complementation 
As described above, two strains, a pyrazinamide sensitive strain (Pyramidll) and a penicillin 
G sensitive strain (PenG 650) were considered candidate strains for further analysis. The initial 
decision taken was to investigate the lipid content of the cell envelope o f the strains to look 
for any gross alterations.
The mycobacterial lipids o f strains Pyramidll and PenG 650 were systematically analyzed 
using the strategy created by G. Dobson et al. (1985), in order to locate any gross alterations 
in the components of the cell envelope. The lipids of wild type M. smegmatis and the 
uncharacterised auxotroph (570) from the second mutagenesis were analysed as controls. This 
work was carried out under the supervision of Dr.D.Minnikin and Mr R.Bolton, Department 
o f  Biochemistry, University of Newcastle.
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3.1.4.1 Non Polar and Polar "free” lipid analysis
The free lipids were extracted from 50mg of the freeze-dried cells from a late log-phase 
culture (0.8 A ^) of each strain (section 2.29). There are a total of six specifically developed 
two-dimensional thin layer chromatographic (2D-TLC) systems (A-F) which are used to 
analyze the range of polar and non polar lipids. Three o f these systems, A, D and F (section 
2.30.1-3) were used to analyze the "free" lipids of the strains, Pyramidll (826), Aux 570, 
PenG 650 andM  smegmatis mc2155.
3.1.4.1.1 System A
System A is the least polar system and this was used to search for menaquinones, 
characteristically found in M. smegmatis, in the four strains. Menaquinones were observed 
under UV light in all four strains. This system can also be used to detect mycoserosates and 
phthiocerols.
3.1.4.1.2. System D,
The most polar of the non polar lipid extracts were analyzed using system D,, which detects 
trehalose dimycolates (cord factor) and the sulpholipids found in M. tuberculosis. Trehalose 
dimycolate (cord factor) was observed in Pyramidll (826), M. smegmatis, Aux 570 and PenG 
650 (Fig.20).
Sulpholipids were not present as would be expected. Other identical but unknown glycolipids 
were also observed in all four strains under this system, all of which reacted positively with 
the a-naphthol sulphuric acid spray, NAS which detects sugar moieties (Fig.20).
3.1.4.1.3 System D2
The least polar of the polar free lipids were also analyzed using system D which revealed the 
glycopeptidolipids or C-mycosides. All four strains appeared to have the same simple
__________________________________________________________ _________________ R e s u l t s
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Fig.20. Two dimensional TLCs of the most polar class of lipids in the non-polar lipid 
fraction of mycobacterial “free” lipids (System D,)
1st direction, chloroform:methanol:water (100:14:0.8 v/v/); 2nd direction, chloroform : 
acetone : methanol (50:60:2.5 v/v). Organisms: a+b) M. smegmatis mc2155, c+d) Pyramidll 
M. smegmatis, e+f) Aux 570 M. smegmatis, g+h) PenG 650 M . smegmatis.
Detection: a,c,e + g - 5% ethanolic molybdophosphoric acid M PA all lipids; b,d,f+ h - a -  
naphthol sulphuric acid for sugars components i.e.CF and GL.
CF - cord factor (trehalose dimycolate)
GL - glycolipids
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Fig.21. Two dimensional TLCs of the least polar class of lipids in the polar lipid fraction 
of mycobacterial "free" lipids (System D2).
1st direction, chloroform:methanol:water (100:14:0.8 v/v/); 2nd direction, chloroform : 
acetone : methanol (50:60:2.5 v/v). Organisms: a+b)M. smegmatis mc2155, c+d) Pyramidll 
M. smegmatis, e+f) Aux 570 M. smegmatis, g+h) PenG 650 M. smegmatis.
GPL - glycopeptidolipid
Detection: a,c,e + g - 5% ethanolic molybdophosphoric acid MPA, all lipids; b,d,f + h - a -  
naphthol sulphuric acid for sugars components i.e. GPL
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Fig.22.Two dimensional TLCs o f  the most polar class of lipids found in the 
mycobacterial polar "free" lipid fraction (System F).
1st direction, chloroform:methanol:water (65:25:4 v/v); 2nd direction chloroform:acetic acid: 
methanol water (80:15:12:4 v/v).
Organisms: a+b) M. smegmatis mc2155, e+f) Aux 570 M. smegmatis strain, c+d) Pyramidll 
M. smegmatis strain, g+h) PenG 650 M . smegmatis strain.
DPG - diphosphatidylglycerol 
PE - phosphatidylethanolamine acid 
PI - phosphatitylinsositol
DPIDM + MPIDM - di and mono acylphosphatidylinsositol dimannosides 
DPIPM + MPEPM - di and mono acylphosphatidylinsositol pentamannosides 
GL - glycolipid
Detection system: a,c,e + g - 5% ethanolic molybdophosphoric acid spray (MPA) for all lipids. 
b,d,f + h a-naphthol sulphuric acid (NAS), for sugar components, i.e. GL, DPIDM, MPIDM, 
DPIPM and MPIPM
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glycopeptidolipid components, revealed with both 5% molybodophosphoric acid (MPA) and 
the a-naphthol sulphuric acid sprays (Fig. 21).
3.1.4.1.4 System F
This system was used to analyze the most polar lipids of the polar lipid fraction, phospholipids 
found in mycobacteria and the polar glycolipids. The polar lipids were detected with MPA 
(Fig.22). The largest proportion o f phospholipids observed were diphosphatidylglycerol and 
phosphatidylethanolamine (Fig.22). Phosphatidylinositol-mannosides (PIMs), were also 
observed in smaller amounts. No gross differences in the proportions o f any of these 
components were noted between the wild type mc2155 and the mutant strains Aux 570, PenG 
650 and Pyramidll.
Fig.22 also shows System F TLC plates of the four strains sprayed with a-naphthol sulphuric 
acid spray, in which the polar glycolipids of each strain could be distinguished better. Three 
glycolipids, GL 1, 2 and 3, were clearly visible, particularly strongly in the Pyramid II strain. 
In strains Aux 570 and PenG 650 another glycolipid appeared to  be running to the right of 
glycolipid 3; a fourth glycolipid was also weakly visible in the wild type strain. This glycolipid 
did not appear to be present in the Pyramidll strain.
3.1.4.2 My colate analysis
The mycolates of the M. smegmatis mc2155, Aux 570, Pyramidll and PenG 650 were also 
analyzed by a 2D-TLC system following an alkali extraction which hydrolysed and the 
esterified the lipids to obtain fatty methyl esters and methyl mycolates (section 2.31). Fig.23 
shows the mycolates o f the four strains, the characteristic a , a ' and epoxymycolates o fM  
smegmatis were observed in all four strains, although there may be differences in the 
actual amounts of each mycolate component in each strain.
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Fig. 23. Two dimensional TLC of the mycolic acid methylester obtained from the 
extraction of mycolic acids
1st direction, petroleum ether (b.p. 60-80°C), acetone (95:5v/v), three times; 2nd direction 
toluene, acetone (97:3, v/v).
Organisms: a)M . smegmatis mc2l 55, b) Aux 570 M. smegmatis c) Pyramidll M. smegmatis
d) PenG 650 M. smegmatis. Detection: MPA all lipids 
a  - a mycolates 
a '- a ' mycolates 
E - epoxymycolates 
FA - Fatty acids
All strains exhibited the expected a , a ' and epoxymycolates expected from M  smegmatis 
strains in similar proportions.
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3.1.4.3 Fatty acid analysis using gas chromatography
The fatty acid methyl esters of the fatty acids produced by the mycolate extraction were 
extracted and analysed by gas chromatography. The gas chromatography was carried out by 
Mr.R.Bolton, University of Newcastle.
Similar amounts of the various fatty acids were found in all four strains (Table. 13). The 
majority of the fatty acids in the strains were oleic acids (40%), closely followed by palmitic 
acid at 30%. Palmitoleic acid and tuberculostearic acid were found in similar amounts at about 
12%. The only slight variation was in the strain PenG 650 which contained slightly less oleic 
acid (32.6%).
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Table. 13. The fatty acid composition of three mutant M. smegmatis strains and the wild 
type M. smegmatis me2155 strain
Fatty Acid M. smegmatis 
mc2155
Pyramidll Aux 570 PenG 650
Palmitoleic acid 
(C16:l) %
11.90 12.21 12.54 10.98
Palmitic acid 
(C:16) %
28.89 31.58 27.2 32.42
Oleic acid 
(C18:l) %
39.83 37.68 40.00 32.60
Tuberculostearic 
acid (C19Br) %
10.72 12.79 13.23 18.66
In conclusion, no gross alterations were observed in the lipid content of the two mutant 
strains, Pyramidll and PenG 650, or in the control mutant strain Aux 570, following this 
systematic analysis.
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3.1.5 Further analysis of PyramidII
Given that no gross alterations were observed in the lipid content o f Pyramidll and PenG 650, 
it was difficult to make the decision on which one to investigate further. On balance the 
decision was made to  pursue Pyramidll, as even if it turned out not to be the permeability 
mutant of interest, little is known o f  the mechanisms employed by mycobacteria to cope with 
pyrazinamide. It was also conceivable that PenG 650 had a defective P -lactamase as opposed 
to a more generalised permeability mutant.
3.1.5.1 Detailed analysis o f the pyrazinam ide sensitivity o f P yram idll in liquid culture. 
The pyrazinamide sensitivity experiment in liquid culture was repeated with strain Pyramidll 
and wild type M. smegmatis mc2155 at 37°C in duplicate (section 2.28.4). The control 
cultures for each strain were grown to two stages of growth, mid log-phase (O ^A ^) and very 
early stationary phase growth (1.0 A ^). The results of these experiments are shown in Fig.24. 
It was observed that strain Pyramidll was more sensitive to pyrazinamide than the wild type 
M . smegmatis at both stages o f  growth. However, the resistance o f both strains to 
pyrazinamide increased with increasing age of the cells in each culture and extended exposure 
o f the cells to a given concentration of the drug. In mid log-phase the greatest difference in 
the sensitivity between the two strains was observed at a 500/ig/ml pyrazinamide where the 
Pyramidll culture had an O ^ S A ^  (2xl07 cfu/ml) while the M. smegmatis mc2l 55 value was 
0.55 A600 (1.4x108 cfu/ml), a difference o f 0 .3 2 5 ^  , which represented a seven fold 
difference in the cfu/ml of each o f  the cultures of the two strains (Fig.24a). At early 
stationary-phase growth the most substantial difference in sensitivity between the two cultures 
was observed at 700//g/ml of pyrazinamide, when the two cultures had a 0.425 A ^  
differential, representing a 10 fold difference in cfu/ml (Fig.24b). Similar observations were 
made on repetition of this experiment and at other phases o f growth. Strain Pyramidll was, 
at all stages of growth, significantly more sensitive to pyrazinamide than the wild type M. 
smegmatis me2155, however the resistance o f  both M. smegmatis strains to
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Fig. 24. A graph depicting the pyrazinamide sensitivity of the Pyramidll M. sm egm atis 
strain in liquid culture, at two growth stages.
An equal number of cells (3xl07) and were added to two sets of 5ml Lemco (pH5.2) 
containing increasing concentrations (200//g/ml-900yug/ml) of pyrazinamide, for Pyramidll 
andM  smegmatis me2155 strains. Control cultures without pyrazinamide were also set up. 
The A^ qo of each culture for set 1 was read when the control reached mid log-phase growth 
A^ oq 0.6 and for set 2 when the control reached late log/early stationary phase growth 1.0 A ^. 
Graph a) represents mid-log phase growth and graph b) represents early stationary phase 
growth. At both stages o f  growth Pyramidll remained more sensitive to pyrazinamide than 
the wild typeM  smegmatis mc2155, although the resistance o f both strains increased with 
stage of growth and also time.
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pyrazinamide increased with the age of the cells and continuing exposure to the drug. This 
increase in resistance with age was more pronounced in the wild type M. smegmatis mc2l 55 
strain than the Pyramidll strain. The increase in resistance with age was probably due to  a 
number of factors such as the decrease in permeability o f elderly cell walls, an increase in the 
pH of the culture with time reducing the efficacy of the drug and the bacteriostatic nature o f 
the drug. It was concluded that strain Pyramidll was a stable pyrazinamide sensitive mutant 
that would be suitable for further analysis.
3.1.5.2 Penicillin sensitivity o f  Pyram idll
In order to  determine whether the increased sensitivity o f Pyramidll was specific to 
pyrazinamide, the penicillin sensitivity of Pyramidll was retested in liquid culture (section 
2.28.4.) The experiment was carried out five times with concentrations of penicillin G 
increasing from 1-1,000/^g/ml in 100/^g/ml increments. Two out of the five times Pyramidll 
showed similarly increased levels o f sensitivity to penicillin G as to pyrazinamide; on the other 
three occasions Pyramidll showed resistance levels similar to the wild type M. smegmatis 
mc2155 (data not shown).
3.1.5.3 M orphology and Acid-Fast Staining
The colonies of Pyramidll had a smoother morphology than the rougher wild type M. 
smegmatis m c2155 strain on both Lemco and Middlebrook 7H10 agar at 28°C or 37°C, as 
illustrated in Fig.25. Both strains were acid fast; although the Pyramidll strain did appear very 
slightly less acid fast than the wild type cells, this may have been due to a slight variation in 
the stage o f growth o f the cells.
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Fig.25.Colony morphology of strain Pyramid n  in comparison to wild type M  
smegmatis me1155
a+b) Pyramidll colonies on Middlebrook 7H10 agar 
c+d)M  smegmatis me2155 on Middlebrook 7H10 agar
All colonies were produced following 10 days growth at 37°C but from different dilutions of 
an early stationary phase culture 1.5 a+c) lxlO-9 dilution and b+d) 1x10'* dilution.
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3 .1 .5 .4  Api-Zym  Test
To ensure both strains were M. smegmatis, an Api-Zym test was carried out according to the 
manufacturer's instructions (section 2.33) on cultures of the wild type M. smegmatis mc2l 55 
and Pyramidll strains. The test results for both strains were concurrent with those for M. 
smegmatis mc2l 55 as shown in Table. 14 and Fig.26. The only variable result between the two 
strains was test 12 for naphthol-(31-phosphohydrolase activity which appeared to be lower 
fo r the Pyramidll mutant strain as indicated by a weak positive blue colour (Fig.26). The 
results for both strains were consistent with their being M. smegmatis.
3 .1 .5 .5  Growth curves
T he growth o f Pyramidll was compared to the wild type M. smegmatis mc2155 strain by 
following the of both strains over time. As shown in Fig.27 the Pyramidll strain has a lag- 
phase at least eight hours longer than the wild type M. smegmatis me2155 strain, having 
initially been seeded with a similar number of cells, 1x10*. The growth rate of both strains 
during log-phase growth appeared identical in both strains. The cfii/ml at each stage of growth 
were very slightly higher in the Pyramidll strain (Fig.27b). The cells o f Pyramidll in culture 
were observed to form more o f an even suspension in culture than the M. smegmatis mc2l 55 
strain and this reduction in clumping may have accounted for the slightly higher numbers of 
colonies formed by the Pyramidll strain in the growth experiment.
3.1.5.6. Further biochemical analysis
Pyramidll strain was further analyzed by Dr.G.Besra, Colorado State University, Colorado 
fo r alterations in the glycosyl composition by HPLC. No alterations were found in the 
arabinogalactan or in the lipoglycan fraction composed of LAM, LM and PIMs. The 
glycolipids, PIMs and trehalose mycolate profiles were re-analyzed by 2D-TLC and again no 
differences were found in Pyramidll lipids when compared to the wild type, M. smegmatis 
m c2155 lipids.
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Fig. 26. The results of the Api-Zym test of Pyramidll and wild type me2155, M. 
smegmatis strains
a) M. smegmatis me2155 wild type and b) Pyramidll M. smegmatis
The results indicated that both both strains were M  smegmatis (Table 14). The results 
obtained from both strains were the same apart from test no. 12 the assay for Naphol-AS-BI- 
phosphate phosphohydrolase which was distinctly lighter in the Pyramidll strain.
Enzymes assayed for:-
1) Control
2) Phosphatase alcaline
3) Esterase (C4)
4) Esterase Lipase (C8)
5) Lipase (C l4)
6) Leucine arylamidase
7) Valine arylamidase
8) Cystine arylamidase 15) ß glucuronidase
9) Trypsin 16) a  glucosidase
10) Chemotrypsin 17) ß glucosidase
11) Phosphatase acid 18) N-acetyl-ß glucosaminidase
12) Napthol-AS-BI-phosphohydrolase
13) a  galactosidase 19) a  mannosidase
14) ß galactosidase 20) a fucosidase
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Enzyme assayed 
for
Substrate Wild-type
M . smegmatis
Pyramid
n
P h o sp h a tase  a lca lin e 2 -n a p h th y l p h o sp h a te + +
E ste ra se  (C 4 ) 2 -n a p h th y l b u ty ra te + +
E ste ra se  L ip a s e  (C 8 ) 2 -n a p h th y l c ap ry la te + +
L ip ase  ( C l 4 ) 2 -n a p h th y l m y ris ta te - -
L eucine  a ry la m id a se L - le u cy l-2 -n a p h th y la m id e -H- + +
V aline  a ry la m id a se L -v a ly l-2 -n a p h th y la m id e + +
C ystine  a ry la m id a se L -cy s ty l-n ap h th y la m id e - -
T rypsin N -b e n z o y l-D L -a rg in in e -2 -
n ap h th y la m id e
+ +
C hym otrypsin N -g lu ta n y l-p h en y la la n in e -2 -
n ap h th y la m id e
- -
P h o sp h a ta se  a c id 2 -n a p h th y l p h o s p h a te + +
N a p h th o l-A S -B I-  
p h o sp h o h y d ro l a sc
N a p h th o l-A S -B I-p h o sp h a te + ±
a  g a la c to s id a sc 6 -B r-2 -n a p h th y l-  a D - 
g a la c to p y ran o s id e
- -
P  g a la c to s id a se 2 -n a p h th y l-p D -g a la c to p y ra n o s id e - -
P g lu c u ro n id a se N a p h tlio l-A S -B l-  p D -g lu c u ro n id e - -
a  g lu co sid ase 2 -n a p h th y l-a D -g lu c o p y ra n o s id e + +
P  g lu co sid ase 6 -B r -2 -n a p h th y l-P D -  
g l u c o p y ra n o sid e
+ + + +
N -a c e ty l-P -
g lu c o sa m m id a sc
1-n a p h th y l-n -a c e ty l-p D -  
g lu c o sa m in id e
- -
a  m a n n o sid ase 6 -B r - 2 -n a p h th y l-a D -
m a n n o p y ra n o s id c
- -
a  fu co sid ase 2  -n a p h th y l - a  L -fu co p y ran o sid e - -
Table. 14. The API-ZYM test results for M. smegmatis me2155 and Pyram idll
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a)
0 20 40 60 80
l i m e  (h r )
Pyramidll
b)
Fig.27 . Graphs comparing the growth of Pyramidll and wild typeM  smegmatis me2155
a) The growth measured in optical density, A^, against time of a 200ml culture of each strain 
in Middlebrook 7H9 medium 0.1% Tween 80, of Pyramidll and M. smegmatis mc2l 55.
b) The growth measured by colony forming units (cfu)/ml against optical density
Graph a) shows a lag-phase o f 8-10 hr for the Pyramidll strain followed by a log-phase 
growth rate not significantly different from the wild ty p eM  smegmatis me2155.
Graph b) shows a slight increase in the efu's produced by Pyramidll when compared with M  
smegmatis mc2l 55 at stages o f growth defined by A ^ .
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3.1.5. 7 Hydrophobicity
A change in the hydrophobicity of a bacterial strain can indicate an alteration in the structure 
o f its outer surface (Rosenberg et al., 1980). The hydrophobicity of Pyramidll was measured 
in comparison to the wild typeM  smegmatis mc2155 using the method of Rosenberg et al. 
(1980)(section 2.32). The basis of this method was to determine the solubility o f cells in an 
organic solvent as a measure of their hydrophobicity. The solubility of a culture in the 
hydrocarbon was assessed by measuring the change in optical density of the aqueous layer on 
the addition o f the hydrocarbon.
A standard volume of hexadecane was added to 1,5ml o f the test strain cultures, which were 
at the same stage of growth and incubated at 28°C for lOmin. The solutions were then 
vortexed, left to settle and the A400 o f the aqueous layer was then measured. The original 
system was adapted slightly to use a non limiting number o f cells i.e. 200ml o f culture in 7H9 
broth were concentrated ten-fold. The hydrophobicity o f the test strains, Pyramidll and 
mc2155, was measured at two stages o f growth, late log-phase (O SA ^) and early stationary 
stage (l.bA^oo), following growth at 37°C. The optical density of the aqueous layer of 
Pyramidll was measured at 400nm and was significantly higher than the wild type culture at 
both stages o f growth, by at least 0.5A4OO, (Table 15).
_____________________________________________________________________  R esults
M le J 5 J h e h 2 d r o g h o b k i^ o f^ r a m id n « n d M _ ^ ^ ^ _ m c |1 5 5
Growth stage of the culture Pyramid II aqueous layer 
A400
M. smegmatis me2155 
aqueous layer Ajno
Late log-phase (O^A**,) 0.59+ 0.1 0.167 ±0.014
Early stationary-phase 1.53 ± 0.05 0.92 ±0.082
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The results shown were the average of two readings for each strain. The results indicated that 
Pyramidll was more hydrophilic than the wild type M. smegmatis. The hydrophilic nature of 
Pyramidll may have been due to the lack o f  a hydrophobic molecule on the cell surface or the 
increase in a hydrophilic molecule which could have resulted in the strain being more 
permeable to hydrophilic molecules such as pyrazinamide.
In summary strain Pyramidll was proven to  be more susceptible to pyrazinamide than the wild 
type M. smegmatis mc2155 strain and variably sensitive to penicillin G. Pyramidll was shown 
to beM  smegmatis through Acid-Fast staining and Api-Zym testing. Pyramidll also exhibited 
a smooth colony morphology and a lag-phase 8-10hr longer than the wild type strain. 
Although no gross differences were detected in the lipid content o f the Pyramidll strain a 
distinct decrease in the hydrophobicity o f the strain was discovered which may be caused by 
some cell envelope defect and may also have caused the increased permeability of the strain 
to hydrophilic molecules such as pyrazinamide.
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3.2 C o m p l e m e n t a t io n  o f  P y r a m id I I  w it h  a  c o s m id  pYUB18::M. l e p r a e
GENOMIC LIBRARY.
The next objective was to isolate a region of M . leprae DNA which would complement the 
pyrazinamide sensitive phenotype o f the M  smegmatis Pyramidll strain.
The proposed strategy was to transform competent Pyramidll M. smegmatis cells with the 
cosmid shuttle vector pYUB18: M . leprae genomic library by electroporation. The 
Pyramidll :M. leprae transformants would then be screened for increased resistance to 
pyrazinamide. Apparent revertants and their cosmids would then be analysed in more detail.
3.2.1 T r a n s f o r m a t i o n  o f  P y r a m i d I I  w i t h  c o s m i d  pYUB18::M l e p r a e  g e n o m i c  
LIBRARY.
T heM  leprae pYUB18 shuttle vector cosmid library was provided by Dr. W.R. Jacobs as 
a phage lysate with a titre of 1x10s pfu/ml. E. coli NM554 cells were transformed with 5/ul 
o f phage lysate (section 2.10) and 2xl04 colonies were produced. The transformation 
efficiency of4xl06 cfu/ml was lower than the lxlO9 (or 5x10* cfu) expected, however 2xl04 
colonies were considered sufficient to be a representative sample of the entire library.
As cosmid DNA is particularly unstable in mycobacteria, small culture volumes were used to 
reduce the loss of unstable cosmids, on the basis that the cells would go through a reduced 
number o f cell divisions. The colonies were therefore resuspended in 10ml LB (Kan 50//g/ml) 
and 1ml volumes o f the resuspension were added to ten 2ml volumes o f LB (Kan 50>ug/ml) 
to form overnight cultures for small scale cosmid preparation (section 2.16). The cosmid 
DNA from each of the extractions was pooled to give a final concentration of 0.5/zg//zl.
Competent cells of the M. smegmatis Pyramidll strain were produced (section 2.25) and 
transformed (section 2.26) with l^ g  pYUB12 (11.2kb) forming 1028 colonies on Lemco
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(Kan 1SpglmY) after 4 days at 37°C, a transformation efficiency of lx l0 3//^g. 400/ul o f 
Pyramidll competent cells were transformed with 2.5//g pYUB18:M. leprae cosmid library 
DNA Three hundred and twelve transformants were formed, a transformation efficiency o f 
1.2xl02///g, eight fold lower than pYUB12, which would be expected due the large size 
(30kb) of the M. leprae insert DNA.
The Pyramidll transformants were of two colony types, smooth and crinkly. The smooth 
colonies were akin to the parental strain and the crinkly ones were crenellated and invaginated, 
generally to an even greater extent than observed in wild type M. smegmatis mc2l 55. Of the 
312 transformants, 48% (150) were smooth and 52% (162) were crinkly. The size of the 
transformed colonies also varied, from 0.5-5mm; the smooth colonies were generally the 
larger.
The transformants were transferred onto Lemco (Kan 15>ug/ml) agar and arranged in arrays 
of 96, divided on the basis of their apparent morphology. The transferred colonies were then 
incubated at 37°C for four days to grow. 130 (41%) of the original transformants did not 
survive the transfer onto Lemco (Kan 15/^g/ml) and 90% of those lost were crinkly colonies, 
with a diameter of 0.5-1mm. This loss of transformants was thought to be due to the small 
colony size of the majority o f lost transformants, which made transfer difficult; it may also 
have been due to the instability o f the cosmid DNA.
182 (59%) transformants were successfully transferred onto Lemco (Kanl5//g/ml) and 
assuming, conservatively, an average insert size of 30kb this was considered a sufficient 
number of transformants to represent the entire estimated genome size of 2.8Mb for M. leprae 
(Clark-Curtiss ela l., 1985; Eiglmeier et a l , 1993).
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3 .2 .2  S c r e e n i n g  o f  P y r a m i d I I : : M . l e p r a e  t r a n s f o r m a n t s  f o r  i n c r e a s e d
RESISTANCE TO  PYRAZINAM IDE
The 182 arrayed Pyramidll.iM leprae transformants were then screened for increased 
resistance to pyrazinamide at 28 °C, to obtain the clearest possible phenotype. The 182 
colonies were replica plated onto Lemco pH5.2 (Kan 15/^g/ml) containing pyrazinamide 
(500/zg/ml) agar and Lemco (Kan 15/zg/ml) agar. The replicated transformants were then 
incubated at 28°C to grow for six days.
132 (75%) transformants grew strongly at 28°C on Lemco (Kan 15/^g/ml) and fourteen 
(9.8%) o f these colonies grew on Lemco pH5.2 (Kan 15//g/ml) agar containing 500/^g/ml 
pyrazinamide. Hence 75% of the 182 PyramidII::M leprae transformants were stable at 28°C 
and 37°C, while 25% were only stable at 37°C. 9.8% o f the 182 transformants initially 
appeared resistant to 500/zg/ml pyrazinamide. This which was a fairly high level o f 
complementation, 1-2% being the expected result. The complementing strains were then 
analysed in more detail.
3.2.2.1 Analysis o f the fourteen PyramidII:M . leprae transformants selected on 
pyrazinam ide (500pg/ml)
3.2.2.1.1 Resistance on solid media at 28 X
The resistance of the 14 transformants was first assessed on solid media at 28°C. The fourteen 
Pyramidll: M . leprae transformants which showed increased resistance to 500/i/g/ml of 
pyrazinamide were placed in 5ml Middlebrook 7H9 broth (Kan 20/ug/ml) and incubated at 
28°C until each culture reached late log-phase culture (0.8 A ^ ). The pyrazinamide sensitivity 
o f the 14 transformants was retested by streaking the late log-phase cultures onto Lemco 
pH5.2 pyrazinamide 500/^g/ml (+Kan 20/^g/ml for the transformants) agar. The growth of the 
14 Pyramid!!:: M. leprae clones was then compared to the Pyramid!! and wild type mc2155
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strains of M  smegmatis following incubation at 28 °C for five days.
The sensitive M  smegmatis Pyramidll strain showed no growth, while Pyramidll ::M leprae 
transformants 42, 59 and 78 showed very weak growth on the pyrazinamide (500/^g/ml) 
containing media. Eleven of the Pyramidll :M . leprae strains showed stronger growth on 
Lemco pH5.2 pyrazinamide (500^tg/ml) agar than the parental Pyramidll strain. The growth 
o f the eleven transformants was, however, not as strong as the wild type me2155 M. 
smegmatis, this may have been due to a reduction in growth rate caused by the presence o f 
cosmid DNA (20-30kb) in the transformants.
An accurate assessment o f  the individual levels of pyrazinamide resistance exhibited by the 14 
transformants was difficult on solid media as the transformants growth rate became the only 
measure of individual levels of pyrazinamide resistance. However, the presence of 30-40kb 
of cosmid DNA within these strains slowed down their growth rate and made individual levels 
of resistance impossible to  ascertain on solid media. In order to gain a true comparison of the 
individual levels of pyrazinamide resistance found in the transformants their sensitivity had to 
be measured at the same stage of growth. This could be done in liquid culture.
3.2.2.1.2 Resistance in liquid culture at 37 °C
In order to observe the degree of increased pyrazinamide resistance in the 14 Pyramidll: M . 
leprae clones at the same stage of growth as the Pyramidn and mc2155 strains further analysis 
was carried out in liquid culture (section 2.28.4).
A set of eight tubes containing 5ml o f Lemco pH5.2 (Kan 15/^g/ml) with pyrazinamide 
concentrations increasing in 100^g/ml quantities, from 200/ig/ml - 900/ug/ml were set up for 
each strain. The range o f  pyrazinamide concentrations selected was based on the results 
obtained for the growth o f  the wild type and the mutant Pyramidll strain (section 3.1.3.3.3).
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A control was set up for each strain containing 5ml Lemco pH5.2 (Kan 20/^g/ml) only. The 
14 Pyramidll: M . leprae clones were grown to early stationary stage (1.5 A ^ )  and an 
approximately equal number of cells (1x10*) from each strain were then added to a series of 
nine tubes. The each series o f tubes were incubated at 37°C, with shaking, until the control 
cultures i.e. those without pyrazinamide, reached mid log-phase growth (0.6 A600). The A ^  
o f the cultures within each series then read.
The resistance o f each Pyramidll:M . leprae clone to increasing concentrations of 
pyrazinamide represented and compared to the parental and wild type M. smegmatis strains. 
The growth of the 14 Pyramidll: M . leprae clones was also compared to that of Pyramidll 
(His), the Pyramidll strain harbouring a cosmid containing the histidinol D gene, hisD  
(Hinshelwood and Stoker, 1992b). This was a control to determine wether the presence of 
random genes in a cosmid would confer a growth advantage that could be misinterpreted as 
increased resistance to  pyrazinamide.
Variable levels of resistance to pyrazinamide were observed for each Pyramidll: M . leprae 
clone in liquid culture, as shown in Figs. 28, 29 and 30. Six clones 10, 33', 45, 57, 83 and 116 
consistently showed levels of growth over and above the parental Pyramidll, Pyramidll(His) 
and the wild type mc2155 M. smegmatis strains in increasing concentrations of pyrazinamide 
(Fig.28). Clones 32, 332, 34 and 38 showed an intermediate increase in resistance to 
pyrazinamide (Fig.29). Clones 42, 59 and 78 showed no increased resistance to pyrazinamide 
in liquid culture (Fig.30) The results for clone 54 are not shown as the strain was tested in 
liquid culture only once before the strain became unculturable from frozen stocks.
As is evident from the growth of the Pyramidll (His) strain in liquid culture and on solid 
media the presence o f these random genes in a given cosmid did not confer any significant 
growth advantage on the parental Pyramidll strain in the presence o f pyrazinamide.
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t------ *-------1---------------- 1-------------- 1------U ---------------------
0  2 0 0  4 0 0  6 0 0  8 0 0  1 0 0 0
p y r a z in a m id c  c o n c e n t r a t io n  U ig /m l)
p y  r a z in a m id c  c o n c e n t r a t i o n  ( l i g / a l )
----------*--------1---------------1--------------1------- T U------
0  2 0 0  4 0 0  6 0 0  8 0 0  1 0 0 0
* Pyramidll •  clone p y r a z l n a « l d c  c o n c e n t r a t i o n  (« ( /n i l )
* PyramidII(His) — o—  M. smegmatis mc2\55
Fig.28. Graphs of Pyramidll: :M.leprae clones which exhibited increased resistance to 
pyrazinamide in liquid culture
An equal number of cells (3xl07) and were added to a set o f 5ml Lemco (pH5.2) containing 
increasing concentrations (200^g/ml-900^g/ml) of pyrazinamide, for six Pyramidll M . leprae 
clones 10, 331, 45, 57, 83, 116. Control cultures without pyrazinamide were also set up. The 
of each culture, in the six sets, was read when the control reached mid log-phase growth 
O^A^oq. The sensitivity of each clone to pyrazinamide was compared to the parental strain, 
the parental strain harbouring an unselected cosmid (PyramidII[His]) and the wild type 
me2155. The graphs represent the following Pyramidll: \M.leprae clones a) 10 b) 33' c) 45 
d) 57 e) 83 and f) 116. All six o f these Pyramidll. M .leprae clones exhibited an increase in 
resistance to pyrazinamide over and above the parental Pyramidll, Pyramidll and the wild type 
M. smegmalis me2155 strains.
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p y r a z i n a m i d e  c o n c e n t r a t i o n  (^ ig /m l)
* Pyramidll(His) * clone
— o—  M. smegmatis me2155
Fig. 29. Graphs ofPyramidII::M/(prae clones which exhibited an intermediate increase 
in resistance to pyrazinamide in liquid culture, in comparison to wild type levels.
An equal number o f  cells (3xl07) and were added to a set of 5ml Lemco (pH5.2) containing 
increasing concentrations (200//g/ml-900^g/ml) of pyrazinamide, for four
Pyramidll:M .leprae clones 32, 332, 34 and 38. Control cultures without pyrazinamide were 
also set up. The of each culture, in the four sets, was read when the control reached mid 
log-phase growth 0.6 A ^. The sensitivity o f each clone to pyrazinamide was compared to the 
parental strain, the parental strain harbouring an unselected cosmid (PyramidII[His]) and the 
wild type mc2155. The graphs represent the following Pyramidll: M .leprae clones a)32 b)332
c)34 and d)38. The four Pyramidll.M .leprae clones exhibited an intermediate increase in 
pyrazinamide resistance in comparison to the wild type and parental strains, in liquid culture.
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a) b)
c)
pyrazinamide c o n c e n t r a t i o n  (f tig /m l)
"•—  clone 
-*—  Pyramidll
3—  M. smegmatis me215 5
PyramidII(His)
Fig.30. Graphs o f Pyram idll::M.leprae clones which did not exhibit any increase in 
resistance to pyrazinamide, in liquid culture.
An equal number o f cells (3x107) and were added to a set o f 5ml Lemco (pH5.2) containing 
increasing concentrations (200^g/ml-900^g/ml) o f pyrazinamide, for three 
PyraimdU M./eprae clones 42, 59, and 78. Control cultures without pyrazinamide were also 
set up. The o f each culture, in the three sets, was read when the control reached mid log-
phase growth 0.6 Aftoo The sensitivity of each clone to pyrazinamide was compared to the 
parental strain, the parental strain harbouring an unselected cosmid (PyramidII[His]) and the 
wild type mc2155. The graphs represent the following Pyramidll: M .leprae clones a)42 b)59
c)78. These three Pyramidll: M .leprae clones, initially isolated as exhibiting some increased 
resistance to pyrazinamide showed no increased resistance in liquid culture when compared 
to the wild type and parental strains, in liquid culture.
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In summary, o f  the initial 14 Pyramidll: M . leprae clones isolated due to their survival 
following replica plating o f  182 Pyramidll vM. leprae transformants onto pyrazinamide 
(500/ig/ml), 11 showed an increased level of resistance when compared with the parental 
Pyramidll strain. Six of the clones exhibited levels of resistance to  pyrazinamide in excess of 
the wild type M . smegmatis mc2155. Four Pyramidll: M . leprae clones showed levels of 
resistance between the parental and the wild type strains. The eleventh strain (54) showed 
resistance to pyrazinamide 500//g/ml on solid media at 28°C.
The final level o f  complementing Pyramidll: M . leprae transformants was 6% of the 182 
transformants which survived the initial transfer onto Lemco (Kan 15/ig/ml) agar. Values are 
higher than would be estimated for the percentage of complementing cosmids; this and the 
varying levels o f  pyrazinamide resistance exhibited by the 11 complementing Pyramidll M. 
leprae clones suggested that there may be more than one region o fM. leprae DNA able to 
complement the pyrazinamide sensitive phenotype.
3.2.3 Isolation of cosmid DNA from PyramidII::M. l e p r a e  transformants 
Cosmid DNA was extracted from all of the initially isolated fourteen Pyramidll: M . leprae 
transformants, in order to compare the DNA of the complementing and non complementing 
clones.
The cosmid DNA was extracted using an adaptation of the method described for the 
extraction of E. coli DNA (section 2.16). Cell pellets from 48hr 5ml Lemco (Kan 15/zg/ml) 
cultures of each transformant strain were resuspended in GET containing lipase (30mg/ml) 
and lysozyme (lOmg/ml) and incubated overnight at 37°C, with shaking. The DNA was then 
extracted by the alkaline lysis method described for small scale cosmid preparation (section 
2.16).
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The DNA extracted from each strain was transformed directly into competent E. coli DH5a 
(transformation efficiency 1x10s cfti/z^g). The number o f E. coli transformants obtained from 
the extracted cosmid DNA of each Pyramidll: :M leprae transformant varied between 
PyramidII::M. leprae strains, but was consistent for individual strains. Generally the number 
of transformants obtained from Pyramidll transformants 10, 32, 33l, 332, 34, 38, 59 and 42 
was lxK^cfus which was 100 fold higher than from strains 45, 57, 83 and 116. E. coli DH5a 
transformants from each Pyramidll transformant strain were inoculated into 2ml Lemco (Kan 
15^g/ml) to reduce rearrangements, incubated at 37°C overnight before the cosmid DNA was 
extracted using the normal method (section 2.16).
Initially the mycobacterial cosmid DNA was transformed into the E. coli strain TG2 but the 
majority of the cosmids appeared unstable. The cosmid DNA extracted from repeated 
transformations o f TG2 with mycobacterial cosmid DNA from a given Pyramidll: M . leprae 
strain varied in size and exhibited varying restriction patterns. A recombination stable E. coli 
strain, DL795, was also tried and while those cosmids recovered appeared stable, the 
transformation efficiency obtainable with DL795 was too poor (lxlO 4 cfu///g) to produce 
transformants from all fourteen mycobacterial cosmids.
Cosmid DNA was obtained from thirteen Pyramidll :M . leprae clones, all except 54, 
following transformation of the mycobacterial cosmid DNA into the E. coli DH5a strain. On 
the whole, the cosmid DNA extracted from DH5a was consistent for each Pyramidll M. 
leprae clone, although occasional rearrangements and deletions of the entire insert DNA were 
observed.
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3.2.3.1. A nalysis o f the cosmid DNA in the P yram idll transformants 
Cosmid DNA from each of the thirteen Pyramidll: M . leprae clones (10 complementing and 
3 non complementing) was individually digested with BamHl, Pst\, EcoRl and ///«dill 
(Fig.31 and Fig.32). Common band sizes were observed in a number o f the cosmids 
suggesting some were overlapping (Table. 16). The P st\ and EcoRl digests both resulted in 
the formation o f  five bands common to a minimum of two cosmids. The EcoRl digests created 
fragment sizes o f  2.55kb from cos83 and cosl 16, 4.2kb from cos332 and cos45, 6.4kb from 
cos57 and cosl 16, 7.6kb from cos33' and cos45 and 9.6kb from cos45 and cos57 . The sixth 
EcoYKl fragment size 4.64kb common to all thirteen cosmids was a fragment from the 
pYUB18 cosmid shuttle vector itself (Fig.32). The P stl digests created fragment sizes of 
0.2kb in cos34 and cos57, l.lkb from cos34 and cos57, 2.45kb from cos34, cos45 and cos83, 
2.75kb from cos33‘ and cosl 16 and 5.5kb from cos45 and cos57. A 0.85kb fragment common 
to all the cosmids is produced from the pYUB18 vector (Fig.31). ///«dill digests created a 
2.4kb fragment found in coslO, cos32, cosl 16 and cos57. A 7.2kb fragment was found in 
cos33‘ and cos57 and a 6.9kb fragment was found in cos42 and cos 3$ (Fig.32). A 5.8kb 
band common to all the cosmids was from the pYUB18 vector (Fig.32). The BamHl digests 
created fragments o f 1.75kb in cos45 and 331, 2 6kb in cos45 and cosf3 and a 3.4kb 
fragment in cos57 and cos78 (Fig.31). pYUB18 vector only DNA was not available for 
analysis.
_________________________________________________________________________R esults
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1 2 3 4 5 5 6 7 8 9 10 11 1213 14 15
Fig. 31. Restriction analysis of complementing and non-complementing cosmids 
using a) BamHX and b) P stl showing shared band sizes (kb).
Complementing cosmids: Non-complementing cosmids Markers:
lane 1) cosl 16 
lane 2) cos83 
lane 5) cos57 
lane 7) cos45 
lane 8) cos38
lane 9) cos34 
lane 10) cos332 
lane 11) cos33‘ 
lane 12) cos32 
lane 13) coslO
lane 3) cos78 
lane 4) cos59 
lane 6) cos 42
lane 14) XHindlll 
lane 15) JJiindlUJEcoRl
a) Shared bands in BamHl digest: 1.75kb in cos45 and cos331, 2.6kb in cos45 and cos331 
and 3.4kb in cos57 and cos78.
b) Shared bands in Pstl digest: 0.2kb in cos34 and cos57, 1.1 kb in cos34 and cos57, 
2.45kb in cos34, cos45 and cos83, 2.75kb in cos33' and cosl 16 and 5.5kb in cos45 and 
cos57. The 0.89kb fragment is from the vector pYUB18 common to all the cosmids.
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(b)
1 2 3 4 5 6 7 8 9 10 11 12 13 14 16 15
Fig. 32. Restriction analysis of complementing and non-complementing cosmids 
using a) fc o R I  and b) HinAWl showing shared band sizes (kb).
Complementing cosmids: Non-complementing cosmids Markers:
lane 1) cosl 16 
lane 2) cos83 
lane 5) cos57 
lane 7) cos45 
lane 8) cos38
lane 9) cos34 
lane 10) cos332 
lane 11) cos33‘ 
lane 12) cos32 
lane 13) coslO
lane 3) cos78 
lane 4) cos59 
lane 6) cos 42
lane 14) XHindlll 
lane 15) kH indllVEcoRl
and
and
a) Shared bands in EcoRl digests: 2.55kb in cos83 and cosl 16, 4.2kb in cos33 
cos45, 6.4kb in cos57 and cosl 16, 7.6kb in cos331 and cos45 and 9.6kb in cos45 
cos57. The 4.6kb fragment common to all cosmids is from the vector pYUB18.
b) Shared bands in H indlll digests: 2.4kb in coslO, cos32, cosl 16 and cos57, 7.2kb in 
cos33' and cos57 and 6.9kb in cos42 and cos332. The 5.8kb band common to all is from 
the vector pYUB18.
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Table. 16 Showing the restriction fragment sizes of various cosmid digests of
PyramidlI:M leprae clones
II . .Restriction enzyme Fragment sizes 
(kb)
PyramidlliM leprae 
cosmid DNA (kb)
BaniiH 1.75 45, 33*
2.60 45, 332
3.40 57, 78
EcoKi 2.55 83, 116
4.20 332, 45
6.40 57, 116
7.60 33', 45
9.60 45, 57
Pstl 0.20 34, 57
1 1.10 34, 57
2.45 34, 45, 83
2.75 33‘, 116
5.50 45, 57,
H indlll 2.40 10, 32, 116
7.20 33', 57
6.90 42, 332
3.2.3.2 Insert sizes
The average sizes of the M. leprae insert DNA contained in the cosmids were calculated from 
an average of the sum of the fragments from each of the four digests (Table. 17). The largest 
inserts were found in cosl 16, cos57 cos83 and cos45 which were 31,6kb, 26kb, 22. lkb and 
18.6kb respectively. The insert sizes of coslO, cos32, cos33', cos332, cos34 and cos78 varied 
between 6-9kb, small for cosmid inserts. Due to the very small predicted insert size and the 
error margin on its calculation it was concluded that cos42 was possibly pYUB 18 vector 
alone. Cosmid 59 and cos38 gave an average size o f 13.8kb ± 4.46 implying that the DNA 
could have been smaller than the vector.
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Table^JJ^ShowinjjJh^total^cosmid^sizesjindA^/i^jra^ûisertjizes
Cosmid Cosmid size (kb) Insert size (kb)
10 20.50 ± 2.56 8.65 ± 3.0
32 19.84 ± 3.78 7.35 ± 3.64
33' 19.00 ± 1.02 7.65 ± 1.38
332 17.95 ± 5.07 5.65 ± 5.00
34 18.66 ± 2.38 6.18 ± 2.10
38 13.80 ± 4.30 N/A
42 15.30 ± 3.47 3.32 ± 3.28
45 30.95 ± 2.30 38.60 ± 2.46
57 38.60 ± 2.46 26.90 ± 2.47
59 13.70 ± 4.30 N/A
78 21.04 ± 0.83 8.37 ± 1.04
83 34.30 ± 4.75 22.13 ± 4.70
116 43.80 ± 4.46 31.60 ± 4.46
From the digests and the cosmid sizes estimated for cos42 it was concluded that the DNA 
consistently extracted from E. coli was probably vector pYUB 18 DNA. Both cos59 and 
cos38 were undigestable with BamHl and gave band sizes smaller than predicted for the 
pYUB18 vector alone with H intIIII, EcoKi. and Pst\ i.e. bands of 5.6kb and 5.8kb were 
produced from a///«dill digest instead of the 6.3 and 5.8kb which would be predicted. This 
implied a deletion of at least lkb had occurred, which included the BamHl cloning site, and 
possibly unstable M  leprae insert DNA. An early cosmid extraction o f  transformant 38 from 
TG2 yielded cosmid DNA which was found to contain an insert on BamHl digestion.
Following single and double digests (not shown) of the other ten cosmids, nine from 
complementing PyramidII::A/. leprae clones and one from a non complementing clone (cos78) 
similar band sizes were observed although a restriction map overlapping all the complementing 
cosmids could not be formed. It may have been that a number of different regions of M.
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leprae DNA were capable of phenotypically complementing the mutant M. smegmatis mc2l 55 
strain.
There was therefore no single M. leprae DNA fragment from one of the cosmids deemed 
suitable for use as a probe in Southern hybridisation, to determine whether any of the cosmids 
were related, at this point.
3.2.4 Morphology of PyramidII::M.leprae transformant strains 
The morphology of the fourteen PyramidlliM leprae strains was o f two types, smooth and 
crinkly, on both Lemco and Middlebrook agar. Complementing strains 10, 32, 332, 34 and non 
complementing strains 42 and 59 showed similar morphology to the Pyramidll strain, (Fig.33) 
The five other complementing strains 331, 45, 57, 83, and 116 exhibited a crinkly morphology 
stronger than the wild type (Fig.33). Complementing strain 38 exhibited a mixture of smooth 
and crinkly morphology colonies, it is possible that the insert DNA had deleted out of the 
cosmids in the smooth colonies. There was no clear cut correlation observed between crinkly 
morphology and complementation. Four transformants 116, 57, 83 and 45 exhibiting crinkly 
morphology had larger M. leprae insert DNA in their cosmids i.e. 116, 57 and 45 see 
Table. 17.
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a)
d)
Fig 33. The colony morphology of the Vyr»m\AU::M.leprae clones.
The Pyramidll: M . leprae clones showed two morphological types, shown above on 
Middlebrook 7H10 agar. Smooth colony morphology similar to the parental strain was 
exhibited by complementing and non complementing PyramidlliiM/eprae clones, a) 
complementing clone 32 b)non complementing clone 42. Only complementing clones 
exhibited crinkly colony morphology c) complementing clone 57 d) complementing clone 45.
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3.2.5 Biochemical analysis of PyramidII::M. l e p r a e  clones
3.2.5.1 Analysis o f polar and non polar "free" lipids
The lipids of a number o f the initial 14 Pyramidll: jV/. leprae clones isolated were analysed to 
establish whether the presence o f the M  leprae containing cosmid DNA had altered the lipid 
profile o f Pyramidll.
Initially, four complementing Pyramidll M . leprae clones 54, 57, 116 and one non 
complementing clone 78, were investigated. The three complementing clones also had a 
crinkly morphology whereas the non complementing clone had a smoother morphology. Clone 
54 was still culturable from frozen culture at the time o f this experiment.
The free lipids, polar and non polar, and the covalently bound lipids were extracted as before 
(section 2.29). The free lipids were analysed by 2D-TLC systems A, D and F. The lipid 
profiles were compared with those of the mc2l 55 wild type and the parental Pyramidll strains 
of M. smegmatis.
3.2.5.1.1 Systems A and D
Two dimensional TLC system A revealed menaquinones in all four Pyramidll vM. leprae 
clones 54, 57, 116 and 78, in the same proportions as wild type.
The most polar lipids o f the non polar lipid fraction of each strain were analysed using 2D- 
TLC system D, to disclose trehalose dimycolates, again in similar proportions to those found 
in the wild type and Pyramidll M . smegmatis strains (Fig.34 and Fig.35). None of the three 
unidentified glycolipids found in M . leprae (Minninkin et al., 1985) using this system, were 
observed.
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Fig. 34. Two dimensional TLCs or the most polar class of lipids in the non-polar lipid 
fraction of mycobacterial "free" lipids of PyramidII::M. leprae clones, (System D„ with 
MPA)
1st direction, chloroform:methanol:water (100:14:0.8 v/v/), 2nd direction, chloroform : 
acetone : methanol (50:60:2.5 v/v). Organisms: a )M  smegmatis mc2155, b) PyramidllM 
smegmatis, Pyramid: M .leprae clones c) 78 (non complementing) d) 54 e) 57 f) 116 
(complementing).
Detection: a-f 5%  ethanolic molybdophosphoric acid, MPA, all lipids.
CF - cord factor (trehalose dimycolate)
GL - glycolipids
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Fig.35. Two dimensional TLCs of the most polar class of lipids in the non-polar lipid 
fraction of mycobacterial "free" lipids of PyramidII::M./eprae clones, (System D„ with 
NAS).
1st direction, chloroform:methanol:water (100:14:0 8 v/v/); 2nd direction, chloroform : 
acetone : methanol (50:60:2.5 v/v). Organisms: a) M  smegmatis mc2l 55, b) Pyramidll M  
smegmatis, Pyramid: M .leprae clones c) 78 (non complementing) d) 54 e) 57 f) 116 
(complementing).
Detection: a-f 5% a-naphthol sulphuric acid, NAS, specifically detects sugar components.i.e. 
CF and GL.
CF - cord factor (trehalose dimycolate)
GL • glycolipids
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a) b)
Fig 36 Two dimensional TLCs of the least polar class of lipids in the polar lipid fraction 
of mycobacterial "free" lipids of complementing and non complementing 
Pyramid!!: :M. leprae clones (System D2, with MPA).
1st direction, chloroform:methanol:water (100:14:0.8 v/v/); 2nd direction, chloroform : 
acetone : methanol (50:60:2.5 v/v). Organisms: a)M . smegmatis mc2l 55, b) PyramidllM 
sm egm atis, Pyramid: M . leprae clones c) 78 (non complementing) d) 54 e) 57 f) 116 
(complementing).
GPL - glycopeptidolipid
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a) b)
d)
Fig.37. Two dimensional TLCs of the least polar class of lipids in the polar lipid fraction 
of mycobacterial "free” lipids of complementing and non complementing 
PyramidlT: :M. leprae clones (System D2, with NAS).
1st direction, chloroform:methanol:water (100:14:0.8 v/v/); 2nd direction, chloroform : 
acetone : methanol (50:60:2.5 v/v). Organisms: a) M. smegmatis mc2155, b) Pyramidll M. 
smegmatis, Pyramid: M . leprae clones c) 78 (non complementing) d) 54 e) 57 f) 116 
(complementing).
GPL - glycopeptidolipid
Detection: a-f a-naphthol sulphuric acid, NAS, for all sugars components i.e. GPL
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The least polar lipids were also analysed using system D2. The four Pyramidll: :M leprae 
clones displayed the same pattern of glycopeptidolipids that were present in the wild type and 
parental M. smegmatis strains and in similar proportions (Fig.36 and Fig.37).
3.2.5.1.2 System F
This was used to investigate the most polar of the polar lipid extracts from each of the four 
clones i.e. phospholipids and phosphatidylinositolmannosides, PIMs. The phospholipids, PIMs 
and glycolipids present in the parental Pyramidll and wild type me2155 M . smegmatis strains 
were also present in the four Pyramidll :M. leprae clones in similar proportions with one 
exception, (Fig.38 and Fig.39). A large quantity o f an unknown lipid, P, was detected in the 
complementing clones 54, 57 and 116 which was barely visible in the non complementing 
clone 78, the parental Pyramidll and the wild type M  smegmatis mc2155, (Fig 38). The 
unknown lipid was not visible under a-naphthol spray (Fig. 3 9) and therefore contained no 
sugar moieties such as mannose.
The free lipid extraction and analysis by system F was repeated in duplicate, with clones 57 
and 116 wild type me2155 and parental strain Pyramidll. The same unknown lipid, P, was 
detected when the plates were sprayed with MPA to detect the lipid. The unknown lipid P 
spot was also detected when plates were sprayed with Molybdenum blue, used to detect 
phospholipids, implying that it was a phospholipid. No phospholipids were detected with this 
spray at the same position in the parental Pyramidn o rM  smegmatis mc2l 55 wild type strain, 
although small amounts o f a lipid were detected in a similar position (Fig.40).
The position of the unknown lipid P, in system E, from which system F was derived, seems 
to correspond to an unknown lipid observed in M. leprae using the same system (Minnikin 
e ta l., 1985) (Fig.41).
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Fig.38.Two dimensional TLCs of the most polar class of lipids found in the 
mycobacterial polar "free" lipid fraction of PyramidII::M./^prae complementing and 
non complementing strains (System F, with MPA).
1st direction, chloroform ¡methanol: water (65:25:4 v/v); 2nd direction chloroform acetic acid: 
methanol water (80:15:12:4 v/v).
Organisms: a )M  smegmatis me215 5, b) Pyramidll M. smegmatis, Pyramid: M . leprae clones
c) 78 (non complementing) d) 54 e) 57 f) 116 (complementing).
DPG - diphosphatidylglycerol 
PE - phosphatidylethanolamine acid 
PI - phosphatitylinsositol
DPIDM + MPIDM - di and mono acylphosphatidylinsositol dimannosides 
DPIPM + MPIPM - di and mono acylphosphatidylinsositol pentamannosides 
GL - glycolipid 
P- unknown lipid
Detection system: a-f 5% ethanolic molybdophosphoric acid spray (MPA) for all lipids.
An unknown lipid was found in the complementing Pyramidll: M .leprae clones (54, 57,116) 
which was not found in the non complementing clone (78), the parental or wild type strains 
in the same quantities.
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Fig.39.Two dimensional TLCs of the most polar class of lipids found in the 
m ycobacterial polar "free" lipid fraction of PyramidO::M .leprae complementing and 
non complementing strains (System F, with NAS).
1st direction, chloroform:methanol:water (65:25:4 v/v); 2nd direction chloroform:acetic acid: 
methanol water (80:15:12:4 v/v).
Organisms: a) M. smegmatis mc2155, b) Pyramidll M. smegmatis, Pyramid: M . leprae clones
c) 78 (non complementing) d) 54 e) 57 f) 116 (complementing).
DPG - diphosphatidylglycerol 
PE  - phosphatidylethanolamine acid 
PI - phosphatitylinsositol
DPIDM + M PIDM  - di and mono acylphosphatidylinsositol dimannosides 
DPEPM + M PIPM  - di and mono acylphosphatidylinsositol pentamannosides 
G L  - glycolipid
Detection system: a-f a-naphthol sulphuric acid (NAS), for sugar components, i.e. GL, 
DPEDM, MPIDM, DPIPM and MPIPM.
P, the unknown lipid found in the complementing Pyramidll: M .leprae clones (54, 57,116) 
but not in the non complementing clone (78), the parental or the wild type strains in the same 
quantities was not dectable with NAS and therefore did not contain a sugar component.
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Fig. 40 Two dimensional TLC of the most polar class of lipids found in the mycobacterial 
polar "free" lipid fraction of PyramidII::M. leprae complementing clone 57, showing 
the unknown phospholipid
1st direction, chloroform: methanol: water (65:25:4 v/v); 2nd direction chlorofomracetic 
acid methanol: water (80:15:12:4 v/v);
Organism: Pyramid:M . leprae complementing clone 57.
Spray: Molybdenum blue which detects phospholipids 
DPG- diphosphatidylglycerol 
PE- phosphatidylethanolamine 
PI- phosphatidylinositol
DPIDM + MPIDM - di and mono acylphosphatidylinositol dimannosides 
DPIPM + MPIPM - di and mono acylphosphatidylinositol pentamannosides 
P confirmed as a  phospholipid, found in the complementing clones 57, 116 and 54.
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d)
Fig. 41. Two dimensional TLCs of the most polar class of lipids found in the 
mycobacterial polar "free" lipid fraction of Pyramid!!, PyramidII::M leprae 
complementing clone 57 and 116 compared with M. leprae using system E (with MPA)
1st direction, chloroform: methanol: water (10:5:1 v/v); 2nd direction chloroform:acetic 
acid:methanol:water (40:25:3:6 v/v);
Organisms a) Pyramid!!M. smegmatis, b)M . leprae taken from Minnikin et al., 1985) c and
d) Pyramid M . leprae complementing clones 116 and 57 respectively.
DPG- diphosphatidylglycerol 
PE-phosphatidylethanolamine 
PI- phosphatidylinositol
DPIDM + MPIDM - di and mono acylphosphatidylinositol dimannosides 
DPIPM + MPIPM - di and mono acylphosphatidylinositol pentamannosides 
P unknown phospholipid found in the complementing clones 57 and 116 and in M. leprae 
(Minnikin et al., 1985) but not in the parental Pyramidll M. smegmatis
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In an attempt to identify the phospholipid produced by the Pyramidll: M . leprae clones, ngs 
o f the phospholipid were isolated and are currently being analysed by gas chromatography 
mass spectrometry. This analysis is being carried out by Dr.P. Wheeler, LSHTM and 
Dr.W.Blackstock, Glaxo pic.
3.2.5.2 Covalently bound lipids
The mycolates of the four Pyramidll :M leprae clones were analysed (Fig.42). The 
characteristic a, a ' and epoxymycolates ofM. smegmatis were present in all four clones in 
similar proportions to those found in the wild type and Pyramidll M. smegmatis strains.
3.2.5.3 Fatty acid analysis using ga s chromatography
The fatty acid composition of the four clones was also analysed using gas chromatography. 
The proportions of the dominant types of non hydroxylated fatty acids were altered in all four 
o f the Pyramidll M . leprae clones in comparison with M. smegmatis mc2l 55 and the parental 
Pyramidll strains (Table. 18).
Table 18. The fatty acid composition of the PyramidII:M.leprae clones in comparison 
with parental and wild type composition
% Fatty acid mc2155 Pyramidll 78 57 54 116
Palmitoleic acid 
(C16:l)
11.90 12.21 10.33 10.67 8.52 11.74
Palmitic acid 
(Cl 6)
28.89 31.58 41.46 38.53 35.34 36.35
Oleic acid (C l8:1) 39.83 37.68 15.67 14.65 13.59 16.06
Stearic acid (C l8) 2.10 1.40 3.16 4.28 3.40 2.50
Tuberculostearic acid 
(C19:Br)
10.72 12.79 23.82 22.35 35.14 H
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Fig.42. Two dimensional TLC of the mycolic acid methylester obtained from the 
extraction of mycolic acids
1st direction, petroleum ether (b.p. 60-80°C), acetone (95:5v/v), three times; 2nd direction 
toluene, acetone (97:3, v/v).
Organisms: a) M. smegmatis mc2155, b) Pyramidll M. smegmatis, Pyramid: M .leprae clones 
c) 78 (non complementing) d) 54 e) 57 f) 116 (complementing).
Detection: MPA all lipids 
a - a  mycolates 
a ’- a ' mycolates 
E - epoxymycolates 
FA - Fatty acids
All Pyramidll .M .leprae clones exhibited the expected a , a ' and epoxymycolates expected 
from M. smegmatis strains in similar proportions.
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The percentage of oleic acid in the clones decreased from 38% in the wild type to 15% in the 
clones. The levels of palmitic acid increased by 5-10% in the clones as compared to the wild 
type or parental strains. The amounts of tuberculostearic acid were up by 10-17% in three 
clones 57, 78 and 116 and by 25% in clone 54, when compared to wild type levels.
In conclusion, the systematic biochemical analysis of the four clones resulted in the detection 
of an unknown phospholipid in the three complementing strains 54, 57 and 116, which was 
not present in the non complementing clone, 78. The proportions of the individual fatty acids 
in the Pyramidll leprae clones also differed significantly from those found in the wild type 
me2155 and the parental Pyramidll M  smegmatis.
3.3 Further analysis of PyramidII complementing cosmid 57
Pyramidll: :M leprae transformant containing cosmid 57 showed increased pyrazinamide 
resistance on solid and in liquid medium, exhibited a crinkly morphology and produced an 
unknown phospholipid in larger quantities than were visible in the parental Pyramidll or M. 
smegmatis mc2155. Strain 116 also displayed these properties, the only difference being that 
it produced slightly smaller amounts of the unknown phospholipid. Cos57 was therefore 
chosen as the cosmid from which to isolate a specific region of M. leprae DNA which 
complemented the pyrazinamide sensitive phenotype of the Pyramidll strain. The relationship, 
if any, between the M. leprae DNA complementing the pyrazinamide sensitivity, the crinkly 
morphology and the phospholipid production, o f  strain 57 could also be investigated.
3 .3 .1  T h e  m a p p i n g  o f  c o s m i d  57 t o  t h e  o r d e r e d  M. leprae c o s m i d  l i b r a r y  
An ordered M  leprae cosmid library exists (Eiglmeier etal., 1993) and the position o f cosmid 
57 M. leprae insert DNA in the M. leprae genome could be determined by Southern 
hybridisation o f a fragment of cos57 DNA to the ordered library. A random fragment of 
cosmid 57 was therefore cloned.
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A 1.2kb fragment created by a BamHl digest o f cosmid 57 (Fig.43) was cloned into the 
ZfcimHI site of pMV206 producing pC57B2. 2^g o f the construct was digested with B atnHI 
and purified as described in section 2.6.1.
The 1.2kb insert DNA was labelled and hybridised to filters of the ordered M. leprae cosmid 
library by Dr.K.Eiglmeier, Institute Pasteur, Paris. The insert DNA was found to hybridise to 
a 1.17kb fragment o f cosmid B1308 in the ordered cosmid library. This cosmid had been 
sequenced and was adjacent to a second sequenced cosmid, L308, at the end of contig 35 
(Fig. 14) (Eiglmeier et al., 1993).
3.3.1.1 M apping o f cosm id 57 to cosmid BIO3
The results of the hybridisation indicated that the length of M. leprae insert DNA contained 
in cosmid 57 mapped within cosmid B1308 or overlapped one of the adjacent cosmids, L308 
or Y236. To ascertain the position of cosmid 57 within the ordered cosmid library and how 
much o f the cosmid was sequenced, the restriction patterns of cosmid 57 were compared with 
those o f cosmid B1308, available from the Mycobacterial Genome Database, MycDB (Bergh 
and Cole, 1994). 0.5/ivg of cosmid 57 was digested with each of the restriction endonucleases 
BamHl, Pstl, H indlll, EcoRl, Notl and EcoRV. The restriction fragments of cosmid 57 
produced by Pstl and BamHl digests and the loci o f  these individual fragments in cosmid 
B1308 are shown in Fig.43.
The average size of the M. leprae DNA insert in cosmid 57, calculated from the band sizes 
produced by the six digests, was 25.7kb ± 1.9kb. Cosmid B1308 is 33,312bp long and and 
the largest region o f B 1308 initially shown to be present in cosmid 57 was the 24.059kb 
between 5,992-30,051 defined by the BamHl and P stl digest of cosmid 57 (Fig.43). The P stl 
rite at 30,051 was confirmed by sequencing in subsequent experiments (3.5.2.4). The EcoRW  
digest also produced a 1.443kb fragment which requires a site at 30,603 also found in later
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Fig 43. The alignment of the P stl and Bam H I fragments of cosmidS7 with restriction 
maps of B1308 as quoted in MycDB.
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experiments (Fig.44 and 45) which would extend the insert size to at least 24.61 lkb. This is 
not in agreement with the Ztor/wHI digest shown, which would be expected to produce a 
5.823kb and 0.69kb fragment due to sites at 29,511, 30,255 and 30,255; it is thought that the 
digest shown is a partial and that the sites closest to the vector have not been cut, due to the 
19kb fragment present which would appear to  be pYUB18 (12kb) and at least another 7kb 
of DNA. It is also possible that one of the BamHl sites has been lost during cloning. The distal 
end o f cosmid 57 was known not to extend beyond 31,624, as there was a Pstl site at this 
locus which would have produced a 1.385kb band not visible following the P.st I digest of 
cosmid 57, (Fig.43). Later experiments implied that another 1.3kb o fM. leprae DNA was 
present in cosmid 57 at the distal locus, extending to position 31,540 of B1308. There is also 
a band o f 5.4kb in the Psll digest which would extend the proximal region o f  the insert to 
3,198, however it is possible that this fragment consists of 2kb of pYUB 18 vector DNA which 
would be created by a Pstl digest and 3.4kb o f  proximal insert DNA; this would extend the 
proximal end o f the insert to at least 5, 236, giving an insert size of at least 26.548kb.
In summary the insert DNA of cosmid 57 was contained within cosmid B1308 and was 
thought to extend from at least bases 5,230 to 31,540 giving a 26.3kb insert. The mapping of 
cosmid 57 within cosmid B1308 confirmed that the entire sequence of cosmid 57 was known. 
Having determined the approximate coordinates of cosmid 57 within B1308, the business of 
narrowing down the complementing region o f  cosmid 57 was begun.
3 .3 .2  T h e  i s o l a t i o n  o f  t h e  s p e c i f i c  l e n g t h  o f  c o m p l e m e n t i n g  D N A  i n  c o s m i d  5 7
3.3.2.1 Cloning o f the B am H Ifragm ents o f  cosmid 57
The initial strategy for narrowing down the area of M. leprae DNA within cosmid 57 
complementing the mutant phenotype, was to  clone the five ZtarmHI fragments of cosmid 57 
into the pMV206 shuttle vector plasmid. The five constructs would be individually 
transformed into Pyramidll and the five transformed Pyramidll strains would then be tested
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for their sensitivity to pyrazinamide.
BamYil fragments were chosen since the sites interrupted only one gene, lysine-6-amino 
transferase, in the cosmid, whereas other restriction enzymes cut through a greater number 
of open reading frames. This information was gleaned from the restriction maps and positions 
of the genes within cosmid B 1308 available from MycDB. The terminal lengths of M. leprae 
DNA would remain attached to  the pYUB 18 vector following a BamHl digest of cosmid 57 
and was not therefore a complete screen o f  all the insert DNA for complementation.
5pg o f  cosmid 57 DNA was digested with ZtormHI restriction enzyme. The digested DNA was 
loaded into the extended well o f  a 0.8% agarose gel and run at 20V overnight. Fig.43 shows 
the bands the bands of fragment sizes 1.1 kb, 2.4kb, 3.4kb, 4.2kb and 4.6kb which were 
excised and the DNA recovered using a Wizard DNA Clean Up Kit (Promega)(section 2.6.1). 
5/ug o f  plasmid vector pMV206 was cut, treated with alkaline phosphatase and run on a 0.8% 
LMP agarose gel from which only cut vector was excised and recovered. Ligation reactions 
were set up for each of the five fragments with 750ng insert DNA and 250ng vector DNA and 
these were subsequently transformed into E.coli DH5a.
The ligation reactions of fragments 1.1 kb and 2.4kb produced on average lxlO3 
transformants//ug and those of fragments 3.4kb, 4.2kb and 4.6kb produced 2xl02 
transformants//ug. Recombinant plasmids containing inserts of 1.1 kb and 2.4kb were 
successfully recovered from the transformants. Recombinant plasmids with the correct insert 
size were not obtainable for 3.4kb, 4.2kb and 4.6kb fragments, after repeated attempts. The 
subcloning of the BamHl fragments was eventually discontinued.
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3 .3 .3  C r e a t i o n  o f  a  s u b - l i b r a r y  o f  c o s m i d  5 7  i n  P M V 2 0 6
The next approach was to make a Sau3M  sublibrary of cosmid 57. 5ug  of cosmid 57 DNA 
was partially digested with Sau3Al, run on a 0.8% LMP agarose gel and DNA fragments of 
3kb and 6kb were size selected by excision. The size selected DNA fragments were purified 
from the agarose using Wizard DNA Clean Up Kit (Promega). 5^g o f pMV206 was linearised 
by digestion with BamHl and alkaline phosphatase treated at 37°C for 15min. The cut, 
phosphatased pMV206 DNA was run on an LMP agarose gel at 80V for 3hr and the linear 
vector band excised and recovered using the Wizard DNA Clean Up Kit (2.6.1).
Individual ligation reactions were set up for both sizes of insert DNA, 3kb and 6kb. l^g  of 
insert was added to 350ng o f cut and phosphatased pMV206 vector. A control vector only 
ligation was also set up. The three ligations were transformed into competent E.coli DH5a 
with a transformation efficiency of lx l0 6cfu///g. 1x103 and 1.5x10 * transformants were 
produced from the 3kb and the 6kb ligation reactions respectively. The plasmid DNA was 
extracted from five colonies o f the 3 kb cos57 sub-library and eight colonies from the 6kb 
cos57 sub-library using the small scale plasmid extraction method (section 2.11). The 
remaining transformants of each sub-library were pooled and used to seed two 100ml Lemco 
which were incubated at 37 °C overnight. The cells from each of two "sub-library" cultures 
were pelleted and the plasmid DNA extracted using the midi plasmid preparation (section 
2.12). 0.5/ig o f plasmid DNA extracted from the two pooled libraries and from the thirteen 
individual plasmid DNAs was digested with Pstl. As there was only one P stl site in pMV206, 
digestion with the enzyme linearised the pMV206 plasmid DNA; those plasmids containing 
inserts could be distinguished by increased size of the plasmid and by "drop out" fragments 
caused by the presence o f P stl sites in the cosmid 57 insert DNA.
Of the five plasmid DNAs o f the 3kb sub-library, four contained small inserts, up to 1 kb, one 
strain appeared to contain no insert DNA. Of the eight plasmid DNAs o f  the 6kb sub-library,
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six appeared to contain inserts ranging in size from 0.2kb-5kb. The .Pstl digests of the pooled 
plasmid DNA of both the 3kb and the 6kb sub-libraries produced the expected DNA "smears". 
The fragment sizes produced from the 6kb sub-library ranged from 9kb to 1 kb, while the 
fragment sizes o f the 3kb sub-library ranged from 6kb to lkb. Strong bands were observed 
at 4kb in the digests of pooled plasmid DNA from both libraries, probably consisting mainly 
of linearised pMV206 without inserts. The 6kb sub-library appeared to be the superior library, 
with a greater number of plasmids which contained insert DNA than the 3kb sub-library; this 
was deduced from the range and brightness of the DNA smear produced from the Pstl 
digestion o f the 6kb sub-library DNA in comparison with that of the 3kb sub-library DNA.
3.3.3.1 Transformation o f  Pyram idll with the 6kb sub-library o f cosmid 57 
Competent Pyramidll M. smegmatis cells were transformed with 2/ig of the 6kb sub-library 
DNA, the cells were then plated onto Lemco (Kan 15^g/ml) and incubated at 37°C for four 
days. 2 X 1 0 3 transformants were produced, the colonies all had a smooth colony morphology, 
except for one which had a crinkly morphology.
3.3.3.2 Screening fo r  increased pyrazinam ide resistance
Initially 96 transformed strains, all with a smooth colony morphology, were selected and 
transferred onto a Lemco (Kan 15/ig/ml) plate and incubated at 37°C for four days to 
recover. The strains were then replica plated on to Lemco pH5.2 agar containing 500pig/ml 
pyrazinamide and a control Lemco agar plate. Both arrays o f the strains were incubated at 
28°C for six days. Fourteen strains grew on 500/^g/ml pyrazinamide, while all strains grew 
on Lemco (Kan 15/^g/ml) at 28°C. The fourteen "resistant" strains were sub-cultured onto 
Lemco (Kan 15/^g/ml) and incubated at 37° C to recover.
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The fourteen PyramidII::cos57 transformant strains were named Pyrl-14. Single colonies 
from Pyrl-14 were used to inoculate 5ml Lemco (Kan 15//g/ml) cultures which were 
incubated at 37 °C until the cultures reached approximately late log-phase of growth O.SA^. 
Control cultures o f Pyramidll and wild type M. smegmatis me2155 strains were also grown 
to late-log phase (OSA^).  The Pyramidll::cos57 cultures, Pyrl-14, were then streaked onto 
Lemco pH5.2 (Kan 15//g/ml) containing 500//g/ml pyrazinamide and incubated at 28°C for 
five days. The control cultures were streaked onto Lemco pH5.2 agar containing 
pyrazinamide 500/zg/ml and also incubated at 28°C for five days. The mutant Pyramidll M. 
smegmatis strain did not grow on 500/zg/ml pyrazinamide. Ten of the Pyramidll::cos57 
strains, Pyrl,3-6 and 10-14, exhibited stronger growth on 500^g/ml pyrazinamide than the 
wild typeM  smegmatis mcz155 while four of the strains Pyr 2,7,8, and 9 showed no growth 
on 500/zg/ml pyrazinamide. This experiment was repeated and the same results obtained.
3.3.3.3 Analysis o f the plasm id DNA in the Pyram idll transform ants 
The recombinant plasmid DNA contained in the fourteen Pyrl-14 strains was extracted using 
the small scale plasmid prep method for mycobacteria from overnight cultures of each strain 
grown in 5ml Lemco (Kan 15/^g/ml) media at 37°C with shaking. The recombinant plasmid 
DNA recovered from each strain was investigated by restriction digest analysis. Initially, the 
plasmids were double digested with Pstl and £coRV and by Pstl and Kpnl restriction 
enzymes. These pairs o f sites were situated either side o f  the BamHl site in the multiple 
cloning region o f pMV206 into which the cos57 insert DNA was cloned. Double digests of 
the plasmid DNAs with these enzyme pairs would therefore "dropout" the insert DNA o f each 
recombinant plasmid. Single digests with PstI, Kpnl and ZscoRV were also carried out. The 
results of the double digests are shown in Fig.44 and illustrate the similarity o f the 
recombinant plasmid DNA in each of complementing strains Pyrl, 3-6 and 10-14, whereas 
the non complementing strains Pyr 2, 7, 8 and 9 were visibly different. The ten complementing 
strains produced 0.8-0.9kb and 1.8kb fragments following a  Pstl, £coRv double digest, not
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Fig. 44. P stl /  EcoRV  and b) Pstl /  K pnl double digests of ten complementing and 
four non-complementing plasmids.
Non-complementing plasmids Markers 
lane 6) pYR9 lane 15) AiZ/wdlll / EcoRl
lane 7) pYR8 lane 16) XJ//>idIII
lane 8) pYR7
lane 13) pYR2
Complementing recombinant plasmids 
lane 1) pYR14 lane 9) pYR6 
lane 10)pYR5 
lane ll)pY R 4 
lane 12) pYR3 
lane 14) pYR2
lane 2) pYR13 
lane 3) pYR12 
lane 4) pYRl 1 
lane 5) pYRIO
pYR 3, 5, 7, 10 and 14 all appear to have lost the EcoRV and Kpnl sites during cloning.
a) Shows the 0.9kb fragment found in all complementing plasmids. The approximate 1.8kb 
fragment was found in pYRl, 3, 4, 6, 10, 11, 12 and 13 and is contained within the region 
between the EcoRl site at 29160 and pMV206 Pstl cloning site (Fig.45). The size o f this 
band varies in the different plasmids, only 1.4kb of the region is apparent in pYR5 and 14. 
The 3.3 kb region is part o f pYUB18 which contains part of the mycbacterial origin of 
replication pAL500 (Fig. 45).
b) The 2.7kb represents the region from the Pstl site at 30051 to the Pstl site in pMV206 
and is present in all the clones containing the 1.8kb EcoRV I Pstl fragment (Fig.45). The 
2.3kb fragment represents the region between the Kpnl site present in pYUB18 and the 
Pstl site at 30051 (Fig.45).
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0.9 1.4
Pstl / Kpnl
1.5 2.3 2.7
Pstl / £coRV 3.3 0.5 0.9 1.8
Pyrl, Pyr4, Pyr 10,
I____________________________ _____________________________ l Pyrl2,Pyrl3
Pyr3,Pyr5,Pyr6,
L ...#/_______________________________ _________________ » -------------- 1 Pyrii.PyrH
Fig.45. Restriction map of the complementing DNA found in Pyramidll strains complemented 
with a sublibrary of complementing cosmid 57.
The complemented clones all contained at least 3.5kb from the distal end o f cosmid, cosmid57 which correponds to the distal region of B1308. 
All the complementing recombinant DNA also contains variable lengths of the pAL5000 region of pYUB18 cloned between the EcoKW/Kpnl and 
Pstl sites of pMV206. The coordinates shown in the region of B1308 are taken from MycBD. The map shows the coordinates for the plasmid DNA 
ofPyrl.4,10,12 and 13. Pyrl4 and Pyr5 contain approximately 0.5-0.6kb lessM leprae DNA proximal to the Pstl site and so the complementing 
region as defined so far is approximately 3.5kb. The plasmid DNA of Pyr3,5,6,11 and 14 appears to have lost its £coRV and Pstl sites.
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present in the Pstl only digest. A 2.75kb fragment produced by a Pst I only digest was not 
present following digestion with PstI, PcoRV.
With the aid of the restriction patterns produced for cosmid B1308, available from the 
MycDB database the complementing length of cosmid 57 DNA was mapped to a 3.5kb region 
o f cosmid B1308 (Fig.45), located at the distal end of both cosmid57 and B1308, between 
28,000 and 31,500 of B 1308 (The coordinates are those found in MycDB which are in the 
opposite orientation to those in the EMBL database).
3.3.3.4 Sequencing Analysis
In order to confirm the mapping of the complementing DNA to the distal end o f both cosmid 
57 and B1308 the ends o f a fragment o f  the complementing plasmid were sequenced.
A 0.9kb Pi/I/£coRv fragment ([E] 29,160-30,0051 [P]) found in all the complementing 
plasmids was subcloned into the PstVEcoRv sites of pMV206. A large scale PsfUEcoKv 
digest of 5/^g of plasmid DNA extracted from Pyrl was run on an 0.8% agarose gel and the 
0.9kb band excised and recovered with Wizard DNA clean up kit. 750ng o f 0.9kb insert DNA 
was placed in a ligation reaction with 250ng of PstUEcoRV digested pMV206. The ligation 
reaction was transformed into Ecoli DH5a, small scale plasmid preparations were carried out 
on overnight cultures of the transformants and the plasmid DNA recovered was digested with 
P stl/E coR v to confirm that it contained the 0.9kb insert DNA. The procedure was then 
repeated with a HindlW Xbal digest o f the pMV206 plasmid, dropping out the 0.9kb 
fragment, and the subsequent cloning o f the 0.9kb insert into HindllUXbal digested pUC19.
Having successfully cloned the 0.9kb fragment into pUC19, universal forward and reverse 
primers could be used to sequence across the ends of the insert DNA. The double stranded 
sequencing was carried out (section 2.17.1, 2 and 3) and the sequence generated aligned to
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q u e r y  f o r ..............................................A T A T C C G C A A G G C G C C A A G TT G TT TG TC T TC G A C C
I I I  I I I I I I I I I I II  I I I I I I I I I I I I I I I I | | | |
B 1 3 0 8  2 9 1 5 1  C T G C C T T C G C C T T C G A T A T C C G C A A G G C G C C A A G TT G TT TG TC T TC G A C C  29 20 0  
G ACG G AAG CG GA A G CTA TA G G CG TTC C G C G G TTC A A CA A A C A G A A G C TG G  
E c o K V
q u e r y  f o r .  C C G A TG G A G A C C G A C C C G A TTG TC A C C G C A G A A G TG G G C G G TT..................
I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I  I I I 
B 1 3 0 8  2 9 2 0 1  C C G A TG G A G A C C G A C C C G A TTG TC A C C G C A G A A G TG G G C G G TTC A G C G C T 29 25 0  
G G C TA C C TC TG G C TG G G C TA A G A G TG G C G TC TTC A C C C G C C A A G TC G C G A
B 1 3 0 8  2 9 9 7 1  G CC AC CC CG CTG G G G TAA G C G G C TG C G C G CTA CG CG C CG CA CC CA CA CC C  3 0 02 0  
C G G TG G G G C G AC C CC ATTCG CC G A CG C G C G A TG C G C G G C G TG G G TG TG G G  
I I I I I I  I I I I I I I I I I I I I I I I I I II I I I I I I I I I I I I I I 
q u e r y  r e v ................................A C C CC ATTCG CC G A C G C G C G A TG C G C G G C G TG G G TG TG G G
P s t I
B 1 3 0 8  3 0 0 2 1  C A TTC A C C A C A G C G TC A C C C G TA G G C TG A A C C G G C C TGCAG G TGA AG ACC 30070  
G TA A G TG G TG TC G C A G TG G G C A TC C G A C TTG G C C G G A C G TC C A C TTC TG G  
I I I I I I I I  I
q u e r y  r e v . G T A A G T G G T ..................................................................................................................
Fig.46.a) An alignment of a sequenced region of cosmid 57 with B1308
An alignment of the sequence obtained from the ends of the0.9kb PstVEcoRV  fragment 
isolated from complementing recombinant plasmid pYRl with B 1038. One end of the 0.9kb 
fragment aligned with the 30,0051 P sll site and the other end with the EcoRW 29,160 site so 
confirming the restriction mapping analysis of the region o f B 1308/57 contained within the 
complementing clones.
Fig 45.b) Table. 19. Homologies of six putative coding regions found at the distal end of 
cosmid B1308
Putative
coding
regions
Location on 
B1308  
(M ycDB)
B e s t
match
Probability 
o f  match
D atabase
P 3 1 0 8 4 -3 2 1 8 7 p ro p io n y l  C o A  c a rb o x y la se 5 x l 0 ,39e EMBLV
S w is s p ro t
i 2 9 4 8 9 -2 9 9 8 3 n o  s ig n ific a n t m atch - -
a  /  c 2 8 1 1 8 -2 8 4 8 6 n o  s ig n ific a n t m atch - -
b 2 8 7 1 5 -2 8 9 6 5 n o  s ig n ific a n t m atch - -
A 2 5 5 7 1 -2 6 1 2 5 P .s a t ir u m  tu r g o r  re sp o n se  
p ro te in  /  a ld e h y d e  
d e h y d ro g e n a s e
6 x l 0 '2,e EMBLV
S w is s p ro t
C 2 5 5 7 1 -2 6 1 2 5 D N A  b in d in g  re p re s so r  
p ro te in  o f  E .c o li  
o s m o re g u la to ry  system
2x1 C e EMBIV
S w is s p ro t
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Fig.47. A map of the region the distal region of cosmid B1308 showing putative coding regions
The map show the positions o f  the putative coding regions p, /', a,and b found in the region o f  B 1308 which complements Pyramidll and o f  tw o  
coding regions upstream o f  / and the complementing region o f  M. leprae D N A , which are believed to  be involved in osmoregulation (Table. 19. 
Fig.46). The complementing region o f  D N A  is represented by the black bar.
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Forward strand
5 0 8 7 -6 1 0 0  p a b B  an tig e n  B
7 5 4 9 -7 8 1 2  M .le p ra e  g en e  s e q u e n c e
7 7 6 1 -8 9 4 2  a c d  acy l c o A  d e h y d ro g e n a s e
9 1 9 7 -9 5 1 6  p u r 6  p h o sp h o rib o sy lam in o im id a zo le  
carb o x y la se
9 5 4 0 -1 0 9 0 7  p u r K  p h o sp h o rib o sy la m in o d a z o le  
c a rb o x y la se  (A T P ase )
1 0 9 4 1 -1 1 6 3 3  M .le p ra e  g en e  s e q u e n c e
1 1 5 8 9 -1 2 2 3 8  M .le p ra e  g e n e  s e q u e n c e
1 2 8 0 2 -1 3 1 3 4  M .lep ra e  g e n e  s e q u e n c e
1 9 2 0 8 -1 9 6 2 1  rpsB  s ig m a  fa c to r  B  
1 9 9 5 0 -2 0 2 2 8  M .le p ra e  g en e  s e q u e n c e  
2 1 4 9 7 -2 2 0 4 5  la tA  L y s in e -6 -a m in o  tran sfe rase
2 8 1 1 8 -2 8 4 8 6  M .le p ra e  g en e  s e q u e n c e  a /c  
2 8 7 1 5 -2 8 9 6 5  M .lep ra e  g en e  s e q u e n c e  b  
3 1 0 8 4 -3 2 1 8 7  M .le p ra e  g en e  s e q u e n c e  p
Reverse strand
4 4 0 6 -4 6 7 2  tra n sp o rt p ro te in
1 3 0 8 9 -1 4 7 7 4  p c c  p rop iony l c o A  carb o x y la se  
1 4 7 9 6 -1 5 6 6 2  M .leprae  spec ific  
1 5 8 6 0 -1 6 7 5 3  r/ifR T h io su lfa te  su lfo tra n sfe ra se  
17231 -1 9 0 8 4  b io tin  carb o x y l c a r r ie r  p ro te in - m e t
2 3 9 9 9 -2 4 2 8 3  M .leprae  g en e  seq u e n c e  
25191 -2 5403  a ldehyde  d e h y d ro g e n ase  
2 5 5 7 1 -2 6 1 2 5  p robab le  d e h y d ro g e n a s e  A 
261 1 5 -2 6 8 5 8  M .leprae  g ene  se q u e n c e  C
2 9 4 8 9 -2 9 9 8 3  M. leprae  g en e  seq u e n c e  i
Fig. 48. A list of open reading frames found in cosmid B1308 and their coordinates on 
the cosmid as defined by MycBD (opposite orientation to GenBank)
The numbers given show the position of each ORF identified in relation to the length o f the 
cosmid. ORFs on the left are on the forward strand; ORFs on the right are on the reverse 
strand. ORFs putatively identified by homolgy with known genes are named; genes without 
homologies to sequences in the database are shown as M. leprae gene sequences.
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that o f B1308 in the region of the 0.9kb PstUEcoRV fragment (Fig.46a). This confirmed the 
position of this fragment and the other mapping of the complementing plasmids generated 
from cosmid 57.
The 3.5kb complementing region has been shown to contain 3 entire open reading frames a/c 
(70aa) b(l 1 laa) and i(142aa) and part of a fourth at the most distal end, p (303) in MycDB; 
while in Genbank (1995) the region was predicted to contain the complete coding region i and 
part o f  p at the distal end (Fig.47). The region was reanalysed for possible coding regions 
using PC gene and shown to contain the same ORFs as predicted on MycDB and in GenBank.
Blast searches were repeated on the four MycDB predicted ORFs contained within the region, 
the genes all appeared M. leprae specific showing no significant homologies to genes of 
bacterial or eukaryotic species listed in the EMBL and Swissprot databases (Fig.46b). The 
results confirmed those of MycDB and GenBank. The complete list of all known and putative 
coding regions on cosmid B1308 are listed in Fig.48.
3.3.4 Pyrazinamide sensitivity and hydrophobicity of PyramidII:cos57
RECOMBINANT STRAIN PYRl
The pyrazinamide sensitivity o f recombinant strain Pyrl was measured in liquid culture 
(section 2.28.4). Strain Pyrl exhibits significantly increased resistance to pyrazinamide when 
compared with the parental mutant strain PyramidI and with wild type M. smegmatis mc2l 55 
in liquid culture (Fig.49).
The hydrophobicity test was repeated for 200ml of early-stationary phase Pyrl culture. The 
strain was found to have a greater hydrophobicity than both the parental Pyramidll strain and 
the wild typeM smegmatis strain, with an aqueous layer A400 of 0.314 compared to 0.9 and 
0.5 for Pyramidll andM  smegmatis mc2155 respectively.
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Fig.49. A graph of strain Pyrl which exhibits increased resistance to pyrazinamide in 
liqiud culture, when compared with the parental strain.
An equal number o f  cells were added to a set o f 5ml Lemco(pH5.2) containing increasing 
concentrations (200 pg/ml-900pg/ml) of pyrazinamide. Control cultures without pyrazianmide 
were also set up. T heA ^ was taken when the control cultures reached, mid log-phase growth 
0.6A«,,, Pyrl was found to exhibit an increased resistance to pyrazinamide over and above the 
levels attained by M . smegmatis me2155 wild type cells.
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The levels of resistance to pyrazinamide and increased hydrophobicity exhibited over and 
above those found in the wild type may be due to increased copy number or to upregulation 
of the gene or genes involved by a mycobacterial promoter found in the length of pYUB18 
vector cloned into pMV206 beside the M. leprae genes, or both.
3.3.5 Biochemistry
The free lipids o f strains Pyrl and another recombinant strain of Pyramidll containing the 
2.2kb BamYW fragment of cosmid57, in pMV206 were analysed. The phospholipids o f  the two 
strains were analysed with the 2D-TLC system F (data not shown). The Pyrl strain does not 
produce the unknown phospholipid in the same quantities as were found in the Pyramidll 
strain containing cosmid 57. This implies that the phospholipid is not encoded by the M  
leprae genes contained in the recombinant plasmid of the Pyrl strain. The genes encoding or 
controlling production of the phospholipid may be located elsewhere on cosmid 57.
3.3.6 Summary
In summary a 3.5kb region of M. leprae DNA was mapped to cosmid B1308 and shown to 
contain four M. leprae putative coding regions (MycDB), confers increased pyrazinamide 
resistance and hydrophobicity in the pyrazinamid sensitive, Pyramidll strain.
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Chapter 4
D i s c u s s i o n
4.1 The Isolation o f M. s m e g m a t is  mc2155 with mutant phenotypes
4.1.1 Pseudolysogeny and the isolation of M . s m e g m a  77.S mc2 155 phage resistant 
MUTANTS
The attempt to isolate spontaneous mycobacteriophage resistant mutants failed due to the 
prevalence o f  pseudolysogeny in M. smegmatis mc2155; what appeared to be phage resistant 
colonies on the overinfection plates were in fact pseudolysogenic strains (section 3.1). A 
number of facts were indicative that the “resistant” strains were pseudolysogenic: the strains 
released mycobacteriophages on spotting of cultures onto a wild type lawn and formed 
spontaneous clear plaques and background plaques on their own uninfected lawns. 
Approximately, l-2xl02 phage "resistant" colonies were formed on the overinfection plates 
for each phage type plated with 1-3x10* M. smegmatis nic 155 cells, a frequency of 
pseudolysogeny of 0.5-lxlO"6 (section 3.1).
The pseudolysogeny observed in M. smegmatis me2155 is believed to be of the carrier type 
found in o ther mycobacteria (Grange and Redmond, 1978) in which the prophage does not 
replicate o r  integrate into the genome and is passed into one daughter cell of the next 
generation. The prophage can be induced into lytic growth thereby reinfecting daughter cells 
which do n o t retain the prophage and maintaining the pseudolysogenic state. A number of 
factors lead to  this conclusion; some colonies (derived from single cells) within a strain were 
positive and some negative when tested for pseudolysogeny, the level o f "resistant" colonies 
within a given strain was reduced by serial subculture and the appearance of background 
plaques within the bacterial lawn (mottled effect). The mottled lawns containing background 
plaques suggested that some phage-infected cells within the lawn were undergoing a lytic 
cycle, infecting others and preventing their reinfection to allow a masking layer of
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pseudolysogenic cells to overgrow plaques within the lawn. The mottled backgrounds often 
occurred in strains that had been serially subcultured.
Pseudolysogenic colonies were smooth and mucoid, a phenomenon noted in other 
pseudolysogenic species, for example M. kansasii mucoid strains all released phage without 
prior infection (Grange and Bird, 1977). This change in morphology may be mediated by the 
chemical alteration of the phage receptor site, presumably undertaken to prevent further phage 
infection e g. the simple LOSs o f a D29 resistant strain of M. smegmatis mc2l 55 were found 
to be O-methylated and O-acylated (Besra et al., 1994b).
The lytic cycle was induced by exposure to UV in most pseudolysogenic strains, improving 
the accuracy of the pseudolysogenic test in most cases and reducing the mucoid nature of the 
"resistant" strains. Only strains pseudolysogenic for D29 appeared unaffected by exposure to 
UV; that is the lytic cycle was not readily induced and the strains retained a mucoid 
appearance. It appears that the D29 prophage is more stable within M. smegmatis than the 
other phages tested.
DNAIII8 and 33D appeared to confer superinfection immunity to each other, a phenomenon 
noted with other mycobacteriophage e g L5 and D29 (Donnelly-Wu et a l., 1993); this effect 
was not exhibited by any o f the other mycobacteriophage used in these experiments.
The number of pfus (lxl09/plate) used to cause confluent lysis was comparable with numbers 
(lxlOVplate) used to select L5 gp71 transformants (Donnelly-Wu et al., 1993). The numbers 
of pfus used to produce confluent lysis were reduced (106) in an attempt to lower the levels 
of pseudolysogeny in later experiments when screening NTG-treated M. smegmatis mc2155 
(1-3x10*) cells; however, this approach was unsuccessful and it may have been preferable to 
have reduced the numbers o f M. smegmatis me2155 cells plated rather than the number of
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pfus.
M . smegmatis infected with LI has been described as having an intermediate host/phage 
relationship between pseudolysogeny and true lysogeny; although phage LI establishes a 
lysogenic relationship with the host, this broke down at high frequencies and led to lysis or 
curing o f the host bacterium. Cured bacteria were then susceptible to reinfection (Tokunaga 
and Sellers, 1970). M. smegmatis mc2155 has been shown from these experiments to establish 
a  similar relationship with D29, 33D, D4 and DNAIII8. How this relationship is maintained 
is a matter o f speculation and some light may be shed on the situation by comparison to the 
biology o f L5 where lysogeny is host induced. For example, if the phage produced residual 
amounts of a repressor protein which switches off the lytic cycle and the levels o f this protein 
are controlled by a host protein as predicted for L5 (Nesbit et al., 1995), an altered host 
environment could lead to a reduction in the host degradative enzyme and an increase in the 
levels o f  the phage inhibitory protein, inhibiting the lytic cycle; if the phages have no 
integrative apparatus i.e. int or attP then they would be unable to form the more stably 
inherited lysogens (Hatfull and Sarkis, 1993).
A  total o f sixty two strains produced on the overinfection plates were screened for resistance 
to  each phage. On the basis that spontaneous L5 resistant strains were observed at a frequency 
o f  lxlO'* on confluent lysis plates when plated with 10*M smegmatis me2155 efus (Donnelly- 
Wu et al., 1993), 1-3 in 100 would have been expected to be spontaneously resistant. It was 
therefore conceivable that a spontaneously resistant mutant would have been identified by 
screening 62 strains, although these numbers were low. Pseudolysogeny would mask a strain 
resistant to phage infection as the result o f a mutation which prevented replication. It is 
unlikely, however that it could mask a mutant resistant through an altered receptor as the 
phage would have been unable to infect the strain to cause pseudolysogeny. However, it is 
possible that a phage resistant strain caused by a receptor mutation would not have been
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detected if it was a mixed culture of pseudolysogenic and phage resistance as resistance to 
infection may have been attributed to a positive pseudolysogeny test.
Phage D4 overinfection produced four colonies which were rough not mucoid and non 
pseudolysogenic, but were infectable on retesting; it is possible that these strains were genuine 
phage resistant mutants that were unstable. This also applies to the two 33D and one D29 non 
pseudolysogenic strains isolated, which were infectable on retesting.
4 .1 .2  M u t a g e n e s i s
The NTG mutagenesis ofM. smegmatis mc2l 55 resulted in the creation of 0.1-0.2% of stable 
auxotrophic mutants, without INH selection. These levels are comparable with those found 
by other groups using NTG to mutagenise M. smegmatis and M . phlei, (0.46% and 0.11%, 
respectively) (Subramanyan et a l, 1989, Konickova-Radochova e t a l, 1970). The use o f INH 
enrichment increased the levels to 0.4%, again comparable to the levels found by others using 
this selection on M. smegmatis, 0.37% (Hinshelwood and Stoker, 1992b) and 0.1-0 9% 
(Holland and Ratledge, 1971). The level of auxotrophy achieved by INH enrichment is 
variable as shown by the results of Holland and Ratledge (1971). In M. phlei and in M. 
smegmatis, this was shown to be due to the percentage survival following the NTG treatment, 
a significant increase in INH enrichment was observed at survival levels below 5%, the 
maximum effect was seen at less than 1% survival auxotrophy (Konickova et al., 1978; 
Holland and Ratledge, 1971). The percentage survival was 8% in the INH-enriched NTG- 
treated M. smegmatis cells in these experiments. This may account for the fact that 3 o f the 
4 auxotrophs isolated following INH enrichment were leaky. The colonies formed following 
mutagenesis were initially mucoid, a phenomenon also noted by Holland and Ratledge (1971).
Both the INH and non-INH NTG-treated sets of M  .smegmatis mcJ155 cells produced 
mutants, with a variety of phenotypes (Mitomycin C resistance, melanin mutants, quinolone
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resistance, penicillin G and pyrazinamide sensitivity) implying that NTG is an appropriate 
mutagen for the creation o f mutant strains of Mycobacterium, corresponding with the findings 
o f other groups (Konickova-Radochova et al., 1970).
The levels o f stable auxotrophs formed were also comparable with the levels formed in 
transposon mutagenesis libraries ofM  smegmatis me2155 (Guilhot et al., 1994) and M. bovis 
BCG, (McAdam et al., 1995). Transposon mutagenesis has the advantages of being able to 
directly select mutants with antibiotic selection markers e g. kanamycin, before screening for 
altered phenotypes, and o f stably maintaining the mutations by selection on kanamycin. 
Transposon mutagenesis is also less likely to cause multiple mutations and may have been 
used if the technology were available at the initiation of this project. However NTG has the 
advantage o f creating point mutations less likely to form lethal mutations which may have 
involved cell wall biosynthesis.
One of the main observations of the NTG procedure was the apparently high levels of 
reversion, within the auxotrophic population. Levels of auxotrophy within the INH enriched 
group fell from 24% on the initial plating to 2.2% on the first serial transfer to a final value 
of 0.4% following individual testing. The first set of values for auxotrophs from Bankl may 
be slightly increased by the decision to test all strains with weak looking growth, but this may 
also have been counter balanced by any accidental elimination of auxotrophic strains due to 
carry over of media to the MM test plates, allowing their growth. Again this phenomenon has 
been observed by others using NTG as a mutagen and the reasons for it are unknown. One 
proposal is that the strain possesses a mutational hotspot which is particularly unstable, 
resulting in high levels of reversion as was observed with glycine/serine mutations o f M. phlei 
with a number of mutagens (Konickova et al., 1970). Alternatively, point mutations may be 
more readily resolved in Mycobacterium in comparison with other genera, for example E. coli 
which formed 40% stable auxotrophs following NTG treatment (Adelberg et al., 1965). The
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high levels o f reversion were also noted when screening for other phenotypes such as 
antibiotic resistance and phage resistance.
4.1.2.1 Conditions fo r  the survival o f cell wall m utants
The penicillin sensitive M. smegmatis mycolic acid mutant described by Kundu et a l, (1991) 
was isolated at 28°C and is temperature sensitive (Dr. P. Chakrabaty personal 
communication). This may be because the production of cell wall components such as 
mycolic acids are reduced at 27°C (Takayama et al., 1978) and the levels of phospholipids 
increase (Taneja et al., 1978) forming a barrier to  the external environment. This natural 
adaptation to low temperatures may therefore increase the chances o f survival o f a cell wall 
mutant by increasing its levels of phospholipid to create a barrier to the environment that the 
mutant would not possess at 37°C. For these reasons the NTG-treated M. smegmatis cells 
were left to recover at 28°C and at 37°C in an attempt to select for temperature sensitive 
mutants and to enhance the survival o f cell wall mutants.
The initial plating of NTG-treated cells which had been INH-enriched appeared to successfully 
select for temperature sensitive mutants. Twenty four percent of INH-enriched cells were only 
able to grow at 28°C on the initial plating of cells onto MM+AA, indicating that the INH 
treatment enriched for temperature sensitive strains better able to survive at 28 °C, even 
though no stable temperature sensitive mutants were isolated. As the NTG-treated M. 
smegmatis strains were grown at 37°C when treated with INH and INH is only bactericidal 
to  growing strains this was as predicited.
The INH-enriched NTG-treated M. smegmatis strains did not display any chromatogenic 
mutants, as opposed to the 0.3% found in SetA, the NTG-treated M. smegmatis cells allowed 
to  recover at 28°C; chromatogenic mutants may have grown rapidly enough at 37°C to have 
been selected out by the INH treatment. There did however, seem to be a slight variation in
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the types of mutant phenotypes selected for by recovery at 28°C alone and subsequent INH 
treatment at 37°C. The initial antibiotic sensitive mutants were selected from SetA which had 
not been INH-enriched; on the basis of these results a second mutagenesis was carried out 
which was not INH-enriched in order to select for antibiotic sensitivity. Although selecting 
for mutants which may have been temperature sensitive as result o f an altered cell wall by 
recovery at 28°C, using the INH selection may have selected against an altered cell wall 
phenotype merely by the required incubation at 37°C. The INH selection may also have 
selected out cell membrane transport protein mutations which if involved in active transport 
are more likely to be able to overcome a mutation at 37°C than at 28°C, when their uptake 
is reduced anyway. If this is the case then they would have been selected out by INH at 37°C 
due to their faster growth. It is possible that simple selection by recovery at 28°C may have 
been the most appropriate way to isolate cell envelope mutants of M. smegmatis me2155.
4.1.3 S c r e e n i n g  f o r  m u t a n t  p h e n o t y p e s  
4.1.3.1.M y cobacteriophage resistance
Bankl and an additional 1,000 strains from SetA were screened for resistance to a number 
of mycobacteriophage, but no phage resistant colonies were isolated. On initial screening for 
phage resistance 2.8% and 2.4% respectively appeared resistant, but on subculture and 
reinfection these were all found to be sensitive. These levels o f initial resistance were 
comparable to those initially found for auxotrophy in the Bankl strains and imply that the 
strains could have been genuinely phage resistant but unstable. It is also possible that the 
strains appeared resistant through an artifact such as low phage titre in the sample added to 
the lawn of the test strain. If these initial strains were genuinely resistant then the seven strains 
from Bankl which were initially resistant to all phage types tested were likely to have had 
mutations effecting the internal mechanisms of phage production, as phage D4 and D29 are 
known to have different phage receptors. An example of such an internal mutation could be 
an alteration in the host RNA polymerase which allowed host protein production but not
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adaptation by the mycobacteriophage for their use.
Screening o f the NTG-treated M. smegmatis strains of Bank 1 and the additional 1,000 strains 
from SetA had the advantage that the strains had not previously been exposed to 
mycobacteriophage when infected and were extremely unlikely to be pseudolysogenic.
The large scale screening of NTG-treated M  smegmatis strains for resistance to 
mycobacteriophage was carried out by plating out large numbers of cells (1x10*) onto agar 
spread with 106 pfii/ml, which resulted in confluent lysis and the formation o f  25-35 "resistant" 
strains, a frequency of lxlO'7. These strains were all pseudolysogenic except for those formed 
on plates spread with D4. The D4 colonies could have been unstably resistant or unstably 
pseudolysogenic strains. These experiments implied that pseudolysogeny is dependent on a 
host mutation as lowering the number of pfus used did not prevent its occurrence.
The inability to isolate stable mycobacteriophage resistant strains may have been dictated by 
a number o f  factors. The specificity of the mycobacteriophage receptors to oligosaccharide 
units of cell wall components e.g. D4 and GPLs (Dhariwal et al., 1986) and the large number 
o f genes encoding enzymes involved in the formation of those structures may make it more 
difficult to mutate the specific enzyme involved in the addition of the specific receptor sugar. 
Mutations further back in the pathway of these cell wall structures are also more likely to 
prove lethal to the host. The mutations required for resistance to mycobacteriophage through 
inhibition o f  the lytic cycle may also have proved lethal to the host e g. an RNA polymerase 
mutation.
4.1.3.2 Temperature sensitive mutations
Again a number of temperature sensitive (ts) mutations were initially isolated from Bankl at 
1%, levels slightly lower than those of the initial auxotrophic mutants found. On subculture
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0.15% remained temperature sensitive; however the temperature sensitivity was lost on 
further subculture from frozen stocks. Temperature sensitive mutations were noted by Holland 
and Ratledge, 1971 using NTG mutagenesis but were apparently not subcultured at all and 
so their degree of stability is unknown. The three ts mutants lost from frozen culture may have 
had cell wall mutations which could not survive being frozen and recultured.
4.1.3.3 Antibiotic resistance and sensitivity mutations
The MICs of the antibiotics to be determined were tested at 28°C and the MICs for 
minocycline, and ethionamide were found to be ten fold higher than those reported by other 
groups, at 37°C (Yamada eta l., 1992; Baneijee et a i , 1994).
Minocycline is the most effective tetracycline against mycobacteria and this is thought to be 
due to its lipophilicity and consequent ability to penetrate the lipid permeability barrier of the 
mycobacterial cell wall. It is thought that the decrease in temperature, causing a decrease in 
the fluidity of the cell wall, has reduced the ability of minocycline to transverse the cell wall. 
Mycolic acid biosynthesis is believed to be the site of action of ethionamide and the reduced 
production of mycolates at low temperatures may have rendered ethionamide less effective, 
as the cell’s ability to survive without mycolates is improved at these low temperatures.
The MICs of the other antibiotics used appeared unaffected by incubation at 28°C. In some 
cases MICs were not available for M. smegmatis and so were compared to MICs for M. bovis 
BCG and M. tuberculosis which are generally ten fold lower (Public Health Laboratories, 
Dulwich, personal communication).
The concentrations used in order to isolate antibiotic resistant and sensitive mutants were 
generally close to the MICs in an attempt to isolate mutants with lower levels of resistance 
and sensitivity, where mutants are perhaps less likely to be in the primary target site of the
-222-
Discussion
drug and perhaps more likely to be cell envelope associated e g. low level INH resistance 
mutants lead to the isolation of the inhA  gene (Baneijee et al., 1994) rather than the higher 
level resistance observed with mutations of the katG  gene (Zhang el al., 1993).
4.1.3.3.1 Antibiotic resistance
O f the seven antibiotics tested only NTG-treated M. smegmatis strains resistant to the 
quinolones ofloxacin (12) and ciprofloxacin (4) were isolated. The initial levels of possible 
antibiotic mutants isolated from Bankl for amikacin (0.2%), minocycline, (0.6%), ethambutol 
(1.45%) and ethionamide (1.95%) were lower than those seen for auxotrophic mutants (2.2%) 
and were all found to be unstable on further subculture. The initial levels of cycloserine 
resistance were very high at 7.8% but again resistance was lost on subculture and retesting.
Large scale screening for resistance to  minocycline, ethionamide, ethambutol and amikacin 
only yielded colonies on the ethionamide and ethambutol plates at frequencies of 1.5x1 O'7 and 
0.6xl0‘9 respectively, which are lower than the spontaneous levels of INH resistance for M. 
smegmatis me2155 (Baneijee et al., 1994). These results implied that the NTG-treated M  
smegmatis cells, grown from frozen culture, had not retained their mutations at a level much 
above wild type on reculture at 28°C.
The higher numbers of quinolone resistant mutants (0.75%) isolated also indicate that it is 
easier to form mutations in some loci than others; the mutations in the quinolone resistant 
strains are more likely to be found in the gyrA and gyrB genes.
The isolation of stable antibiotic resistant mutants appeared more difficult even from initial 
levels o f possible mutants, this may have been caused to some extent by the selection 
concentration being too high, particularly in the case o f minocycline and amikacin. Resistance 
to all of these drugs particularly ethambutol and ethionamide could have been caused by a cell
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wall mutation; it is possible that the essential nature of some o f the cell wall components may 
lead to a selection pressure for revertants, resulting in the isolation of unstable mutants. A 
mutation in less essential genes, possibly the gyrA  gene, may not adversely affect the strain 
resulting in the maintenance of the mutation.
4.1.3.3.2 Antibiotic sensitivity screening
The screening for increased antibiotic sensitivity was generally more successful than the 
screening for antibiotic resistance. A pyrazinamide sensitive strain (0.05%), five penicillin G 
sensitive strains (0.5%) and eight other strains with poor growth were isolated, the majority 
from the second mutagenesis procedure. Screening for sensitivity tended to throw up other 
types of mutants with slow growth as well as strains genuinely sensitive to the test antibiotic 
e g. auxotrophic mutants AM2 and 570 were isolated from screens for pyrazinamide and 
penicillin G respectively. The antibiotic sensitive strains seemed to have survived better 
without INH enrichment as discussed above. Again the MICs o f  M. smegmatis mc2155 wild 
type differed at 37°C and 28°C by decreasing at 37°C, presumably as the result of an increase 
in the permeability o f  the strain at this higher temperature.
4 .2  C h a r a c t e r is a t io n  o f  m u t a n t  s t r a in s  o f M . s m e g m a t is
4 .2 .1  A u x o t r o p h i c  m u t a n t s
One stable proline mutant (AMI) and one mutant auxotrophic for aspartate, phenylalanine, 
serine and valine were isolated from Bankl.
Proline biosynthesis involves the conversion of glutamic acid to  glutamate semialdehyde 
dehydrogenase which spontaneously converts to A-l-pyrroline-5-carboxylate, which is 
converted to proline by pyrroline-5-carboxylase. The proline mutant could have altered 
glutamate dehydrogenase or pyrroline-5-carboxylase enzymes. Which enzyme is mutated 
could be determined by adding only glutamic acid semialdehyde to  MM. If the strain did not
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grow on glutamic acid semialdehyde it would indicate a pyrroline-5-carboxylase reductase 
mutation, whereas if the strain grew on the glutamic acid semialdehyde this would indicate 
that the mutation was in the glutamate kinase or hydrogenase enzyme.
Proline mutants of mycobacteria had been previously isolated (Subramanyan et al., 1989) and 
the M. leprae genes encoding glutamate kinase (argB) and dehydrogenase (gadCfD) and 
pyrroline-5-carboxylate reductase (proC) have been identified (GenBank., 1995).
The second auxotrophic mutant investigated, AM2, was able to grow on single amino acid 
plates containing either aspartate, arginine, phenylalanine, serine or valine. The exact nature 
o f this mutation is not obvious; there may be an alteration in the transaminase enzyme 
glutamate dehydrogenase, o r  in the glutamine synthetase and glutamate synthase. However, 
the synthesis of other amino acids, tyrosine and L-alanine also require transamination. E. coli 
posseses several glutamate dehydrogenase enzymes that are specific for linear, branched and 
aromatic amino acid biosynthesis. M. smegmatis may also possess several glutamate 
dehydrogenase enzymes , some of which may be specific to the formation of aspartate, 
phenylalanine, serine and valine. Although it is not specifically transaminated, arginine 
biosynthesis requires a-oxoglutarate, the by product of transamination from glutamate; 
reduced transamination may therefore result in low levels o f a-oxoglutarate and hence 
arginine.
The mutant would not grow  on "drop out" plates without methionine, tryptophan, proline, 
asparagine and glycine. The biosynthesis o f methionine and asparagine, glycine and tryptophan 
requires aspartate and serine respectively. It therefore also possible that AM2 is a double 
mutant in serine and aspartate production.
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4 .2 .2  P i g m e n t a t i o n  m u t a n t s
Two mutants with altered pigmentation, one orange and one white were isolated from Bankl 
and their pigmentation analysed, along with wild type M . smegmatis me2155.
The adsorption spectra analysis of the pigments of M. smegmatis mc2155 wild type revealed 
the presence of two pigments; small amounts of a P-carotene like xanthophyll 4-ketorulene, 
and the main pigment theophytin, a chlorophyll degradation product which absorbs at 409nm. 
The white mutant (17) contained no pigments while the orange mutant (96) contained more 
4-ketorulene. M. smegmatis is known to contain 4-ketorulene, but not the leprotene or a -  
carotene found in M. leprae and M. aurum or the P-carotene found in M. phlei (David, 
1984). The formation of the 4-ketorulene is believed to occur via the route 
phytoene-phytofluene-carotene-neurosporene-4-ketorulene (David, 1984). In most other 
species neurosporene is converted to lycopene which undergoes cyclisation to form first the 
mono and then the dicyclic leprotene, a and P carotenes. The xanthophylls in other species 
are also generally formed using lycopene as a precursor, however M. smegmatis does not 
contain lycopene.
Carotenoid mutants, one white and one red, have been used in M. aurum to isolate the 
leprotene and a-carotene coding region (Houssaini-Iraqui et al., 1992 and 1993a). The genes 
encoding the biosynthesis of carotenes in M  aurum are clustered in a 10.83kb operon, while 
the genes to convert lycopene into xanthophylls appeared to be located elsewhere in the M . 
aurum genome, as when the gene cluster was placed in M . smegmatis only small amounts o f 
xanthophyll accumulated (Houssaini-Iraqui et al., 1993b). The white (17) and orange (96) 
mutants could be used to investigate the unusual production of the xanthophyll 4-ketorulene 
and the theophytin pigment. The pigment encoding genes are probably regulated from a 
similar area or found in an operon, as the white mutant contains neither pigment and the levels 
o f both pigment are increased in the orange mutant.
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Two M. smegmatis strains were isolated with an inability to synthesis melanin on tyrosine 
containing media, one of which was leaky. The melanin mutant has been complemented with 
a M. smegmatis cosmid library and the complementing genes cloned; it is hoped that melanin 
production could be used as a selectable marker in mycobacteria that do not produce melanin 
and in mutant strains of those that do.
4.2.3  M i t o m y c i n  C  m u t a n t s
Relatively large numbers of mutants (2.4%) were found on screening for sensitivity to 
mitomycin C which interferes with DNA recombination. These strains were deficient in their 
recombinational and repair mechanisms; the fact that there are large numbers of enzymes 
involved in these processes would explain the higher frequencies o f mutants isolated from the 
mitomycin C screen. This screen was carried out in the search for a recK  mutant The twelve 
stable strains were sent to Dr. E. Davis, NIMR for further analysis.
4.2.4  QUINOLONE RESISTANCE
The 12 ofloxacin and 3 ciprofloxacin resistance mutants isolated could contain mutations in 
their gyrA and/or gyrB genes, which code for the A and B subunits o f topoisomerase DNA 
II. Point mutations have been identified in the gyrA genes o f ciprofloxacin resistant mutants 
ofM  tuberculosis and M  bovis (TakifFet al., 1994). None were observed in the gyrB gene 
which has been shown to result in low level resistance in other species. Mutations in the gyrA 
gene are thought to cause high level resistance as the A subunit o f the DNA topoisomerase 
II is the binding site of the quinolones.
The ten ofloxacin resistant strains were cross-resistant to ciprofloxacin and must have 
mutations in a site of action of both drugs i.e. gyrA ox gyrB  genes, or a transport protein. The 
M. tuberculosis gyrA  and gyrB sequences could be used to design PCR primers to the gyrA 
and gyrB  genes o f  the resistant M. smegmatis strains; PCR products could be screened for
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single strand conformational polymorphisms which would indicate defective gyrA  or gyrB 
genes. Any strains not defective in these genes could have altered permeability caused by a 
change in the cell wall structure or transport proteins across the cell wall or the cell membrane 
or other novel sites of action o f the drugs, and could be investigated further. Three 
ciprofloxacin mutants and 2 ofloxacin mutants were not cross-resistant, which could imply 
that the mode o f transport of the two drugs varies, possibly differing uptake proteins in the 
cell membrane
4.2.5 Penicillin G
Five stable penicillin G sensitive strains were isolated, four of which showed low level 
sensitivity (1 OO/^g/ml lower than wild-type), and one which showed high level sensitivity, 
PenG 650, (300/^g/ml less) in comparison with the wild type (500/yg/ml at 37°). It was not 
possible to compare the levels of penicillin G sensitivity of these strains with the mycolic acid 
mutant (Kundu et al., 1991) as the degree of penicillin sensitivity of the strain was not 
published.
High levels of resistance to penicillin and other P -lactams may result from factors including 
low permeability to the drugs, P-lactamase activity and the affinity of penicillin binding 
proteins (PBPs) for the drug (Jarlier et al., 1991; Fattorini et al., 1992). The degree of the 
effect of each factor on penicillin resistance is variable, although altered permeability and 
lower affinity o f PBPs have been shown to produce up to 512-fold greater resistance to 
amoxicillin in a M. fortuitum  mutant with normal p-lactamase activity (Fattorini et al., 1992). 
Increased sensitivity could have resulted from a mutation which caused increased permeability 
to the drug, reduced P-lactamase activity or increased affinity o f the PBPs for the drug.
Mutant PenG650 was chosen for further analysis as it was the most sensitive to  penicillin G, 
and since high levels of resistance were noted with permeability changes in M. fortu itum  it was
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possible that they could be the cause of high level sensitivity as well. PenG650 was analysed 
for any gross changes in the cell envelope lipids on the basis that the M. smegmatis mycolic 
acid mutant was penicillin sensitive and it may therefore contain cell wall alterations; whilst 
remaining aware it was equally possible that the increased sensitivity could be caused by 
decreased P-lactamase activity or an increased affinity of PBPs for penicillin G.
A change in permeability could have been caused by an alteration in the cell wall structure, 
but no gross changes were noted in any o f the cell wall components studied; a a ' and epoxy 
mycolates were all present, as were the glycolipids, GPLs, LOSs, cord factor and 
phospholipids. The increased permeability could still have been caused by a more subtle 
change in a cell wall component; for example the amounts of each mycolate type present may 
vary - this could be determined by HPLC analysis of the mycolates which is more quantitative. 
Increased permeability could also be caused by an upregulation o f a transport protein or by 
an increase in porin production.
The five penicillin G mutants require further analysis to determine the exact nature o f their 
increased sensitivity which could be identified by assessing their P -lactamase activity and 
PBPs affinities for penicillin G, as well as by assaying for a change in permeability.
4,2.6 P y r a z i n a m i d e  s e n s i t i v e  m u t a n t s
Two pyrazinamide-sensitive mutants were isolated from BankI; Pyramidll (discussed below) 
and AM2 (415). As discussed above, the screening for antibiotic sensitive mutants resulted 
in the isolation o f other slow growing mutants e g. auxotrophs. The possible transaminase 
mutant AM2 was isolated on the screen for pyrazinamide sensitive mutants and appeared 
genuinely sensitive to pyrazinamide at 28°C but not at 37°C. It is possible that the increased 
sensitivity to pyrazinamide is a secondary effect of a lack of transaminase enzyme, which may 
result in the reduction of substrate for the pyrazinamidase/nicotinamidase enzyme; this would
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reduce any competition for the enzyme leaving it free to hydrolyse pyrazinamide, producing 
more pyrazinoic acid and apparently increasing the sensitivity of the mutant to pyrazinamide. 
This effect is probably recognised to  a greater degree at 28 °C where the active uptake of the 
required amino acids will be lower resulting in an internal lack of substrate for the 
pyrazinamidase.
4.3 C h a r a c t e r is t ic s  o f  P y r a m id  II
4.3.1 Pyrazinamide sensitivity on solid and in liquid culture 
Pyramidll exhibits increased sensitivity to pyrazinamide on solid and in liquid media, when 
compared with the wild type M. smegmatis strain at 28°C and at 37°C. The actual MIC for 
Pyramidll varied under different conditions but was consistently at least lOO/zg/ml lower than 
the wild type MIC, a 20% increase in sensitivity. For example on solid media at 28° Pyramidll 
was unable to grow on a 500^g/ml concentration, 100/ig/ml lower than the wild type MIC 
600//g/ml, whereas at 37°C Pyramidll was unable to grow on 400/^g/ml while the MIC for 
wild type was 500/^g/ml. The MIC for liquid culture increased with the growth stage of the 
cultures as pyrazinamide is bacteriostatic not bactericidal.
The level of sensitivity of Pyramidll and the wild type to pyrazinamide appeared to be higher 
in mid log-phase growth as opposed to early stationary-phase growth and the differential 
between them was higher at early stationary-phase growth. Both strains would be expected 
to exhibit higher levels of sensitivity during mid log-phase compared to stationary phase 
growth as the permeability o f the cell envelope would be predicted to decrease towards the 
end o f stationary growth; However, the fact that the difference between the two strains 
increases from a 7-10 fold differential in the numbers of cfu/ml indicates that pyrazinamide is 
able to maintain a greater effect on early stationary phase Pyramidll cells than on early 
stationary phase wild type cells. This may indicate that the mutant does not present as strong 
a permeability barrier as the wild type cells at stationary phase.
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The exact mode of action of pyrazinamide is unknown, pyrazinamide is known to be a pro­
drug converted by pyrazinamidase to pyrazinoic acid, which is believed to be the active form. 
However, as M. smegmatis is ostensibly resistant to pyrazinamide despite the fact that it 
produces pyrazinamidase, unlike the resistant M. bovis which does not produce 
pyrazinamidase (Konno et al., 1967) it must employ other mechanisms of resistance to 
pyrazinamide. Possible resistance mechanisms include reduced permeability caused by the cell 
wall structure of M. smegmatis, increased efflux of pyrazinamide or pyrazinoic acid, or a 
mechanism capable of degrading pyrazinoic acid. Pyramidll may have a mutation which 
causes increased permeability, this may be an alteration in a cell wall structure, an upregulated 
transport protein or an increase in porin production. The increased sensitivity o f Pyramidll 
to pyrazinamide could also be a result of down regulated efflux or pyrazinoic acid control 
system or upregulation o f the pyrazinamidase enzyme.
4.3,2 Identity, colony morphology and growth
The identity o f Pyramidll as a mycobacterium was confirmed by the results of the acid-fast 
test and as M. smegmatis me2155 by the results o f the API-ZYM test.
Pyramidll colonies were smooth and filamentous, as opposed to the wild type which are 
uneven and invaginated, which was also reported for the mycolic acid mutant of M. smegmatis 
(Kundu et al., 1991). Changes in morphology have been associated with alterations in cell wall 
components e g. rough morphology mutants o f M. kansasii and M. avium  have lost the 
oligosaccharide components of their LOSs and GPLs respectively, resulting in a loss of 
smooth morphology (Hunter et al., 1985; Belisle and Brennan, 1989). These results would 
imply that smooth morphology is associated with the presence o f  oligosaccharides on the cell 
surface, although the M. avium  SmT smooth variant has recently been shown to contain a 
66kDa cytosolic protein not present in the SmD or the rough variants (Prinzis et a l., 1994). 
It is possible that the Pyramidll strain is upregulating a cytosolic protein that is causing a
- 2 3 1 -
D iscussion
morphological change o r that an additional oligosaccharide has been exposed or expressed 
on the cell surface which was too small to have been detected by the biochemical analysis.
Pyramidll formed an even suspension in liquid culture; the reduction in clumping may have 
been due to a slight alteration in the cell wall surface, preventing adherence to neighbouring 
cells. The slightly variable acid-fast stain may also have been the result o f cell wall alteration, 
although an internal mutation may have had a similar effect. The slight variation in growth 
phase of the cells in comparison with a wild type culture may also have created this effect.
Pyramidll was able to grow at 28°C and 37°C and exhibited an additional 8hr lag-phase in 
comparison to wild type growth, when grown at 37°C. This implied that the mutation was in 
a function that is required for the early growth of the strain to the point at which log-phase 
growth can be initiated. The log-phase growth rate appears identical to the wild type M. 
smegmatis me2155 strain implying that the mutation is no longer inhibitory to the growth of 
the strain. The viable cell counts for Pyramidll are slightly higher than for the mutant, but this 
is believed to be caused by the reduced clumping o f the strain in comparison with M. 
smegmatis me215 5.
4 .3 .3  BIO CH EM ISTRY  AND HYDROPHOBICITY
The systematic analysis of the cell envelope lipid components of Pyramidll by 2D-TLC 
analysis did not reveal any gross alterations in the mycolates, glycolipid, glycopeptidolipid or 
phospholipids. HPLC analysis of the arabinogalactan, LAM and LM ( Dr.G. Besra, Colorado 
State University, Colorado) did not reveal any alterations either. These results indicate that 
there is no gross alteration of a cell envelope component, and suggest that the strain is not 
harbouring a major cell wall mutation. It is however possible that subtle changes are present, 
only detectable by techniques such as GCMS, NMR as with the O-methylation and O- 
acytylation o f the simple LOS inM  smegmatis resistant to D29 infection (Besra et al., 1994).
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Alterations in the quantities of mycolates formed would not have been detected using these 
methods, but should be found using HPLC analysis. The alterations in waxes and 
mycocerosate components were not screened for using the 2D-TLC system and so alterations 
in these would not be noted.
Pyramidll was found to be less hydrophobic than the wild type M  smegmatis in late log-phase 
and early stationary phase, which indicates an alteration in the cell surface. In other species
E. coli and Salmonella typhimurium , rough mutants lacking oligosaccharides have been 
shown to be more hydrophobic (Rosenburg et al., 1980) using a similar methodology. The 
reduced hydrophobicity of Pyramidll may be caused by the upregulated production o f a sugar 
moiety at the cell surface or by the reduced production o f fatty acid components such as 
mycolates.
4.3.4 Summary of PyramidII
The exact mutation of Pyramidll is unknown. An alteration in its cell surface is suggested by 
its decreased hydrophobicity and its smooth colony morphology; however, no alterations in 
the cell wall components which may be responsible have been detected. Other possibilities 
include a mutation resulting in an increased pyrazinamidase activity, a decreased efflux or a 
change in an other internal mechanism controlling the composition of the pyrazinoic acid. The 
Pyramidll mutant was chosen for complementation without being categorically defined as a 
cell envelope mutation as little is known of the resistance mechanisms o f M. smegmatis or 
other mycobacteria e g. M. leprae and M. avium  to pyrazinamide.
4.4 C o m p l e m e n t a t io n  o f  p y r a m id  II
4.4.1 Transformation with pYUB18::A/. l e p r a e  genomic cosmid library 
Pyramidll was successfully transformed with a representative coverage of the M . leprae 
genome in pYUB18 shuttle vector cosmid; the transformants exhibited variable colony
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morphology which was attributed to the expression of the M. leprae genes contained in the 
transformants.
Complementing cosmid clones were isolated at a frequency of 6%. This is a relatively high 
frequency o f  complementation, which should theroretically be 1-2% (Hinshelwood and 
Stoker, 1992b). The high frequency of complementation may have been a result of the ability 
o f more than one gene to complement the mutation or due to a higher representation of the 
complementing cosmid in the pYUB18::M. leprae DNA used to transform the strain.
The 11 complementing clones all grew well on pyrazinamide in solid media and exhibited 
intermediate (4) and higher than wild type (7) resistance in liquid culture. The intermediate 
degree of complementation in liquid culture could have been caused by a number of factors: 
a number o f  different cosmids may be complementing the mutation, conferring different levels 
o f complementation, or if all of the required complementing region is not present the DNA 
may only be partially complementing the mutation. It is also possible that the recombinant 
strains with intermediate growth contain cosmids with unstable insert DNA which has been 
deleted in a proportion of the cells resulting in a mixed culture of complemented and non- 
complemented cells, e.g. cos38 is unstable in E. coli, the recombinant M. smegmatis strain 
exhibits intermediate resistance to pyrazinamide in liquid culture and on solid media displays 
colonies with both smooth and crinkly morphology types.
When using the liquid culture method, the results were taken when the control was as close 
to O .bA ^ as possible, and the slower growth o f cosmid containing clones meant that the 
incubation times required to reach this A ^  were generally longer.
Three clones which appeared resistant to pyrazinamide on the initial replica screening of the 
transformants onto pyrazinamide were found to  grow very weakly on pyrazimamide in solid
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agar while apparently not exhibiting any increased resistance in liquid culture. The 
bacteriostatic nature of pyrazinamide may have allowed the initial growth of these strains.
4.4.2 C h a r a c t e r i s a t i o n  o f  t h e  c o m p l e m e n t i n g  M .  l e p r a e  DNA 
The extraction of complementing cosmid DNA from M. smegmatis strains proved difficult, 
despite adapting the cosmid DNA extraction method for mycobacteria by the addition of 
lipase type IV to the overnight cultures to improve the lysis step. Cosmid DNA was found to 
be unstable in E. coli despite the use of recombination deficient strains and small culture 
volumes, the cosmid DNA of all the complementing recombinant strains was unstable to some 
extent. The instability of mycobacterial insert DNA from both plasmid and cosmid vectors in 
E. coli has been noted by other groups and generally occurs in the form o f  deletions. 
Instability of recombinant DNA within the homologous M. smegmatis and M. bovis BCG 
strains has also been noted (Haeseleer, 1994)).
Restriction analysis of the complementing clones revealed a number of similar bands between 
cosmids but no clear map could be formed. The insert sizes of five o f the cosmids were 
particularly small (6-9kb) and the insert appeared to have been completely deleted from other 
cosmids e.g.cos38.
The complementing cosmid cos57 was mapped to cosmid B1308 of the overlapping M. leprae 
cosmid library (Eiglmeier et al., 1993) .This cosmid is found at one end of the four contigs 
and any o f the complementing cosmids containing M. leprae DNA which extends towards the 
end of the contig is likely to be unstable as this region o f DNA has so far proved unclonable 
(Eiglmeier et al., 1993). This could also account for the small predicted insert sizes (6-9kb) 
of some clones and the complete deletion of others. The inability to form a map may be due 
to deletions of regions of the M. leprae insert within certain cosmids, or it may be due to the 
fact that different genes are complementing the mutation, or both.
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Successful complementation of the pyrazinamide sensitivity o f Pyramidll with the M  leprae 
DNA indicates that M  leprae genes can be expressed inM . smegmatis mc2155.
4.4.3 Complementation with c o s57
Complemented recombinant strain 57, exhibited increased pyrazinamide resistance, a crinkly 
morphology and the production of the unknown phospholipid, and was used to narrow down 
the region of complementing DNA to  investigate these phenomena.
The cosmid was shown to map to B 1308; open reading frames and their possible functions 
as predicted in MycDB and in GenBank (GB) 1995, are listed in Fig 48. Using the available 
information on MycBD an attempt to  narrow down the complementing region was made by 
subcloning BamHl fragments known not to disrupt ORFs, however the larger fragments 
proved unclonable.
Transformation of Pyramidll with a plasmid sublibrary of cos57 DNA in pMV206 resulted 
in the isolation of 1% of transformants which restored resistance to pyrazinamide at a level 
over and above that of wild type, on  solid and in liquid media. The 3.5kb complementing 
fragment ofM  leprae DNA contained within the transformants was mapped to the distal end 
o f  B1308 between 28,000-31,500 (1,812-5,312 GB). This region of B1308 maps next to 
L308 on the contig, away from the  unknown end of the contig (Fig.47). This region is 
predicted to contain three complete ORFs of unknown function; ORF / (142aa), ORF a/c 
(70aa) and ORF 6(11 laa) and the terminal end of ORF p  (303aa) predicted in the MycDB 
database while in the GenBank database the region is predicted to contain only the terminal 
end o f ORF p  and the complete ORF/.
PC Gene was used to predict potential ORFs in the 3.5kb region; these were found to be in 
keeping with the predictions put forward by both groups and suggested that the GenBank
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predictions had eliminated any ORFs under 300bp. Repeat searches of the EMBL and 
SWISSPROT databases were carried out using the predicted amino acid sequences of ORFs 
/, b, and a/c, no significant homologies were found for b or a/c in either database (Table 19).
As ORF/ is found in all complementing clones it is possible that this is the complementing 
region. ORF /' is contained within the 0.8-0.9kb EcoYW-Pst\ fragment subcloned for sequence 
analysis. This region was subcloned into pMV206 and used to transform Pyramidll. The 
recombinant clone was then tested for pyrazinamide sensitivity, preliminary data suggest that 
the fragment does not complement Pyramidll, however the fragment used only contained a 
300bp region upstream of ORF/ and may not contain the promoter region of the gene. No 
putative promoters were found in the upstream region o f ORF/ but the promoter may be an 
unrecognisable mycobacterial type of promoter; alternatively it is possible that the ORF/ is 
expressed as part of an operon from a promoter upstream of ORFs a  and c (Fig.47).
The region upstream from the complementing region contains a putative turgor response 
aldehyde dehyrogenase protein, A (179aa) and an osmotic repressor protein, C (201aa), it is 
therefore conceivable that protein /  is encoded within the complementing region and is part 
o f an osmoregulatory operon.
The homologies found for the ORFs a/c and b were generally proteins from other GC rich 
organisms and did not appear significant; it is therefore possible that the ORFs do not 
represent genuine coding regions (Table 19 ). Alternatively it is possible that ORFs a/c and 
b are genuine and expressing the complementing gene products.
The region of complementing DNA requires further analysis to determine the exact source of 
the complementation. This can be achieved by further subcloning regions e g. the 2.75kb Pst 1 
fragment which covers the region containing ORF/ and approximately 1.9kb of upstream
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sequence. Alternatively, transposon mutagenesis of the region could be carried out to 
determine the exact complementing region (Jacobs et al., 1991; Mills et al., 1994))
4.5 B io c h e m ic a l  a n a l y s is
The expected M. smegmatis lipid components were found in both M. smegmatis and 
Pyramidll, although the actual amounts of each component present are unknown, and no 
alterations were found in the lipoglycan fraction analysed by HPLC (Dr. G Besra, Colorado 
State University, Colorado). The specific amounts and proportions of the mycolates in all 
strains could be measured by HPLC which may uncover differences not apparent in the 2D- 
TLC system. Equally the Pyramidll strain could be analysed further with techniques (NMR) 
which may pick up subtle changes e g. O-methylation or O-acylation of sugars which may not 
have been detected by the systems used.
The lipid components of the cosmid-containing complemented clones 57, 54 and 116 analysed 
contained all the components observed in wild type M. smegmatis me2155 strain as well as 
an unknown phospholipid. This phospholipid appears to be present in M. leprae (Minnikin 
et al., 1985) and may be a  direct product of an M. leprae gene or a secondary product. The 
second explanation seems most likely, since acetyl CoA carboxylase ( accC), the nucleotide 
biosynthesis genes pur6 and purk and the phosphate-transport protein genes ( pstB) which are 
all found on B1308 (Fig.48) all have the potential to indirectly alter phospholipid biosynthesis. 
Phospholipid accumulation may have been enhanced by the apparently reduced activity of 
phosphohydrolase enzyme found in Pyramid II.
Changes in the regulation of phospholipid biosynthesis could also lead to the accumulation 
of a secondary product which is not generally visible. The phospholipid is less polar than PI 
and PIMs and more polar than DPG and PE; the decrease in polarity in comparison with PI 
may be due to methylation or acylation which may then block alternative pathways. This
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méthylation or acylation may be encoded by a gene found on the cosmids. It is also possible 
that a specific M. leprae gene on the cosmids encodes an enzyme responsible for a 
méthylation or acylation event which causes a block in the pathway, again leading to a visible 
intermediate.
The unknown phospholipid produced in complementing strains 57, 54 and 116 has not yet 
been specifically identified by GCMS.
The fatty acid content of the cosmid-containing strains appeared to be significantly altered in 
the levels o f palmitic acid and tuberculostearic acid, these increased by approximately 10% 
in all cosmid-containing strains. The increase in palmitic acid and the larger tuberculostearic 
acid, both of which contain no saturated bonds, would result in a decreased fluidity of the cell 
membrane and may be connected to the mechanism of kanamycin resistance since it occurred 
in all cosmid containing strains.
4.6 F u t u r e  W o r k
The nature of the Pyramidll mutant should be investigated further; the permeability of the cell 
envelope could be measured (Nikaido and Jarlier, 1991; Connell and Nikaido, 1994) and 
sensitivity to other antibiotics investigated. An amide test could be carried out to ensure the 
mutation was not caused by upregulation o f the pyrazinamidase enzyme.
The complementing region ofM  leprae DNA needs to be narrowed down to a gene function 
as stated and could be achieved by subcloning or transposon mutagenesis (Jacobs et al., 1991 ; 
Mills et al., 1994). The 0.9kb fragment containing ORFi could be cloned into an expression 
vector to determine whether it was able to complement, when expressed from a mycobacterial 
promoter. The 0.9kb fragment could also be used as a probe to analyse the other 
complementing cosmids for homologous regions to categorically determine whether they all
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contain the same complementing cosmids or whether they encode varying complementing 
regions. The complementing gene could be used to probe a M. smegmatis genomic library to 
determine whether the gene is present in M. smegmatis, if so it could be cloned and PCR- 
SSCP analysis carried out to determine wether the M. smegmatis homolog was in fact 
mutated. Pyramidll could be transformed with an M. smegmatis cosmid or plasmid genomic 
library and the complementing region of DNA determined directly; this could then be used to 
probe the M. leprae complementing region to determine whether they were homologs. The 
complementing DNA, when isolated may also be used to carry out a zoo blot on a number of 
mycobacterial strains, including M. smegmatis to determine whether the gene is M. leprae- 
specific and therefore not the true homolog of the mutation or if it is present in other strains.
Cell free extracts o f  complemented Pyramidll (containing pYRI) could be extracted and 
western blots ran to  try and identify any protein being overproduced which could be purified 
and further analysed.
Other mutants generated by this project e g. penicillin G sensitive mutants, auxotrophic 
mutants and fluoroquinone mutants all require further analysis and transformation with an M. 
smegmatis genomic library to isolate the complementing genes.
4.7 S u m m a r y
This project has resulted in the formation o f two banks ofNTG-treated M. smegmatis me2155 
and has led to the isolation of a number of M. smegmatis mutants with alterations in a variety 
of phenotypes e.g. penicillin sensitivity, fluoroquinone resistance and melanin production.
A pyrazinamide sensitive mutant with decreased hydrophobicity, smooth colony morphology 
and variable increased sensitivity to penicillin was isolated. Pyramidll may have altered cell 
envelope permeability which could be due to a variety of factors i.e. upregulation of porin
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production or a subtle alteration in the cell wall structure, implied by the decrease in 
hydrophobicity and the altered colony morphology. Increased sensitivity to pyrazinamide 
could be caused by an upregulated efflux system, upregulated pyrazinamidase enzyme or by 
another mutation in an unknown internal mechanism for resistance to pyrazinamide in M. 
smegmatis.
A 3.5kb region ofM  leprae DNA was found to complement this mutation and contains three 
putative ORFs. The region is found down stream of a putative osmoregulatory site and it is 
possible that one or all three o f these coding regions are involved in osmoregulation. If 
Pyramidll has altered permeability it would follow that it would require a change in its 
osmoregulation, to overcome the change in permeability. It is therefore possible that the 
complementing region of M. leprae DNA is involved in osmoregulation.
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A p p e n d ix  A : M e d ia  a n d  a n t ib io t ic s
M9 Minimal Medium (MM) 
5x M9 salts *
Distilled water
200ml
800ml
sterilize by autoclaving
add 20ml 20% glucose (autoclaved) and 1ml 1% thiamine (filter sterilized) 
for agar plates Bacto agar was added to 1.5% 
cas-amino acids were added at 1 g/1 for MM+AA
*5x M9 salts
Na2H P04.7H20
k h 2p o 4
NaCl
NH4C1
Distilled water 
sterilize by autoclaving
64g
15g
2.5g
5g
to 1000ml
Luria Broth  (LB) 
Bacto-tryptone 
Bacto-yeast extract 
NaCl
Distilled water
10g
5g
10g
to 1000ml
sterilize by autoclaving
for agar plates Bacto agar was added to 1.5%
SOB
Bacto-tryptone 
Yeast extract 
NaCl
Distilled water 
sterilize by autoclaving
20g
5g 
0.5g 
to 1000ml
Lem co  Broth
Bacto-peptone
Bacto Lab Lemco powder
NaCl
10g
5g
5g
Distilled water to 1000ml
pH to 7.2 with 2M NaOH, sterilize by autoclaving 
for Lemco soft top, Bacto agar was added to 0.75% 
for agar plates Bacto agar was added to 1.5%
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M lD D L E B R O O K  7 H 9  MEDIUM
Ammonium sulphate 0.5g
Monopotaasium phosphate l.Og
Disodium phosphate 2.5g
Sodium citrate O.lg
Magnesium sulphate 0.05g
Calcium chloride 0.0005g
Zinc sulphate 0.001 g
Copper sulphate 0.001 g
L-glutamic acid 0.5g
Ferric ammonium citrate 0.04g
Pyridoxine 0.001g
Biotin 0.0005g
Distilled water to 900ml
sterilize by autoclaving, cool to 50-55 °C and add 100ml ADC+ enrichment (filter sterilized)
M lD D L E B R O O K  7 H 1 0  AGAR
Ammonium sulphate 0.5g
Monopotaasium phosphate 1.5g
Disodium phosphate 1.5g
Sodium citrate 0.4g
Magnesium sulphate 0.025g
Calcium chloride 0.0005g
Zinc sulphate 0.001 g
Copper sulphate 0.001 g
L-glutamic acid 0.5g
Ferric ammonium citrate 0.04g
Pyridoxine 0.001 g
Biotin 0.0005g
Malachite green 0.00025g
Bacto agar lSg
Distilled water to 900ml
sterilize by autoclaving, cool to 50-55°C and add 100ml ADC+ enrichment (filter sterilized)
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M i d d l e b r o o k  7 H 1 1  a g a r
Pancreatic digest of casein lg
Ammonium sulphate 0.5g
Monopotaasium phosphate 1.5g
Disodium phosphate 1.5g
Sodium citrate 0.4g
Magnesium sulphate 0.05g
L-glutamic acid 0.5g
Ferric ammonium citrate 0.04g
Pyridoxine 0.001 g
Biotin 0.0005g
Malachite green 0.001 g
Bacto agar 15g
Distilled water to 900ml
sterilize by autoclaving, cool to 50-55°C and add 100ml ADC* enrichment i
ADC* EN RICH M EN T
Albumin Fraction V, Bovine 5g
Dextrose 2g
Catalase (beef) 0.003g
distilled water 100ml
sterilize by filtration
A n t i b i o t i c  s t o c k  s o l u t i o n s
Penicillin G 10 mg/ml in H20  (buffered with NaOH)
Pyrazinamide 10 mg/ml in H20  (pH to 5.2 with HC1)
Ethionamide
Ethambutol
Kanamycin 50 mg/ml in H20
Ampicillin 50 mg/ml in H20
Ciprofloxacin 50 mg/ml in H20
Oxofloxacin 50 mg/ml in H20
Minocycline 50 mg/ml in DMF
Amikacin 50 mg/ml in H20
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A p p e n d ix  b : b u f f e r s
TAE
50x stock
Tris base 242g
glacial acetic acid 57.1ml
0.5M EDTA pH8.0 100ml
Distilled water to 1000ml
Tbe
5x stock
Tris base 54g
boric acid 27.5g
0.5M EDTA pH8.0 20ml
Distilled water to 1000ml
TE
2M Tris-Cl pH8.0 0.5ml
0.5M EDTA pH8.0 0.2ml
Distilled water to 100ml
sterilize by autoclaving
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A p p e n d ix  c : b a c t e r ia l  s t r a in s  a n d  p l a s m id s
E.coli
DH5a
TG2
NM554
DL795
F-, <|>80D/acZAM15, ree A l, endAl, gyrA46, th i-1, hsdR il (rK-,mK+), supE44, 
relA\,deoR, A(ZacZYA-argF)U 169
supE, hsdA5, thi, A(lac-proAB), A (srl-recA) 306::Tnl0 {tef), F ' {traD 36 
proAB+ laclq lacZA M 15}
ree A 13 araD139 A(ara-leu)7696 A(/ac)/7A gal\J galK hsdR rpsh (StrO mcrA  
mcrB
AhsdKMS, mcrBC, mrr, e!4 mcrA°; sbcC2Q\ ; recA::Cmr
M.smegmatis
me2155 high efficiency of electroporation strain of M.smegmatis 607
P l a s m id s
pYUB 18:.* 
M. leprae 
pYUB12 
pMV206 
pUC19
library of genomic M.leprae DNA in shuttle cosmid pYUB 18 (kanr) 
E.co/i-mycobacterium shuttle plasmid (kanr)
E.co/i'-mycobacterium shuttle plasmid (kanr)
E.coli cloning vector (ampr)
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Appendum
5.1 M . LEPRAE GENES IDENTIFIED THAT MAY BE RELEVANT TO PERMEABILITY
The permeability o f  bacterial cell envelopes are defined by the structure of their cytoplasmic and outer 
membranes and the transport systems found within these membranes. The relatively low permeability of 
the mycobacterial cell envelope is believed to be effected by the complex cell wall structure but may also 
be effected by low activity of transport systems e g. specific uptake proteins and porins and the presence 
o f efflux systems in the cytoplasmic cell membrane. The effects on permeability made by selected M. 
leprae gene products may be investigated by cloning the genes by PCR, overexpressing them in a model 
organism such as M.smegmatis or M. bovis BCG and measuring their permeability (5.4). Alternatively 
the homologous genes could be cloned from the model organisms by degenerative PCR, knockouts made 
using homologous recombination and the permeability of the mutated strains could then be investigated.
General alteration o f  permeability is most likely to be caused by the mutation of genes encoding products 
involved in the formation of the cell wall. M. leprae homologues of the peptidoglycan mur genes (B,CJ),G  
and Z) would be possible candidates for investigation as would genes involved in glucose metabolism, 
such as glgC, as glucose is thought to be a precursor of arabinogalactan (Silve et al., 1993). The gene 
products involved in the formation of mycolic acids may effect the permeability e g. the M. leprae 
homologue of cma2 which forms the proximal cyclopropane ring in mycolates.. Other M. leprae 
homologues which may be involved in mycolate biosynthesis include the inhA gene encoding an enoyl- 
ACP-reductase, the fatty acid biosynthesis and synthase genes fab B, D, G  and J  and u l 3s, u l3 t and u!3u  
respectively (as the short chain fatty acids are thought to be precursors o f mycolates) and the xclC  long 
chain fatty acid ligase gene. T heM  leprae mycocerosate synthase genes masA, B  and C may also be 
worth investigating as an altered expression could lead to a change in permeabilty.
The M. leprae genome sequencing project has identified sixty seven ORFs which show significant 
homology to genes in other species to encoding transport proteins, found in the cytoplasmic membrane 
or in the ‘periplasmic’ space. Permeability to specific substrates such as cystidine, maltose and phosphate 
could be investigated by the altered expression of the M. leprae homologue encoding their transport
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systems cysA, m alf and g  and phoS, T, U, W, X  and Y respectively. The investigation o f possible efflux 
proteins would be of particular interest as they would affect the apparent permeability to certain 
antibiotics; the M. leprae homologues o f efflux proteins drrA and ddrB as well the arsA gene which 
extrude danorubicin and arsenicals respectively, are possible candidates. No M. leprae porin homologues 
have been identified as yet and it is possible that they do not contain any.
5.2 Alternative secretory pathways in bacteria
Bacterial proteins destined for secretion usually contain a cleavable hydrophobic signal peptide at the N- 
terminus of the polypeptide that target them to the cytoplasmic membrane via the secretion apparatus 
encoded by the sec genes, the classical secretory pathway. Signal peptide independant pathways also exist 
in bacteria, particularly for toxins e g. the related E.coli haemolysin and Pasturella hemolytica leucotoxin 
and unrelatd E.coli colicin V. The targeting signals for all these toxins have been located in the last lOOaa 
o f the carboxy terminus which are predicted to form amphipathic a-helices. The related toxins also 
contain conserved repeat domains of a glycine rich sequence GGXGXD located close to the carboxy­
terminal sequence, thought to be involved in correct folding for passage through the membranes. The 
secretion and translocation of these Gram-negative toxins occurs as a single event across both membranes 
without stopping in the periplasmic space at the junction of the two membrane (Wandersman, 1992)
The superoxide dismutase and ESAT6 proteins of M. tuberculosis are apparently secreted into the 
culture supernatant of early logarithmic cultures but contain no signal peptides. It is possible they are 
released by damaged cells within the culture or they contain as yet undefined signal sequences such as the 
carboxyterminal or internal sequences o f toxins such as haemolysin which allow their secretion.
5.3 The structure and function of porins and efflux proteins 
5.3.1 Porins
Porins are transport proteins (Nikaido, 1992) found in the outer membranes of Gram-negative bacteria 
which have recently been detected in the cell walls of the Gram-positive Mycobacterium (Trias et al., 
1992; Trias and Benz, 1993 and 1994). ‘Classical’ non-specific porins o f  the enteric bacteria studied
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include the OmpF, OmpC and PhoE porins of E.coli. These porins are 34-50kDa in size and exist as 
trimeric complexes, each monomer producing a water filled channel. The porin proteins are not 
hydrophobic, instead the monomeric polypeptide chain traverses the membrane as antiparallel P-strands 
which form a P-barrel thus creating a channel. Loops extend from the P-barrel of the polypeptides into 
the periplasmic and external side of the outer membrane and one of the external loops appears to fold 
back into the channel producing a narrowing of the channel opening to a diameter o f  approximately lnm 
(Nikaido and Saier, 1992). Specific porin-like channels have similar structures but with specific ligand 
binding sites. Monomeric porins found have been shown to have similar p-sheet structures e g. the non­
specific OprF of P. aeruginosa (Nikaido, 1992).
Porins have been shown to exist in both M. chelonae and M . smegmatis and are thought to exist in M. 
tuberculosis ( Trias etal., 1992; Trias and Benz, 1994; Brennan and Nikaido, 1995). TheM. cheolonae 
protein is known to be 59kDa, present in relatively small amounts and the only porin present. M. 
smegmatis and M. chelonae porins have a relatively large pore size, 3nm and 2nm repectively, with 
negative point charges at their openings o f 3.5 and 2.5 respectively. The exact structure and the presence 
of P-sheets in mycobacterial porins has not yet been established but the M. chelonae porin is believed 
to be monomeric.
The function of porins is to transport specific or non-specific substrates, nutrients and waste products 
across the outer membranes. The majority of Gram-negative bacteria contain more than one type o f porin 
which may be specific or general diffusion porins, trimeric or monomeric and are often the most abundant 
outer membrane proteins present. The penetration rates of solutes through general diffusion channels is 
inversely proportional to the size of the molecules and reduced for hydrophobic molecules. General porins 
may also display a preference for cations or anions as a result of charges present on the diameter 
constricting loops at the channel openings e g. M. smegmatis, M. chelonae OmpC and OmpF channels 
prefer cations. Mycobacterial porins are apparently less active than the porins of other bacteria e.g. E.coli 
this may be because they are monomeric and present in small numbers (Trias and Benz, 1994).
5 .3 .2  E f f l u x  p r o t e i n s
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There are four families of efflux systems in bacteria; the major facilitator (MF) family, the resistance- 
nodulation-division-family (RND), the staphylococcal multidrug resistance family (Smr) and the ABC 
type systems. The MF, RND and Smr systems consist of a single cytoplasmic membrane protein that 
extrudes drugs using a proton motive force i.e. as an H+ antiporter. The ABC system consists of two 
transmembrane transporter proteins and two ATP-binding subunits which function as ATPases. The 
cytoplasmic membrane proteins contain an even number of hydrophobic transmembrane a helices, only 
4 in Smr transporters. MF efflux proteins differ from nutrient transporters in that they contain the 
consensus sequence G-X-X-X-G-P-X-X-G-G. The function of efflux proteins is to extrude toxic 
substances, antibiotics and proteins produced by the bacteria.
An efflux protein sequence, IfrA, has recently been identified in M. smegmatis by selection for increased 
resistance to fluoroquinones (Takiff et al., 1996). The protein is predicted to be 504 amino acids long 
and to contain 14 transmembrane helices, as predicted for the encoded streptomyces MF efflux proteins 
o f  quaC, actll, tcmA and mmr (35-27% identity and 60-52% similarity). The LfrA protein of M  
smegmatis extrudes ciprofloxacin, ofloxacin, levofloxacin, EtBr, acriflavine and CTAB but not the 
hydrophobic fluoroquinolones such as sparfloxacin, similar substrates as the efflux proteins to which it 
is homologous. However, IfrA was not mutated and conferred resistance by increased expression from 
a vector promoter. It is possible that the resistant M  smegmatis strain has a mutation in another pump 
or in a regulatory locus eg. mar which would increase the expression of LfrA or the relevant efflux pump.
5.4 M e t h o d s  f o r  m e a s u r in g  t h e  p e r m e a b il it y  o f  M . s m e g m a t is  m u t a n t s  
5.4.1 Measurement of the permeability to b-lactam cephalosporins 
The permeability coefficient, P, a measure of permeability, is determined by measuring the comparative 
rates of hydrolysis of P -lactam cephalosporins by intact M. smegmatis cells and cell extracts (Trias and 
Benz, 1994), using a similar method to that developed for M. chelonae (Jarlier and Nikaido, 1990). The 
method is based on the principles that 1) the net rate of diffusion across the cell wall (V,) should occur 
according to  Fick first law o f passive diffusion 2) that the rate o f hydrolysis of the cephalosporin in the 
space between the cell wall and the cell membrane (V2) occurs according to Michaelis-Menten kinetics
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and 3) at steady state the net rate of drug influx should be equal to the rate o f  drug degradation i.e. V,=V2.
The hydrolysis of the cephalosporins leads to the disruption o f the P-lactam ring and the loss o f u.v. 
absorption in the 260nm range allowing the rate o f  hydrolysis to be measured spectrophotometrically. 
To measure rates of hydrolysis of cephalosporins (cephaloride, cephalothin, cefamandole) intact cells 
were resuspended in PIPES buffer pH6-6.5 to  a turbidity of lOOKletts units and a final 0.5mM 
concentration o f cephalosporin, the optical density of the solution was measured over 40min at 25°C. 
The P-lactamase activity o f supernatants and cell extracts obtained from a portion o f the original cell 
suspension were assessed in the same way. The Michaelis-Menten constants, for each cephalosporin 
used were determined by measuring their rates o f hydrolysis with increasing concentrations. The internal 
rate of hydrolysis of cephalosporins, V2 ,was calculated in pmol/min/mg from the rate of change o f A260 
with the sonicated cell extract and the w as determined. As V2 Ci/(I^, +Ci) Ci the internal 
concentration o f the drug could then be determined. From Fick’s law of diffusion V,=PA (Co-Ci) where 
A is the cell surface/unit weight o f cells and C o is the external concentration o f the drug, V, was 
calculated in pmol/min/mg from the rate of change o f  A ^  with the intact cells, so P, could be determined.
5.4.2 Measurement of permeability to small hydrophilic molecules 
This method was employed to measure the permeability of M. chelonae (Jarlier and Nikaido, 1990) but 
may also be feasible for M. smegmatis strains. Permeability to small hydrophobic molecules can be 
estimated from their uptake kinetics. Cell suspensions are diluted in 2mM PIPES-NaOH (pH6.5) and 
0.5mM MgCl2 to give a final turbidity of 1,000 Klett units. Increasing final concentrations o f [14C] 
glucose, [3H] glycerol, f 4 C] glycine and t  H] leucine were added to samples of the cell suspension. 
Samples were removed at regular time intervals, washed, dried and scintillation counted. The initial cell 
suspension was dried and weighed to measure the exact concentration o f cells in the assay. Rates of 
uptakes were determined in gmoles/mg/min, the and of overall transport were calculated 
graphically from rates of uptake and at different concentrations of substrates.The permeability coefficients 
were calculated assuming that the overall transport system was functioning at half maximal capacity 
• e and Co=K„, and that Ci is negligible due active transport therefore P = ( V ^ l / A  x K ,^).
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i
16 LAGQLLDHVELRELCNPEVITATERQLQNLLDNRVGHDTEAIADLLRLLGPLTAADAAAWSNGCSD 81
L LL V+ EL +P+VI E +LQ L R E + DLLR LGP+T D A  G S+
3630  LLRNLLGQVDPGELLDPQVIRQVEEELQRLAPGRRAKGEEGLFDLLRELGPMTVEDLAQRHTGSSE 3827
rnt
b) o/c 16 WRSRNSRNSSQRNACRMCRGPGGS 39  
WR+R R ++R A C G S 
1 3 1 4 7  WRARARRARARRRARCACSGARSS 1 3 2 1 8
ryanodine receptor gene
c / c  34 RGPGGSVLRS RRRVGLGGR 52
RGPGG +R R R+GLGGR 
1 3 9 2 2  RGPGGCRVRGRLRLGLGGR 1 3 9 7 8
30  CRMCRGPGGSVL 41 
-CR+CRG G VL 
1640  CRVCRGRGS*VL 1 6 7 5
9 RPATPTGWRSRNSR 22 
RPATP G R SR 
4 0 7 0  RPATPGGGRGPGSR 4111
ryanodine receptor gene
c)
, 12 ARRSCAAAPRMGCPGP 27
"  ARRS A+ PR G P
16783 ARRS VAS RPRAGRSAP 1 6 8 3 0
S. lincolnensis lincomycin gene
10 VWARRSCAAAP 20 
VW R C AAP 
880 VWTARRCTAAP 912
b 11 WARRSCAAAPRMGCPG 2 6 WARR+ APR G G 
15473 WARRTGRGAPRCGSTG 1552 0
26 GPDGVAPLAG 35 
GPDG+AP+ G
16981 GPDGLAPVGG 17010
S. lincolnensis lincomycin gene
Fig. 50 Alignments of the three complete ORFs i, a/c and b in the complementing region with 
possible protein homologues
a) Shows the alignment of 65aa of a putative protein of 141aa from ORF / with the long helicase-related 
region o f the E.coli RnaseT (mt) gene, with a 40% identitiy and a 51% similarity in this region. It is 
possible that ORF / encodes an area o f helicase activity rather than encoding a protein, although the 
region of homology is small and may not be significant.
b) Shows the alignment of several short regions of 70aa the putative polypeptide encoded by a/c with the 
rabbit skeletal muscle mRNA for ryanodine receptor
c) Shows the alignment o f the 11 laa putative protein encoded by ORF b with several short regions of 
of the protein with the Streptococcus lincolnensis lincomycin production genes, presumably pulled out 
due to the GC rich DNA o f  streptomyces.
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b)
Fig 51. Hydrophobicity analysis of th e  three complete OFRs i, a/c and b in the complementing 
region of M. leprae DNA.
a) Shows the hydrophobicity plot of putative protein i , with one hydrophobic region itis predicted to be 
an integral membrane protein, by the PC gene program.
b) Shows the hydrophobicty plot of putative protein a/c predicted to be a peripheral protein associated 
with cell membrane
c) Shows the hydrophobicity plot of putative protein b predicted to be a peripheral protein, associated 
with the cell membrane.
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Fig.52 a) A restriction m ap of pYUB18
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Fig. 52 b) O ther restriction sites of pYUB18
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A ppendum
B St XI
cf no
d a i  
CviJI 
D d e l  
Dpnl 
Dral 
Dirai I 
DralII 
DrdI 
Deal 
Eael 
EamllOS 
Ecll36 
Eco31 
Eco47-3 
Eco57 
Eco78 
EcoNI 
" c o R I  
.„coRII 
EcoRV 
Esp3I 
Espi 
P n u 4 H  
FokI 
FepI 
Gdill 
Gsul 
Hael 
Haell 
HaelII 
Hgal 
HgiAI 
Hhal 
H i n d i  
HindiII 
Hinf I 
HinPI 
«oal 
pali 
Hphl 
Rasi 
Kpnl 
Ksp6 3 
Mael 
Mae II 
MaelII 
MboII 
Mmel 
MnlI 
Msel 
Munì 
Nael 
Nari 
Neil 
Ncol 
NgoMI 
Nhel 
NlalII

